data_1qlc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qlc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.693 0.282 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 14.7 ptp -132.03 154.51 49.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.882 0.373 . . . . 0.0 111.25 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.93 145.08 30.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 41.1 mm -125.44 116.71 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.408 ' HG2' ' CG1' ' A' ' 238' ' ' VAL . 12.8 mtmt -90.7 131.51 36.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.004 0.431 . . . . 0.0 111.108 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.42 HD11 ' CE1' ' A' ' 172' ' ' PHE . 2.1 mt -121.23 128.39 52.36 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 238' ' ' VAL . 13.0 mm -97.25 134.21 36.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 111.375 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.15 56.99 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.043 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.99 -156.0 0.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.51 -22.98 44.05 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.212 1.941 . . . . 0.0 112.434 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -4.49 47.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.1 -130.84 10.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.271 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.37 -36.46 82.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 110.95 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 26.56 23.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.109 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 163' ' ' LEU . 1.7 p90 -174.57 -168.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 111.202 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -134.7 158.96 42.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.73 160.49 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.448 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -125.05 137.3 54.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 225' ' ' HIS . . . -110.16 129.91 9.61 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.499 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.15 -22.67 54.2 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.76 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 19.8 t -89.99 118.64 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.89 -57.12 4.96 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.967 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -110.39 52.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.429 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.6 tt0 -44.8 116.21 1.03 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.448 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 16.6 t60 -103.89 -27.75 12.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.238 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.43 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.41 123.45 54.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.371 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.62 81.47 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.007 1.804 . . . . 0.0 112.648 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.28 55.32 0.68 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.028 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.41 129.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.812 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -103.74 29.46 5.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m -111.0 -160.9 0.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 189' ' ' ILE . 1.7 mm -110.79 136.65 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.9 m-85 -135.47 154.06 51.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.545 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.9 142.22 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.41 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.2 t -123.97 -24.09 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -155.43 138.52 15.54 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.72 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.27 135.12 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.498 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.86 123.62 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -39.53 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.58 26.11 37.55 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.283 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.27 -69.23 1.4 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.172 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.46 -59.31 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.954 0.407 . . . . 0.0 110.388 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.81 94.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.43 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -66.07 -55.8 14.75 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -69.4 -52.76 23.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -75.01 -50.56 16.14 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.9 -31.25 49.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.134 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 62.19 32.23 17.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.179 0.49 . . . . 0.0 110.182 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 pp -101.3 140.32 35.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.904 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -123.01 167.21 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 208' ' ' ILE . 46.2 mt -58.06 116.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.3 -17.94 3.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.439 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -78.95 149.16 32.39 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 120.743 0.306 . . . . 0.0 111.062 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 190' ' ' TYR . 5.9 ptmt -112.94 128.87 56.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.462 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 26.9 mm -90.1 121.58 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.315 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.73 2.5 38.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 163.83 155.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 239' ' ' VAL . 57.5 t -132.14 118.57 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.424 ' HA ' ' CE2' ' A' ' 240' ' ' TYR . 26.9 m-20 58.08 -85.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.5 OUTLIER -141.18 14.32 2.23 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.668 177.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.17 140.38 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.97 0.414 . . . . 0.0 111.3 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.75 94.61 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.1 OUTLIER -102.31 44.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.696 0.76 . . . . 0.0 109.026 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 25.58 5.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.601 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.71 33.38 0.4 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.745 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 227' ' ' ASP . 10.1 p -152.76 166.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.039 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.69 170.52 2.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.725 0.774 . . . . 0.0 112.284 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.432 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 60.2 t60 -57.55 -36.28 71.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.307 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.18 -52.56 54.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.417 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 2.4 t0 -62.01 -35.22 77.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.959 0.409 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.407 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.46 -39.15 89.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.872 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.2 t -59.37 -41.36 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.31 -33.25 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.474 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -64.23 -41.48 96.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.5 mt -73.96 -48.77 28.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.611 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -61.49 -34.54 75.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.957 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -64.39 -20.22 66.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.732 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.407 ' CG2' HG23 ' A' ' 239' ' ' VAL . 18.3 p -66.01 -162.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.516 0.198 . . . . 0.0 111.443 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 236' ' ' TYR . 1.7 m-85 -131.02 -153.46 0.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.146 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.19 -77.03 0.02 OUTLIER 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.566 0.347 . . . . 0.0 111.787 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 164' ' ' ILE . 53.5 t -102.88 121.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.106 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.435 HG23 ' CG1' ' A' ' 215' ' ' VAL . 10.6 p -118.87 124.07 72.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -94.76 138.03 33.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.405 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.77 147.25 40.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.76 119.8 40.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 110.304 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.8 t -128.75 146.63 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.787 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.98 132.1 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.675 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.911 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.3 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.18 147.5 52.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.61 144.15 27.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 43.0 mm -125.45 118.94 53.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -97.57 126.31 42.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.401 ' CD1' ' CE1' ' A' ' 172' ' ' PHE . 12.4 mt -127.41 128.92 46.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.326 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -101.28 133.5 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.053 0.454 . . . . 0.0 110.719 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -68.9 74.17 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.089 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.74 -161.61 0.4 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.368 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.72 -24.37 25.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.327 2.018 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -101.32 -1.95 32.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.04 -138.02 14.68 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.365 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.6 -33.59 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.844 0.355 . . . . 0.0 111.126 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.29 27.63 11.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.491 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CE1' ' CD1' ' A' ' 163' ' ' LEU . 3.7 p90 -170.58 -169.27 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.0 t -136.92 162.97 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -123.6 160.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.467 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -128.02 138.01 52.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -109.35 130.18 9.85 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.818 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -83.78 -23.2 53.77 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.425 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.5 t -89.88 120.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.66 -56.43 5.05 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.075 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.06 57.58 0.79 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.543 0.687 . . . . 0.0 109.391 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.445 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 6.6 tt0 -47.66 116.95 1.62 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.467 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 6.0 t60 -102.06 -25.16 13.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.952 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.433 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.1 mp -96.48 129.44 33.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.35 78.1 2.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.053 1.835 . . . . 0.0 112.829 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.57 50.96 0.63 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.748 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.13 123.87 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.741 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 28.74 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 -166.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.58 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 189' ' ' ILE . 1.4 mm -102.98 134.89 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.226 0.536 . . . . 0.0 110.522 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.3 m-85 -135.33 154.23 51.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.684 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 44.6 t -80.7 141.43 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.402 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.8 t -123.07 -26.04 4.43 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.61 137.18 18.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.912 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 194' ' ' ILE . 1.3 mm -121.28 135.25 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 195' ' ' ILE . 27.4 mm -81.33 118.39 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.52 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.57 23.97 16.05 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.136 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.18 -78.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.431 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -137.56 -58.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.954 0.407 . . . . 0.0 110.879 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.92 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -59.13 -55.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.953 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -52.06 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.64 -50.51 20.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.4 -32.81 27.18 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.259 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 63.2 31.92 15.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.281 0.541 . . . . 0.0 110.259 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.7 pp -102.68 140.43 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.638 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 176.33 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.283 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 208' ' ' ILE . 51.1 mt -64.28 112.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.07 -17.0 2.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.865 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.9 147.87 32.94 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.923 0.362 . . . . 0.0 111.028 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 190' ' ' TYR . 0.1 OUTLIER -110.48 129.17 55.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.326 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 43.0 mm -92.17 116.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.5 -2.27 45.52 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.122 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 166.47 152.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 217' ' ' SER . 40.8 t -130.55 118.63 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.14 -84.51 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.317 0.386 . . . . 0.0 110.066 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 215' ' ' VAL . 50.4 m -139.94 11.69 2.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.23 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.19 140.71 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.65 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.21 108.72 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.442 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.37 50.6 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.457 0.646 . . . . 0.0 109.492 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 26.05 4.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.532 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -159.9 30.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.322 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.7 166.44 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.342 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 170.69 2.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.697 0.761 . . . . 0.0 112.256 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 62.9 t60 -57.74 -37.42 73.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.086 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.27 -52.53 46.64 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -34.68 77.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.105 0.478 . . . . 0.0 109.886 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -60.93 -38.73 86.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.653 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.88 -41.52 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.136 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.45 72.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.411 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.23 -42.61 93.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.281 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.59 -41.94 62.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.491 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.08 -40.91 86.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.62 -20.41 32.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.786 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.411 ' CG2' HG23 ' A' ' 239' ' ' VAL . 21.2 p -66.09 -166.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 0.0 111.044 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.45 -150.14 0.33 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.329 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 165' ' ' LYS . 5.5 m-20 -44.4 -80.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.327 0.251 . . . . 0.0 111.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.6 121.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.985 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.411 HG23 ' CG2' ' A' ' 235' ' ' THR . 9.3 p -120.77 130.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 4.2 m-85 -99.74 120.67 40.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mt -96.92 137.92 35.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -107.26 120.74 42.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 52.8 t -122.58 147.58 26.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.251 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.26 131.79 56.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.151 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.796 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.849 0.356 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 18.9 ptm -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -95.49 143.81 26.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.549 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 35.6 mm -125.28 119.13 54.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -105.31 129.21 53.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 111.681 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.37 129.99 45.46 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.34 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.5 133.42 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.575 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -72.47 102.04 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.153 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.92 -153.86 20.99 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.936 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.31 -22.46 46.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.105 1.87 . . . . 0.0 112.364 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.73 -4.23 26.81 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.54 -138.94 14.89 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 3.9 mm? -57.07 -37.85 72.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.1 37.61 9.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.893 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -174.52 -166.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.398 . . . . 0.0 111.039 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.2 t -138.83 158.34 44.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.863 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.91 161.92 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.133 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -128.06 137.53 52.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 225' ' ' HIS . . . -110.91 129.84 9.48 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.807 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -85.77 -20.71 55.42 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.755 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 t -90.23 117.94 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.44 -56.55 5.01 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.181 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -112.88 55.23 0.7 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.635 0.731 . . . . 0.0 109.301 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.35 119.96 2.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.729 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.436 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 14.7 t60 -103.05 -31.0 10.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.931 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.441 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -97.14 125.09 47.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.214 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.69 78.98 0.95 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.15 1.9 . . . . 0.0 112.861 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.75 46.07 0.49 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.199 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.11 128.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -98.66 12.49 35.24 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.476 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -165.99 1.35 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 189' ' ' ILE . 1.0 OUTLIER -103.41 139.84 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.124 0.488 . . . . 0.0 110.559 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.441 ' CG ' HG12 ' A' ' 183' ' ' ILE . 29.5 m-85 -136.09 151.55 49.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.47 140.31 16.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.7 t -124.68 -25.45 3.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.8 tttp -149.27 135.41 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 111.761 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.01 135.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.186 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.22 117.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -36.39 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.49 23.88 29.13 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.076 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.0 -82.27 0.11 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.325 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.44 -57.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.2 85.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -62.52 -55.62 25.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.536 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -69.68 -52.2 27.84 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -74.08 -50.45 19.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.92 -29.98 33.11 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.913 -0.661 . . . . 0.0 114.488 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 61.41 33.56 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.307 0.554 . . . . 0.0 110.47 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.8 pp -101.01 142.13 32.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -121.6 171.99 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 53.2 mt -63.96 132.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.05 9.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.734 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.66 150.68 39.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.117 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.82 129.15 56.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.554 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 38.9 mm -89.88 117.38 33.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.3 pp -97.79 -2.24 41.5 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 166.31 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.243 -0.286 . . . . 0.0 110.853 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 24.5 t -132.3 119.27 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.234 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.4 m120 59.29 -85.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 p -141.98 13.49 2.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.893 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.8 p -109.39 140.33 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.69 100.57 2.16 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -108.97 48.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.716 0.769 . . . . 0.0 109.061 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.74 27.39 4.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.592 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.28 32.72 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.131 0.491 . . . . 0.0 110.124 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.401 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 7.6 p -149.38 166.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.101 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.74 169.19 3.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.736 0.779 . . . . 0.0 112.009 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.413 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 60.3 t60 -57.52 -36.4 71.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.84 -52.42 50.59 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.401 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 0.9 OUTLIER -61.65 -34.95 76.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.044 0.45 . . . . 0.0 109.985 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -60.88 -39.24 88.46 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.622 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.156 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.61 73.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.213 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -64.02 -40.87 97.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.086 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.5 mt -70.6 -40.88 72.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.126 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -37.31 86.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -20.76 43.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.554 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.5 p -70.38 -166.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.637 0.256 . . . . 0.0 111.069 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.94 -150.5 0.33 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.411 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 85.2 m-20 -43.42 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 122.442 0.297 . . . . 0.0 111.515 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.69 120.57 45.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.69 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 9.5 p -120.26 133.43 67.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -105.06 118.9 37.7 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.276 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.13 139.38 34.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -107.29 130.9 54.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 0.0 110.492 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.68 146.06 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.83 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.9 ptp -129.49 151.68 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -99.41 143.58 29.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 111.544 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 47.9 mm -118.09 117.93 56.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.498 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 129.28 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.35 129.78 39.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.066 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 164' ' ' ILE . 0.2 OUTLIER -98.43 133.89 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 110.572 179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.1 OUTLIER -75.85 137.41 40.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.278 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -155.21 -153.29 6.47 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.379 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.83 -21.67 49.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.273 1.982 . . . . 0.0 112.586 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -97.0 -4.6 39.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.85 -127.73 8.13 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.643 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.725 0.298 . . . . 0.0 110.591 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.25 22.91 25.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.572 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.65 -171.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.2 t -133.16 164.36 27.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.49 158.5 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.157 0.503 . . . . 0.0 112.029 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.457 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -129.24 138.87 51.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.139 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.88 134.18 11.8 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.85 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.22 -24.58 47.31 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.614 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.4 t -89.98 120.28 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.31 4.97 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.374 -0.441 . . . . 0.0 113.112 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -118.09 56.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.448 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.9 tt0 -46.67 118.75 2.14 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.457 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 13.4 t60 -107.69 -24.22 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.375 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.424 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.77 133.24 24.7 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.86 80.86 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.096 1.864 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.21 55.76 0.76 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.875 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.68 131.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.42 30.43 5.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.3 t -111.04 -166.94 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 189' ' ' ILE . 1.2 mm -106.04 135.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 0.0 110.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.424 ' CG ' HG12 ' A' ' 183' ' ' ILE . 17.8 m-85 -133.98 152.83 52.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.734 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.421 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 29.4 t -80.41 140.62 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.502 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.5 t -123.29 -24.7 4.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.12 134.71 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 111.722 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.421 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 1.0 OUTLIER -120.81 135.21 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.114 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.3 mm -81.12 116.93 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.28 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.875 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.06 24.21 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.078 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.99 -71.36 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -140.02 -67.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.715 0.293 . . . . 0.0 111.098 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -60.47 -46.96 88.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -59.54 -55.96 27.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -70.53 -53.09 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.22 -50.21 20.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.1 -30.44 46.63 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.827 -0.701 . . . . 0.0 114.129 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.91 46.97 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.402 0.62 . . . . 0.0 109.98 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.27 139.63 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.082 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.44 169.27 9.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.975 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 208' ' ' ILE . 39.7 mt -61.57 119.17 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.577 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.18 -17.65 4.81 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.64 146.94 44.2 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 117.008 0.404 . . . . 0.0 110.696 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 190' ' ' TYR . 2.1 ptpt -106.78 128.59 54.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 29.0 mm -95.39 115.72 35.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.14 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.52 -9.68 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.971 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 176.21 148.09 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.765 0.316 . . . . 0.0 110.692 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.82 118.98 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.448 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 57.58 -85.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.005 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.1 m -139.0 13.09 2.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.618 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.34 141.27 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 122.534 0.334 . . . . 0.0 110.768 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -105.55 87.91 0.55 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.213 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -5.7 45.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 111.268 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -67.3 167.81 11.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 t70 46.83 26.27 0.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.962 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.36 165.24 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.643 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.82 168.25 11.89 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.703 0.763 . . . . 0.0 111.606 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.405 ' O ' ' CG2' ' A' ' 229' ' ' VAL . 58.0 t60 -58.37 -36.89 74.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.998 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -52.76 38.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -34.8 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.0 110.118 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -63.64 -38.86 92.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.963 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 225' ' ' HIS . 21.8 t -58.27 -42.08 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.16 77.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.222 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.28 93.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.173 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.5 mt -73.5 -42.32 61.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -58.75 -34.06 70.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -62.84 -20.23 64.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.399 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 26.2 p -64.49 -171.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.767 0.318 . . . . 0.0 111.151 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -143.1 -151.61 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.229 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.9 OUTLIER -43.03 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.538 0.335 . . . . 0.0 111.479 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.96 120.42 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.689 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.79 120.26 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -100.57 120.15 39.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.79 149.4 23.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.004 0.431 . . . . 0.0 110.522 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -108.62 118.26 36.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.196 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.27 149.2 27.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.967 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.023 -179.347 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.81 0.338 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -132.26 147.1 52.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -101.66 132.34 47.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.45 118.47 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.186 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -99.08 137.55 37.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.309 0.576 . . . . 0.0 112.295 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.42 ' CD1' ' CD1' ' A' ' 241' ' ' LEU . 5.7 mt -118.7 140.38 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.525 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 238' ' ' VAL . 19.9 mm -96.46 131.46 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.067 0.461 . . . . 0.0 111.16 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 57.03 2.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.262 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.06 -161.64 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.062 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -20.24 54.06 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.208 1.939 . . . . 0.0 112.689 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -96.68 8.27 44.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.3 -145.14 18.32 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.11 -37.27 82.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.761 0.315 . . . . 0.0 111.045 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.76 26.72 8.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.685 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.63 -169.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.017 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.6 t -134.84 158.62 43.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.77 160.21 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' A' ' 182' ' ' HIS . . . -127.0 138.15 53.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.414 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -110.17 129.45 9.36 Favored Glycine 0 CA--C 1.5 -0.847 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.964 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -78.1 -28.58 55.97 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.76 122.16 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.11 -55.37 4.96 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.936 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -116.63 49.77 1.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.497 0.665 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.3 tt0 -42.37 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 16.7 t60 -83.58 -28.11 28.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.129 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -96.52 129.64 32.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 81.91 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.056 1.837 . . . . 0.0 113.128 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.55 52.86 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.195 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.94 135.2 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.574 0.226 . . . . 0.0 110.74 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . 0.406 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.5 OUTLIER -108.12 24.14 13.44 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.83 -168.13 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 189' ' ' ILE . 2.4 mm -104.58 134.42 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.278 0.561 . . . . 0.0 110.281 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.42 ' CD1' HG12 ' A' ' 183' ' ' ILE . 26.0 m-85 -135.19 151.17 50.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 39.2 t -80.12 141.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.284 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -122.94 -23.01 5.1 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -150.36 134.19 16.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.75 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -119.78 135.38 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.18 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.01 118.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.422 . . . . 0.0 109.919 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -37.75 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 50.03 31.69 18.52 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.392 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.68 -75.94 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.363 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -134.86 -60.21 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 0.0 110.731 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.14 77.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.379 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -60.21 -56.13 25.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.528 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -70.53 -53.19 17.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -51.35 15.07 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.14 -31.04 53.99 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.822 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 60.56 30.45 19.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.125 0.462 . . . . 0.0 110.636 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.0 pp -102.31 129.14 48.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.19 173.81 6.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 208' ' ' ILE . 39.1 mt -64.44 113.44 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.38 -15.04 3.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.78 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.05 142.21 39.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.935 0.368 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -102.58 128.83 49.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.111 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 212' ' ' ILE . 30.4 mm -96.71 116.42 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.5 mt -79.3 -68.01 0.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.48 47.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 217' ' ' SER . 3.1 t -114.82 119.32 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 58.45 -84.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -140.32 12.94 2.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.839 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.69 139.87 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.003 0.43 . . . . 0.0 111.039 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.88 111.06 3.04 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.392 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.17 40.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 109.932 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -97.23 163.5 12.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.787 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 48.72 27.47 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.415 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 6.2 p -131.2 163.73 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.585 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.57 169.93 11.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.703 0.763 . . . . 0.0 112.176 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.414 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 58.8 t60 -56.93 -36.36 70.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.318 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -52.13 60.94 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.415 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 0.6 OUTLIER -60.13 -36.25 77.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.443 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -63.61 -39.22 93.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.999 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.88 -41.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.219 0.533 . . . . 0.0 109.595 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.25 -33.39 75.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.13 94.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.646 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 -47.3 37.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.877 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.45 -40.37 78.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.73 -20.34 33.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.899 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.402 ' CG2' ' CG2' ' A' ' 239' ' ' VAL . 16.7 p -65.99 -163.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.286 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -139.67 -150.58 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.52 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.872 0.469 . . . . 0.0 112.097 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 164' ' ' ILE . 23.7 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.361 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 235' ' ' THR . 12.9 p -116.56 131.15 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -90.94 141.98 28.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.351 0.595 . . . . 0.0 111.421 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.42 ' CD1' ' CD1' ' A' ' 163' ' ' LEU . 6.8 mt -118.89 138.14 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.92 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -106.61 124.27 49.35 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.66 149.67 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.91 121.11 42.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.558 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.726 0.298 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 15.5 ptm -126.68 146.31 50.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.431 . . . . 0.0 111.351 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.96 140.76 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.06 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 36.6 mm -120.41 117.34 53.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -103.91 127.85 51.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.71 0.29 . . . . 0.0 111.73 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.446 ' CD1' ' CE1' ' A' ' 172' ' ' PHE . 0.9 OUTLIER -127.37 129.07 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.309 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.02 127.38 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.187 0.518 . . . . 0.0 110.693 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 79.47 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.848 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.73 38.64 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.14 -20.92 48.7 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.339 2.026 . . . . 0.0 112.431 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -99.29 -5.06 30.45 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.82 -133.71 12.01 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.078 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 172' ' ' PHE . 1.9 mm? -60.76 -36.02 77.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 80.2 33.29 32.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.045 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.446 ' CE1' ' CD1' ' A' ' 163' ' ' LEU . 3.7 p90 -177.09 -173.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.69 159.63 40.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.04 161.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.023 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.438 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -131.05 138.1 49.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -114.68 131.21 9.67 Favored Glycine 0 CA--C 1.502 -0.729 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.673 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -82.79 -22.16 58.41 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.54 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.87 117.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.98 5.02 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.077 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -113.09 55.0 0.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.528 0.68 . . . . 0.0 109.384 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.44 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.56 115.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.438 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 38.3 t60 -100.39 -32.14 10.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.537 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.411 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.2 mm -96.7 127.41 39.56 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.146 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.36 78.73 2.26 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.021 1.814 . . . . 0.0 113.079 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.4 10.14 4.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.016 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.01 134.58 44.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.525 0.662 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -106.74 26.27 10.21 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.28 -164.66 0.93 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.64 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.446 HD13 ' CB ' ' A' ' 228' ' ' ALA . 1.7 mm -105.64 132.46 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.243 0.544 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.411 ' CD1' HG13 ' A' ' 183' ' ' ILE . 9.8 m-85 -135.13 153.99 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.496 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 33.1 t -79.54 141.34 15.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.268 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 8.1 t -121.53 -21.55 6.2 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.32 136.79 14.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.964 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.41 HG23 ' CG ' ' A' ' 201' ' ' HIS . 1.9 mm -121.2 136.23 58.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -79.92 115.31 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.032 0.444 . . . . 0.0 109.809 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -37.76 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.932 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.03 50.8 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.827 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.03 -81.75 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -129.56 -60.94 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.932 0.396 . . . . 0.0 111.163 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.35 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.41 ' CG ' HG23 ' A' ' 194' ' ' ILE . 5.3 t-160 -63.75 -55.38 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -51.63 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.5 -49.1 28.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.1 -37.16 11.6 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.885 -0.674 . . . . 0.0 114.363 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.51 51.33 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.453 0.644 . . . . 0.0 109.936 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -116.64 139.76 50.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.779 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.5 165.13 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 208' ' ' ILE . 37.8 mt -60.8 112.45 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.85 -14.59 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.61 143.23 36.6 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.123 0.462 . . . . 0.0 111.141 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -103.95 129.22 51.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.302 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.5 mm -90.74 124.8 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 111.693 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.55 -39.11 11.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.581 0.705 . . . . 0.0 110.098 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -166.21 154.67 10.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 24.2 t -124.47 119.88 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.583 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 61.3 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.4 m -143.26 13.52 1.81 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.8 140.25 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 111.425 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.97 107.48 2.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.038 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.39 37.84 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.258 0.552 . . . . 0.0 110.242 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -99.56 162.85 12.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.473 0.654 . . . . 0.0 111.881 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 48.41 27.56 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.645 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 4.9 p -132.67 162.9 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 168.4 9.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.793 0.806 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.411 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 57.9 t60 -57.51 -36.32 71.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.929 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.17 -51.79 58.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.404 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 1.1 t70 -59.23 -36.64 75.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.032 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 16.6 t -56.38 -41.57 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.647 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.64 74.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.481 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.19 -50.35 66.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.867 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.6 -40.74 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.475 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -37.95 74.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.476 . . . . 0.0 111.481 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.49 -20.31 59.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.792 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.7 p -61.72 -163.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.403 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -138.35 -151.13 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.42 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.342 0.26 0 C-N-CA 122.391 0.277 . . . . 0.0 111.673 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.06 118.76 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.41 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 14.2 p -120.51 126.13 74.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.262 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.85 120.22 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.13 142.7 29.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -107.12 118.09 35.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 37.7 t -123.5 149.19 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.099 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -132.86 128.03 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.579 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.206 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.05 0.452 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.38 155.18 48.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.397 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -124.08 126.98 47.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.963 0.411 . . . . 0.0 111.203 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 35.4 mm -99.32 118.92 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.583 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -106.36 127.94 53.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.565 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.22 152.22 51.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.866 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.99 130.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 90.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.26 170.89 44.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.549 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.3 -20.46 32.21 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.264 1.976 . . . . 0.0 112.645 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -2.0 35.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.08 -150.51 18.71 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.929 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.49 -37.52 81.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.04 29.29 10.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.701 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.55 179.3 1.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.6 t -124.64 164.0 20.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.0 162.65 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.319 0.581 . . . . 0.0 112.292 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.474 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -130.51 139.91 50.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.159 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -117.3 133.74 10.77 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.108 -1.044 . . . . 0.0 113.908 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -88.18 -15.41 60.76 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.716 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 5.4 t -90.68 115.55 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 117.604 0.702 . . . . 0.0 112.204 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -57.29 4.03 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.223 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.09 54.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.423 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.1 mt-30 -45.79 119.69 2.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.629 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.474 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 28.4 t60 -109.43 -28.42 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.72 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.74 121.72 58.85 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.797 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.61 80.76 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.217 1.945 . . . . 0.0 112.486 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.37 54.31 0.7 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.986 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.64 119.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -96.14 38.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 m -119.44 -166.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.009 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 189' ' ' ILE . 1.8 mm -104.67 135.74 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.128 0.49 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 25.6 m-85 -135.72 150.89 49.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.685 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.95 142.12 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.506 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.403 ' CG2' ' CB ' ' A' ' 175' ' ' ALA . 6.7 p -117.1 -39.76 3.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -137.53 137.99 39.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.899 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.2 mm -120.6 134.74 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.66 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.48 113.71 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.382 . . . . 0.0 110.101 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -36.42 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.463 -0.79 . . . . 0.0 113.123 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.55 21.3 27.49 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.247 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.78 -91.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.093 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.2 -46.53 90.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.23 -57.27 13.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -71.13 -52.8 17.24 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.55 -50.62 20.44 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.11 -33.5 49.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.714 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.5 34.99 17.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.126 0.489 . . . . 0.0 110.003 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.5 pp -108.07 139.94 41.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.222 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -115.99 -179.42 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 21.4 mt -69.18 134.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.34 -14.03 30.63 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.244 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.27 134.59 46.92 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.201 0.501 . . . . 0.0 110.936 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.404 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 18.9 tttt -92.29 129.2 38.3 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 120.896 0.379 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.7 mm -109.78 138.61 36.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.481 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.2 pp -118.2 -9.31 10.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -170.59 153.4 4.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.973 0.416 . . . . 0.0 111.675 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.414 HG11 ' CG2' ' A' ' 239' ' ' VAL . 0.3 OUTLIER -125.62 118.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.1 t30 56.04 -87.48 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 215' ' ' VAL . 10.4 m -137.25 13.74 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.614 0.245 . . . . 0.0 110.637 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.4 p -109.24 140.57 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -99.6 92.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.597 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.75 -3.92 43.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -68.26 167.54 14.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 111.229 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.05 25.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.623 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.01 162.48 31.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.446 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 8.4 mtt -67.19 169.25 8.94 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.739 0.78 . . . . 0.0 111.955 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.403 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 53.5 t60 -58.29 -36.97 74.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.193 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.21 -52.34 42.36 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -34.9 77.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 109.884 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.52 -38.85 88.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.686 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 225' ' ' HIS . 23.3 t -59.1 -41.61 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.258 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.6 74.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.299 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.79 -38.71 76.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.1 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.97 -39.74 65.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.658 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -33.61 76.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.161 0.505 . . . . 0.0 110.785 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.1 -20.3 65.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 71.2 p -51.86 176.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.74 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -139.33 -148.94 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -41.61 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.654 0.381 . . . . 0.0 111.785 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.43 124.95 59.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.414 ' CG2' HG11 ' A' ' 215' ' ' VAL . 8.1 p -113.6 120.21 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.416 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.93 118.27 35.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 109.65 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mp -100.4 153.17 19.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.31 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.44 116.32 31.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 211' ' ' LYS . 7.1 p -113.24 144.56 20.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.436 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.49 122.74 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.765 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.2 mttm . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 -179.656 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptm -132.15 152.23 51.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -100.53 139.37 36.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.53 118.64 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.47 139.42 35.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.293 0.568 . . . . 0.0 112.13 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.29 129.55 45.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.026 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.91 134.49 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 111.64 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 94.34 2.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.925 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.45 -158.57 24.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.139 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.52 -23.34 75.08 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.234 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -101.86 -4.28 26.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.11 -136.5 13.63 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.444 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 3.9 mm? -59.75 -33.27 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.61 31.7 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.546 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -175.13 -172.93 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 110.871 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -132.98 160.49 36.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.882 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -121.95 155.99 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.165 0.507 . . . . 0.0 111.226 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.459 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -126.63 138.32 53.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.235 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.4 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.26 129.98 9.19 Favored Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.759 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.83 -16.0 66.5 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.696 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 t -90.96 115.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.672 0.736 . . . . 0.0 112.012 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.86 -57.74 4.27 Favored Glycine 0 C--N 1.329 0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.083 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -102.72 51.8 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.442 0.639 . . . . 0.0 109.684 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.2 mt-30 -45.23 117.9 1.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.459 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 24.1 t60 -105.87 -32.06 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.843 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 190' ' ' TYR . 19.1 mm -95.47 126.05 47.26 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.338 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 77.62 1.19 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.29 1.993 . . . . 0.0 113.24 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.33 10.62 4.51 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.12 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -133.45 131.4 39.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.585 0.693 . . . . 0.0 111.348 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . 0.402 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 9.8 m120 -103.8 29.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.44 -165.01 1.01 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.42 HD13 ' CB ' ' A' ' 228' ' ' ALA . 1.4 mm -103.3 129.88 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.195 0.521 . . . . 0.0 110.421 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.437 ' CD1' HG13 ' A' ' 183' ' ' ILE . 4.5 m-85 -134.54 155.06 51.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.981 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.408 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 32.1 t -80.33 138.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.619 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 t -121.67 -19.07 6.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 133.17 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 0.0 111.609 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.408 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 0.3 OUTLIER -120.58 134.03 65.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 mm -82.31 117.65 28.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.401 . . . . 0.0 110.034 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -41.97 101.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.61 24.21 38.83 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.84 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.23 -89.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.329 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -131.44 -56.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.983 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.87 -46.3 75.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -59.99 -56.06 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.681 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -52.62 22.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.38 -51.13 15.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.46 -28.57 51.98 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.022 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 63.57 30.87 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.022 0.411 . . . . 0.0 110.522 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pp -102.91 141.12 36.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.05 167.86 13.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 208' ' ' ILE . 35.1 mt -59.0 106.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 145.48 -16.95 1.85 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.914 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.4 148.04 32.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.946 0.373 . . . . 0.0 110.894 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -112.21 130.34 55.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.821 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.6 mm -92.97 116.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.444 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.84 -10.39 39.95 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 172.12 145.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.499 0.32 . . . . 0.0 110.339 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.9 t -118.85 119.35 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.402 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 36.7 t30 56.56 -86.6 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.153 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 5.8 m -137.5 12.61 2.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.655 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.4 140.6 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.694 0.283 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.8 87.46 0.55 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.261 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.12 -9.05 57.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.107 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.67 168.22 11.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 0.0 110.873 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 t70 49.15 24.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.963 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.4 163.73 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.651 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -66.84 167.11 12.03 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.596 0.712 . . . . 0.0 111.447 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.4 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 58.6 t60 -58.01 -36.46 72.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.046 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -52.33 49.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -34.74 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.49 -38.38 87.11 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.565 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 37.6 t -59.16 -41.03 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.379 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.09 74.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.51 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.39 81.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.321 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.12 -39.77 63.12 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -58.23 -46.52 85.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -57.81 -19.81 31.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.282 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.401 ' CG2' ' CG2' ' A' ' 239' ' ' VAL . 29.9 p -56.4 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.682 0.277 . . . . 0.0 111.372 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -153.07 0.45 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.371 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -42.49 -80.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.407 0.283 . . . . 0.0 111.55 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.15 116.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.052 0.453 . . . . 0.0 110.831 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 235' ' ' THR . 13.5 p -112.91 126.81 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.752 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.57 141.79 28.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.719 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.7 mt -118.16 136.56 53.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.491 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.41 117.72 34.84 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 73.6 t -125.2 151.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.81 125.96 54.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.84 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.893 -179.22 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.968 0.413 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 9.3 ptp -132.73 148.58 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -105.26 140.54 38.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.1 mt -104.87 119.24 53.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -99.54 119.92 38.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.412 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.3 pp -137.25 146.09 44.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.83 135.21 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.279 0.562 . . . . 0.0 111.783 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.83 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.395 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.46 156.0 7.51 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.512 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.39 -24.09 41.55 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.995 1.797 . . . . 0.0 112.245 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.22 15.37 29.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.69 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 119.24 -151.05 17.72 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.257 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.38 -37.05 66.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 0.0 110.926 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.09 34.22 6.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.402 ' CD2' HD12 ' A' ' 206' ' ' LEU . 0.3 OUTLIER -176.49 -172.7 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.3 m -137.69 157.64 46.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.59 162.52 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.276 0.56 . . . . 0.0 111.444 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.445 ' HB2' ' CG ' ' A' ' 182' ' ' HIS . . . -125.43 139.2 53.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.074 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 189' ' ' ILE . . . -108.99 129.44 9.52 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.959 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -79.91 -31.11 40.57 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.559 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.28 123.2 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.12 -56.07 5.06 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.008 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -114.48 48.8 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.554 0.693 . . . . 0.0 109.542 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.424 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.0 tt0 -43.19 105.95 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.445 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 34.4 t60 -90.29 -31.72 16.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.786 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.6 mm -96.84 121.74 58.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.152 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.45 78.99 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.118 1.878 . . . . 0.0 113.111 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 128.55 6.64 4.59 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.114 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.36 129.43 44.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.6 0.7 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 27.7 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 -162.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.955 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.442 HD12 ' HA3' ' A' ' 176' ' ' GLY . 4.8 mm -102.33 137.3 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.482 0.658 . . . . 0.0 110.781 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 175' ' ' ALA . 14.1 m-85 -135.43 144.62 46.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.961 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 47.8 t -80.29 139.03 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.814 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.0 t -123.74 -14.66 7.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -155.32 133.27 11.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.068 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 1.2 mm -121.36 135.29 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.77 118.01 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -38.36 100.72 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.946 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.8 22.97 35.73 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.127 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.73 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.225 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.82 -53.61 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 110.692 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.53 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.42 -56.36 23.04 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -52.89 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.76 -50.42 20.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.53 -27.3 59.51 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.883 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 59.86 26.06 15.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.1 0.45 . . . . 0.0 110.797 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.402 HD12 ' CD2' ' A' ' 172' ' ' PHE . 3.7 pp -97.6 139.7 33.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -121.79 170.16 10.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.95 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.84 112.66 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.5 3.74 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.255 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.83 138.3 38.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.126 0.463 . . . . 0.0 111.296 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.39 129.82 40.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.316 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.8 mm -110.8 134.65 52.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.477 . . . . 0.0 111.899 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.06 -3.12 11.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.694 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -172.97 148.34 1.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.968 0.413 . . . . 0.0 111.523 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.06 119.97 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.054 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 61.26 -85.39 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.0 t -144.17 14.79 1.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.951 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.04 140.0 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.96 0.409 . . . . 0.0 111.595 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.65 102.95 2.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.261 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.403 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -100.29 38.33 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.531 . . . . 0.0 110.197 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -93.4 164.21 13.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.448 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.6 t0 45.38 29.99 0.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.504 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.67 167.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.2 mtm -75.41 172.72 12.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.779 0.8 . . . . 0.0 112.654 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 58.5 t60 -57.29 -38.51 74.08 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.362 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.33 -51.79 64.54 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -60.0 -36.32 76.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.85 0.357 . . . . 0.0 110.806 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -64.55 -38.89 92.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.2 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.7 -43.05 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.166 0.508 . . . . 0.0 109.631 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.97 -32.61 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.21 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -63.9 -39.32 93.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.542 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.1 mt -70.38 -42.93 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.61 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.02 -33.55 72.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.94 -25.2 66.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.0 p -56.17 -173.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.034 0.445 . . . . 0.0 111.638 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -145.21 -149.85 0.3 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -39.15 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.036 0.534 . . . . 0.0 112.383 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.02 120.93 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.885 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.03 119.97 57.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.52 118.81 34.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.731 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.9 mp -98.82 153.11 19.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -106.4 117.05 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.71 144.22 35.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.511 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -115.35 127.17 55.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.463 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.143 -179.565 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.56 153.96 50.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.55 126.33 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.8 mt -98.4 118.9 45.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -106.62 121.92 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.46 145.92 45.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.716 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.29 134.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.124 0.487 . . . . 0.0 111.473 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.67 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.391 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.42 166.89 8.42 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.779 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.38 -27.4 75.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.297 1.998 . . . . 0.0 112.317 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -101.65 15.56 28.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.875 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.52 -152.86 17.53 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.724 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.78 -34.47 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.726 0.298 . . . . 0.0 111.151 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.03 35.99 6.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.41 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -165.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.745 0.307 . . . . 0.0 110.688 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.9 t -139.52 162.48 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.54 159.86 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.214 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 182' ' ' HIS . . . -125.52 137.97 53.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 225' ' ' HIS . . . -109.12 130.47 10.03 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.859 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -82.4 -25.16 52.09 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.416 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.408 ' HB ' ' N ' ' A' ' 224' ' ' MET . 18.0 t -89.93 117.3 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -56.05 5.05 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.092 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -109.8 49.22 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.563 0.697 . . . . 0.0 109.31 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.427 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 6.2 tt0 -43.55 115.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.439 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 11.2 t60 -107.04 -26.32 11.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.497 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.412 HG12 ' CD1' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -96.22 126.74 43.01 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.35 81.24 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.151 1.901 . . . . 0.0 112.909 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.82 56.67 0.84 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.019 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 117.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.685 0.279 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -95.11 44.43 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.928 0.394 . . . . 0.0 111.066 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.17 -161.13 0.94 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.452 HD13 ' CB ' ' A' ' 228' ' ' ALA . 1.8 mm -111.66 134.44 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 211' ' ' LYS . 21.3 m-85 -135.45 154.28 51.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.633 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.418 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 36.2 t -80.22 143.18 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.753 0.311 . . . . 0.0 111.117 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' THR . . . . . 0.413 HG23 ' CE1' ' A' ' 182' ' ' HIS . 18.1 p -117.7 -49.37 2.55 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -136.58 139.38 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 111.95 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 194' ' ' ILE . 2.2 mm -118.22 136.36 55.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.753 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 195' ' ' ILE . 27.6 mm -79.64 113.85 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.444 . . . . 0.0 109.946 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -35.56 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.346 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.93 27.37 44.48 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.239 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -70.82 -70.82 1.12 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.386 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.16 -61.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.34 94.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.107 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -59.31 -56.42 22.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.885 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -52.87 18.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.8 -50.87 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.21 -33.89 43.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.838 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 38.35 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.184 0.516 . . . . 0.0 110.399 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.7 pp -107.97 140.46 41.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.029 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -124.56 174.43 7.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.648 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.7 mm -64.21 127.74 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 121.59 -16.49 9.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.702 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.36 139.65 37.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.922 0.361 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.415 ' HB2' ' CE2' ' A' ' 190' ' ' TYR . 2.1 ttmt -100.61 128.8 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.249 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.8 mm -94.78 119.14 42.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.849 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.5 -5.49 42.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 175.3 154.26 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.15 120.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.68 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.2 t30 59.33 -86.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.7 m -141.14 12.98 2.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.913 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.43 140.59 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.34 104.71 2.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.672 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.1 33.56 2.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.449 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -93.57 158.87 15.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.405 0.621 . . . . 0.0 112.036 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 49.73 30.44 3.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.329 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 5.0 p -134.16 164.83 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.408 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.0 OUTLIER -68.19 169.54 10.18 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.745 0.783 . . . . 0.0 112.493 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.405 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 60.9 t60 -57.89 -36.57 72.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.861 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -51.46 60.44 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.44 -36.34 75.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.989 0.423 . . . . 0.0 110.918 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.452 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -64.97 -39.75 93.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.04 -41.47 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.239 0.543 . . . . 0.0 109.553 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.84 74.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.675 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.73 68.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.993 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.62 -40.73 63.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.769 0.318 . . . . 0.0 111.222 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -33.29 71.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.571 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -21.18 63.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.902 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.8 p -54.19 -175.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -136.17 -145.78 0.22 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -38.72 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 128.06 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 0.0 111.765 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 38.9 t -114.4 119.88 62.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.525 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.51 119.95 37.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mt -96.73 145.77 25.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.937 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -107.86 117.15 33.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 75.7 t -127.85 150.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.378 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -123.82 123.51 40.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 mttp . . . . . 0 CA--C 1.533 0.321 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.062 -179.36 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.985 0.421 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.12 154.05 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.64 134.7 55.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 38.3 mm -119.37 118.78 58.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -99.71 131.65 45.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.5 mt -133.24 129.06 37.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.017 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -99.59 135.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.12 0.486 . . . . 0.0 111.12 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -76.08 98.71 4.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.833 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.46 -147.93 13.05 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.029 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.01 -22.91 34.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.486 2.124 . . . . 0.0 112.26 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -101.7 -4.44 26.48 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.96 -138.83 16.47 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.173 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.77 -37.38 73.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 81.41 39.2 12.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.793 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.53 -177.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.054 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t -133.24 158.87 41.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.27 162.17 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -128.62 138.42 52.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.526 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -108.86 130.35 9.99 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.007 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -82.37 -27.47 43.67 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.443 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 18.3 t -89.65 119.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.45 -55.83 5.04 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.047 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -112.6 50.42 0.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.529 0.68 . . . . 0.0 109.523 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.422 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 6.6 tt0 -43.81 115.91 0.89 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.453 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 7.3 t60 -106.8 -25.87 11.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.452 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.429 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -95.74 123.91 54.35 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.394 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.93 80.85 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.058 1.839 . . . . 0.0 112.27 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.71 55.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.26 123.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.749 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 28.37 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.81 -166.24 1.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 189' ' ' ILE . 1.9 mm -102.8 134.89 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.429 ' CG ' HG12 ' A' ' 183' ' ' ILE . 18.1 m-85 -134.45 153.13 52.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.588 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.424 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 49.0 t -80.29 142.06 14.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.084 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.2 t -124.47 -17.79 5.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -159.31 136.27 9.54 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.174 0.512 . . . . 0.0 112.061 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 194' ' ' ILE . 1.2 mm -120.85 135.12 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.747 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.54 117.66 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -36.95 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.005 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.11 23.75 25.76 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.999 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.74 -78.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.229 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -139.11 -57.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.772 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.97 -45.79 76.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -59.33 -55.73 31.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.876 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -51.45 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.36 -50.27 22.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.87 -34.8 29.74 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 114.096 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 66.26 34.66 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.153 0.477 . . . . 0.0 110.21 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.1 pp -102.5 140.17 37.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.992 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -117.59 169.62 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.902 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 208' ' ' ILE . 34.1 mt -62.97 127.78 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.768 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.91 -21.34 7.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.778 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.85 159.82 29.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 111.242 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.96 129.89 56.34 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.362 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 32.4 mm -100.29 117.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.562 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.67 -5.74 34.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 175.26 149.66 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.85 0.357 . . . . 0.0 111.297 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.87 119.18 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.895 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 57.9 -85.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.217 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 59.6 p -139.35 10.99 2.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.26 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.8 140.74 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.46 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.12 106.08 2.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.223 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.418 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -99.15 37.54 1.53 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.143 0.497 . . . . 0.0 110.269 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -98.6 166.65 11.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.338 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 46.12 27.98 0.6 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.903 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.78 164.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.762 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 169.26 14.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.733 0.778 . . . . 0.0 112.093 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.419 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 61.8 t60 -57.27 -36.85 71.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.76 -52.38 51.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -35.64 76.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.678 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.435 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.024 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.77 -41.72 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.247 0.546 . . . . 0.0 109.855 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.657 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.418 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -66.54 -50.39 63.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.0 pp -73.27 -40.03 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -36.39 84.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.372 . . . . 0.0 111.825 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -20.53 46.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.661 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.404 ' CG2' HG23 ' A' ' 239' ' ' VAL . 28.3 p -58.14 -172.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.274 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.11 -149.81 0.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.389 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 165' ' ' LYS . 55.6 m-20 -45.03 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 121.16 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.929 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.404 HG23 ' CG2' ' A' ' 235' ' ' THR . 12.5 p -120.6 128.01 75.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.116 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.5 OUTLIER -101.62 120.41 40.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mp -96.73 142.2 29.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -106.5 121.35 44.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.365 0.602 . . . . 0.0 110.102 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 54.0 t -120.28 150.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.474 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.83 126.17 51.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.964 -179.258 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.742 0.306 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 ptp -128.61 140.97 51.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -98.04 138.51 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 34.7 mm -124.97 119.52 56.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 10.1 ttpp -110.23 133.63 53.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.81 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.41 129.88 43.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.141 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.41 122.97 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.192 0.52 . . . . 0.0 110.09 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.76 90.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.267 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.59 43.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.97 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.06 -21.33 72.23 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.239 1.959 . . . . 0.0 112.334 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -102.25 -4.28 25.96 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.92 -147.47 18.1 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.14 -38.06 87.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 111.338 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.6 35.49 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -173.43 -170.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 m -133.95 163.47 29.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.45 158.15 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.053 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -129.4 138.0 51.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.4 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.31 133.05 11.02 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.889 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -85.95 -20.41 55.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.847 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.36 117.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.69 4.83 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.919 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.52 54.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.205 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.464 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 3.0 tt0 -46.45 118.87 2.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.451 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 35.2 t60 -103.0 -30.47 10.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.999 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.428 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.3 mm -95.96 133.48 25.25 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.76 75.44 4.47 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.045 1.83 . . . . 0.0 112.961 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.19 20.13 3.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.687 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -141.48 126.81 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.383 0.592 . . . . 0.0 111.153 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -101.92 42.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.3 -164.79 1.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.324 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.444 HD11 HG21 ' A' ' 189' ' ' ILE . 1.4 mm -105.28 133.49 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 110.111 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.428 ' CD1' HG13 ' A' ' 183' ' ' ILE . 20.7 m-85 -134.87 153.68 51.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 21.2 t -80.21 141.4 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.335 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 t -122.69 -20.18 6.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -157.58 136.14 11.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.046 0.451 . . . . 0.0 111.995 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.406 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 1.2 mm -120.24 135.15 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.8 mm -81.19 117.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -37.4 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.94 24.04 40.76 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.982 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.85 -67.85 1.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.28 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.56 -58.27 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.32 -47.08 83.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -59.42 -56.34 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.759 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -51.98 29.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.42 -50.65 20.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.74 -32.12 25.09 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.461 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.42 45.78 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.357 0.579 . . . . 0.0 110.202 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.52 140.23 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.089 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.68 164.02 15.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.546 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 42.1 mt -57.67 139.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.94 -18.75 28.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.81 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.11 144.23 45.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.414 ' HG3' ' CE1' ' A' ' 190' ' ' TYR . 3.3 ttpm? -104.97 129.46 53.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.285 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.1 mm -91.21 116.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.7 pp -90.14 -8.43 51.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 166.55 155.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 0.0 110.523 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 23.3 t -131.13 119.39 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.159 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.72 -85.57 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.9 t -141.56 13.38 2.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.146 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.16 140.23 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.383 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -102.28 100.1 1.95 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.218 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.21 45.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.503 0.668 . . . . 0.0 109.387 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.84 27.11 5.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.422 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -158.94 29.82 0.21 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.338 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 227' ' ' ASP . 8.8 p -152.43 166.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.046 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 17.1 mtt -58.52 168.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.738 0.78 . . . . 0.0 112.793 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.4 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 57.2 t60 -57.4 -35.52 70.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.58 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.38 -51.81 57.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.615 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.416 ' HB2' HG23 ' A' ' 223' ' ' VAL . 1.1 m-20 -59.91 -36.09 76.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -62.91 -38.87 92.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.81 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.7 t -57.52 -41.32 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.55 74.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.53 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.16 -43.0 88.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.563 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.4 -46.37 49.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.45 -34.16 70.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.176 0.513 . . . . 0.0 111.152 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -60.35 -20.76 60.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.356 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.8 p -69.42 -166.59 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.902 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.68 -148.98 0.26 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.504 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.74 -81.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.49 118.55 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.015 0.436 . . . . 0.0 110.742 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.407 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 12.3 p -120.23 136.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.207 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.2 m-85 -106.74 119.33 39.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.151 0.5 . . . . 0.0 111.736 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.06 134.81 45.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.26 133.87 51.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.824 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 69.2 t -130.81 148.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.482 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.7 124.47 51.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.78 45.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 0.0 111.419 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.4 131.38 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 30.5 mm -120.67 133.87 65.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.813 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.448 ' CD ' ' CE2' ' A' ' 240' ' ' TYR . 27.2 ttpt -122.01 129.22 52.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.527 0.204 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' A' ' 172' ' ' PHE . 2.0 mt -127.32 141.17 51.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.563 0.22 . . . . 0.0 110.429 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.78 132.55 53.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 110.592 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.39 82.59 1.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.817 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.2 -167.4 38.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.156 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.26 -20.4 66.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.185 1.923 . . . . 0.0 112.407 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -96.77 -2.13 44.91 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.1 -148.95 17.4 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.437 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.02 -37.37 76.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.006 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 100.32 19.29 19.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.212 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.453 ' CE1' ' CD1' ' A' ' 163' ' ' LEU . 1.5 p90 -170.6 -170.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.934 0.367 . . . . 0.0 110.803 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.75 161.84 34.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.018 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.58 159.53 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.449 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -129.53 137.69 50.92 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.02 129.9 9.75 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 120.003 -1.094 . . . . 0.0 114.147 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -81.55 -22.6 59.9 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.402 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.3 t -89.85 116.51 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.14 -56.0 5.05 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.996 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -110.23 52.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.418 0.628 . . . . 0.0 109.322 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.429 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 6.7 tt0 -46.35 114.3 0.78 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.449 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 6.4 t60 -103.13 -25.41 13.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.1 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.438 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -95.34 132.21 28.23 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.204 -179.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.26 79.97 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.147 1.898 . . . . 0.0 112.831 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.5 55.17 0.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.965 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -169.21 130.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.648 0.261 . . . . 0.0 110.937 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.12 28.78 6.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.8 t -111.32 -162.89 0.82 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.25 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.447 HD13 ' CB ' ' A' ' 228' ' ' ALA . 1.9 mm -106.36 133.21 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.283 0.564 . . . . 0.0 110.483 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.438 ' CG ' HG12 ' A' ' 183' ' ' ILE . 22.9 m-85 -135.14 154.59 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 42.7 t -80.14 141.21 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.656 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.0 t -121.91 -26.12 4.86 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 137.59 22.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.922 0.392 . . . . 0.0 111.641 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 194' ' ' ILE . 1.2 mm -120.95 135.74 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.543 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.01 114.16 21.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -39.8 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.819 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.54 31.25 57.22 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.059 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.06 -53.94 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -162.8 -57.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.004 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.45 -45.57 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -60.03 -56.58 19.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.664 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -52.1 25.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.67 -50.57 20.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.402 ' HA2' ' CD2' ' A' ' 163' ' ' LEU . . . -77.79 -31.61 48.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.897 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 61.71 30.59 18.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.987 0.422 . . . . 0.0 110.354 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.4 140.48 40.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.861 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -125.82 177.32 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 208' ' ' ILE . 55.5 mt -61.58 114.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 135.33 -17.67 4.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.907 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.67 149.34 32.85 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.901 0.351 . . . . 0.0 111.189 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -109.04 129.91 55.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 212' ' ' ILE . 22.5 mm -94.35 119.09 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.651 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.3 pp -94.91 -9.23 34.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 174.15 152.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.412 ' CG1' HG23 ' A' ' 239' ' ' VAL . 4.3 t -122.99 119.34 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.967 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 57.98 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 94.2 p -140.54 14.02 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.596 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.41 139.73 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.287 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.78 107.11 2.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.971 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.63 39.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.195 0.522 . . . . 0.0 110.607 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.26 168.77 10.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.46 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.0 p30 47.13 26.75 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.105 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 5.4 p -135.8 163.4 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.808 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 mtm -67.13 170.25 7.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.739 0.78 . . . . 0.0 111.903 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.417 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 67.4 t60 -57.42 -36.05 70.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.253 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -62.3 -52.35 64.04 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -36.55 78.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.577 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.447 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.53 -38.59 87.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.023 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.32 -41.78 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.619 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.83 76.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.8 96.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.607 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.2 -41.74 63.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -57.42 -41.05 79.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.178 0.513 . . . . 0.0 111.591 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.54 -19.97 42.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.91 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 18.4 p -67.39 -171.49 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 111.439 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -143.89 -145.47 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.342 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -44.47 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 118.004 0.365 . . . . 0.0 111.696 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.55 119.78 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.412 HG23 ' CG1' ' A' ' 215' ' ' VAL . 9.8 p -118.07 131.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.784 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 7.2 m-85 -102.18 118.11 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.265 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 161' ' ' ILE . 4.1 mp -97.37 139.73 32.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.01 130.71 54.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.175 0.512 . . . . 0.0 110.348 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.89 148.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.0 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.28 131.98 54.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.755 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt . . . . . 0 C--N 1.327 -0.373 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.071 -179.281 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.131 0.491 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.73 152.7 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.297 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -112.62 120.6 42.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.2 mm -100.36 118.54 47.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.375 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.53 132.4 48.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 129.57 31.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.856 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 164' ' ' ILE . 0.2 OUTLIER -97.97 135.16 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 0.0 111.42 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 91.37 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.669 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.87 -165.61 32.92 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.368 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -20.54 50.53 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.197 1.931 . . . . 0.0 112.214 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.26 -4.49 31.8 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.42 -135.15 12.88 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.338 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.74 -37.86 77.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.807 0.337 . . . . 0.0 110.96 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 86.87 27.26 29.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.098 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -175.21 -172.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -131.0 160.91 33.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.42 155.55 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.458 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -129.48 138.0 51.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.67 136.44 13.36 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.0 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -88.17 -21.07 46.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.535 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.12 116.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.43 -57.46 4.44 Favored Glycine 0 C--N 1.329 0.15 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.91 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -104.99 49.46 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.484 0.659 . . . . 0.0 109.323 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.45 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 3.9 tt0 -44.41 112.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.458 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 45.4 t60 -97.78 -30.94 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.782 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.438 HG13 ' CD1' ' A' ' 190' ' ' TYR . 18.3 mm -96.72 127.9 37.81 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.398 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.68 78.37 2.44 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.005 1.804 . . . . 0.0 112.876 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.26 10.97 3.56 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.049 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.75 136.72 42.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.572 0.686 . . . . 0.0 111.333 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -108.74 30.68 6.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.428 ' HB3' ' CE1' ' A' ' 190' ' ' TYR . 5.0 t -116.28 -164.25 0.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 189' ' ' ILE . 1.1 mm -109.11 131.32 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.082 0.468 . . . . 0.0 110.541 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.438 ' CD1' HG13 ' A' ' 183' ' ' ILE . 3.1 m-85 -135.1 155.58 50.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.11 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.79 140.27 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.585 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.1 t -124.67 -14.74 6.72 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.49 133.59 12.43 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.062 0.458 . . . . 0.0 111.566 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.09 134.45 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.019 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.0 118.37 29.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.086 0.47 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -41.99 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.485 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.69 28.68 57.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.868 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.09 -80.17 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.34 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -137.99 -62.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -62.14 -46.38 89.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.21 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -62.25 -55.86 24.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.661 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -69.79 -52.62 23.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -74.47 -50.93 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.47 -29.32 36.65 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.337 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 64.69 32.11 11.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.392 0.596 . . . . 0.0 110.508 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.6 pp -102.88 140.45 37.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.752 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -123.67 175.65 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 111.08 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 39.7 mt -62.32 115.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 133.16 -17.9 4.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.53 154.78 40.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.034 0.417 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -112.6 129.91 56.21 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.42 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 212' ' ' ILE . 14.8 mm -102.03 116.03 44.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.67 -12.96 26.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -178.94 148.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.872 0.368 . . . . 0.0 111.531 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.0 119.53 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.1 t30 56.55 -87.8 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.4 m -135.98 11.0 3.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.657 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.4 p -109.63 140.82 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 122.549 0.339 . . . . 0.0 110.661 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.84 105.44 2.64 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.525 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.76 30.11 3.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.113 0.483 . . . . 0.0 110.144 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.71 163.93 12.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 23.4 t70 45.04 27.77 0.32 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.653 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.3 p -133.12 165.81 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.438 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.07 165.39 18.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.607 0.718 . . . . 0.0 111.794 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -57.59 -35.82 70.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.676 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -35.98 76.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.413 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -62.96 -38.66 91.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.008 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.78 -42.18 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.718 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.25 79.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.356 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.51 97.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.8 mt -74.03 -40.43 62.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.019 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -55.35 -46.31 76.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -60.75 -20.22 60.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.571 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 43.9 p -54.58 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.73 0.3 . . . . 0.0 111.562 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.66 -151.8 0.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -45.35 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.861 0.3 . . . . 0.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -93.98 120.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.741 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 9.5 p -115.07 119.32 61.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.085 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.88 119.5 38.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.915 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.66 151.38 20.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 117.9 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.822 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.47 152.23 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.75 120.92 36.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.84 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.004 -179.41 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.794 0.33 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.29 152.1 38.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.01 146.81 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 31.1 mm -123.18 119.14 56.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.716 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -107.81 119.45 39.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.614 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.17 138.7 40.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.439 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.89 131.57 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 0.0 110.981 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 90.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.6 171.98 5.28 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.671 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.06 -31.76 91.18 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.101 1.867 . . . . 0.0 112.399 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.23 15.67 28.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.54 -160.42 13.43 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.42 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -27.2 68.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.52 0.2 . . . . 0.0 111.405 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.81 41.84 5.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.656 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.61 -173.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.818 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -134.26 156.11 48.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.94 160.86 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 182' ' ' HIS . . . -130.57 139.36 50.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.218 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.426 ' HA3' HD12 ' A' ' 189' ' ' ILE . . . -110.83 132.27 10.85 Favored Glycine 0 CA--C 1.502 -0.751 0 C-N-CA 120.141 -1.028 . . . . 0.0 114.336 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.24 -24.05 49.24 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 114.927 -0.636 . . . . 0.0 113.227 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.0 117.06 32.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.67 -57.51 4.75 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.884 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.91 45.97 0.94 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.415 0.626 . . . . 0.0 109.46 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.448 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -42.3 112.16 0.31 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.438 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 21.9 t60 -98.73 -30.11 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.616 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 mm -96.57 124.87 49.22 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.24 77.74 2.39 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.778 1.652 . . . . 0.0 112.469 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.15 14.56 2.69 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.043 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -139.14 131.16 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.621 0.71 . . . . 0.0 111.117 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.77 25.28 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.2 t -110.06 -164.61 0.94 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 189' ' ' ILE . 2.2 mm -101.75 134.3 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.205 0.526 . . . . 0.0 110.095 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -133.37 148.81 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.524 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.4 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 34.3 t -79.99 141.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.608 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.0 t -121.97 -26.67 4.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -147.63 136.57 22.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 111.822 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -121.52 135.87 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.157 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.0 mm -80.61 114.0 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.75 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.718 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.24 25.23 53.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.881 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.24 -108.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.2 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -106.3 -62.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.64 -45.13 80.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.569 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -59.08 -57.41 13.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -53.16 18.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.67 -50.99 15.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.99 53.21 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.813 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 62.15 28.42 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.913 0.357 . . . . 0.0 110.803 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.9 pp -99.41 139.13 35.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.279 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.96 177.34 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 40.0 mt -64.43 126.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.732 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.43 -14.9 10.8 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.93 145.79 33.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.057 0.429 . . . . 0.0 110.858 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.401 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 13.2 ttmt -103.05 128.57 49.86 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 33.9 mm -99.98 120.49 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 112.141 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.46 -60.72 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.239 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -134.39 155.4 50.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.961 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.14 120.41 58.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.911 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 59.99 -85.21 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.4 m -142.86 13.45 1.89 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.829 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.77 140.43 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.021 0.439 . . . . 0.0 111.659 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.96 104.93 2.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.082 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -99.16 37.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 110.704 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -91.93 159.29 15.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.845 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 48.39 31.23 2.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.486 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 3.9 p -133.58 161.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.008 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 11.1 mtt -68.32 170.03 9.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.716 0.77 . . . . 0.0 112.117 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.419 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 57.3 t60 -57.33 -36.88 71.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.306 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.65 -51.81 60.61 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.409 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 1.1 t0 -59.64 -36.43 76.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.438 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.976 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.1 t -57.16 -41.81 78.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.01 75.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.202 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -64.82 -40.28 94.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.604 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.05 -48.74 56.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -58.41 -33.68 69.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.07 0.462 . . . . 0.0 111.404 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -59.33 -21.24 59.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.2 p -63.51 -166.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.729 0.3 . . . . 0.0 111.088 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.85 -148.28 0.25 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' A' ' 240' ' ' TYR . 0.5 OUTLIER -96.54 123.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 16.7 t -111.84 137.11 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.722 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 2.1 m-85 -115.61 118.74 33.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.671 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.77 139.35 33.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -106.92 130.04 54.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 211' ' ' LYS . 60.9 t -136.97 149.6 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.23 121.79 37.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.066 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mttm . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.288 -179.151 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.765 0.317 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.09 147.56 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.592 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -115.55 120.69 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.2 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 31.9 mm -109.76 118.19 56.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.675 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.91 129.06 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.33 132.32 51.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.11 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 164' ' ' ILE . 0.4 OUTLIER -97.06 124.51 49.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 110.353 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 87.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.27 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.07 179.01 53.55 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.125 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.6 -20.37 33.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.187 1.924 . . . . 0.0 112.394 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.91 8.18 41.24 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.97 -150.27 18.22 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.35 -37.99 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.73 0.3 . . . . 0.0 111.288 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 100.9 33.39 5.0 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.005 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.418 ' CD2' HD12 ' A' ' 206' ' ' LEU . 0.2 OUTLIER -173.89 -166.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.093 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -137.4 161.54 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.794 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.33 158.51 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.462 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -127.13 137.65 53.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.494 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -109.43 130.14 9.82 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.783 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -83.83 -23.39 52.97 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.63 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.91 116.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.48 -56.27 4.69 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.995 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.79 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.345 0.593 . . . . 0.0 109.434 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.431 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 5.3 tt0 -43.61 112.92 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.462 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 5.8 t60 -104.3 -25.0 13.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.326 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.15 130.32 31.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.332 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.6 76.52 3.21 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.104 1.869 . . . . 0.0 112.779 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.62 48.41 0.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.05 123.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.65 25.33 5.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.295 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -109.61 -168.14 1.29 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 189' ' ' ILE . 1.6 mm -99.51 136.88 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.197 0.522 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 20.6 m-85 -135.5 152.29 51.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.7 t -80.18 140.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 t -125.14 -24.02 4.09 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -150.56 136.55 18.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.104 0.478 . . . . 0.0 111.889 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.425 HG23 ' CG ' ' A' ' 201' ' ' HIS . 1.3 mm -121.12 135.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.182 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.13 113.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -36.48 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.83 40.19 49.01 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.202 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.06 -60.74 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.96 -61.96 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.751 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -65.24 -46.59 79.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.297 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . 0.425 ' CG ' HG23 ' A' ' 194' ' ' ILE . 6.6 t-160 -61.42 -56.13 23.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.01 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -52.36 25.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -74.31 -50.74 17.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.41 -36.64 26.25 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 121.086 -0.578 . . . . 0.0 114.167 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 39.38 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.05 0.453 . . . . 0.0 110.681 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.418 HD12 ' CD2' ' A' ' 172' ' ' PHE . 1.7 pt? -109.61 140.33 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.536 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -121.79 171.71 8.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 0.0 111.159 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 208' ' ' ILE . 53.5 mt -62.49 120.63 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.64 -19.55 4.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.9 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.66 152.51 31.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.85 0.325 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 0.3 OUTLIER -113.52 129.22 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.387 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 31.8 mm -90.08 119.24 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 111.507 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -26.42 20.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -171.89 149.21 2.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 217' ' ' SER . 2.5 t -117.42 119.0 60.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.83 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 56.2 -85.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 215' ' ' VAL . 9.5 m -138.18 12.18 2.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.663 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -109.63 140.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-O 120.922 0.391 . . . . 0.0 111.056 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.02 89.49 0.71 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.728 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.4 ' O ' ' CG1' ' A' ' 223' ' ' VAL . 0.4 OUTLIER -71.72 -7.66 49.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.37 178.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -62.29 168.72 3.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.194 0.521 . . . . 0.0 110.831 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 t0 47.52 25.5 0.65 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 220' ' ' LEU . 2.9 p -136.44 164.41 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.807 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.5 168.87 11.94 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.65 0.738 . . . . 0.0 111.576 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -57.96 -37.21 73.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.042 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.94 -52.88 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -34.34 76.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 109.888 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.95 -38.77 89.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.778 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.41 -41.72 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.767 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.44 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.703 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.29 -50.66 62.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.867 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.57 -39.67 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -59.05 -39.62 82.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.402 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -59.09 -20.34 52.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.741 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . 0.4 ' CG2' HG23 ' A' ' 239' ' ' VAL . 34.6 p -57.75 -172.17 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.574 0.226 . . . . 0.0 111.323 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -133.88 -146.9 0.27 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.877 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -81.95 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 122.543 0.337 . . . . 0.0 111.792 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.27 122.34 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.408 HG23 ' CG1' ' A' ' 215' ' ' VAL . 12.9 p -117.53 132.69 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.9 m-85 -105.4 119.45 39.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.922 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 mp -97.71 140.59 31.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.51 117.74 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.213 0.53 . . . . 0.0 110.215 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 211' ' ' LYS . 65.2 t -117.61 147.81 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.069 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.35 121.25 39.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.733 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.798 0.333 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.0 ptm -124.58 154.4 40.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.313 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.03 130.89 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.398 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.9 mm -100.52 117.09 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -98.66 125.12 43.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.108 0.48 . . . . 0.0 112.273 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 129.51 31.59 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.39 131.08 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.123 0.487 . . . . 0.0 111.292 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 69.31 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.52 -160.22 7.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.27 -20.13 49.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.132 1.888 . . . . 0.0 112.401 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -92.26 -4.63 53.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.36 -149.41 19.45 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.57 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.427 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 4.2 mm? -56.96 -37.87 72.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 110.982 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.2 26.41 18.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.972 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 4.1 p90 -174.97 -168.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 110.943 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.0 m -135.65 163.85 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.17 161.17 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 111.301 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -128.92 137.88 51.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.31 130.34 9.53 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.712 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.86 -18.23 61.83 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.558 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.96 117.76 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.38 -57.87 4.67 Favored Glycine 0 C--N 1.329 0.141 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.055 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -109.78 57.39 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.592 0.71 . . . . 0.0 109.301 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.445 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 3.2 tt0 -48.5 116.26 1.52 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.453 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 10.0 t60 -101.6 -27.02 13.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.913 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.417 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.24 134.57 23.43 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 79.41 2.59 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.138 1.892 . . . . 0.0 113.101 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.52 50.95 0.73 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.242 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -168.9 131.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.663 0.268 . . . . 0.0 110.884 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.065 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -169.1 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 189' ' ' ILE . 1.5 mm -102.69 134.96 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.253 0.549 . . . . 0.0 110.112 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.417 ' CG ' HG12 ' A' ' 183' ' ' ILE . 15.3 m-85 -133.84 155.35 50.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.626 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.428 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 40.3 t -80.28 141.44 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.329 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 7.9 t -125.53 -21.55 4.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -153.42 136.13 15.27 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.683 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 194' ' ' ILE . 2.5 mm -120.87 135.91 59.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.69 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.5 mm -80.17 116.88 25.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 110.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -37.03 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.023 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.74 27.19 34.9 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.981 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.56 -115.53 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.42 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -98.58 -57.42 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.15 71.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.905 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -59.52 -56.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.24 -52.74 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -74.0 -51.36 16.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.0 -38.19 36.19 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.728 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.28 41.21 4.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.292 0.568 . . . . 0.0 110.198 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.28 140.23 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -118.77 179.53 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.763 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 7.4 mm -72.41 113.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.058 0.456 . . . . 0.0 111.556 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.2 -13.57 3.54 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.662 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -78.93 159.3 27.78 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 117.038 0.419 . . . . 0.0 110.982 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 130.12 53.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 32.7 mm -93.17 117.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.409 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.33 -4.97 44.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 166.63 153.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.755 0.312 . . . . 0.0 110.347 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.418 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 42.7 t -132.23 119.63 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 59.94 -84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.44 13.02 1.96 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.07 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.31 139.84 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.943 0.401 . . . . 0.0 111.529 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.14 101.9 2.33 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.387 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.17 45.66 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.478 0.656 . . . . 0.0 109.65 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 26.78 4.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.164 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -158.12 32.19 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.952 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 7.0 p -153.4 166.1 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.9 mtm -62.13 168.43 3.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.632 0.729 . . . . 0.0 112.076 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -56.93 -36.18 69.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.031 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.15 -52.89 52.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.4 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -62.36 -34.98 77.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.166 0.508 . . . . 0.0 109.929 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -60.67 -38.39 84.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.664 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.2 t -59.52 -41.64 85.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.89 -33.22 72.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.058 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.3 -41.15 96.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.896 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.99 -41.9 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.102 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -61.77 -39.57 92.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.149 0.499 . . . . 0.0 111.237 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -60.67 -19.61 58.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 30.2 p -57.73 -166.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.761 -0.2 . . . . 0.0 110.928 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -152.93 -160.74 1.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.233 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -28.82 -61.6 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.21 126.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.418 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 4.2 p -120.65 126.11 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 121.32 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.763 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.24 146.57 24.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.067 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.39 118.02 35.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.022 0.439 . . . . 0.0 109.936 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.56 148.77 32.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.983 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.2 121.46 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.084 0.468 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.12 154.55 49.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.998 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.83 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 0.0 111.794 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 34.5 mm -113.66 118.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.611 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.54 131.23 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.689 0.281 . . . . 0.0 111.331 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.5 mt -131.71 128.79 39.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.829 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 164' ' ' ILE . 0.3 OUTLIER -98.25 128.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.13 0.49 . . . . 0.0 110.145 179.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -63.15 91.94 0.05 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.008 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.14 -171.04 37.37 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.892 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.84 -24.8 74.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.211 1.94 . . . . 0.0 112.535 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -4.18 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.48 -144.27 18.37 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.366 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.3 mt -67.14 -37.83 84.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.271 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 97.94 34.26 5.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.622 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -175.07 -168.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 111.013 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.7 t -136.33 161.02 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.52 161.48 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.997 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.44 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -131.1 138.7 49.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.6 130.67 9.67 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.598 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -81.58 -25.08 54.88 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.637 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.53 120.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.91 5.02 Favored Glycine 0 C--N 1.331 0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 113.004 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -114.93 54.14 0.79 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.43 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -45.54 107.33 0.1 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.44 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 15.0 t60 -93.74 -26.78 16.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.011 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.429 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -96.46 121.85 59.0 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.034 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.72 71.01 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.999 1.799 . . . . 0.0 112.532 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 123.66 51.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.712 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.89 129.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.3 30.89 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.4 t -114.52 -165.73 1.04 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 189' ' ' ILE . 1.8 mm -103.22 135.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 211' ' ' LYS . 20.6 m-85 -135.87 153.72 51.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.736 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 46.5 t -80.76 142.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.9 t -122.7 -20.73 5.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.59 136.95 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.997 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.403 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 2.8 mm -120.57 135.65 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.995 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 195' ' ' ILE . 33.6 mm -80.45 116.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -37.82 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.9 24.22 41.08 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.216 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.48 -114.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.121 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -109.94 -48.11 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.07 72.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -59.55 -56.08 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -69.77 -52.0 29.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.85 -51.15 17.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.62 -34.77 21.52 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.217 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 66.02 26.67 10.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.188 0.494 . . . . 0.0 110.552 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.05 140.86 30.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -122.04 170.15 10.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 34.6 mt -58.22 113.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.51 -19.61 3.18 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.723 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.14 129.88 39.03 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.824 0.312 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -96.48 129.11 43.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.627 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.2 mm -103.13 137.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.802 0.334 . . . . 0.0 111.667 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.4 pp -115.53 -12.59 11.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.034 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -175.9 152.45 1.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 110.657 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 38.4 t -130.43 119.09 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 58.43 -85.04 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.99 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 12.95 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.674 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.4 p -109.29 140.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 120.827 0.346 . . . . 0.0 110.669 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.58 100.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.049 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.25 34.73 2.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.383 0.611 . . . . 0.0 109.864 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -103.35 163.68 12.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 46.38 26.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.665 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.402 HG23 ' CB ' ' A' ' 227' ' ' ASP . 5.2 p -134.21 165.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.9 mtt -69.51 168.34 14.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.718 0.77 . . . . 0.0 112.026 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . 0.405 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 64.2 t60 -58.11 -36.31 72.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.017 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.6 -51.72 57.52 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.402 ' CB ' HG23 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.42 -35.57 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.473 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -65.23 -39.14 92.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.403 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.09 -41.83 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.97 74.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.4 85.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.234 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 mt -73.44 -45.18 55.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -34.62 71.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.816 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -64.47 -20.35 66.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.63 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 26.2 p -62.25 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.032 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -140.76 -150.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 7.1 m-20 -45.08 -81.18 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.286 0.234 . . . . 0.0 111.609 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.8 118.48 42.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.168 0.509 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.42 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 10.6 p -120.82 127.31 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.199 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.34 123.79 46.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.07 149.32 22.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.64 116.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.06 140.36 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.881 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.55 121.73 40.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.167 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.751 0.31 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.84 149.27 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.43 142.85 28.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.306 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.03 119.62 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.783 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -100.84 130.75 46.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.002 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.09 132.04 42.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.816 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 164' ' ' ILE . 0.3 OUTLIER -97.2 135.09 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.242 0.544 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -70.11 96.01 1.03 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.085 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.8 -158.25 27.58 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.959 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.86 -20.72 68.76 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.097 1.865 . . . . 0.0 112.422 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.27 -2.49 31.0 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.4 -135.77 14.25 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.126 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 4.4 mm? -58.21 -33.25 69.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 111.046 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.03 32.99 37.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.699 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 11.6 p90 -175.42 -174.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.4 m -129.85 160.29 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 111.545 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.91 157.09 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.445 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -127.99 137.53 52.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -111.45 130.92 9.99 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.753 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -81.62 -23.74 57.55 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.587 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.1 t -90.06 117.92 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.96 -56.04 5.03 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.918 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -112.42 53.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.439 0.638 . . . . 0.0 109.414 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.432 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.5 tt0 -45.87 113.24 0.58 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.445 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 9.4 t60 -102.66 -26.04 13.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.277 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.434 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -95.99 132.99 25.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.275 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.88 76.34 4.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 113.007 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.59 47.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.083 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.64 130.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 0.0 110.948 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -102.47 28.13 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.28 -162.46 0.8 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.751 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 189' ' ' ILE . 1.4 mm -106.38 136.04 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.434 ' CG ' HG12 ' A' ' 183' ' ' ILE . 21.8 m-85 -135.77 150.3 49.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.388 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 26.9 t -80.73 138.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 t -123.23 -18.48 6.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -152.16 133.53 14.49 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.782 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 194' ' ' ILE . 1.6 mm -120.93 135.6 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.151 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -81.02 113.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 109.866 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -37.19 102.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.28 23.6 13.32 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.262 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.0 -107.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.411 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -104.44 -58.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.99 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.035 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -58.46 -56.11 26.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -52.32 27.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.44 -51.38 15.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.52 -35.78 11.45 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.686 -0.768 . . . . 0.0 114.402 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 62.17 0.74 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.401 0.62 . . . . 0.0 110.578 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.5 132.88 54.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.92 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -112.14 165.72 11.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.972 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 208' ' ' ILE . 37.9 mt -64.06 111.54 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.76 -14.07 2.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.204 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.24 153.01 28.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.107 0.453 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.4 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 0.0 OUTLIER -114.32 129.36 56.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 43.1 mm -90.5 122.93 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.566 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.46 -27.09 19.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.171 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 177.09 150.21 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.738 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.19 118.92 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.017 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 56.42 -86.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.28 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.6 m -136.39 11.06 3.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.072 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.23 140.39 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -108.64 88.53 0.53 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.056 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -13.81 62.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -63.24 169.59 3.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.19 0.519 . . . . 0.0 110.72 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.39 24.42 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.795 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.402 HG12 ' CB ' ' A' ' 227' ' ' ASP . 4.2 p -144.86 156.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.92 167.5 0.79 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.93 0.872 . . . . 0.0 112.592 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -57.66 -35.01 69.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.099 -1.41 . . . . 0.0 110.685 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.3 -52.05 51.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.052 0.454 . . . . 0.0 111.996 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.402 ' CB ' HG12 ' A' ' 223' ' ' VAL . 8.6 m-20 -61.27 -35.42 77.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.419 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -62.65 -38.49 90.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.775 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.04 -41.3 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.12 75.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.1 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.74 95.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.32 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.16 -44.24 60.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.166 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -37.0 70.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 111.575 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.0 -20.3 65.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.909 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 22.8 p -65.43 -175.67 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.754 0.312 . . . . 0.0 111.323 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.53 -150.03 0.35 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.227 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 165' ' ' LYS . 2.1 m-20 -44.31 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.712 0.233 . . . . 0.0 111.288 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.11 122.54 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.676 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 10.6 p -118.83 135.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -102.63 135.33 44.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mt -113.46 135.34 53.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -106.66 117.5 34.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.174 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 211' ' ' LYS . 75.1 t -129.48 148.79 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.95 121.12 35.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.963 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.165 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.637 0.256 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -93.39 140.01 30.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.63 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 48.6 mm -123.9 119.21 56.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -105.57 132.31 51.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.373 . . . . 0.0 111.606 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.3 mt -131.61 129.77 41.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.062 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.17 134.54 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 110.973 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -74.79 106.31 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.912 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.14 -147.13 8.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.217 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.38 -23.06 38.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.064 1.842 . . . . 0.0 112.055 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -102.14 -4.73 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.62 -135.32 13.67 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.109 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.49 -37.11 74.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.115 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.48 39.35 9.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.651 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.25 -173.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.97 0.414 . . . . 0.0 110.704 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 m -133.13 160.39 37.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -125.84 162.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.074 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -108.83 129.38 9.5 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.431 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -85.67 -20.6 55.88 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.255 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 17.6 t -89.83 116.99 32.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.27 -58.5 4.03 Favored Glycine 0 C--N 1.329 0.164 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.944 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -102.97 48.55 0.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.472 0.654 . . . . 0.0 109.429 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.437 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -44.51 113.5 0.55 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.45 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 18.9 t60 -98.44 -31.31 12.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.743 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.442 HG13 ' CG ' ' A' ' 190' ' ' TYR . 9.8 mm -96.4 123.91 52.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.198 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.49 78.67 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.982 1.788 . . . . 0.0 112.566 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 130.88 5.73 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.013 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -132.88 144.85 50.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.669 0.735 . . . . 0.0 111.35 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . 0.407 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.1 m120 -104.85 -28.05 11.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -62.98 -163.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 189' ' ' ILE . 1.5 mm -101.13 141.35 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.25 0.548 . . . . 0.0 110.819 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.442 ' CG ' HG13 ' A' ' 183' ' ' ILE . 17.6 m-85 -135.58 155.05 51.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.839 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.411 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 36.7 t -85.16 142.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.451 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 t -123.74 -24.26 4.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.15 138.25 13.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.09 0.472 . . . . 0.0 112.01 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.411 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 1.6 mm -121.35 135.78 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.483 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.5 mp -80.73 115.6 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -38.26 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.97 29.37 43.04 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.167 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.99 -64.73 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.182 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.21 -57.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.388 . . . . 0.0 110.689 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.44 -44.55 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.811 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -59.63 -55.89 28.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.678 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -51.54 30.29 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.84 -49.47 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.64 -35.24 14.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.789 -0.72 . . . . 0.0 114.398 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 51.66 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.375 0.607 . . . . 0.0 109.962 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.81 140.44 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.224 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.71 174.97 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.019 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 35.9 mt -67.6 126.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.827 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 127.03 -19.39 6.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.622 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -77.03 149.44 35.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -110.83 128.21 55.69 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.896 0.379 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 212' ' ' ILE . 26.8 mm -92.79 124.71 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.884 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.3 mt -85.48 -67.26 0.82 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.263 0.554 . . . . 0.0 110.151 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.03 155.11 50.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.703 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.413 HG13 HG23 ' A' ' 239' ' ' VAL . 26.0 t -124.3 120.11 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.61 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 t30 59.31 -86.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.9 t -141.26 14.44 2.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.665 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.75 140.64 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.89 97.33 1.42 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.051 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.84 43.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -120.12 30.07 7.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.732 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -168.65 33.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.405 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 9.6 p -152.41 165.29 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -63.51 172.68 1.93 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.727 0.775 . . . . 0.0 112.173 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -57.44 -37.62 73.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.583 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.54 -53.14 46.36 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.405 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -63.12 -34.21 77.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -60.78 -38.21 84.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.646 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.8 t -60.08 -41.39 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.142 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.91 -32.81 74.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.875 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.08 93.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.315 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -48.07 34.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.446 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.48 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 111.979 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.53 -20.7 57.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.715 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 30.6 p -60.82 -169.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.687 0.279 . . . . 0.0 111.269 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.71 -152.01 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -44.34 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.549 0.214 . . . . 0.0 111.439 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.05 121.81 47.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.944 0.402 . . . . 0.0 110.711 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.413 HG23 HG13 ' A' ' 215' ' ' VAL . 12.5 p -120.16 132.95 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 2.6 m-85 -105.21 119.58 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.55 138.19 38.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.06 129.22 54.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.986 0.422 . . . . 0.0 110.046 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 211' ' ' LYS . 53.6 t -130.82 148.32 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.691 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.7 131.09 52.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.768 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.082 -179.665 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.83 0.348 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -100.44 158.98 15.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 144.73 36.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.31 125.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 14.7 ptp -132.03 154.51 49.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.882 0.373 . . . . 0.0 111.25 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.93 145.08 30.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 41.1 mm -125.44 116.71 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.408 ' HG2' ' CG1' ' A' ' 238' ' ' VAL . 12.8 mtmt -90.7 131.51 36.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.004 0.431 . . . . 0.0 111.108 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.42 HD11 ' CE1' ' A' ' 172' ' ' PHE . 2.1 mt -121.23 128.39 52.36 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 238' ' ' VAL . 13.0 mm -97.25 134.21 36.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 111.375 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.15 56.99 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.043 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.99 -156.0 0.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.51 -22.98 44.05 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.212 1.941 . . . . 0.0 112.434 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -4.49 47.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.1 -130.84 10.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.271 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.37 -36.46 82.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 110.95 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 26.56 23.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.109 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 163' ' ' LEU . 1.7 p90 -174.57 -168.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 111.202 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -134.7 158.96 42.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.73 160.49 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.448 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -125.05 137.3 54.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 225' ' ' HIS . . . -110.16 129.91 9.61 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.499 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.15 -22.67 54.2 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.76 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 19.8 t -89.99 118.64 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.89 -57.12 4.96 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.967 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -110.39 52.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.429 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.6 tt0 -44.8 116.21 1.03 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.448 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 16.6 t60 -103.89 -27.75 12.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.238 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.43 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.41 123.45 54.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.371 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.62 81.47 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.007 1.804 . . . . 0.0 112.648 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.28 55.32 0.68 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.028 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.41 129.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.812 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -103.74 29.46 5.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m -111.0 -160.9 0.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 189' ' ' ILE . 1.7 mm -110.79 136.65 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.43 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.9 m-85 -135.47 154.06 51.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.545 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.9 142.22 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.41 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.2 t -123.97 -24.09 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -155.43 138.52 15.54 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.72 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -121.27 135.12 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.498 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.86 123.62 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -39.53 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.58 26.11 37.55 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.283 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.27 -69.23 1.4 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.172 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.46 -59.31 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.954 0.407 . . . . 0.0 110.388 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.81 94.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.43 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -66.07 -55.8 14.75 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -69.4 -52.76 23.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -75.01 -50.56 16.14 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.9 -31.25 49.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.134 -178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 62.19 32.23 17.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.179 0.49 . . . . 0.0 110.182 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 pp -101.3 140.32 35.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.904 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -123.01 167.21 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 208' ' ' ILE . 46.2 mt -58.06 116.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.3 -17.94 3.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.439 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -78.95 149.16 32.39 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 120.743 0.306 . . . . 0.0 111.062 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.405 ' HB3' ' CE2' ' A' ' 190' ' ' TYR . 5.9 ptmt -112.94 128.87 56.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.462 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 26.9 mm -90.1 121.58 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.315 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.73 2.5 38.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 163.83 155.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 239' ' ' VAL . 57.5 t -132.14 118.57 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.424 ' HA ' ' CE2' ' A' ' 240' ' ' TYR . 26.9 m-20 58.08 -85.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.5 OUTLIER -141.18 14.32 2.23 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.668 177.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.17 140.38 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.97 0.414 . . . . 0.0 111.3 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.75 94.61 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.1 OUTLIER -102.31 44.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.696 0.76 . . . . 0.0 109.026 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 25.58 5.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.601 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.71 33.38 0.4 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.745 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 227' ' ' ASP . 10.1 p -152.76 166.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.039 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.69 170.52 2.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.725 0.774 . . . . 0.0 112.284 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.432 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 60.2 t60 -57.55 -36.28 71.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.307 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.18 -52.56 54.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.417 ' HB3' ' CG1' ' A' ' 223' ' ' VAL . 2.4 t0 -62.01 -35.22 77.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.959 0.409 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.407 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.46 -39.15 89.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.872 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.2 t -59.37 -41.36 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.31 -33.25 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.474 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -64.23 -41.48 96.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.5 mt -73.96 -48.77 28.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.611 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -61.49 -34.54 75.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.957 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -64.39 -20.22 66.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.732 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.407 ' CG2' HG23 ' A' ' 239' ' ' VAL . 18.3 p -66.01 -162.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.516 0.198 . . . . 0.0 111.443 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 236' ' ' TYR . 1.7 m-85 -131.02 -153.46 0.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.146 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.19 -77.03 0.02 OUTLIER 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.566 0.347 . . . . 0.0 111.787 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 164' ' ' ILE . 53.5 t -102.88 121.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.106 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.435 HG23 ' CG1' ' A' ' 215' ' ' VAL . 10.6 p -118.87 124.07 72.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.6 OUTLIER -94.76 138.03 33.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.405 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.77 147.25 40.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.76 119.8 40.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 110.304 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.8 t -128.75 146.63 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.787 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.98 132.1 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.675 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -94.88 128.64 38.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.911 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.13 111.38 3.06 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.043 1.828 . . . . 0.0 112.459 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 m -96.3 121.57 38.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -82.94 81.19 8.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.956 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.101 179.883 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 61.61 -179.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.661 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -82.74 105.47 13.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 130.95 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.18 147.5 52.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.61 144.15 27.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 43.0 mm -125.45 118.94 53.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -97.57 126.31 42.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.401 ' CD1' ' CE1' ' A' ' 172' ' ' PHE . 12.4 mt -127.41 128.92 46.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.326 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -101.28 133.5 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.053 0.454 . . . . 0.0 110.719 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -68.9 74.17 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.089 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.74 -161.61 0.4 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.368 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.72 -24.37 25.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.327 2.018 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -101.32 -1.95 32.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.04 -138.02 14.68 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.365 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.6 -33.59 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.844 0.355 . . . . 0.0 111.126 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.29 27.63 11.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.491 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CE1' ' CD1' ' A' ' 163' ' ' LEU . 3.7 p90 -170.58 -169.27 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.0 t -136.92 162.97 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -123.6 160.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.467 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -128.02 138.01 52.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -109.35 130.18 9.85 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.818 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -83.78 -23.2 53.77 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.425 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.5 t -89.88 120.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.66 -56.43 5.05 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.075 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.06 57.58 0.79 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.543 0.687 . . . . 0.0 109.391 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.445 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 6.6 tt0 -47.66 116.95 1.62 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.467 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 6.0 t60 -102.06 -25.16 13.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.952 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.433 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.1 mp -96.48 129.44 33.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.35 78.1 2.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.053 1.835 . . . . 0.0 112.829 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.57 50.96 0.63 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.748 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.13 123.87 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.741 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 28.74 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 -166.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.58 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 189' ' ' ILE . 1.4 mm -102.98 134.89 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.226 0.536 . . . . 0.0 110.522 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.3 m-85 -135.33 154.23 51.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.684 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 44.6 t -80.7 141.43 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.402 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.8 t -123.07 -26.04 4.43 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.61 137.18 18.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.912 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 194' ' ' ILE . 1.3 mm -121.28 135.25 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 195' ' ' ILE . 27.4 mm -81.33 118.39 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.52 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.57 23.97 16.05 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.136 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.18 -78.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.431 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -137.56 -58.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.954 0.407 . . . . 0.0 110.879 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.31 -45.92 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -59.13 -55.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.953 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -52.06 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.64 -50.51 20.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.4 -32.81 27.18 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.259 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 63.2 31.92 15.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.281 0.541 . . . . 0.0 110.259 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.7 pp -102.68 140.43 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.638 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 176.33 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.283 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 208' ' ' ILE . 51.1 mt -64.28 112.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.07 -17.0 2.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.865 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.9 147.87 32.94 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.923 0.362 . . . . 0.0 111.028 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 190' ' ' TYR . 0.1 OUTLIER -110.48 129.17 55.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.326 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 43.0 mm -92.17 116.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.5 -2.27 45.52 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.122 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 166.47 152.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 217' ' ' SER . 40.8 t -130.55 118.63 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.14 -84.51 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.317 0.386 . . . . 0.0 110.066 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 215' ' ' VAL . 50.4 m -139.94 11.69 2.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.23 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.1 p -109.19 140.71 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.65 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.21 108.72 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.442 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.37 50.6 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.457 0.646 . . . . 0.0 109.492 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 26.05 4.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.532 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -159.9 30.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.322 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.7 166.44 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.342 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 170.69 2.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.697 0.761 . . . . 0.0 112.256 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 62.9 t60 -57.74 -37.42 73.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.086 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.27 -52.53 46.64 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.5 -34.68 77.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.105 0.478 . . . . 0.0 109.886 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -60.93 -38.73 86.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.653 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.7 t -59.88 -41.52 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.136 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.45 72.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.411 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.23 -42.61 93.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.281 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.59 -41.94 62.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.491 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.08 -40.91 86.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.62 -20.41 32.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.786 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.411 ' CG2' HG23 ' A' ' 239' ' ' VAL . 21.2 p -66.09 -166.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 0.0 111.044 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.45 -150.14 0.33 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.329 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 165' ' ' LYS . 5.5 m-20 -44.4 -80.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.327 0.251 . . . . 0.0 111.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.6 121.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.985 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.411 HG23 ' CG2' ' A' ' 235' ' ' THR . 9.3 p -120.77 130.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 4.2 m-85 -99.74 120.67 40.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mt -96.92 137.92 35.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -107.26 120.74 42.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 52.8 t -122.58 147.58 26.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.251 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.26 131.79 56.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.151 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 128.13 44.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.01 50.31 3.07 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.18 1.92 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.99 153.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.74 78.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.058 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -91.22 172.61 8.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.809 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -112.22 118.44 35.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.7 120.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 18.9 ptm -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -95.49 143.81 26.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.549 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 35.6 mm -125.28 119.13 54.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -105.31 129.21 53.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 111.681 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.37 129.99 45.46 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.34 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.5 133.42 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.575 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -72.47 102.04 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.153 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.92 -153.86 20.99 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.936 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.31 -22.46 46.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.105 1.87 . . . . 0.0 112.364 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.73 -4.23 26.81 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.54 -138.94 14.89 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 3.9 mm? -57.07 -37.85 72.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.1 37.61 9.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.893 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -174.52 -166.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.398 . . . . 0.0 111.039 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.2 t -138.83 158.34 44.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.863 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -123.91 161.92 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.133 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -128.06 137.53 52.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 225' ' ' HIS . . . -110.91 129.84 9.48 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.807 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -85.77 -20.71 55.42 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.755 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.5 t -90.23 117.94 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.44 -56.55 5.01 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.181 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -112.88 55.23 0.7 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.635 0.731 . . . . 0.0 109.301 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.35 119.96 2.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.729 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.436 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 14.7 t60 -103.05 -31.0 10.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.931 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.441 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -97.14 125.09 47.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.214 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.69 78.98 0.95 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.15 1.9 . . . . 0.0 112.861 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.75 46.07 0.49 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.199 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.11 128.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -98.66 12.49 35.24 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.476 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -165.99 1.35 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 189' ' ' ILE . 1.0 OUTLIER -103.41 139.84 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.124 0.488 . . . . 0.0 110.559 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.441 ' CG ' HG12 ' A' ' 183' ' ' ILE . 29.5 m-85 -136.09 151.55 49.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.47 140.31 16.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.7 t -124.68 -25.45 3.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 9.8 tttp -149.27 135.41 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 111.761 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.01 135.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.186 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.22 117.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -36.39 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.49 23.88 29.13 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.076 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.0 -82.27 0.11 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.325 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.44 -57.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.2 85.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -62.52 -55.62 25.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.536 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -69.68 -52.2 27.84 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -74.08 -50.45 19.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.92 -29.98 33.11 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.913 -0.661 . . . . 0.0 114.488 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 61.41 33.56 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.307 0.554 . . . . 0.0 110.47 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.8 pp -101.01 142.13 32.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -121.6 171.99 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 53.2 mt -63.96 132.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.05 9.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.734 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.66 150.68 39.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.117 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.82 129.15 56.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.554 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 38.9 mm -89.88 117.38 33.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.3 pp -97.79 -2.24 41.5 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 166.31 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.243 -0.286 . . . . 0.0 110.853 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 24.5 t -132.3 119.27 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.234 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.4 m120 59.29 -85.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 p -141.98 13.49 2.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.893 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.8 p -109.39 140.33 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.69 100.57 2.16 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -108.97 48.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.716 0.769 . . . . 0.0 109.061 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.74 27.39 4.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.592 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.28 32.72 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.131 0.491 . . . . 0.0 110.124 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.401 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 7.6 p -149.38 166.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.101 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.74 169.19 3.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.736 0.779 . . . . 0.0 112.009 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.413 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 60.3 t60 -57.52 -36.4 71.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.84 -52.42 50.59 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.401 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 0.9 OUTLIER -61.65 -34.95 76.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.044 0.45 . . . . 0.0 109.985 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -60.88 -39.24 88.46 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.622 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.156 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.61 73.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.213 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -64.02 -40.87 97.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.086 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.5 mt -70.6 -40.88 72.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.126 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -37.31 86.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -20.76 43.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.554 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.5 p -70.38 -166.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.637 0.256 . . . . 0.0 111.069 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.94 -150.5 0.33 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.411 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 85.2 m-20 -43.42 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 122.442 0.297 . . . . 0.0 111.515 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.69 120.57 45.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.69 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.402 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 9.5 p -120.26 133.43 67.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -105.06 118.9 37.7 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.276 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.13 139.38 34.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -107.29 130.9 54.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 0.0 110.492 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.68 146.06 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.83 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.31 127.9 44.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.38 66.95 6.73 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.435 2.09 . . . . 0.0 112.423 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.02 156.65 41.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 59.8 34.73 21.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.146 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.916 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.0 -176.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -79.66 97.32 6.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.37 124.52 68.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.351 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.9 ptp -129.49 151.68 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -99.41 143.58 29.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 111.544 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 47.9 mm -118.09 117.93 56.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.498 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 129.28 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.35 129.78 39.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.066 179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 164' ' ' ILE . 0.2 OUTLIER -98.43 133.89 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 110.572 179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.1 OUTLIER -75.85 137.41 40.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.278 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -155.21 -153.29 6.47 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.379 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.83 -21.67 49.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.273 1.982 . . . . 0.0 112.586 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -97.0 -4.6 39.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.85 -127.73 8.13 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.643 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.725 0.298 . . . . 0.0 110.591 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.25 22.91 25.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.572 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.65 -171.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.2 t -133.16 164.36 27.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.49 158.5 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.157 0.503 . . . . 0.0 112.029 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.457 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -129.24 138.87 51.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.139 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.88 134.18 11.8 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.85 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.22 -24.58 47.31 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.614 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.4 t -89.98 120.28 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.31 4.97 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.374 -0.441 . . . . 0.0 113.112 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -118.09 56.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.448 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.9 tt0 -46.67 118.75 2.14 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.457 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 13.4 t60 -107.69 -24.22 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.375 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.424 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.77 133.24 24.7 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.86 80.86 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.096 1.864 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.21 55.76 0.76 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.875 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.68 131.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.42 30.43 5.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.3 t -111.04 -166.94 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 189' ' ' ILE . 1.2 mm -106.04 135.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 0.0 110.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.424 ' CG ' HG12 ' A' ' 183' ' ' ILE . 17.8 m-85 -133.98 152.83 52.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.734 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.421 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 29.4 t -80.41 140.62 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.502 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.5 t -123.29 -24.7 4.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.12 134.71 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 111.722 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.421 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 1.0 OUTLIER -120.81 135.21 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.114 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.3 mm -81.12 116.93 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.28 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.875 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.06 24.21 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.078 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.99 -71.36 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -140.02 -67.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.715 0.293 . . . . 0.0 111.098 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -60.47 -46.96 88.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -59.54 -55.96 27.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -70.53 -53.09 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.22 -50.21 20.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.1 -30.44 46.63 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.827 -0.701 . . . . 0.0 114.129 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.91 46.97 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.402 0.62 . . . . 0.0 109.98 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.27 139.63 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.082 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.44 169.27 9.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.975 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 208' ' ' ILE . 39.7 mt -61.57 119.17 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.577 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.18 -17.65 4.81 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.64 146.94 44.2 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 117.008 0.404 . . . . 0.0 110.696 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 190' ' ' TYR . 2.1 ptpt -106.78 128.59 54.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 29.0 mm -95.39 115.72 35.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.14 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.52 -9.68 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.971 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 176.21 148.09 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.765 0.316 . . . . 0.0 110.692 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.82 118.98 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.448 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 57.58 -85.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.005 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.1 m -139.0 13.09 2.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.618 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.34 141.27 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 122.534 0.334 . . . . 0.0 110.768 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -105.55 87.91 0.55 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.213 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -5.7 45.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 111.268 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -67.3 167.81 11.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 t70 46.83 26.27 0.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.962 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.36 165.24 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.643 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.82 168.25 11.89 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.703 0.763 . . . . 0.0 111.606 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.405 ' O ' ' CG2' ' A' ' 229' ' ' VAL . 58.0 t60 -58.37 -36.89 74.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.998 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -52.76 38.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -34.8 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.0 110.118 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -63.64 -38.86 92.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.963 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 225' ' ' HIS . 21.8 t -58.27 -42.08 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.16 77.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.222 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.28 93.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.173 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.5 mt -73.5 -42.32 61.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -58.75 -34.06 70.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -62.84 -20.23 64.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.399 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 26.2 p -64.49 -171.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.767 0.318 . . . . 0.0 111.151 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -143.1 -151.61 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.229 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.9 OUTLIER -43.03 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.538 0.335 . . . . 0.0 111.479 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.96 120.42 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.689 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.79 120.26 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -100.57 120.15 39.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.79 149.4 23.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.004 0.431 . . . . 0.0 110.522 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -108.62 118.26 36.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.196 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.27 149.2 27.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.967 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.14 133.44 28.69 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.023 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.9 115.24 3.01 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.273 1.982 . . . . 0.0 112.624 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.9 m -82.84 176.9 8.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.704 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 60.31 81.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.006 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -119.01 152.89 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.03 131.98 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.49 137.27 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -132.26 147.1 52.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -101.66 132.34 47.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.45 118.47 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.186 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -99.08 137.55 37.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.309 0.576 . . . . 0.0 112.295 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.42 ' CD1' ' CD1' ' A' ' 241' ' ' LEU . 5.7 mt -118.7 140.38 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.525 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 238' ' ' VAL . 19.9 mm -96.46 131.46 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.067 0.461 . . . . 0.0 111.16 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 57.03 2.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.262 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.06 -161.64 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.062 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -20.24 54.06 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.208 1.939 . . . . 0.0 112.689 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -96.68 8.27 44.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.3 -145.14 18.32 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.11 -37.27 82.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.761 0.315 . . . . 0.0 111.045 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.76 26.72 8.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.685 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.63 -169.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.017 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.6 t -134.84 158.62 43.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.77 160.21 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' A' ' 182' ' ' HIS . . . -127.0 138.15 53.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.414 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -110.17 129.45 9.36 Favored Glycine 0 CA--C 1.5 -0.847 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.964 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -78.1 -28.58 55.97 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.76 122.16 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.11 -55.37 4.96 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.936 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -116.63 49.77 1.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.497 0.665 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.3 tt0 -42.37 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 16.7 t60 -83.58 -28.11 28.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.129 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -96.52 129.64 32.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 81.91 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.056 1.837 . . . . 0.0 113.128 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.55 52.86 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.195 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.94 135.2 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.574 0.226 . . . . 0.0 110.74 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . 0.406 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.5 OUTLIER -108.12 24.14 13.44 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.83 -168.13 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 189' ' ' ILE . 2.4 mm -104.58 134.42 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.278 0.561 . . . . 0.0 110.281 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.42 ' CD1' HG12 ' A' ' 183' ' ' ILE . 26.0 m-85 -135.19 151.17 50.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 39.2 t -80.12 141.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.284 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.7 t -122.94 -23.01 5.1 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -150.36 134.19 16.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.75 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -119.78 135.38 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.18 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.01 118.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.422 . . . . 0.0 109.919 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -37.75 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 50.03 31.69 18.52 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.392 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.68 -75.94 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.363 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -134.86 -60.21 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 0.0 110.731 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.14 77.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.379 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -60.21 -56.13 25.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.528 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -70.53 -53.19 17.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -51.35 15.07 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.14 -31.04 53.99 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.822 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 60.56 30.45 19.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.125 0.462 . . . . 0.0 110.636 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.0 pp -102.31 129.14 48.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.19 173.81 6.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 208' ' ' ILE . 39.1 mt -64.44 113.44 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.38 -15.04 3.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.78 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.05 142.21 39.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.935 0.368 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 3.8 ttpm? -102.58 128.83 49.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.111 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 212' ' ' ILE . 30.4 mm -96.71 116.42 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.5 mt -79.3 -68.01 0.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.48 47.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 217' ' ' SER . 3.1 t -114.82 119.32 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 58.45 -84.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -140.32 12.94 2.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.839 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.69 139.87 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.003 0.43 . . . . 0.0 111.039 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.88 111.06 3.04 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.392 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.17 40.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 109.932 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -97.23 163.5 12.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.787 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 48.72 27.47 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.415 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 6.2 p -131.2 163.73 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.585 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -69.57 169.93 11.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.703 0.763 . . . . 0.0 112.176 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.414 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 58.8 t60 -56.93 -36.36 70.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.318 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -52.13 60.94 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.415 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 0.6 OUTLIER -60.13 -36.25 77.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.443 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -63.61 -39.22 93.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.999 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.88 -41.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.219 0.533 . . . . 0.0 109.595 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.25 -33.39 75.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.13 94.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.646 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 -47.3 37.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.877 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.45 -40.37 78.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.73 -20.34 33.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.899 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.402 ' CG2' ' CG2' ' A' ' 239' ' ' VAL . 16.7 p -65.99 -163.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.286 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -139.67 -150.58 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.52 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.872 0.469 . . . . 0.0 112.097 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 164' ' ' ILE . 23.7 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.361 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.402 ' CG2' ' CG2' ' A' ' 235' ' ' THR . 12.9 p -116.56 131.15 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -90.94 141.98 28.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.351 0.595 . . . . 0.0 111.421 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.42 ' CD1' ' CD1' ' A' ' 163' ' ' LEU . 6.8 mt -118.89 138.14 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.92 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -106.61 124.27 49.35 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.66 149.67 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.91 121.11 42.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.558 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.97 114.19 62.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.33 112.02 3.43 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.023 1.815 . . . . 0.0 112.431 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 t -143.79 36.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.786 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -88.87 -31.57 18.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.145 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.856 0.36 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.26 155.76 50.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.48 131.63 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.1 t -114.28 127.64 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 15.5 ptm -126.68 146.31 50.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.431 . . . . 0.0 111.351 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.96 140.76 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.06 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 36.6 mm -120.41 117.34 53.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -103.91 127.85 51.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.71 0.29 . . . . 0.0 111.73 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.446 ' CD1' ' CE1' ' A' ' 172' ' ' PHE . 0.9 OUTLIER -127.37 129.07 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.309 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -99.02 127.38 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.187 0.518 . . . . 0.0 110.693 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 79.47 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.848 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.73 38.64 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.14 -20.92 48.7 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.339 2.026 . . . . 0.0 112.431 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -99.29 -5.06 30.45 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.82 -133.71 12.01 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.078 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 172' ' ' PHE . 1.9 mm? -60.76 -36.02 77.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 80.2 33.29 32.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.045 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.446 ' CE1' ' CD1' ' A' ' 163' ' ' LEU . 3.7 p90 -177.09 -173.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.69 159.63 40.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.04 161.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.023 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.438 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -131.05 138.1 49.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -114.68 131.21 9.67 Favored Glycine 0 CA--C 1.502 -0.729 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.673 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -82.79 -22.16 58.41 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.54 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.87 117.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.98 5.02 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.077 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -113.09 55.0 0.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.528 0.68 . . . . 0.0 109.384 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.44 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.56 115.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.438 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 38.3 t60 -100.39 -32.14 10.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.537 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.411 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.2 mm -96.7 127.41 39.56 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.146 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.36 78.73 2.26 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.021 1.814 . . . . 0.0 113.079 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.4 10.14 4.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.016 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.01 134.58 44.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.525 0.662 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -106.74 26.27 10.21 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.28 -164.66 0.93 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.64 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.446 HD13 ' CB ' ' A' ' 228' ' ' ALA . 1.7 mm -105.64 132.46 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.243 0.544 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.411 ' CD1' HG13 ' A' ' 183' ' ' ILE . 9.8 m-85 -135.13 153.99 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.496 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 33.1 t -79.54 141.34 15.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.268 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 8.1 t -121.53 -21.55 6.2 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.32 136.79 14.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.964 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.41 HG23 ' CG ' ' A' ' 201' ' ' HIS . 1.9 mm -121.2 136.23 58.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -79.92 115.31 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.032 0.444 . . . . 0.0 109.809 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -37.76 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.932 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.03 50.8 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.827 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.03 -81.75 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -129.56 -60.94 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.932 0.396 . . . . 0.0 111.163 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.35 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.41 ' CG ' HG23 ' A' ' 194' ' ' ILE . 5.3 t-160 -63.75 -55.38 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -51.63 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.5 -49.1 28.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.1 -37.16 11.6 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.885 -0.674 . . . . 0.0 114.363 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.51 51.33 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.453 0.644 . . . . 0.0 109.936 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -116.64 139.76 50.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.779 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.5 165.13 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 208' ' ' ILE . 37.8 mt -60.8 112.45 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.85 -14.59 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.61 143.23 36.6 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.123 0.462 . . . . 0.0 111.141 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -103.95 129.22 51.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.302 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.5 mm -90.74 124.8 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 111.693 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.55 -39.11 11.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.581 0.705 . . . . 0.0 110.098 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -166.21 154.67 10.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 24.2 t -124.47 119.88 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.583 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 61.3 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.4 m -143.26 13.52 1.81 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.8 140.25 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 111.425 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.97 107.48 2.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.038 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.39 37.84 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.258 0.552 . . . . 0.0 110.242 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -99.56 162.85 12.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.473 0.654 . . . . 0.0 111.881 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 48.41 27.56 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.645 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 4.9 p -132.67 162.9 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 168.4 9.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.793 0.806 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.411 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 57.9 t60 -57.51 -36.32 71.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.929 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.17 -51.79 58.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.404 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 1.1 t70 -59.23 -36.64 75.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.032 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 16.6 t -56.38 -41.57 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.647 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.64 74.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.481 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.19 -50.35 66.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.867 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.6 -40.74 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.475 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -37.95 74.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.476 . . . . 0.0 111.481 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.49 -20.31 59.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.792 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.7 p -61.72 -163.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.403 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -138.35 -151.13 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.42 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.342 0.26 0 C-N-CA 122.391 0.277 . . . . 0.0 111.673 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.06 118.76 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.41 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 14.2 p -120.51 126.13 74.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.262 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.85 120.22 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.7 mp -98.13 142.7 29.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -107.12 118.09 35.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 37.7 t -123.5 149.19 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.099 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -132.86 128.03 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.579 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 109.44 42.67 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.43 84.3 1.19 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.14 1.893 . . . . 0.0 111.853 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.4 m -157.19 161.6 39.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -137.25 30.15 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.124 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -135.95 -179.79 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -95.86 138.9 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 120.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.648 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.38 155.18 48.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.397 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -124.08 126.98 47.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.963 0.411 . . . . 0.0 111.203 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 35.4 mm -99.32 118.92 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.583 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -106.36 127.94 53.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.565 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.22 152.22 51.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.866 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.99 130.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 90.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.26 170.89 44.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.549 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.3 -20.46 32.21 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.264 1.976 . . . . 0.0 112.645 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -2.0 35.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.08 -150.51 18.71 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.929 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.49 -37.52 81.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.04 29.29 10.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.701 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.55 179.3 1.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.6 t -124.64 164.0 20.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.0 162.65 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.319 0.581 . . . . 0.0 112.292 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.474 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -130.51 139.91 50.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.159 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.403 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -117.3 133.74 10.77 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.108 -1.044 . . . . 0.0 113.908 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -88.18 -15.41 60.76 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.716 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 5.4 t -90.68 115.55 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 117.604 0.702 . . . . 0.0 112.204 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -57.29 4.03 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.223 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.09 54.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.423 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.1 mt-30 -45.79 119.69 2.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.629 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.474 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 28.4 t60 -109.43 -28.42 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.72 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.74 121.72 58.85 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.797 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.61 80.76 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.217 1.945 . . . . 0.0 112.486 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.37 54.31 0.7 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.986 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.64 119.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -96.14 38.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 m -119.44 -166.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.009 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 189' ' ' ILE . 1.8 mm -104.67 135.74 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.128 0.49 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 25.6 m-85 -135.72 150.89 49.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.685 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.95 142.12 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.506 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.403 ' CG2' ' CB ' ' A' ' 175' ' ' ALA . 6.7 p -117.1 -39.76 3.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -137.53 137.99 39.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.899 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.2 mm -120.6 134.74 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.66 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.48 113.71 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.382 . . . . 0.0 110.101 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -36.42 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.463 -0.79 . . . . 0.0 113.123 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.55 21.3 27.49 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.247 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.78 -91.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.093 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -61.2 -46.53 90.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.23 -57.27 13.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -71.13 -52.8 17.24 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.55 -50.62 20.44 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.11 -33.5 49.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.714 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.5 34.99 17.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.126 0.489 . . . . 0.0 110.003 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.5 pp -108.07 139.94 41.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.222 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -115.99 -179.42 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 21.4 mt -69.18 134.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.34 -14.03 30.63 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.244 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.27 134.59 46.92 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.201 0.501 . . . . 0.0 110.936 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.404 ' O ' ' CG2' ' A' ' 243' ' ' VAL . 18.9 tttt -92.29 129.2 38.3 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 120.896 0.379 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 18.7 mm -109.78 138.61 36.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.481 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.2 pp -118.2 -9.31 10.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -170.59 153.4 4.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.973 0.416 . . . . 0.0 111.675 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.414 HG11 ' CG2' ' A' ' 239' ' ' VAL . 0.3 OUTLIER -125.62 118.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 28.1 t30 56.04 -87.48 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 215' ' ' VAL . 10.4 m -137.25 13.74 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.614 0.245 . . . . 0.0 110.637 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.4 p -109.24 140.57 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -99.6 92.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.597 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.75 -3.92 43.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -68.26 167.54 14.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 111.229 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.05 25.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.623 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.01 162.48 31.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.446 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 8.4 mtt -67.19 169.25 8.94 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.739 0.78 . . . . 0.0 111.955 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.403 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 53.5 t60 -58.29 -36.97 74.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.193 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.21 -52.34 42.36 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.1 -34.9 77.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 109.884 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.52 -38.85 88.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.686 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 225' ' ' HIS . 23.3 t -59.1 -41.61 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.258 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.6 74.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.299 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.79 -38.71 76.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.1 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.97 -39.74 65.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.658 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -33.61 76.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.161 0.505 . . . . 0.0 110.785 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.1 -20.3 65.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 71.2 p -51.86 176.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.74 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -139.33 -148.94 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -41.61 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.654 0.381 . . . . 0.0 111.785 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.43 124.95 59.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.414 ' CG2' HG11 ' A' ' 215' ' ' VAL . 8.1 p -113.6 120.21 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.416 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.93 118.27 35.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 109.65 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.6 mp -100.4 153.17 19.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.31 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.44 116.32 31.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 211' ' ' LYS . 7.1 p -113.24 144.56 20.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.436 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.49 122.74 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.765 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -102.11 133.88 20.39 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 108.3 2.66 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.17 1.914 . . . . 0.0 112.31 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.1 t -63.6 -24.64 67.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.644 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.98 -60.11 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.927 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.162 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.805 0.335 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.65 -179.66 4.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 94.8 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.96 131.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptm -132.15 152.23 51.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -100.53 139.37 36.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.5 mt -125.53 118.64 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.47 139.42 35.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.293 0.568 . . . . 0.0 112.13 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.29 129.55 45.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.026 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.91 134.49 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 111.64 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 94.34 2.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.925 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.45 -158.57 24.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.139 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.52 -23.34 75.08 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.234 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -101.86 -4.28 26.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.11 -136.5 13.63 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.444 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 3.9 mm? -59.75 -33.27 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.61 31.7 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.546 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -175.13 -172.93 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 110.871 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -132.98 160.49 36.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.882 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -121.95 155.99 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.165 0.507 . . . . 0.0 111.226 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.459 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -126.63 138.32 53.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.235 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.4 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.26 129.98 9.19 Favored Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.759 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.83 -16.0 66.5 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.696 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 t -90.96 115.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.672 0.736 . . . . 0.0 112.012 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.86 -57.74 4.27 Favored Glycine 0 C--N 1.329 0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.083 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -102.72 51.8 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.442 0.639 . . . . 0.0 109.684 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.2 mt-30 -45.23 117.9 1.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.459 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 24.1 t60 -105.87 -32.06 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.843 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.437 HG13 ' CD1' ' A' ' 190' ' ' TYR . 19.1 mm -95.47 126.05 47.26 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.338 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 77.62 1.19 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.29 1.993 . . . . 0.0 113.24 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.33 10.62 4.51 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.12 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -133.45 131.4 39.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.585 0.693 . . . . 0.0 111.348 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . 0.402 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 9.8 m120 -103.8 29.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.44 -165.01 1.01 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.42 HD13 ' CB ' ' A' ' 228' ' ' ALA . 1.4 mm -103.3 129.88 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.195 0.521 . . . . 0.0 110.421 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.437 ' CD1' HG13 ' A' ' 183' ' ' ILE . 4.5 m-85 -134.54 155.06 51.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.981 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.408 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 32.1 t -80.33 138.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.619 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 t -121.67 -19.07 6.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 133.17 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 0.0 111.609 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.408 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 0.3 OUTLIER -120.58 134.03 65.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 mm -82.31 117.65 28.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.401 . . . . 0.0 110.034 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -41.97 101.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.61 24.21 38.83 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.84 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.23 -89.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.329 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -131.44 -56.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.983 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.87 -46.3 75.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -59.99 -56.06 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.681 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -52.62 22.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.38 -51.13 15.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.46 -28.57 51.98 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.022 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 63.57 30.87 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.022 0.411 . . . . 0.0 110.522 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pp -102.91 141.12 36.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.05 167.86 13.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 208' ' ' ILE . 35.1 mt -59.0 106.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 145.48 -16.95 1.85 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.914 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.4 148.04 32.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.946 0.373 . . . . 0.0 110.894 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -112.21 130.34 55.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.821 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.6 mm -92.97 116.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.444 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.84 -10.39 39.95 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 172.12 145.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.499 0.32 . . . . 0.0 110.339 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.9 t -118.85 119.35 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.402 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 36.7 t30 56.56 -86.6 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.153 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 5.8 m -137.5 12.61 2.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.655 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.4 140.6 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.694 0.283 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.8 87.46 0.55 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.261 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.12 -9.05 57.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.107 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.67 168.22 11.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 0.0 110.873 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 t70 49.15 24.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.963 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.4 163.73 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.651 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -66.84 167.11 12.03 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.596 0.712 . . . . 0.0 111.447 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.4 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 58.6 t60 -58.01 -36.46 72.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.046 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -52.33 49.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -34.74 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.49 -38.38 87.11 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.565 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 37.6 t -59.16 -41.03 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.379 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.09 74.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.51 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.97 -45.39 81.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.321 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.12 -39.77 63.12 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -58.23 -46.52 85.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -57.81 -19.81 31.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.282 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.401 ' CG2' ' CG2' ' A' ' 239' ' ' VAL . 29.9 p -56.4 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.682 0.277 . . . . 0.0 111.372 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -153.07 0.45 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.371 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -42.49 -80.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.407 0.283 . . . . 0.0 111.55 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.6 p -98.15 116.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.052 0.453 . . . . 0.0 110.831 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 235' ' ' THR . 13.5 p -112.91 126.81 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.752 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.57 141.79 28.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.719 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.7 mt -118.16 136.56 53.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.491 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.41 117.72 34.84 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 73.6 t -125.2 151.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.81 125.96 54.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.84 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.89 109.72 41.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.893 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.38 82.92 2.13 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.179 1.92 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.32 138.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -103.7 82.63 2.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.073 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.922 0.392 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.48 -170.94 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.74 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.58 93.66 6.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.525 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.45 120.23 47.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.608 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 9.3 ptp -132.73 148.58 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -105.26 140.54 38.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.1 mt -104.87 119.24 53.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -99.54 119.92 38.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.412 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.3 pp -137.25 146.09 44.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.83 135.21 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.279 0.562 . . . . 0.0 111.783 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.83 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.395 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.46 156.0 7.51 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.512 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.39 -24.09 41.55 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.995 1.797 . . . . 0.0 112.245 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.22 15.37 29.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.69 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 119.24 -151.05 17.72 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.257 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.38 -37.05 66.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 0.0 110.926 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.09 34.22 6.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.402 ' CD2' HD12 ' A' ' 206' ' ' LEU . 0.3 OUTLIER -176.49 -172.7 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.3 m -137.69 157.64 46.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.59 162.52 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.276 0.56 . . . . 0.0 111.444 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.445 ' HB2' ' CG ' ' A' ' 182' ' ' HIS . . . -125.43 139.2 53.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.074 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.442 ' HA3' HD12 ' A' ' 189' ' ' ILE . . . -108.99 129.44 9.52 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.959 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -79.91 -31.11 40.57 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.559 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.28 123.2 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.12 -56.07 5.06 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.008 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -114.48 48.8 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.554 0.693 . . . . 0.0 109.542 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.424 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.0 tt0 -43.19 105.95 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.445 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 34.4 t60 -90.29 -31.72 16.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.786 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 10.6 mm -96.84 121.74 58.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.152 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.45 78.99 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.118 1.878 . . . . 0.0 113.111 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 128.55 6.64 4.59 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.114 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.36 129.43 44.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.6 0.7 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 27.7 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 -162.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.955 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.442 HD12 ' HA3' ' A' ' 176' ' ' GLY . 4.8 mm -102.33 137.3 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.482 0.658 . . . . 0.0 110.781 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 175' ' ' ALA . 14.1 m-85 -135.43 144.62 46.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.961 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 47.8 t -80.29 139.03 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.814 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.0 t -123.74 -14.66 7.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -155.32 133.27 11.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.068 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.407 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 1.2 mm -121.36 135.29 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.8 mp -80.77 118.01 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -38.36 100.72 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.946 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.8 22.97 35.73 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.127 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.73 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.225 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.82 -53.61 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 110.692 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -65.07 -45.53 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.42 -56.36 23.04 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -52.89 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.76 -50.42 20.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.53 -27.3 59.51 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.883 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 59.86 26.06 15.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.1 0.45 . . . . 0.0 110.797 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.402 HD12 ' CD2' ' A' ' 172' ' ' PHE . 3.7 pp -97.6 139.7 33.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -121.79 170.16 10.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.95 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.84 112.66 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.5 3.74 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.255 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.83 138.3 38.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.126 0.463 . . . . 0.0 111.296 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.39 129.82 40.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.316 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.8 mm -110.8 134.65 52.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.477 . . . . 0.0 111.899 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.06 -3.12 11.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.694 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -172.97 148.34 1.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.968 0.413 . . . . 0.0 111.523 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.06 119.97 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.054 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 61.26 -85.39 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.0 t -144.17 14.79 1.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.951 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.04 140.0 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.96 0.409 . . . . 0.0 111.595 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.65 102.95 2.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.261 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.403 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -100.29 38.33 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.531 . . . . 0.0 110.197 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -93.4 164.21 13.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.448 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.6 t0 45.38 29.99 0.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.504 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.67 167.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.2 mtm -75.41 172.72 12.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.779 0.8 . . . . 0.0 112.654 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 58.5 t60 -57.29 -38.51 74.08 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.362 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.33 -51.79 64.54 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -60.0 -36.32 76.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.85 0.357 . . . . 0.0 110.806 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -64.55 -38.89 92.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.2 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.7 -43.05 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.166 0.508 . . . . 0.0 109.631 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.97 -32.61 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.21 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -63.9 -39.32 93.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.542 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.1 mt -70.38 -42.93 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.61 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.02 -33.55 72.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.94 -25.2 66.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.0 p -56.17 -173.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.034 0.445 . . . . 0.0 111.638 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -145.21 -149.85 0.3 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -39.15 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.036 0.534 . . . . 0.0 112.383 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.02 120.93 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.885 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.03 119.97 57.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.52 118.81 34.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.731 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 4.9 mp -98.82 153.11 19.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -106.4 117.05 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.71 144.22 35.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.511 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -115.35 127.17 55.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.463 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -93.84 109.25 40.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.59 120.54 6.99 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.177 1.918 . . . . 0.0 111.908 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 4.9 p 50.62 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.455 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.26 -76.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.844 0.354 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -109.94 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -96.61 137.27 35.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.005 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.03 120.44 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.115 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.56 153.96 50.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.55 126.33 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.8 mt -98.4 118.9 45.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -106.62 121.92 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.4 pp -136.46 145.92 45.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.716 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.29 134.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.124 0.487 . . . . 0.0 111.473 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.67 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.391 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.42 166.89 8.42 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.779 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.38 -27.4 75.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.297 1.998 . . . . 0.0 112.317 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -101.65 15.56 28.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.875 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.52 -152.86 17.53 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.724 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.78 -34.47 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.726 0.298 . . . . 0.0 111.151 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.03 35.99 6.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.41 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -165.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.745 0.307 . . . . 0.0 110.688 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.9 t -139.52 162.48 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.54 159.86 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.214 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 182' ' ' HIS . . . -125.52 137.97 53.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 225' ' ' HIS . . . -109.12 130.47 10.03 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.859 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -82.4 -25.16 52.09 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.416 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.408 ' HB ' ' N ' ' A' ' 224' ' ' MET . 18.0 t -89.93 117.3 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -56.05 5.05 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.092 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -109.8 49.22 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.563 0.697 . . . . 0.0 109.31 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.427 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 6.2 tt0 -43.55 115.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.439 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 11.2 t60 -107.04 -26.32 11.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.497 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.412 HG12 ' CD1' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -96.22 126.74 43.01 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.35 81.24 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.151 1.901 . . . . 0.0 112.909 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.82 56.67 0.84 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.019 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 117.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.685 0.279 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -95.11 44.43 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.928 0.394 . . . . 0.0 111.066 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.17 -161.13 0.94 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.452 HD13 ' CB ' ' A' ' 228' ' ' ALA . 1.8 mm -111.66 134.44 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 211' ' ' LYS . 21.3 m-85 -135.45 154.28 51.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.633 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.418 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 36.2 t -80.22 143.18 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.753 0.311 . . . . 0.0 111.117 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' THR . . . . . 0.413 HG23 ' CE1' ' A' ' 182' ' ' HIS . 18.1 p -117.7 -49.37 2.55 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -136.58 139.38 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 111.95 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 194' ' ' ILE . 2.2 mm -118.22 136.36 55.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.753 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 195' ' ' ILE . 27.6 mm -79.64 113.85 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.444 . . . . 0.0 109.946 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -35.56 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.346 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.93 27.37 44.48 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.239 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -70.82 -70.82 1.12 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.386 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.16 -61.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -60.85 -45.34 94.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.107 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -59.31 -56.42 22.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.885 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -52.87 18.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.8 -50.87 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.21 -33.89 43.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.838 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 38.35 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.184 0.516 . . . . 0.0 110.399 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.7 pp -107.97 140.46 41.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.029 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -124.56 174.43 7.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.648 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.7 mm -64.21 127.74 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 121.59 -16.49 9.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.702 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.36 139.65 37.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.922 0.361 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.415 ' HB2' ' CE2' ' A' ' 190' ' ' TYR . 2.1 ttmt -100.61 128.8 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.249 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.8 mm -94.78 119.14 42.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.849 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.5 -5.49 42.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 175.3 154.26 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.15 120.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.68 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.2 t30 59.33 -86.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.7 m -141.14 12.98 2.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.913 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.43 140.59 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.34 104.71 2.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.672 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.1 33.56 2.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.449 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -93.57 158.87 15.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.405 0.621 . . . . 0.0 112.036 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 49.73 30.44 3.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.329 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 5.0 p -134.16 164.83 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.408 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.0 OUTLIER -68.19 169.54 10.18 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.745 0.783 . . . . 0.0 112.493 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.405 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 60.9 t60 -57.89 -36.57 72.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.861 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -51.46 60.44 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.44 -36.34 75.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.989 0.423 . . . . 0.0 110.918 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.452 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -64.97 -39.75 93.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.04 -41.47 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.239 0.543 . . . . 0.0 109.553 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.84 74.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.675 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.73 68.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.993 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.62 -40.73 63.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.769 0.318 . . . . 0.0 111.222 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -33.29 71.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.571 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -21.18 63.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.902 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 32.8 p -54.19 -175.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -136.17 -145.78 0.22 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -38.72 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 128.06 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 0.0 111.765 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 38.9 t -114.4 119.88 62.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.525 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.51 119.95 37.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.1 mt -96.73 145.77 25.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.937 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -107.86 117.15 33.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 75.7 t -127.85 150.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.378 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -123.82 123.51 40.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -93.09 129.73 38.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.39 103.98 1.5 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.17 1.913 . . . . 0.0 112.196 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 p -95.05 146.29 24.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.944 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -80.09 -59.56 2.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.05 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.778 0.323 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -146.89 -176.89 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.9 131.49 36.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 t -108.6 139.72 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.985 0.421 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.12 154.05 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.64 134.7 55.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 38.3 mm -119.37 118.78 58.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -99.71 131.65 45.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.5 mt -133.24 129.06 37.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.017 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -99.59 135.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.12 0.486 . . . . 0.0 111.12 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -76.08 98.71 4.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.833 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.46 -147.93 13.05 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.029 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.01 -22.91 34.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.486 2.124 . . . . 0.0 112.26 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -101.7 -4.44 26.48 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.96 -138.83 16.47 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.173 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.77 -37.38 73.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 81.41 39.2 12.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.793 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.53 -177.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.054 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t -133.24 158.87 41.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.27 162.17 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -128.62 138.42 52.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.526 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.419 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -108.86 130.35 9.99 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.007 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.422 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -82.37 -27.47 43.67 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.443 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 18.3 t -89.65 119.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.45 -55.83 5.04 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.047 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -112.6 50.42 0.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.529 0.68 . . . . 0.0 109.523 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.422 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 6.6 tt0 -43.81 115.91 0.89 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.453 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 7.3 t60 -106.8 -25.87 11.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.452 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.429 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -95.74 123.91 54.35 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.394 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.93 80.85 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.058 1.839 . . . . 0.0 112.27 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.71 55.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.26 123.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.749 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 28.37 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.81 -166.24 1.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 189' ' ' ILE . 1.9 mm -102.8 134.89 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.429 ' CG ' HG12 ' A' ' 183' ' ' ILE . 18.1 m-85 -134.45 153.13 52.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.588 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.424 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 49.0 t -80.29 142.06 14.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.084 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.2 t -124.47 -17.79 5.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -159.31 136.27 9.54 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.174 0.512 . . . . 0.0 112.061 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 194' ' ' ILE . 1.2 mm -120.85 135.12 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.747 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.54 117.66 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -36.95 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.005 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.11 23.75 25.76 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.999 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.74 -78.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.229 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -139.11 -57.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.772 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.97 -45.79 76.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -59.33 -55.73 31.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.876 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -51.45 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.36 -50.27 22.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.87 -34.8 29.74 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 114.096 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 66.26 34.66 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.153 0.477 . . . . 0.0 110.21 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.1 pp -102.5 140.17 37.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.992 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -117.59 169.62 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.902 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 208' ' ' ILE . 34.1 mt -62.97 127.78 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.768 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.91 -21.34 7.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.778 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.85 159.82 29.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 111.242 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.96 129.89 56.34 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.362 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 32.4 mm -100.29 117.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.562 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.67 -5.74 34.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 175.26 149.66 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.85 0.357 . . . . 0.0 111.297 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.87 119.18 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.895 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 57.9 -85.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.217 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 59.6 p -139.35 10.99 2.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.26 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.8 140.74 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.46 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.12 106.08 2.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.223 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.418 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -99.15 37.54 1.53 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.143 0.497 . . . . 0.0 110.269 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -98.6 166.65 11.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.338 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 46.12 27.98 0.6 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.903 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.78 164.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.762 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.46 169.26 14.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.733 0.778 . . . . 0.0 112.093 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.419 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 61.8 t60 -57.27 -36.85 71.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.76 -52.38 51.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -35.64 76.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.678 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.435 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.024 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.77 -41.72 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.247 0.546 . . . . 0.0 109.855 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.657 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.418 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -66.54 -50.39 63.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.0 pp -73.27 -40.03 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -36.39 84.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.372 . . . . 0.0 111.825 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -20.53 46.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.661 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.404 ' CG2' HG23 ' A' ' 239' ' ' VAL . 28.3 p -58.14 -172.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.274 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.11 -149.81 0.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.389 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 165' ' ' LYS . 55.6 m-20 -45.03 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 121.16 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.929 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.404 HG23 ' CG2' ' A' ' 235' ' ' THR . 12.5 p -120.6 128.01 75.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.116 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.5 OUTLIER -101.62 120.41 40.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 mp -96.73 142.2 29.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -106.5 121.35 44.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.365 0.602 . . . . 0.0 110.102 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 54.0 t -120.28 150.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.474 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.83 126.17 51.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -93.42 117.74 67.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.964 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.66 67.95 8.44 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.179 1.919 . . . . 0.0 112.186 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.7 t 60.77 174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -146.92 -70.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.042 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.293 -0.861 . . . . 0.0 111.031 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.921 0.391 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.24 -177.01 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -108.71 108.6 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.16 129.19 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 ptp -128.61 140.97 51.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -98.04 138.51 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 34.7 mm -124.97 119.52 56.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 10.1 ttpp -110.23 133.63 53.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.81 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.41 129.88 43.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.141 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.41 122.97 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.192 0.52 . . . . 0.0 110.09 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.76 90.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.267 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.59 43.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.97 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.06 -21.33 72.23 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.239 1.959 . . . . 0.0 112.334 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -102.25 -4.28 25.96 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.92 -147.47 18.1 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.14 -38.06 87.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 111.338 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.6 35.49 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -173.43 -170.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 m -133.95 163.47 29.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.45 158.15 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.053 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -129.4 138.0 51.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.4 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.31 133.05 11.02 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.889 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -85.95 -20.41 55.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.847 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.2 t -89.36 117.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.69 4.83 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.919 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.52 54.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.205 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.464 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 3.0 tt0 -46.45 118.87 2.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.451 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 35.2 t60 -103.0 -30.47 10.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.999 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.428 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.3 mm -95.96 133.48 25.25 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.76 75.44 4.47 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.045 1.83 . . . . 0.0 112.961 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.19 20.13 3.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.687 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -141.48 126.81 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.383 0.592 . . . . 0.0 111.153 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -101.92 42.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.3 -164.79 1.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.324 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.444 HD11 HG21 ' A' ' 189' ' ' ILE . 1.4 mm -105.28 133.49 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 110.111 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.428 ' CD1' HG13 ' A' ' 183' ' ' ILE . 20.7 m-85 -134.87 153.68 51.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 21.2 t -80.21 141.4 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.335 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 t -122.69 -20.18 6.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -157.58 136.14 11.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.046 0.451 . . . . 0.0 111.995 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.406 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 1.2 mm -120.24 135.15 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.8 mm -81.19 117.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -37.4 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.94 24.04 40.76 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.982 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.85 -67.85 1.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.28 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.56 -58.27 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -63.32 -47.08 83.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -59.42 -56.34 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.759 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -51.98 29.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.42 -50.65 20.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -83.74 -32.12 25.09 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.461 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.42 45.78 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.357 0.579 . . . . 0.0 110.202 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.52 140.23 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.089 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.68 164.02 15.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.546 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 42.1 mt -57.67 139.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.94 -18.75 28.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.81 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.11 144.23 45.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.414 ' HG3' ' CE1' ' A' ' 190' ' ' TYR . 3.3 ttpm? -104.97 129.46 53.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.285 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.1 mm -91.21 116.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.7 pp -90.14 -8.43 51.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 166.55 155.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 0.0 110.523 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 23.3 t -131.13 119.39 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.159 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.72 -85.57 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.9 t -141.56 13.38 2.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.146 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.16 140.23 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.383 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -102.28 100.1 1.95 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.218 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.21 45.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.503 0.668 . . . . 0.0 109.387 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.84 27.11 5.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.422 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -158.94 29.82 0.21 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.338 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 227' ' ' ASP . 8.8 p -152.43 166.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.046 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 17.1 mtt -58.52 168.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.738 0.78 . . . . 0.0 112.793 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.4 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 57.2 t60 -57.4 -35.52 70.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.58 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.38 -51.81 57.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.615 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.416 ' HB2' HG23 ' A' ' 223' ' ' VAL . 1.1 m-20 -59.91 -36.09 76.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -62.91 -38.87 92.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.81 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.7 t -57.52 -41.32 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.55 74.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.53 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.16 -43.0 88.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.563 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.4 -46.37 49.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.45 -34.16 70.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.176 0.513 . . . . 0.0 111.152 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -60.35 -20.76 60.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.356 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.8 p -69.42 -166.59 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.902 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.68 -148.98 0.26 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.504 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.74 -81.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.49 118.55 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.015 0.436 . . . . 0.0 110.742 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.407 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 12.3 p -120.23 136.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.207 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.2 m-85 -106.74 119.33 39.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.151 0.5 . . . . 0.0 111.736 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.06 134.81 45.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.26 133.87 51.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.824 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 69.2 t -130.81 148.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.482 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.7 124.47 51.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 111.22 51.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.212 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.6 101.52 1.2 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.272 1.982 . . . . 0.0 112.368 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.8 m -157.86 161.41 38.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -84.35 116.81 23.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.995 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.801 0.334 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -95.79 178.55 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -88.15 145.45 25.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.101 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.17 130.02 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.774 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.78 45.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 0.0 111.419 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.4 131.38 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 30.5 mm -120.67 133.87 65.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.813 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.448 ' CD ' ' CE2' ' A' ' 240' ' ' TYR . 27.2 ttpt -122.01 129.22 52.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.527 0.204 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' A' ' 172' ' ' PHE . 2.0 mt -127.32 141.17 51.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.563 0.22 . . . . 0.0 110.429 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.78 132.55 53.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 110.592 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.39 82.59 1.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.817 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.2 -167.4 38.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.156 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.26 -20.4 66.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.185 1.923 . . . . 0.0 112.407 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -96.77 -2.13 44.91 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.1 -148.95 17.4 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.437 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.02 -37.37 76.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.006 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 100.32 19.29 19.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.212 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.453 ' CE1' ' CD1' ' A' ' 163' ' ' LEU . 1.5 p90 -170.6 -170.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.934 0.367 . . . . 0.0 110.803 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.75 161.84 34.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.018 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.58 159.53 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.783 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.449 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -129.53 137.69 50.92 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.02 129.9 9.75 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 120.003 -1.094 . . . . 0.0 114.147 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -81.55 -22.6 59.9 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.402 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.3 t -89.85 116.51 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.14 -56.0 5.05 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.996 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -110.23 52.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.418 0.628 . . . . 0.0 109.322 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.429 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 6.7 tt0 -46.35 114.3 0.78 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.449 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 6.4 t60 -103.13 -25.41 13.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.1 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.438 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -95.34 132.21 28.23 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.204 -179.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.26 79.97 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.147 1.898 . . . . 0.0 112.831 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.5 55.17 0.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.965 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -169.21 130.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.648 0.261 . . . . 0.0 110.937 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.12 28.78 6.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.8 t -111.32 -162.89 0.82 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.25 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.447 HD13 ' CB ' ' A' ' 228' ' ' ALA . 1.9 mm -106.36 133.21 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.283 0.564 . . . . 0.0 110.483 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.438 ' CG ' HG12 ' A' ' 183' ' ' ILE . 22.9 m-85 -135.14 154.59 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 42.7 t -80.14 141.21 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.656 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.0 t -121.91 -26.12 4.86 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 137.59 22.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.922 0.392 . . . . 0.0 111.641 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 194' ' ' ILE . 1.2 mm -120.95 135.74 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.543 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.01 114.16 21.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -39.8 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.819 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.54 31.25 57.22 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.059 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.06 -53.94 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -162.8 -57.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.004 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.45 -45.57 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -60.03 -56.58 19.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.664 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -52.1 25.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.67 -50.57 20.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.402 ' HA2' ' CD2' ' A' ' 163' ' ' LEU . . . -77.79 -31.61 48.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.897 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 61.71 30.59 18.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.987 0.422 . . . . 0.0 110.354 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.4 140.48 40.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.861 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -125.82 177.32 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 208' ' ' ILE . 55.5 mt -61.58 114.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 135.33 -17.67 4.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.907 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.67 149.34 32.85 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.901 0.351 . . . . 0.0 111.189 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -109.04 129.91 55.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 212' ' ' ILE . 22.5 mm -94.35 119.09 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.651 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.3 pp -94.91 -9.23 34.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 174.15 152.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.412 ' CG1' HG23 ' A' ' 239' ' ' VAL . 4.3 t -122.99 119.34 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.967 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 57.98 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 94.2 p -140.54 14.02 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.596 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.41 139.73 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.287 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.78 107.11 2.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.971 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.63 39.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.195 0.522 . . . . 0.0 110.607 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.26 168.77 10.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.46 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.0 p30 47.13 26.75 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.105 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 5.4 p -135.8 163.4 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.808 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 mtm -67.13 170.25 7.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.739 0.78 . . . . 0.0 111.903 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.417 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 67.4 t60 -57.42 -36.05 70.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.253 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -62.3 -52.35 64.04 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.49 -36.55 78.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.577 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.447 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.53 -38.59 87.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.023 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.32 -41.78 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.619 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.83 76.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.8 96.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.607 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.2 -41.74 63.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -57.42 -41.05 79.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.178 0.513 . . . . 0.0 111.591 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.54 -19.97 42.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.91 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 18.4 p -67.39 -171.49 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 111.439 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -143.89 -145.47 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.342 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -44.47 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 118.004 0.365 . . . . 0.0 111.696 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.55 119.78 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.412 HG23 ' CG1' ' A' ' 215' ' ' VAL . 9.8 p -118.07 131.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.784 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 7.2 m-85 -102.18 118.11 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.265 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 161' ' ' ILE . 4.1 mp -97.37 139.73 32.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.01 130.71 54.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.175 0.512 . . . . 0.0 110.348 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.89 148.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.0 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.28 131.98 54.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.755 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -93.33 116.13 66.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.071 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.06 118.33 4.37 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.138 1.892 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 64.0 m -118.35 147.02 43.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.054 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.2 m120 67.59 -69.48 0.14 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.174 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.0 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -99.7 -165.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 119.78 40.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.797 0.332 . . . . 0.0 111.071 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 13.2 t -100.14 139.71 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.175 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.73 152.7 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.297 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -112.62 120.6 42.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 41.2 mm -100.36 118.54 47.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.375 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.53 132.4 48.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.14 129.57 31.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.856 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 164' ' ' ILE . 0.2 OUTLIER -97.97 135.16 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 0.0 111.42 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 91.37 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.669 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.87 -165.61 32.92 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.368 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -20.54 50.53 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.197 1.931 . . . . 0.0 112.214 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.26 -4.49 31.8 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.42 -135.15 12.88 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.338 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.74 -37.86 77.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.807 0.337 . . . . 0.0 110.96 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 86.87 27.26 29.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.098 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -175.21 -172.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -131.0 160.91 33.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.42 155.55 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.458 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -129.48 138.0 51.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -113.67 136.44 13.36 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.0 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -88.17 -21.07 46.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.535 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.12 116.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.43 -57.46 4.44 Favored Glycine 0 C--N 1.329 0.15 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.91 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -104.99 49.46 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.484 0.659 . . . . 0.0 109.323 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.45 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 3.9 tt0 -44.41 112.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.458 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 45.4 t60 -97.78 -30.94 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.782 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.438 HG13 ' CD1' ' A' ' 190' ' ' TYR . 18.3 mm -96.72 127.9 37.81 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.398 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.68 78.37 2.44 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.005 1.804 . . . . 0.0 112.876 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.26 10.97 3.56 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.049 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.75 136.72 42.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.572 0.686 . . . . 0.0 111.333 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -108.74 30.68 6.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.428 ' HB3' ' CE1' ' A' ' 190' ' ' TYR . 5.0 t -116.28 -164.25 0.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 189' ' ' ILE . 1.1 mm -109.11 131.32 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.082 0.468 . . . . 0.0 110.541 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.438 ' CD1' HG13 ' A' ' 183' ' ' ILE . 3.1 m-85 -135.1 155.58 50.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.11 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.8 t -79.79 140.27 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.585 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 4.1 t -124.67 -14.74 6.72 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.49 133.59 12.43 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.062 0.458 . . . . 0.0 111.566 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.09 134.45 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.019 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.0 118.37 29.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.086 0.47 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -41.99 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.485 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.69 28.68 57.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.868 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.09 -80.17 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.34 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -137.99 -62.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -62.14 -46.38 89.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.21 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -62.25 -55.86 24.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.661 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -69.79 -52.62 23.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -74.47 -50.93 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.47 -29.32 36.65 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.337 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 64.69 32.11 11.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.392 0.596 . . . . 0.0 110.508 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.6 pp -102.88 140.45 37.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.752 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -123.67 175.65 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 111.08 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 39.7 mt -62.32 115.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 133.16 -17.9 4.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.53 154.78 40.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.034 0.417 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -112.6 129.91 56.21 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.42 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 212' ' ' ILE . 14.8 mm -102.03 116.03 44.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.67 -12.96 26.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -178.94 148.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.872 0.368 . . . . 0.0 111.531 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.0 119.53 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.1 t30 56.55 -87.8 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.4 m -135.98 11.0 3.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.657 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.4 p -109.63 140.82 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 122.549 0.339 . . . . 0.0 110.661 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.84 105.44 2.64 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.525 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.76 30.11 3.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.113 0.483 . . . . 0.0 110.144 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.71 163.93 12.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 23.4 t70 45.04 27.77 0.32 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.653 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.3 p -133.12 165.81 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.438 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.07 165.39 18.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.607 0.718 . . . . 0.0 111.794 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -57.59 -35.82 70.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.676 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -35.98 76.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.413 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -62.96 -38.66 91.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.008 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.78 -42.18 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.718 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.25 79.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.356 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.51 97.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.8 mt -74.03 -40.43 62.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.019 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -55.35 -46.31 76.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -60.75 -20.22 60.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.571 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 43.9 p -54.58 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.73 0.3 . . . . 0.0 111.562 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.66 -151.8 0.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -45.35 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.861 0.3 . . . . 0.0 111.2 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -93.98 120.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.741 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 9.5 p -115.07 119.32 61.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.085 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.88 119.5 38.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.915 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.66 151.38 20.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 117.9 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.822 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.47 152.23 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.75 120.92 36.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.84 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -93.7 122.02 63.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.28 130.46 7.18 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.157 1.904 . . . . 0.0 112.455 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.2 160.24 14.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.76 -74.94 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.866 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.182 179.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -71.51 -177.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.702 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.9 111.23 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.857 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.98 125.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.243 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.29 152.1 38.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.01 146.81 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 31.1 mm -123.18 119.14 56.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.716 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -107.81 119.45 39.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.614 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.17 138.7 40.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.439 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.89 131.57 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 0.0 110.981 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 90.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.6 171.98 5.28 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.671 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.06 -31.76 91.18 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.101 1.867 . . . . 0.0 112.399 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.23 15.67 28.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.54 -160.42 13.43 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.42 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -27.2 68.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.52 0.2 . . . . 0.0 111.405 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.81 41.84 5.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.656 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -175.61 -173.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.818 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -134.26 156.11 48.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.94 160.86 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 182' ' ' HIS . . . -130.57 139.36 50.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.218 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.426 ' HA3' HD12 ' A' ' 189' ' ' ILE . . . -110.83 132.27 10.85 Favored Glycine 0 CA--C 1.502 -0.751 0 C-N-CA 120.141 -1.028 . . . . 0.0 114.336 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.24 -24.05 49.24 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 114.927 -0.636 . . . . 0.0 113.227 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.0 117.06 32.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.67 -57.51 4.75 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.884 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.91 45.97 0.94 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.415 0.626 . . . . 0.0 109.46 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.448 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -42.3 112.16 0.31 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.438 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 21.9 t60 -98.73 -30.11 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.616 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 8.9 mm -96.57 124.87 49.22 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.24 77.74 2.39 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.778 1.652 . . . . 0.0 112.469 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.15 14.56 2.69 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.043 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -139.14 131.16 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.621 0.71 . . . . 0.0 111.117 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.77 25.28 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.2 t -110.06 -164.61 0.94 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 189' ' ' ILE . 2.2 mm -101.75 134.3 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.205 0.526 . . . . 0.0 110.095 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -133.37 148.81 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.524 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.4 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 34.3 t -79.99 141.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.608 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.0 t -121.97 -26.67 4.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -147.63 136.57 22.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 111.822 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -121.52 135.87 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.157 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.0 mm -80.61 114.0 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.75 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.718 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.24 25.23 53.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.881 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.24 -108.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.2 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -106.3 -62.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -66.64 -45.13 80.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.569 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -59.08 -57.41 13.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -53.16 18.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.67 -50.99 15.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.99 53.21 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.813 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 62.15 28.42 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.913 0.357 . . . . 0.0 110.803 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.9 pp -99.41 139.13 35.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.279 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.96 177.34 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 40.0 mt -64.43 126.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.732 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.43 -14.9 10.8 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.93 145.79 33.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.057 0.429 . . . . 0.0 110.858 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.401 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 13.2 ttmt -103.05 128.57 49.86 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 33.9 mm -99.98 120.49 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 112.141 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.46 -60.72 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.239 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -134.39 155.4 50.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.961 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.14 120.41 58.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.911 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 59.99 -85.21 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.4 m -142.86 13.45 1.89 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.829 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.77 140.43 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.021 0.439 . . . . 0.0 111.659 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.96 104.93 2.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.082 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.404 ' HB3' ' CB ' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -99.16 37.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 110.704 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -91.93 159.29 15.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.845 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 48.39 31.23 2.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.486 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 3.9 p -133.58 161.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.008 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 11.1 mtt -68.32 170.03 9.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.716 0.77 . . . . 0.0 112.117 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.419 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 57.3 t60 -57.33 -36.88 71.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.306 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.65 -51.81 60.61 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.409 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 1.1 t0 -59.64 -36.43 76.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.438 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.976 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.1 t -57.16 -41.81 78.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.01 75.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.202 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 220' ' ' LEU . . . -64.82 -40.28 94.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.604 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.05 -48.74 56.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -58.41 -33.68 69.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.07 0.462 . . . . 0.0 111.404 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -59.33 -21.24 59.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.2 p -63.51 -166.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.729 0.3 . . . . 0.0 111.088 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.85 -148.28 0.25 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' A' ' 240' ' ' TYR . 0.5 OUTLIER -96.54 123.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 16.7 t -111.84 137.11 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.722 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 2.1 m-85 -115.61 118.74 33.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.671 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.77 139.35 33.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -106.92 130.04 54.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 211' ' ' LYS . 60.9 t -136.97 149.6 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.23 121.79 37.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.066 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.76 134.14 26.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.288 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.7 109.59 2.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.226 1.951 . . . . 0.0 112.326 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 m -60.94 150.75 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.988 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -164.86 114.09 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.073 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.814 0.34 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.16 176.65 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -80.25 105.2 11.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.86 137.23 26.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.576 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.09 147.56 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.592 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -115.55 120.69 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.2 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 31.9 mm -109.76 118.19 56.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.675 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -103.91 129.06 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.33 132.32 51.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.11 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 164' ' ' ILE . 0.4 OUTLIER -97.06 124.51 49.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 110.353 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 87.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.27 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.07 179.01 53.55 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.125 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.6 -20.37 33.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.187 1.924 . . . . 0.0 112.394 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.91 8.18 41.24 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.97 -150.27 18.22 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.35 -37.99 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.73 0.3 . . . . 0.0 111.288 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 100.9 33.39 5.0 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.005 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.418 ' CD2' HD12 ' A' ' 206' ' ' LEU . 0.2 OUTLIER -173.89 -166.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.093 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -137.4 161.54 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.794 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.33 158.51 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.462 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -127.13 137.65 53.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.494 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -109.43 130.14 9.82 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.783 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -83.83 -23.39 52.97 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.63 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.91 116.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.48 -56.27 4.69 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.995 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.79 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.345 0.593 . . . . 0.0 109.434 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.431 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 5.3 tt0 -43.61 112.92 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.462 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 5.8 t60 -104.3 -25.0 13.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.326 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.15 130.32 31.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.332 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.6 76.52 3.21 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.104 1.869 . . . . 0.0 112.779 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.62 48.41 0.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.05 123.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.65 25.33 5.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.295 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -109.61 -168.14 1.29 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.465 HG22 HD11 ' A' ' 189' ' ' ILE . 1.6 mm -99.51 136.88 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.197 0.522 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 20.6 m-85 -135.5 152.29 51.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 29.7 t -80.18 140.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 t -125.14 -24.02 4.09 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -150.56 136.55 18.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.104 0.478 . . . . 0.0 111.889 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.425 HG23 ' CG ' ' A' ' 201' ' ' HIS . 1.3 mm -121.12 135.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.182 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.13 113.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -36.48 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.83 40.19 49.01 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.202 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.06 -60.74 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.96 -61.96 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.751 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -65.24 -46.59 79.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.297 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . 0.425 ' CG ' HG23 ' A' ' 194' ' ' ILE . 6.6 t-160 -61.42 -56.13 23.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.01 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -52.36 25.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -74.31 -50.74 17.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.41 -36.64 26.25 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 121.086 -0.578 . . . . 0.0 114.167 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 39.38 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.05 0.453 . . . . 0.0 110.681 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.418 HD12 ' CD2' ' A' ' 172' ' ' PHE . 1.7 pt? -109.61 140.33 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.536 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -121.79 171.71 8.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 0.0 111.159 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 208' ' ' ILE . 53.5 mt -62.49 120.63 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.64 -19.55 4.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.9 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.66 152.51 31.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.85 0.325 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.402 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 0.3 OUTLIER -113.52 129.22 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.387 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 31.8 mm -90.08 119.24 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 111.507 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -26.42 20.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -171.89 149.21 2.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 217' ' ' SER . 2.5 t -117.42 119.0 60.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.83 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 56.2 -85.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 215' ' ' VAL . 9.5 m -138.18 12.18 2.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.663 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -109.63 140.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-O 120.922 0.391 . . . . 0.0 111.056 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.02 89.49 0.71 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.728 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.4 ' O ' ' CG1' ' A' ' 223' ' ' VAL . 0.4 OUTLIER -71.72 -7.66 49.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.37 178.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -62.29 168.72 3.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.194 0.521 . . . . 0.0 110.831 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 t0 47.52 25.5 0.65 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 220' ' ' LEU . 2.9 p -136.44 164.41 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.807 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.5 168.87 11.94 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.65 0.738 . . . . 0.0 111.576 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -57.96 -37.21 73.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.042 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.94 -52.88 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -34.34 76.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 109.888 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -61.95 -38.77 89.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.778 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.0 t -59.41 -41.72 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.767 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.44 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.703 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.29 -50.66 62.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.867 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.57 -39.67 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -59.05 -39.62 82.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.402 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -59.09 -20.34 52.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.741 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . 0.4 ' CG2' HG23 ' A' ' 239' ' ' VAL . 34.6 p -57.75 -172.17 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.574 0.226 . . . . 0.0 111.323 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -133.88 -146.9 0.27 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.877 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -81.95 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 122.543 0.337 . . . . 0.0 111.792 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.27 122.34 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.408 HG23 ' CG1' ' A' ' 215' ' ' VAL . 12.9 p -117.53 132.69 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.9 m-85 -105.4 119.45 39.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.922 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 mp -97.71 140.59 31.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.51 117.74 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.213 0.53 . . . . 0.0 110.215 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 211' ' ' LYS . 65.2 t -117.61 147.81 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.069 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.35 121.25 39.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.733 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 122.4 61.86 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.73 91.38 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.002 1.802 . . . . 0.0 112.192 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -174.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.158 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -164.51 86.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.135 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -126.67 -170.6 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -116.58 105.02 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 p -101.76 127.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.743 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.0 ptm -124.58 154.4 40.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.313 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.03 130.89 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.398 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.9 mm -100.52 117.09 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -98.66 125.12 43.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.108 0.48 . . . . 0.0 112.273 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.28 129.51 31.59 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.39 131.08 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.123 0.487 . . . . 0.0 111.292 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 69.31 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.52 -160.22 7.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.27 -20.13 49.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.132 1.888 . . . . 0.0 112.401 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -92.26 -4.63 53.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.36 -149.41 19.45 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.57 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.427 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 4.2 mm? -56.96 -37.87 72.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 110.982 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.2 26.41 18.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.972 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 4.1 p90 -174.97 -168.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 110.943 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.0 m -135.65 163.85 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.585 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -129.17 161.17 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 111.301 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.453 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -128.92 137.88 51.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -112.31 130.34 9.53 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.712 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -84.86 -18.23 61.83 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.558 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.96 117.76 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.38 -57.87 4.67 Favored Glycine 0 C--N 1.329 0.141 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.055 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -109.78 57.39 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.592 0.71 . . . . 0.0 109.301 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.445 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 3.2 tt0 -48.5 116.26 1.52 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.453 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 10.0 t60 -101.6 -27.02 13.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.913 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.417 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.24 134.57 23.43 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 79.41 2.59 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.138 1.892 . . . . 0.0 113.101 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.52 50.95 0.73 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.242 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -168.9 131.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.663 0.268 . . . . 0.0 110.884 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.065 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -169.1 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 189' ' ' ILE . 1.5 mm -102.69 134.96 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.253 0.549 . . . . 0.0 110.112 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.417 ' CG ' HG12 ' A' ' 183' ' ' ILE . 15.3 m-85 -133.84 155.35 50.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.626 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.428 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 40.3 t -80.28 141.44 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.329 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 7.9 t -125.53 -21.55 4.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -153.42 136.13 15.27 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.683 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 194' ' ' ILE . 2.5 mm -120.87 135.91 59.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.69 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.5 mm -80.17 116.88 25.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 110.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -37.03 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.023 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.74 27.19 34.9 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.981 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.56 -115.53 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.42 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -98.58 -57.42 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 111.075 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.15 71.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.905 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -59.52 -56.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.24 -52.74 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -74.0 -51.36 16.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.0 -38.19 36.19 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.728 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.28 41.21 4.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.292 0.568 . . . . 0.0 110.198 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.28 140.23 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -118.77 179.53 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.763 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 7.4 mm -72.41 113.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.058 0.456 . . . . 0.0 111.556 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.2 -13.57 3.54 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.662 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -78.93 159.3 27.78 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 117.038 0.419 . . . . 0.0 110.982 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 130.12 53.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 32.7 mm -93.17 117.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.409 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.33 -4.97 44.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 166.63 153.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.755 0.312 . . . . 0.0 110.347 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.418 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 42.7 t -132.23 119.63 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 59.94 -84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.44 13.02 1.96 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.07 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.31 139.84 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.943 0.401 . . . . 0.0 111.529 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.14 101.9 2.33 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.387 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.17 45.66 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.478 0.656 . . . . 0.0 109.65 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 26.78 4.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.164 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -158.12 32.19 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.952 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 7.0 p -153.4 166.1 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.9 mtm -62.13 168.43 3.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.632 0.729 . . . . 0.0 112.076 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -56.93 -36.18 69.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.031 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.15 -52.89 52.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.4 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -62.36 -34.98 77.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.166 0.508 . . . . 0.0 109.929 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -60.67 -38.39 84.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.664 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.2 t -59.52 -41.64 85.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.89 -33.22 72.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.058 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.3 -41.15 96.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.896 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.99 -41.9 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.102 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -61.77 -39.57 92.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.149 0.499 . . . . 0.0 111.237 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -60.67 -19.61 58.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 30.2 p -57.73 -166.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.761 -0.2 . . . . 0.0 110.928 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -152.93 -160.74 1.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.233 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -28.82 -61.6 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.21 126.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.418 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 4.2 p -120.65 126.11 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 121.32 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.763 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.24 146.57 24.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.067 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.39 118.02 35.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.022 0.439 . . . . 0.0 109.936 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.56 148.77 32.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.983 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.2 121.46 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 122.32 60.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.031 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.69 93.27 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.131 1.888 . . . . 0.0 112.195 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.79 -169.66 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.8 32.09 20.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.11 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.763 0.316 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -177.44 3.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.986 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.4 96.05 3.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.0 t -101.34 134.62 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.73 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.12 154.55 49.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.998 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.83 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 0.0 111.794 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 34.5 mm -113.66 118.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.611 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.54 131.23 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.689 0.281 . . . . 0.0 111.331 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 11.5 mt -131.71 128.79 39.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.829 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 164' ' ' ILE . 0.3 OUTLIER -98.25 128.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.13 0.49 . . . . 0.0 110.145 179.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -63.15 91.94 0.05 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.008 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.14 -171.04 37.37 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.892 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.84 -24.8 74.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.211 1.94 . . . . 0.0 112.535 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -4.18 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.48 -144.27 18.37 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.366 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.3 mt -67.14 -37.83 84.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.271 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 97.94 34.26 5.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.622 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -175.07 -168.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 111.013 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.7 t -136.33 161.02 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.52 161.48 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.997 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.44 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -131.1 138.7 49.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.6 130.67 9.67 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.598 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -81.58 -25.08 54.88 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.637 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.53 120.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.91 5.02 Favored Glycine 0 C--N 1.331 0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 113.004 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -114.93 54.14 0.79 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.43 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -45.54 107.33 0.1 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.44 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 15.0 t60 -93.74 -26.78 16.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.011 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.429 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -96.46 121.85 59.0 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.034 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.72 71.01 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.999 1.799 . . . . 0.0 112.532 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 123.66 51.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.712 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.89 129.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.3 30.89 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.4 t -114.52 -165.73 1.04 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 189' ' ' ILE . 1.8 mm -103.22 135.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 211' ' ' LYS . 20.6 m-85 -135.87 153.72 51.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.736 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 46.5 t -80.76 142.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.9 t -122.7 -20.73 5.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.59 136.95 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.997 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.403 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 2.8 mm -120.57 135.65 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.995 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 195' ' ' ILE . 33.6 mm -80.45 116.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -37.82 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.9 24.22 41.08 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.216 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.48 -114.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.121 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -109.94 -48.11 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.07 72.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -59.55 -56.08 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -69.77 -52.0 29.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.85 -51.15 17.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.62 -34.77 21.52 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.217 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 66.02 26.67 10.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.188 0.494 . . . . 0.0 110.552 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.05 140.86 30.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -122.04 170.15 10.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 34.6 mt -58.22 113.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.51 -19.61 3.18 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.723 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.14 129.88 39.03 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.824 0.312 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -96.48 129.11 43.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.627 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.2 mm -103.13 137.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.802 0.334 . . . . 0.0 111.667 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.4 pp -115.53 -12.59 11.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.034 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -175.9 152.45 1.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 110.657 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 239' ' ' VAL . 38.4 t -130.43 119.09 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 58.43 -85.04 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.99 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 12.95 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.674 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.4 p -109.29 140.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 120.827 0.346 . . . . 0.0 110.669 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.58 100.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.049 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.25 34.73 2.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.383 0.611 . . . . 0.0 109.864 178.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -103.35 163.68 12.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 46.38 26.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.665 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.402 HG23 ' CB ' ' A' ' 227' ' ' ASP . 5.2 p -134.21 165.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.9 mtt -69.51 168.34 14.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.718 0.77 . . . . 0.0 112.026 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . 0.405 ' HB2' ' N ' ' A' ' 176' ' ' GLY . 64.2 t60 -58.11 -36.31 72.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.017 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.6 -51.72 57.52 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.402 ' CB ' HG23 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.42 -35.57 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.473 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.418 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -65.23 -39.14 92.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.403 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.09 -41.83 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.97 74.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.4 85.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.234 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 mt -73.44 -45.18 55.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -34.62 71.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.816 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -64.47 -20.35 66.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.63 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 26.2 p -62.25 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.032 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -140.76 -150.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 7.1 m-20 -45.08 -81.18 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.286 0.234 . . . . 0.0 111.609 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.8 118.48 42.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.168 0.509 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.42 ' CG2' ' CG1' ' A' ' 215' ' ' VAL . 10.6 p -120.82 127.31 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.199 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.34 123.79 46.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.07 149.32 22.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.64 116.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.06 140.36 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.881 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.55 121.73 40.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.167 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.32 115.91 65.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.87 66.54 8.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.191 1.927 . . . . 0.0 112.094 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.98 34.18 11.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.3 t30 60.0 85.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.077 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.31 113.58 23.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.8 t -107.88 122.88 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.25 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.84 149.27 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.43 142.85 28.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.306 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.03 119.62 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.783 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.9 ttpt -100.84 130.75 46.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.002 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.09 132.04 42.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.816 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 164' ' ' ILE . 0.3 OUTLIER -97.2 135.09 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.242 0.544 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -70.11 96.01 1.03 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.085 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.8 -158.25 27.58 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.959 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.86 -20.72 68.76 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.097 1.865 . . . . 0.0 112.422 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.27 -2.49 31.0 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.4 -135.77 14.25 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.126 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 4.4 mm? -58.21 -33.25 69.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 111.046 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.03 32.99 37.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.699 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 11.6 p90 -175.42 -174.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.4 m -129.85 160.29 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 111.545 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.91 157.09 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.445 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -127.99 137.53 52.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -111.45 130.92 9.99 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.753 -178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -81.62 -23.74 57.55 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.587 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.1 t -90.06 117.92 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.96 -56.04 5.03 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.918 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -112.42 53.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.439 0.638 . . . . 0.0 109.414 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.432 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.5 tt0 -45.87 113.24 0.58 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.445 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 9.4 t60 -102.66 -26.04 13.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.277 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.434 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -95.99 132.99 25.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.275 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.88 76.34 4.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 113.007 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.59 47.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.083 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.64 130.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 0.0 110.948 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -102.47 28.13 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.28 -162.46 0.8 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.751 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 189' ' ' ILE . 1.4 mm -106.38 136.04 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.434 ' CG ' HG12 ' A' ' 183' ' ' ILE . 21.8 m-85 -135.77 150.3 49.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.388 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 26.9 t -80.73 138.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.6 t -123.23 -18.48 6.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -152.16 133.53 14.49 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.782 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 194' ' ' ILE . 1.6 mm -120.93 135.6 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.151 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -81.02 113.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 109.866 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -37.19 102.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.28 23.6 13.32 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.262 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.0 -107.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.411 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -104.44 -58.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.99 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.035 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -58.46 -56.11 26.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -52.32 27.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.44 -51.38 15.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.52 -35.78 11.45 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.686 -0.768 . . . . 0.0 114.402 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 62.17 0.74 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.401 0.62 . . . . 0.0 110.578 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.5 132.88 54.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.92 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -112.14 165.72 11.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.972 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 208' ' ' ILE . 37.9 mt -64.06 111.54 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.76 -14.07 2.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.204 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.24 153.01 28.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.107 0.453 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.4 ' O ' ' CG1' ' A' ' 243' ' ' VAL . 0.0 OUTLIER -114.32 129.36 56.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 43.1 mm -90.5 122.93 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.566 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.46 -27.09 19.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.171 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 177.09 150.21 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.738 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.19 118.92 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.017 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 56.42 -86.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.28 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.6 m -136.39 11.06 3.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.072 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -109.23 140.39 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -108.64 88.53 0.53 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.056 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -13.81 62.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -63.24 169.59 3.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.19 0.519 . . . . 0.0 110.72 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.39 24.42 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.795 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.402 HG12 ' CB ' ' A' ' 227' ' ' ASP . 4.2 p -144.86 156.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.92 167.5 0.79 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.93 0.872 . . . . 0.0 112.592 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -57.66 -35.01 69.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.099 -1.41 . . . . 0.0 110.685 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.3 -52.05 51.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.052 0.454 . . . . 0.0 111.996 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.402 ' CB ' HG12 ' A' ' 223' ' ' VAL . 8.6 m-20 -61.27 -35.42 77.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.419 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -62.65 -38.49 90.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.775 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.04 -41.3 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.12 75.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.1 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.74 95.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.32 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.0 mt -73.16 -44.24 60.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.166 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -37.0 70.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 111.575 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.0 -20.3 65.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.909 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 22.8 p -65.43 -175.67 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.754 0.312 . . . . 0.0 111.323 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.53 -150.03 0.35 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.227 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 165' ' ' LYS . 2.1 m-20 -44.31 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.712 0.233 . . . . 0.0 111.288 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.11 122.54 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.676 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 10.6 p -118.83 135.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -102.63 135.33 44.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mt -113.46 135.34 53.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -106.66 117.5 34.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.174 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 211' ' ' LYS . 75.1 t -129.48 148.79 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.95 121.12 35.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.963 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 133.37 27.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.165 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.08 113.92 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.967 1.778 . . . . 0.0 111.917 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.43 155.11 36.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.243 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -157.92 -59.96 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.807 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.062 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -143.66 151.92 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -95.44 121.86 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.56 135.1 56.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -93.39 140.01 30.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.63 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 48.6 mm -123.9 119.21 56.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -105.57 132.31 51.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.373 . . . . 0.0 111.606 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.3 mt -131.61 129.77 41.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.062 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.17 134.54 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 110.973 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -74.79 106.31 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.912 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.14 -147.13 8.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.217 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.38 -23.06 38.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.064 1.842 . . . . 0.0 112.055 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -102.14 -4.73 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.62 -135.32 13.67 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.109 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -58.49 -37.11 74.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.115 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.48 39.35 9.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.651 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.25 -173.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.97 0.414 . . . . 0.0 110.704 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 m -133.13 160.39 37.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -125.84 162.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 182' ' ' HIS . . . -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.074 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -108.83 129.38 9.5 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.431 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 181' ' ' GLN . . . -85.67 -20.6 55.88 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.255 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 17.6 t -89.83 116.99 32.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.27 -58.5 4.03 Favored Glycine 0 C--N 1.329 0.164 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.944 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -102.97 48.55 0.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.472 0.654 . . . . 0.0 109.429 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.437 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -44.51 113.5 0.55 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.45 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 18.9 t60 -98.44 -31.31 12.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.743 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.442 HG13 ' CG ' ' A' ' 190' ' ' TYR . 9.8 mm -96.4 123.91 52.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.198 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.49 78.67 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.982 1.788 . . . . 0.0 112.566 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 130.88 5.73 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.013 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -132.88 144.85 50.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.669 0.735 . . . . 0.0 111.35 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . 0.407 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.1 m120 -104.85 -28.05 11.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -62.98 -163.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 189' ' ' ILE . 1.5 mm -101.13 141.35 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.25 0.548 . . . . 0.0 110.819 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.442 ' CG ' HG13 ' A' ' 183' ' ' ILE . 17.6 m-85 -135.58 155.05 51.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.839 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.411 ' CG1' ' CD1' ' A' ' 194' ' ' ILE . 36.7 t -85.16 142.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.451 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.4 t -123.74 -24.26 4.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.15 138.25 13.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.09 0.472 . . . . 0.0 112.01 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.411 ' CD1' ' CG1' ' A' ' 191' ' ' VAL . 1.6 mm -121.35 135.78 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.483 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.5 mp -80.73 115.6 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -38.26 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.97 29.37 43.04 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.167 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.99 -64.73 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.182 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.21 -57.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.388 . . . . 0.0 110.689 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -67.44 -44.55 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.811 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -59.63 -55.89 28.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.678 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -51.54 30.29 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.84 -49.47 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.64 -35.24 14.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.789 -0.72 . . . . 0.0 114.398 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 51.66 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.375 0.607 . . . . 0.0 109.962 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.1 pp -120.81 140.44 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.224 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.71 174.97 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.019 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 35.9 mt -67.6 126.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.827 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 127.03 -19.39 6.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.622 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -77.03 149.44 35.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -110.83 128.21 55.69 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.896 0.379 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 212' ' ' ILE . 26.8 mm -92.79 124.71 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.884 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.3 mt -85.48 -67.26 0.82 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.263 0.554 . . . . 0.0 110.151 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.03 155.11 50.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.703 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.413 HG13 HG23 ' A' ' 239' ' ' VAL . 26.0 t -124.3 120.11 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.61 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 t30 59.31 -86.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.9 t -141.26 14.44 2.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.665 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.75 140.64 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.882 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.89 97.33 1.42 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.051 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.84 43.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -120.12 30.07 7.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.732 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -168.65 33.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.405 ' CG2' ' CB ' ' A' ' 227' ' ' ASP . 9.6 p -152.41 165.29 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -63.51 172.68 1.93 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.727 0.775 . . . . 0.0 112.173 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -57.44 -37.62 73.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.583 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.54 -53.14 46.36 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.405 ' CB ' ' CG2' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -63.12 -34.21 77.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.42 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -60.78 -38.21 84.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.646 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.8 t -60.08 -41.39 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.142 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.91 -32.81 74.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.875 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.08 93.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.315 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -48.07 34.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.446 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.48 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 111.979 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.53 -20.7 57.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.715 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 30.6 p -60.82 -169.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.687 0.279 . . . . 0.0 111.269 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.71 -152.01 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -44.34 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.549 0.214 . . . . 0.0 111.439 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.05 121.81 47.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.944 0.402 . . . . 0.0 110.711 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.413 HG23 HG13 ' A' ' 215' ' ' VAL . 12.5 p -120.16 132.95 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 2.6 m-85 -105.21 119.58 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.55 138.19 38.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.06 129.22 54.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.986 0.422 . . . . 0.0 110.046 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' A' ' 211' ' ' LYS . 53.6 t -130.82 148.32 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.691 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.7 131.09 52.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.768 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -93.61 109.86 43.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.082 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.39 111.09 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.049 1.833 . . . . 0.0 112.249 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 73.2 m -92.14 66.09 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.46 35.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.016 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.693 0.282 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 14.7 ptp -132.03 154.51 49.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.882 0.373 . . . . 0.0 111.25 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.93 145.08 30.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.829 HG21 HD23 ' A' ' 206' ' ' LEU . 41.1 mm -125.44 116.71 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.728 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.8 mtmt -90.7 131.51 36.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.004 0.431 . . . . 0.0 111.108 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.006 HD11 HD11 ' A' ' 241' ' ' LEU . 2.1 mt -121.23 128.39 52.36 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.967 HD12 HG22 ' A' ' 238' ' ' VAL . 13.0 mm -97.25 134.21 36.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 111.375 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.475 ' HE2' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -80.15 56.99 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.043 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.99 -156.0 0.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.51 -22.98 44.05 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.212 1.941 . . . . 0.0 112.434 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -4.49 47.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.1 -130.84 10.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.271 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 163' ' ' LEU . 4.5 mm? -62.37 -36.46 82.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 110.95 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 26.56 23.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.109 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 1.7 p90 -174.57 -168.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 111.202 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -134.7 158.96 42.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.729 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -124.73 160.49 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.918 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -125.05 137.3 54.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.16 129.91 9.61 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.499 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.15 -22.67 54.2 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.76 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 187' ' ' ASN . 19.8 t -89.99 118.64 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.89 -57.12 4.96 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.967 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -110.39 52.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.6 tt0 -44.8 116.21 1.03 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.671 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 8.7 t-80 -103.89 -27.75 12.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.238 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.436 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.41 123.45 54.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.371 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.62 81.47 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.007 1.804 . . . . 0.0 112.648 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.28 55.32 0.68 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.028 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.41 129.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.812 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.54 ' HB3' HG22 ' A' ' 178' ' ' VAL . 7.7 m120 -103.74 29.46 5.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m -111.0 -160.9 0.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.7 mm -110.79 136.65 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.9 m-85 -135.47 154.06 51.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.545 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.504 HG11 ' CD1' ' A' ' 194' ' ' ILE . 40.1 t -80.9 142.22 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.2 t -123.97 -24.09 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.54 ' C ' HD13 ' A' ' 194' ' ' ILE . 9.4 ttpt -155.43 138.52 15.54 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.72 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.724 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -121.27 135.12 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.498 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.86 123.62 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -39.53 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.58 26.11 37.55 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.283 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.27 -69.23 1.4 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.172 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.456 ' HB1' ' H ' ' A' ' 164' ' ' ILE . . . -148.46 -59.31 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.954 0.407 . . . . 0.0 110.388 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.691 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -63.97 -43.81 94.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.724 ' HB2' HG22 ' A' ' 194' ' ' ILE . 7.7 t-160 -66.07 -55.8 14.75 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -69.4 -52.76 23.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 164' ' ' ILE . 2.5 t70 -75.01 -50.56 16.14 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.474 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -77.9 -31.25 49.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.134 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 62.19 32.23 17.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.179 0.49 . . . . 0.0 110.182 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.829 HD23 HG21 ' A' ' 161' ' ' ILE . 3.8 pp -101.3 140.32 35.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.904 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 194' ' ' ILE . 11.3 pt20 -123.01 167.21 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 46.2 mt -58.06 116.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.3 -17.94 3.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.439 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -78.95 149.16 32.39 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 120.743 0.306 . . . . 0.0 111.062 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.771 ' O ' HG13 ' A' ' 243' ' ' VAL . 5.9 ptmt -112.94 128.87 56.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.462 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.725 ' HA ' HG22 ' A' ' 243' ' ' VAL . 26.9 mm -90.1 121.58 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.315 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 0.7 OUTLIER -101.73 2.5 38.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 163.83 155.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.814 HG13 ' CD2' ' A' ' 241' ' ' LEU . 57.5 t -132.14 118.57 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.441 ' HA ' ' CE2' ' A' ' 240' ' ' TYR . 26.9 m-20 58.08 -85.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.5 OUTLIER -141.18 14.32 2.23 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.668 177.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.749 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.2 p -109.17 140.38 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.97 0.414 . . . . 0.0 111.3 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.75 94.61 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.968 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.1 OUTLIER -102.31 44.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.696 0.76 . . . . 0.0 109.026 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 25.58 5.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.601 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.71 33.38 0.4 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.745 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 227' ' ' ASP . 10.1 p -152.76 166.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.039 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.46 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.69 170.52 2.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.725 0.774 . . . . 0.0 112.284 -179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.869 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.2 t60 -57.55 -36.28 71.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.307 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.18 -52.56 54.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.498 ' CB ' HG21 ' A' ' 223' ' ' VAL . 2.4 t0 -62.01 -35.22 77.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.959 0.409 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.15 89.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.872 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 225' ' ' HIS . 18.2 t -59.37 -41.36 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.31 -33.25 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.474 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.968 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.23 -41.48 96.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 174' ' ' ILE . 3.5 mt -73.96 -48.77 28.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.611 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -61.49 -34.54 75.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.957 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -64.39 -20.22 66.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.732 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . 1.141 HG21 HG21 ' A' ' 239' ' ' VAL . 18.3 p -66.01 -162.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.516 0.198 . . . . 0.0 111.443 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 236' ' ' TYR . 1.7 m-85 -131.02 -153.46 0.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.146 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.19 -77.03 0.02 OUTLIER 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.566 0.347 . . . . 0.0 111.787 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.967 HG22 HD12 ' A' ' 164' ' ' ILE . 53.5 t -102.88 121.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.106 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.141 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -118.87 124.07 72.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.588 ' C ' HD23 ' A' ' 241' ' ' LEU . 0.6 OUTLIER -94.76 138.03 33.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.405 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 1.006 HD11 HD11 ' A' ' 163' ' ' LEU . 0.8 OUTLIER -114.77 147.25 40.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.76 119.8 40.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 110.304 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 211' ' ' LYS . 71.8 t -128.75 146.63 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.787 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.98 132.1 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.675 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.911 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.3 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.52 ' SD ' HD11 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -132.18 147.5 52.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.117 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.61 144.15 27.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.963 HG21 HD23 ' A' ' 206' ' ' LEU . 43.0 mm -125.45 118.94 53.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.636 ' O ' HD23 ' A' ' 163' ' ' LEU . 8.9 ttmt -97.57 126.31 42.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 241' ' ' LEU . 12.4 mt -127.41 128.92 46.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.326 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.787 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -101.28 133.5 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.053 0.454 . . . . 0.0 110.719 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.787 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -68.9 74.17 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.089 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.74 -161.61 0.4 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.368 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.72 -24.37 25.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.327 2.018 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -101.32 -1.95 32.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.04 -138.02 14.68 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.365 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 24.1 mt -69.6 -33.59 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.844 0.355 . . . . 0.0 111.126 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.29 27.63 11.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.491 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 3.7 p90 -170.58 -169.27 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.0 t -136.92 162.97 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.686 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -123.6 160.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.187 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.906 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.02 138.01 52.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -109.35 130.18 9.85 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.818 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -83.78 -23.2 53.77 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.425 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.403 ' HB ' ' N ' ' A' ' 224' ' ' MET . 10.5 t -89.88 120.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.66 -56.43 5.05 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.075 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.06 57.58 0.79 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.543 0.687 . . . . 0.0 109.391 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.452 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.6 tt0 -47.66 116.95 1.62 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.706 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 2.4 t-80 -102.06 -25.16 13.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.952 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.1 mp -96.48 129.44 33.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.35 78.1 2.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.053 1.835 . . . . 0.0 112.829 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.57 50.96 0.63 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.748 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.13 123.87 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.741 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 28.74 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 -166.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.58 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.906 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -102.98 134.89 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.226 0.536 . . . . 0.0 110.522 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.442 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.3 m-85 -135.33 154.23 51.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.684 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 206' ' ' LEU . 44.6 t -80.7 141.43 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.402 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.8 t -123.07 -26.04 4.43 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.478 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -150.61 137.18 18.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.912 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 191' ' ' VAL . 1.3 mm -121.28 135.25 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.33 118.39 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.52 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.57 23.97 16.05 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.136 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.18 -78.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.431 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -137.56 -58.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.954 0.407 . . . . 0.0 110.879 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.859 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -63.31 -45.92 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -59.13 -55.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.953 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -52.06 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.64 -50.51 20.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -82.4 -32.81 27.18 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.259 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 63.2 31.92 15.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.281 0.541 . . . . 0.0 110.259 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.963 HD23 HG21 ' A' ' 161' ' ' ILE . 4.7 pp -102.68 140.43 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.638 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 176.33 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.283 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 51.1 mt -64.28 112.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.07 -17.0 2.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.865 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.9 147.87 32.94 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.923 0.362 . . . . 0.0 111.028 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.733 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -110.48 129.17 55.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.326 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.72 HD13 ' CG2' ' A' ' 243' ' ' VAL . 43.0 mm -92.17 116.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 0.9 OUTLIER -96.5 -2.27 45.52 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.122 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.47 152.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.731 HG23 HD21 ' A' ' 220' ' ' LEU . 40.8 t -130.55 118.63 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.14 -84.51 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.317 0.386 . . . . 0.0 110.066 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 215' ' ' VAL . 50.4 m -139.94 11.69 2.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.23 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.1 p -109.19 140.71 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.65 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.21 108.72 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.442 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.939 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -119.37 50.6 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.457 0.646 . . . . 0.0 109.492 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 26.05 4.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.532 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -159.9 30.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.322 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 227' ' ' ASP . 9.7 p -148.7 166.44 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.342 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.421 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.38 170.69 2.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.697 0.761 . . . . 0.0 112.256 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.88 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.9 t60 -57.74 -37.42 73.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.086 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.27 -52.53 46.64 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.468 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -62.5 -34.68 77.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.105 0.478 . . . . 0.0 109.886 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.414 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.93 -38.73 86.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.653 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.7 t -59.88 -41.52 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.136 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.45 72.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.411 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.939 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -65.23 -42.61 93.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.281 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.686 HD11 HG21 ' A' ' 174' ' ' ILE . 1.7 mt -73.59 -41.94 62.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.491 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.08 -40.91 86.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.62 -20.41 32.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.786 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . 1.04 HG21 HG21 ' A' ' 239' ' ' VAL . 21.2 p -66.09 -166.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 0.0 111.044 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.45 -150.14 0.33 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.329 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 165' ' ' LYS . 5.5 m-20 -44.4 -80.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.327 0.251 . . . . 0.0 111.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.6 121.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.985 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.04 HG21 HG21 ' A' ' 235' ' ' THR . 9.3 p -120.77 130.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 4.2 m-85 -99.74 120.67 40.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 163' ' ' LEU . 1.3 mt -96.92 137.92 35.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.44 ' HG2' HD21 ' A' ' 213' ' ' LEU . 18.8 ttpt -107.26 120.74 42.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 211' ' ' LYS . 52.8 t -122.58 147.58 26.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.251 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.431 ' HB2' HD22 ' A' ' 213' ' ' LEU . . . -117.26 131.79 56.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.151 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.796 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.849 0.356 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 18.9 ptm -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -95.49 143.81 26.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.549 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.953 HG21 HD23 ' A' ' 206' ' ' LEU . 35.6 mm -125.28 119.13 54.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.78 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.7 ttpt -105.31 129.21 53.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 111.681 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.951 HD21 HG22 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -129.37 129.99 45.46 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.34 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.755 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -97.5 133.42 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.575 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.755 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -72.47 102.04 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.153 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.92 -153.86 20.99 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.936 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.31 -22.46 46.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.105 1.87 . . . . 0.0 112.364 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.73 -4.23 26.81 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.54 -138.94 14.89 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 163' ' ' LEU . 3.9 mm? -57.07 -37.85 72.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.1 37.61 9.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.893 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -174.52 -166.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.398 . . . . 0.0 111.039 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 192' ' ' THR . 9.2 t -138.83 158.34 44.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.863 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.664 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -123.91 161.92 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.922 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.06 137.53 52.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.435 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.91 129.84 9.48 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.807 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.77 -20.71 55.42 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.755 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.408 ' HB ' ' N ' ' A' ' 224' ' ' MET . 9.5 t -90.23 117.94 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.44 -56.55 5.01 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.181 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -112.88 55.23 0.7 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.635 0.731 . . . . 0.0 109.301 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.446 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.35 119.96 2.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.729 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 7.7 t-80 -103.05 -31.0 10.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.931 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.445 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -97.14 125.09 47.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.214 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.69 78.98 0.95 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.15 1.9 . . . . 0.0 112.861 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.75 46.07 0.49 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.199 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.11 128.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -98.66 12.49 35.24 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.476 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -165.99 1.35 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.0 OUTLIER -103.41 139.84 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.124 0.488 . . . . 0.0 110.559 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.445 ' CG ' HG12 ' A' ' 183' ' ' ILE . 29.5 m-85 -136.09 151.55 49.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 194' ' ' ILE . 21.4 t -81.47 140.31 16.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.562 ' HA ' HG23 ' A' ' 208' ' ' ILE . 3.7 t -124.68 -25.45 3.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.555 ' C ' HD13 ' A' ' 194' ' ' ILE . 9.8 tttp -149.27 135.41 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 111.761 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.555 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.0 OUTLIER -121.01 135.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.186 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.22 117.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -36.39 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.49 23.88 29.13 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.076 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.0 -82.27 0.11 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.325 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.44 -57.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.816 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.02 -44.2 85.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.516 ' HB2' HG22 ' A' ' 194' ' ' ILE . 4.2 t-160 -62.52 -55.62 25.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.536 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -69.68 -52.2 27.84 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -74.08 -50.45 19.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.92 -29.98 33.11 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.913 -0.661 . . . . 0.0 114.488 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 61.41 33.56 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.307 0.554 . . . . 0.0 110.47 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.953 HD23 HG21 ' A' ' 161' ' ' ILE . 1.8 pp -101.01 142.13 32.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -121.6 171.99 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 192' ' ' THR . 53.2 mt -63.96 132.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.05 9.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.734 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.66 150.68 39.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.117 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.729 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -112.82 129.15 56.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.554 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.764 HD13 ' CG2' ' A' ' 243' ' ' VAL . 38.9 mm -89.88 117.38 33.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.597 HD21 ' HG2' ' A' ' 242' ' ' LYS . 2.3 pp -97.79 -2.24 41.5 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.31 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.243 -0.286 . . . . 0.0 110.853 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 218' ' ' VAL . 24.5 t -132.3 119.27 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.234 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.47 ' OD1' HG23 ' A' ' 239' ' ' VAL . 2.4 m120 59.29 -85.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 p -141.98 13.49 2.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.893 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.708 HG13 ' CD2' ' A' ' 220' ' ' LEU . 10.8 p -109.39 140.33 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.69 100.57 2.16 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 1.013 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -108.97 48.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.716 0.769 . . . . 0.0 109.061 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.74 27.39 4.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.592 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.28 32.72 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.131 0.491 . . . . 0.0 110.124 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.483 HG21 ' CB ' ' A' ' 227' ' ' ASP . 7.6 p -149.38 166.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.101 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.44 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.74 169.19 3.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.736 0.779 . . . . 0.0 112.009 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.3 t60 -57.52 -36.4 71.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.84 -52.42 50.59 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.9 OUTLIER -61.65 -34.95 76.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.044 0.45 . . . . 0.0 109.985 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.423 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.88 -39.24 88.46 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.622 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.1 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.156 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.61 73.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.213 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 1.013 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.02 -40.87 97.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.086 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 174' ' ' ILE . 6.5 mt -70.6 -40.88 72.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.126 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -37.31 86.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -20.76 43.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.554 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . 1.051 HG21 HG21 ' A' ' 239' ' ' VAL . 17.5 p -70.38 -166.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.637 0.256 . . . . 0.0 111.069 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.94 -150.5 0.33 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.411 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 85.2 m-20 -43.42 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 122.442 0.297 . . . . 0.0 111.515 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.434 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.3 OUTLIER -95.69 120.57 45.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.69 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.051 HG21 HG21 ' A' ' 235' ' ' THR . 9.5 p -120.26 133.43 67.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -105.06 118.9 37.7 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.276 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.7 mp -99.13 139.38 34.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.597 ' HG2' HD21 ' A' ' 213' ' ' LEU . 16.7 ttmt -107.29 130.9 54.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 0.0 110.492 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.764 ' CG2' HD13 ' A' ' 212' ' ' ILE . 56.2 t -132.68 146.06 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.83 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.9 ptp -129.49 151.68 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -99.41 143.58 29.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 111.544 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.853 HG22 HD21 ' A' ' 163' ' ' LEU . 47.9 mm -118.09 117.93 56.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.498 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.617 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -103.74 129.28 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.853 HD21 HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -132.35 129.78 39.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.066 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.826 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -98.43 133.89 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 110.572 179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.826 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -75.85 137.41 40.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.278 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -155.21 -153.29 6.47 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.379 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.83 -21.67 49.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.273 1.982 . . . . 0.0 112.586 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -97.0 -4.6 39.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.85 -127.73 8.13 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.643 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.68 HD22 ' HE2' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.725 0.298 . . . . 0.0 110.591 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.6 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 93.25 22.91 25.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.572 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.65 -171.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.2 t -133.16 164.36 27.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.699 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -128.49 158.5 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.157 0.503 . . . . 0.0 112.029 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.916 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.24 138.87 51.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.139 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.88 134.18 11.8 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.85 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.22 -24.58 47.31 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.614 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 187' ' ' ASN . 10.4 t -89.98 120.28 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.31 4.97 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.374 -0.441 . . . . 0.0 113.112 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -118.09 56.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.9 tt0 -46.67 118.75 2.14 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.689 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 6.1 t-80 -107.69 -24.22 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.375 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.427 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.77 133.24 24.7 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.86 80.86 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.096 1.864 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.21 55.76 0.76 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.875 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.68 131.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.411 ' HB2' HG22 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -104.42 30.43 5.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.3 t -111.04 -166.94 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.2 mm -106.04 135.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 0.0 110.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 211' ' ' LYS . 17.8 m-85 -133.98 152.83 52.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.734 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.507 HG21 HD13 ' A' ' 206' ' ' LEU . 29.4 t -80.41 140.62 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.502 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.554 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.5 t -123.29 -24.7 4.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.729 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.5 OUTLIER -146.12 134.71 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 111.722 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.729 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.0 OUTLIER -120.81 135.21 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.114 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.3 mm -81.12 116.93 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.28 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.875 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.06 24.21 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.078 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.99 -71.36 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.6 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -140.02 -67.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.715 0.293 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.773 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -60.47 -46.96 88.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.021 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.718 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.8 t-160 -59.54 -55.96 27.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -70.53 -53.09 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.22 -50.21 20.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.1 -30.44 46.63 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.827 -0.701 . . . . 0.0 114.129 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.91 46.97 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.402 0.62 . . . . 0.0 109.98 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.773 HD21 ' HB1' ' A' ' 200' ' ' ALA . 3.4 pp -117.27 139.63 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.082 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.44 169.27 9.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.975 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.7 mt -61.57 119.17 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.577 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.18 -17.65 4.81 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.64 146.94 44.2 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 117.008 0.404 . . . . 0.0 110.696 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.728 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.1 ptpt -106.78 128.59 54.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.56 ' HA ' HG22 ' A' ' 243' ' ' VAL . 29.0 mm -95.39 115.72 35.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.14 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.663 HD21 ' CG ' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -94.52 -9.68 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.971 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 176.21 148.09 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.765 0.316 . . . . 0.0 110.692 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.792 HG13 ' HG ' ' A' ' 241' ' ' LEU . 10.2 t -122.82 118.98 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.448 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 57.58 -85.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.005 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.1 m -139.0 13.09 2.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.618 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.34 141.27 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 122.534 0.334 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -105.55 87.91 0.55 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.213 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.899 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -75.16 -5.7 45.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 111.268 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.532 ' N ' HD12 ' A' ' 220' ' ' LEU . 4.0 pt-20 -67.3 167.81 11.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 t70 46.83 26.27 0.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.962 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.899 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.1 p -136.36 165.24 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.643 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.437 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -67.82 168.25 11.89 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.703 0.763 . . . . 0.0 111.606 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.0 t60 -58.37 -36.89 74.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.998 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -52.76 38.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.446 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.2 OUTLIER -61.13 -34.8 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.0 110.118 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.86 92.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.963 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.8 t -58.27 -42.08 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.16 77.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.222 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -64.6 -39.28 93.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.173 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.77 HD12 ' HA ' ' A' ' 229' ' ' VAL . 2.5 mt -73.5 -42.32 61.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -58.75 -34.06 70.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -62.84 -20.23 64.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.399 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.922 HG21 HG21 ' A' ' 239' ' ' VAL . 26.2 p -64.49 -171.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.767 0.318 . . . . 0.0 111.151 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -143.1 -151.61 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.229 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.9 OUTLIER -43.03 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.538 0.335 . . . . 0.0 111.479 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.449 HG21 ' HD3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER -94.96 120.42 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.689 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.922 HG21 HG21 ' A' ' 235' ' ' THR . 9.2 p -119.79 120.26 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -100.57 120.15 39.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.792 ' HG ' HG13 ' A' ' 215' ' ' VAL . 1.0 OUTLIER -99.79 149.4 23.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.004 0.431 . . . . 0.0 110.522 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.663 ' CG ' HD21 ' A' ' 213' ' ' LEU . 2.7 tpmt? -108.62 118.26 36.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.196 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 211' ' ' LYS . 54.4 t -123.27 149.2 27.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.967 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.023 -179.347 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.688 HG11 ' HD2' ' A' ' 242' ' ' LYS . 24.1 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.81 0.338 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -132.26 147.1 52.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -101.66 132.34 47.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.632 HG21 HD23 ' A' ' 206' ' ' LEU . 4.3 mt -125.45 118.47 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.186 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.418 ' HB2' HG12 ' A' ' 238' ' ' VAL . 1.5 pttt -99.08 137.55 37.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.309 0.576 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.728 HD11 ' CD1' ' A' ' 241' ' ' LEU . 5.7 mt -118.7 140.38 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.525 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.84 ' CD1' HG22 ' A' ' 238' ' ' VAL . 19.9 mm -96.46 131.46 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.067 0.461 . . . . 0.0 111.16 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 57.03 2.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.262 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.06 -161.64 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.062 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -20.24 54.06 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.208 1.939 . . . . 0.0 112.689 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -96.68 8.27 44.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.3 -145.14 18.32 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.493 HD12 HD12 ' A' ' 163' ' ' LEU . 4.3 mm? -61.11 -37.27 82.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.761 0.315 . . . . 0.0 111.045 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.76 26.72 8.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.685 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -175.63 -169.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.017 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.6 t -134.84 158.62 43.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.691 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.77 160.21 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.833 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.0 138.15 53.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.17 129.45 9.36 Favored Glycine 0 CA--C 1.5 -0.847 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.964 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -78.1 -28.58 55.97 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.76 122.16 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.11 -55.37 4.96 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.936 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -116.63 49.77 1.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.497 0.665 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.3 tt0 -42.37 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.669 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 5.6 t-80 -83.58 -28.11 28.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.129 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -96.52 129.64 32.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 81.91 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.056 1.837 . . . . 0.0 113.128 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.55 52.86 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.195 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.94 135.2 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.574 0.226 . . . . 0.0 110.74 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.419 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.5 OUTLIER -108.12 24.14 13.44 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.83 -168.13 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.833 HD13 ' O ' ' A' ' 175' ' ' ALA . 2.4 mm -104.58 134.42 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.278 0.561 . . . . 0.0 110.281 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.409 ' CD1' HG12 ' A' ' 183' ' ' ILE . 26.0 m-85 -135.19 151.17 50.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.593 HG21 HD13 ' A' ' 206' ' ' LEU . 39.2 t -80.12 141.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.284 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.439 ' HA ' HG23 ' A' ' 208' ' ' ILE . 2.7 t -122.94 -23.01 5.1 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -150.36 134.19 16.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.75 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 206' ' ' LEU . 1.0 OUTLIER -119.78 135.38 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.18 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.01 118.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.422 . . . . 0.0 109.919 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -37.75 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 50.03 31.69 18.52 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.392 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.68 -75.94 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.363 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -134.86 -60.21 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 0.0 110.731 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.672 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.36 -45.14 77.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.3 t-160 -60.21 -56.13 25.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.528 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -70.53 -53.19 17.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -51.35 15.07 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.568 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -77.14 -31.04 53.99 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.822 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 60.56 30.45 19.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.125 0.462 . . . . 0.0 110.636 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.632 HD23 HG21 ' A' ' 161' ' ' ILE . 4.0 pp -102.31 129.14 48.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.19 173.81 6.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.1 mt -64.44 113.44 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.38 -15.04 3.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.78 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.05 142.21 39.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.935 0.368 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.721 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.8 ttpm? -102.58 128.83 49.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.111 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.75 HD13 ' CG2' ' A' ' 243' ' ' VAL . 30.4 mm -96.71 116.42 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 244' ' ' ALA . 2.5 mt -79.3 -68.01 0.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.48 47.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.945 HG22 HD23 ' A' ' 241' ' ' LEU . 3.1 t -114.82 119.32 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.497 ' ND2' HG23 ' A' ' 239' ' ' VAL . 55.7 m-20 58.45 -84.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -140.32 12.94 2.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.839 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.6 p -109.69 139.87 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.003 0.43 . . . . 0.0 111.039 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.88 111.06 3.04 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.392 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.6 OUTLIER -104.17 40.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 109.932 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -97.23 163.5 12.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.787 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 48.72 27.47 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.519 HG21 ' CB ' ' A' ' 227' ' ' ASP . 6.2 p -131.2 163.73 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.585 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -69.57 169.93 11.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.703 0.763 . . . . 0.0 112.176 -179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.8 t60 -56.93 -36.36 70.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.318 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -52.13 60.94 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.519 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -60.13 -36.25 77.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.22 93.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.3 t -57.88 -41.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.219 0.533 . . . . 0.0 109.595 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.25 -33.39 75.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.714 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -64.76 -43.13 94.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.646 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -74.11 -47.3 37.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.877 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.45 -40.37 78.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.73 -20.34 33.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.899 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . 1.096 HG21 HG21 ' A' ' 239' ' ' VAL . 16.7 p -65.99 -163.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.286 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -139.67 -150.58 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.52 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.872 0.469 . . . . 0.0 112.097 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.84 HG22 ' CD1' ' A' ' 164' ' ' ILE . 23.7 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.361 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.096 HG21 HG21 ' A' ' 235' ' ' THR . 12.9 p -116.56 131.15 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -90.94 141.98 28.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.351 0.595 . . . . 0.0 111.421 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.945 HD23 HG22 ' A' ' 215' ' ' VAL . 6.8 mt -118.89 138.14 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.92 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.688 ' HD2' HG11 ' A' ' 158' ' ' VAL . 3.6 ttpm? -106.61 124.27 49.35 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.75 ' CG2' HD13 ' A' ' 212' ' ' ILE . 53.6 t -131.66 149.67 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 213' ' ' LEU . . . -114.91 121.11 42.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.558 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.726 0.298 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 15.5 ptm -126.68 146.31 50.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.431 . . . . 0.0 111.351 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.96 140.76 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.06 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.94 HG22 HD21 ' A' ' 163' ' ' LEU . 36.6 mm -120.41 117.34 53.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.782 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.2 ttmt -103.91 127.85 51.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.71 0.29 . . . . 0.0 111.73 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.94 HD21 HG22 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -127.37 129.07 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.309 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -99.02 127.38 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.187 0.518 . . . . 0.0 110.693 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.587 ' HE2' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -66.65 79.47 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.848 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.73 38.64 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.14 -20.92 48.7 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.339 2.026 . . . . 0.0 112.431 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -99.29 -5.06 30.45 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.82 -133.71 12.01 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.078 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.745 HD12 HD12 ' A' ' 163' ' ' LEU . 1.9 mm? -60.76 -36.02 77.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.596 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 80.2 33.29 32.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.045 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.585 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 3.7 p90 -177.09 -173.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 192' ' ' THR . 0.6 OUTLIER -134.69 159.63 40.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.04 161.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.023 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.887 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -131.05 138.1 49.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -114.68 131.21 9.67 Favored Glycine 0 CA--C 1.502 -0.729 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.673 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.79 -22.16 58.41 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.54 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.87 117.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.98 5.02 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.077 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -113.09 55.0 0.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.528 0.68 . . . . 0.0 109.384 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.56 115.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.69 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 14.2 t-80 -100.39 -32.14 10.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.537 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.2 mm -96.7 127.41 39.56 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.146 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.36 78.73 2.26 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.021 1.814 . . . . 0.0 113.079 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.4 10.14 4.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.016 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.01 134.58 44.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.525 0.662 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 10.7 m-80 -106.74 26.27 10.21 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.28 -164.66 0.93 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.64 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.7 mm -105.64 132.46 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.243 0.544 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.422 ' CD1' HG13 ' A' ' 183' ' ' ILE . 9.8 m-85 -135.13 153.99 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.496 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.604 HG21 HD12 ' A' ' 206' ' ' LEU . 33.1 t -79.54 141.34 15.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.268 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 173' ' ' SER . 8.1 t -121.53 -21.55 6.2 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.32 136.79 14.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.964 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.9 mm -121.2 136.23 58.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -79.92 115.31 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.032 0.444 . . . . 0.0 109.809 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -37.76 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.932 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.03 50.8 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.827 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.03 -81.75 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.596 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -129.56 -60.94 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.932 0.396 . . . . 0.0 111.163 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.899 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -66.57 -42.35 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.628 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.3 t-160 -63.75 -55.38 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -51.63 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.5 -49.1 28.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.1 -37.16 11.6 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.885 -0.674 . . . . 0.0 114.363 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.51 51.33 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.453 0.644 . . . . 0.0 109.936 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.899 HD21 ' HB1' ' A' ' 200' ' ' ALA . 1.9 pt? -116.64 139.76 50.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.779 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.5 165.13 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 192' ' ' THR . 37.8 mt -60.8 112.45 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.85 -14.59 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.61 143.23 36.6 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.123 0.462 . . . . 0.0 111.141 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.741 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.1 ttpt -103.95 129.22 51.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.302 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.916 HD13 ' CG2' ' A' ' 243' ' ' VAL . 20.5 mm -90.74 124.8 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 111.693 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.49 HD12 ' HG2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -93.55 -39.11 11.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.581 0.705 . . . . 0.0 110.098 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -166.21 154.67 10.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.918 HG23 HD21 ' A' ' 220' ' ' LEU . 24.2 t -124.47 119.88 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.583 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 61.3 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.4 m -143.26 13.52 1.81 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.8 140.25 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 111.425 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.97 107.48 2.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.038 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.918 HD21 HG23 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -100.39 37.84 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.258 0.552 . . . . 0.0 110.242 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -99.56 162.85 12.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.473 0.654 . . . . 0.0 111.881 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 48.41 27.56 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.645 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.437 HG21 ' CB ' ' A' ' 227' ' ' ASP . 4.9 p -132.67 162.9 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 168.4 9.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.793 0.806 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.835 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.9 t60 -57.51 -36.32 71.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.929 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.17 -51.79 58.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.437 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.1 t70 -59.23 -36.64 75.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.032 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 225' ' ' HIS . 16.6 t -56.38 -41.57 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.647 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.64 74.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.481 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 220' ' ' LEU . . . -65.19 -50.35 66.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.867 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 235' ' ' THR . 3.7 pp -73.6 -40.74 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.475 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.539 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -57.79 -37.95 74.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.476 . . . . 0.0 111.481 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.49 -20.31 59.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.792 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . 1.093 HG21 HG21 ' A' ' 239' ' ' VAL . 25.7 p -61.72 -163.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.403 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -138.35 -151.13 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 1.5 m-20 -44.42 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.342 0.26 0 C-N-CA 122.391 0.277 . . . . 0.0 111.673 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.06 118.76 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.093 HG21 HG21 ' A' ' 235' ' ' THR . 14.2 p -120.51 126.13 74.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.262 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.85 120.22 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.775 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.7 mp -98.13 142.7 29.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.49 ' HG2' HD12 ' A' ' 213' ' ' LEU . 1.9 ttpt -107.12 118.09 35.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.916 ' CG2' HD13 ' A' ' 212' ' ' ILE . 37.7 t -123.5 149.19 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.099 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 213' ' ' LEU . . . -132.86 128.03 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.206 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.05 0.452 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.38 155.18 48.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.397 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -124.08 126.98 47.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.963 0.411 . . . . 0.0 111.203 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.835 HG21 HD23 ' A' ' 206' ' ' LEU . 35.4 mm -99.32 118.92 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.583 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 240' ' ' TYR . 2.7 ttpp -106.36 127.94 53.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.763 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -135.22 152.22 51.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.866 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.568 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -108.99 130.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.568 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -54.65 90.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.127 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.26 170.89 44.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.549 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.3 -20.46 32.21 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.264 1.976 . . . . 0.0 112.645 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -2.0 35.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.08 -150.51 18.71 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.929 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.425 ' CD1' HG11 ' A' ' 239' ' ' VAL . 4.5 mm? -60.49 -37.52 81.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.04 29.29 10.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.701 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.55 179.3 1.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.6 t -124.64 164.0 20.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.774 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -128.0 162.65 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.319 0.581 . . . . 0.0 112.292 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.908 ' HB2' ' CG2' ' A' ' 192' ' ' THR . . . -130.51 139.91 50.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.159 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -117.3 133.74 10.77 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.108 -1.044 . . . . 0.0 113.908 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -88.18 -15.41 60.76 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.716 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 224' ' ' MET . 5.4 t -90.68 115.55 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 117.604 0.702 . . . . 0.0 112.204 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -57.29 4.03 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.223 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.09 54.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.1 mt-30 -45.79 119.69 2.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.629 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 16.9 t-80 -109.43 -28.42 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.72 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.74 121.72 58.85 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.797 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.61 80.76 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.217 1.945 . . . . 0.0 112.486 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.37 54.31 0.7 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.986 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.64 119.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.8 m120 -96.14 38.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 m -119.44 -166.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.009 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.873 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -104.67 135.74 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.128 0.49 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 25.6 m-85 -135.72 150.89 49.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.685 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.489 HG21 HD13 ' A' ' 206' ' ' LEU . 21.5 t -79.95 142.12 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.506 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.908 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 6.7 p -117.1 -39.76 3.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.552 ' C ' HD13 ' A' ' 194' ' ' ILE . 29.9 tttp -137.53 137.99 39.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.899 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.634 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -120.6 134.74 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.66 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.48 113.71 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.382 . . . . 0.0 110.101 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -36.42 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.463 -0.79 . . . . 0.0 113.123 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.55 21.3 27.49 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.247 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.78 -91.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.093 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -61.2 -46.53 90.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.634 ' HB2' HG22 ' A' ' 194' ' ' ILE . 2.8 t-80 -59.23 -57.27 13.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -71.13 -52.8 17.24 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.55 -50.62 20.44 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 161' ' ' ILE . . . -76.11 -33.5 49.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.714 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.5 34.99 17.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.126 0.489 . . . . 0.0 110.003 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.835 HD23 HG21 ' A' ' 161' ' ' ILE . 3.5 pp -108.07 139.94 41.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.222 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -115.99 -179.42 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 191' ' ' VAL . 21.4 mt -69.18 134.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.34 -14.03 30.63 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.244 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.27 134.59 46.92 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.201 0.501 . . . . 0.0 110.936 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.869 ' O ' HG23 ' A' ' 243' ' ' VAL . 18.9 tttt -92.29 129.2 38.3 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 120.896 0.379 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.462 HG21 HD23 ' A' ' 241' ' ' LEU . 18.7 mm -109.78 138.61 36.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.481 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.789 HD21 ' HG2' ' A' ' 242' ' ' LYS . 2.2 pp -118.2 -9.31 10.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -170.59 153.4 4.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.973 0.416 . . . . 0.0 111.675 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.778 HG12 ' CG2' ' A' ' 239' ' ' VAL . 0.3 OUTLIER -125.62 118.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.56 ' HB2' HG23 ' A' ' 239' ' ' VAL . 28.1 t30 56.04 -87.48 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 215' ' ' VAL . 10.4 m -137.25 13.74 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.614 0.245 . . . . 0.0 110.637 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.24 140.57 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -99.6 92.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.597 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.869 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -77.75 -3.92 43.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 178.279 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.479 ' N ' HD12 ' A' ' 220' ' ' LEU . 3.4 pt-20 -68.26 167.54 14.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 111.229 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.05 25.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.623 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 220' ' ' LEU . 3.1 p -138.01 162.48 31.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.446 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.413 ' HA ' ' HB ' ' A' ' 178' ' ' VAL . 8.4 mtt -67.19 169.25 8.94 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.739 0.78 . . . . 0.0 111.955 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.88 ' O ' HG23 ' A' ' 229' ' ' VAL . 53.5 t60 -58.29 -36.97 74.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.193 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.21 -52.34 42.36 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.1 OUTLIER -62.1 -34.9 77.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 109.884 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.85 88.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.686 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 225' ' ' HIS . 23.3 t -59.1 -41.61 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.258 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.6 74.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.299 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.594 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -69.79 -38.71 76.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.1 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.774 HD11 HG21 ' A' ' 174' ' ' ILE . 1.5 mt -72.97 -39.74 65.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.658 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -33.61 76.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.161 0.505 . . . . 0.0 110.785 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.1 -20.3 65.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.69 HG21 HG21 ' A' ' 239' ' ' VAL . 71.2 p -51.86 176.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.74 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -139.33 -148.94 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -41.61 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.654 0.381 . . . . 0.0 111.785 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.43 124.95 59.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.778 ' CG2' HG12 ' A' ' 215' ' ' VAL . 8.1 p -113.6 120.21 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.416 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -111.93 118.27 35.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 109.65 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.604 ' HG ' HG13 ' A' ' 215' ' ' VAL . 1.6 mp -100.4 153.17 19.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.789 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.3 OUTLIER -106.44 116.32 31.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.1 p -113.24 144.56 20.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.436 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.49 122.74 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.765 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.2 mttm . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 -179.656 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptm -132.15 152.23 51.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -100.53 139.37 36.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 206' ' ' LEU . 10.5 mt -125.53 118.64 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.753 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -99.47 139.42 35.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.293 0.568 . . . . 0.0 112.13 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.987 HD11 HD11 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -129.29 129.55 45.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.026 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.764 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -96.91 134.49 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.764 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -73.29 94.34 2.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.925 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.45 -158.57 24.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.139 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.52 -23.34 75.08 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.234 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -101.86 -4.28 26.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.11 -136.5 13.63 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.444 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.543 HD13 ' HE2' ' A' ' 165' ' ' LYS . 3.9 mm? -59.75 -33.27 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.61 31.7 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.546 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.594 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -175.13 -172.93 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 110.871 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -132.98 160.49 36.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.882 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.632 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -121.95 155.99 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.165 0.507 . . . . 0.0 111.226 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.913 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -126.63 138.32 53.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.235 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.26 129.98 9.19 Favored Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.759 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 187' ' ' ASN . . . -84.83 -16.0 66.5 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.696 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.4 ' HB ' ' N ' ' A' ' 224' ' ' MET . 11.3 t -90.96 115.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.672 0.736 . . . . 0.0 112.012 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.86 -57.74 4.27 Favored Glycine 0 C--N 1.329 0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.083 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -102.72 51.8 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.442 0.639 . . . . 0.0 109.684 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.424 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.2 mt-30 -45.23 117.9 1.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.664 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 8.1 t-80 -105.87 -32.06 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.843 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 190' ' ' TYR . 19.1 mm -95.47 126.05 47.26 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.338 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 77.62 1.19 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.29 1.993 . . . . 0.0 113.24 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.33 10.62 4.51 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.12 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -133.45 131.4 39.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.585 0.693 . . . . 0.0 111.348 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.431 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 9.8 m120 -103.8 29.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.44 -165.01 1.01 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -103.3 129.88 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.195 0.521 . . . . 0.0 110.421 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.452 ' CD1' HG13 ' A' ' 183' ' ' ILE . 4.5 m-85 -134.54 155.06 51.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.981 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.506 HG11 ' CD1' ' A' ' 194' ' ' ILE . 32.1 t -80.33 138.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.619 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.505 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.8 t -121.67 -19.07 6.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 133.17 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 0.0 111.609 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.677 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.3 OUTLIER -120.58 134.03 65.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 mm -82.31 117.65 28.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.401 . . . . 0.0 110.034 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -41.97 101.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.61 24.21 38.83 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.84 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.23 -89.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.329 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -131.44 -56.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.983 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -66.87 -46.3 75.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.677 ' HB2' HG22 ' A' ' 194' ' ' ILE . 9.7 t-160 -59.99 -56.06 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.681 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -52.62 22.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.38 -51.13 15.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.545 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -79.46 -28.57 51.98 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.022 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 63.57 30.87 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.022 0.411 . . . . 0.0 110.522 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 206' ' ' LEU . 2.6 pp -102.91 141.12 36.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.05 167.86 13.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.505 HG23 ' HA ' ' A' ' 192' ' ' THR . 35.1 mt -59.0 106.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 145.48 -16.95 1.85 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.914 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.55 ' OD2' HG11 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -79.4 148.04 32.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.946 0.373 . . . . 0.0 110.894 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.694 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.7 OUTLIER -112.21 130.34 55.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.821 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.621 HG21 HD21 ' A' ' 220' ' ' LEU . 19.6 mm -92.97 116.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.444 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.69 HD21 ' HG3' ' A' ' 242' ' ' LYS . 0.9 OUTLIER -91.84 -10.39 39.95 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 172.12 145.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.499 0.32 . . . . 0.0 110.339 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.935 HG22 HD23 ' A' ' 241' ' ' LEU . 4.9 t -118.85 119.35 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 36.7 t30 56.56 -86.6 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.153 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 5.8 m -137.5 12.61 2.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.655 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.2 p -109.4 140.6 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.694 0.283 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.8 87.46 0.55 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.261 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.885 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -72.12 -9.05 57.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.107 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.563 ' N ' HD12 ' A' ' 220' ' ' LEU . 2.1 pt-20 -67.67 168.22 11.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 t70 49.15 24.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.963 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.885 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.7 p -137.4 163.73 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.651 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.4 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.8 OUTLIER -66.84 167.11 12.03 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.596 0.712 . . . . 0.0 111.447 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.6 t60 -58.01 -36.46 72.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.046 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -52.33 49.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -61.93 -34.74 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.38 87.11 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.565 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 225' ' ' HIS . 37.6 t -59.16 -41.03 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.379 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.09 74.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.51 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -65.97 -45.39 81.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 174' ' ' ILE . 1.1 mt -74.12 -39.77 63.12 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.426 ' HG3' HG12 ' A' ' 229' ' ' VAL . 11.2 mmtt -58.23 -46.52 85.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -57.81 -19.81 31.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.282 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 239' ' ' VAL . 29.9 p -56.4 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.682 0.277 . . . . 0.0 111.372 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -153.07 0.45 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.371 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 165' ' ' LYS . 3.7 m-20 -42.49 -80.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.407 0.283 . . . . 0.0 111.55 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 238' ' ' VAL . 2.6 p -98.15 116.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.052 0.453 . . . . 0.0 110.831 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 235' ' ' THR . 13.5 p -112.91 126.81 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.752 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.57 141.79 28.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.719 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.987 HD11 HD11 ' A' ' 163' ' ' LEU . 6.7 mt -118.16 136.56 53.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.491 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.69 ' HG3' HD21 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -107.41 117.72 34.84 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 211' ' ' LYS . 73.6 t -125.2 151.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.81 125.96 54.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.84 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.893 -179.22 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.968 0.413 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.421 ' O ' HG12 ' A' ' 243' ' ' VAL . 9.3 ptp -132.73 148.58 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -105.26 140.54 38.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.898 HD13 ' HB3' ' A' ' 206' ' ' LEU . 2.1 mt -104.87 119.24 53.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -99.54 119.92 38.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.412 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 170' ' ' LEU . 3.3 pp -137.25 146.09 44.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.553 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -97.83 135.21 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.279 0.562 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.553 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -49.83 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.395 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.46 156.0 7.51 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.512 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.39 -24.09 41.55 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.995 1.797 . . . . 0.0 112.245 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.22 15.37 29.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.69 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 119.24 -151.05 17.72 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.257 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.44 HD11 HG21 ' A' ' 239' ' ' VAL . 4.6 mm? -73.38 -37.05 66.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.497 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 96.09 34.22 6.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.506 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.545 ' N ' HD13 ' A' ' 195' ' ' ILE . 0.3 OUTLIER -176.49 -172.7 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.3 m -137.69 157.64 46.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 228' ' ' ALA . 1.0 OUTLIER -121.59 162.52 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.276 0.56 . . . . 0.0 111.444 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 182' ' ' HIS . . . -125.43 139.2 53.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.074 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.99 129.44 9.52 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.959 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -79.91 -31.11 40.57 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.559 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.28 123.2 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.12 -56.07 5.06 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.008 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -114.48 48.8 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.554 0.693 . . . . 0.0 109.542 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.0 tt0 -43.19 105.95 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.713 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 15.4 t-80 -90.29 -31.72 16.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.786 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.402 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.6 mm -96.84 121.74 58.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.152 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.45 78.99 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.118 1.878 . . . . 0.0 113.111 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 128.55 6.64 4.59 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.114 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.36 129.43 44.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.6 0.7 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 27.7 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 -162.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.955 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 175' ' ' ALA . 4.8 mm -102.33 137.3 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.482 0.658 . . . . 0.0 110.781 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.402 ' CD1' HG13 ' A' ' 183' ' ' ILE . 14.1 m-85 -135.43 144.62 46.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.961 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 206' ' ' LEU . 47.8 t -80.29 139.03 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.814 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.757 ' HA ' HG23 ' A' ' 208' ' ' ILE . 5.0 t -123.74 -14.66 7.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.638 ' C ' HD13 ' A' ' 194' ' ' ILE . 14.8 ttmt -155.32 133.27 11.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.068 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.646 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -121.36 135.29 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.545 HD13 ' N ' ' A' ' 172' ' ' PHE . 1.8 mp -80.77 118.01 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -38.36 100.72 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.946 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.8 22.97 35.73 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.127 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.73 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.225 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.82 -53.61 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 110.692 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -65.07 -45.53 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.646 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.9 t-160 -59.42 -56.36 23.04 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -52.89 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.76 -50.42 20.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.53 -27.3 59.51 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.883 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 59.86 26.06 15.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.1 0.45 . . . . 0.0 110.797 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.898 ' HB3' HD13 ' A' ' 161' ' ' ILE . 3.7 pp -97.6 139.7 33.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -121.79 170.16 10.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.95 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.757 HG23 ' HA ' ' A' ' 192' ' ' THR . 46.8 mt -60.84 112.66 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.5 3.74 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.255 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.771 ' OD2' HG21 ' A' ' 243' ' ' VAL . 0.8 OUTLIER -77.83 138.3 38.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.126 0.463 . . . . 0.0 111.296 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.877 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -94.39 129.82 40.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.316 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.58 HG21 HD23 ' A' ' 241' ' ' LEU . 22.8 mm -110.8 134.65 52.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.477 . . . . 0.0 111.899 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.438 HD11 ' HG2' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -117.06 -3.12 11.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.694 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -172.97 148.34 1.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.968 0.413 . . . . 0.0 111.523 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.744 HG13 ' HG ' ' A' ' 241' ' ' LEU . 3.3 t -130.06 119.97 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.054 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 61.26 -85.39 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.0 t -144.17 14.79 1.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.951 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.4 p -109.04 140.0 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.96 0.409 . . . . 0.0 111.595 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.65 102.95 2.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.261 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -100.29 38.33 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.531 . . . . 0.0 110.197 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -93.4 164.21 13.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.448 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.6 t0 45.38 29.99 0.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.504 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 224' ' ' MET . 3.5 p -133.67 167.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.48 ' H ' HG22 ' A' ' 223' ' ' VAL . 4.2 mtm -75.41 172.72 12.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.779 0.8 . . . . 0.0 112.654 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 229' ' ' VAL . 17.1 t-80 -57.29 -38.51 74.08 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.362 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.33 -51.79 64.54 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.421 ' CB ' HG21 ' A' ' 223' ' ' VAL . 4.2 t0 -60.0 -36.32 76.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.85 0.357 . . . . 0.0 110.806 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.528 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.55 -38.89 92.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.2 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.5 t -57.7 -43.05 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.166 0.508 . . . . 0.0 109.631 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.97 -32.61 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.21 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.717 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -63.9 -39.32 93.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.542 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 229' ' ' VAL . 2.1 mt -70.38 -42.93 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.61 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.02 -33.55 72.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.94 -25.2 66.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.72 ' HB ' HG22 ' A' ' 239' ' ' VAL . 31.0 p -56.17 -173.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.034 0.445 . . . . 0.0 111.638 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -145.21 -149.85 0.3 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -39.15 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.036 0.534 . . . . 0.0 112.383 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.02 120.93 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.885 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.72 HG22 ' HB ' ' A' ' 235' ' ' THR . 42.9 t -107.03 119.97 57.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.52 118.81 34.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.731 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.744 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.9 mp -98.82 153.11 19.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' A' ' 213' ' ' LEU . 1.7 tppp? -106.4 117.05 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.5 p -124.71 144.22 35.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.511 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.607 ' HB3' ' HD2' ' A' ' 211' ' ' LYS . . . -115.35 127.17 55.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.143 -179.565 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.56 153.96 50.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.55 126.33 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.927 HD13 ' HB3' ' A' ' 206' ' ' LEU . 1.8 mt -98.4 118.9 45.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -106.62 121.92 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.646 HD11 ' CD1' ' A' ' 170' ' ' LEU . 3.4 pp -136.46 145.92 45.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.716 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -97.29 134.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.124 0.487 . . . . 0.0 111.473 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -48.67 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.391 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.42 166.89 8.42 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.779 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.38 -27.4 75.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.297 1.998 . . . . 0.0 112.317 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -101.65 15.56 28.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.875 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.52 -152.86 17.53 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.724 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.646 ' CD1' HD11 ' A' ' 163' ' ' LEU . 4.1 mm? -61.78 -34.47 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.726 0.298 . . . . 0.0 111.151 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.03 35.99 6.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.41 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -165.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.745 0.307 . . . . 0.0 110.688 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.9 t -139.52 162.48 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.409 HD12 ' ND1' ' A' ' 225' ' ' HIS . 1.3 pp -129.54 159.86 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.214 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.914 ' HB2' ' CG2' ' A' ' 192' ' ' THR . . . -125.52 137.97 53.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -109.12 130.47 10.03 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.859 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.4 -25.16 52.09 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.416 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 187' ' ' ASN . 18.0 t -89.93 117.3 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -56.05 5.05 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.092 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -109.8 49.22 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.563 0.697 . . . . 0.0 109.31 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.6 tt0 -43.55 115.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.67 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 4.8 t-80 -107.04 -26.32 11.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.497 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 126.74 43.01 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.35 81.24 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.151 1.901 . . . . 0.0 112.909 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.82 56.67 0.84 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.019 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 117.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.685 0.279 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 178' ' ' VAL . 65.7 m-20 -95.11 44.43 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.928 0.394 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.17 -161.13 0.94 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.882 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -111.66 134.44 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 211' ' ' LYS . 21.3 m-85 -135.45 154.28 51.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.633 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG11 HD11 ' A' ' 194' ' ' ILE . 36.2 t -80.22 143.18 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.753 0.311 . . . . 0.0 111.117 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.914 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 18.1 p -117.7 -49.37 2.55 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -136.58 139.38 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 111.95 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 HD12 ' A' ' 206' ' ' LEU . 2.2 mm -118.22 136.36 55.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.753 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.64 113.85 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.444 . . . . 0.0 109.946 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -35.56 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.346 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.93 27.37 44.48 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.239 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -70.82 -70.82 1.12 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.386 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.16 -61.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -60.85 -45.34 94.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.517 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.2 t-160 -59.31 -56.42 22.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.885 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -52.87 18.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.8 -50.87 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.21 -33.89 43.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.838 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 38.35 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.184 0.516 . . . . 0.0 110.399 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.927 ' HB3' HD13 ' A' ' 161' ' ' ILE . 3.7 pp -107.97 140.46 41.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.029 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -124.56 174.43 7.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.648 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 192' ' ' THR . 2.7 mm -64.21 127.74 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 121.59 -16.49 9.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.702 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.36 139.65 37.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.922 0.361 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.726 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.1 ttmt -100.61 128.8 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.249 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.598 ' HA ' HG22 ' A' ' 243' ' ' VAL . 20.8 mm -94.78 119.14 42.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.849 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -95.5 -5.49 42.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 175.3 154.26 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.799 HG13 HD23 ' A' ' 241' ' ' LEU . 2.4 t -126.15 120.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.68 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.2 t30 59.33 -86.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.7 m -141.14 12.98 2.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.913 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 215' ' ' VAL . 8.1 p -109.43 140.59 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.34 104.71 2.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.672 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.43 HD22 ' HB1' ' A' ' 228' ' ' ALA . 0.3 OUTLIER -98.1 33.56 2.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.449 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -93.57 158.87 15.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.405 0.621 . . . . 0.0 112.036 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 49.73 30.44 3.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.329 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 224' ' ' MET . 5.0 p -134.16 164.83 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.19 169.54 10.18 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.745 0.783 . . . . 0.0 112.493 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.879 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.9 t60 -57.89 -36.57 72.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.861 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -51.46 60.44 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.411 ' CB ' HG21 ' A' ' 223' ' ' VAL . 7.8 t70 -59.44 -36.34 75.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.989 0.423 . . . . 0.0 110.918 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.43 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.97 -39.75 93.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.6 t -57.04 -41.47 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.239 0.543 . . . . 0.0 109.553 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.84 74.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.675 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.491 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -63.68 -50.73 68.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.993 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 233' ' ' LYS . 3.8 pp -73.62 -40.73 63.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.769 0.318 . . . . 0.0 111.222 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.606 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.2 OUTLIER -59.38 -33.29 71.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.571 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -21.18 63.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.902 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 232' ' ' LEU . 32.8 p -54.19 -175.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -136.17 -145.78 0.22 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -38.72 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 128.06 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 0.0 111.765 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 170' ' ' LEU . 38.9 t -114.4 119.88 62.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.51 119.95 37.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 215' ' ' VAL . 1.1 mt -96.73 145.77 25.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.937 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -107.86 117.15 33.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 211' ' ' LYS . 75.7 t -127.85 150.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.378 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -123.82 123.51 40.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 mttp . . . . . 0 CA--C 1.533 0.321 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.062 -179.36 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.985 0.421 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.12 154.05 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.64 134.7 55.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.783 HG22 HD21 ' A' ' 163' ' ' LEU . 38.3 mm -119.37 118.78 58.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.84 ' O ' HD23 ' A' ' 163' ' ' LEU . 4.9 ttmm -99.71 131.65 45.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.84 HD23 ' O ' ' A' ' 162' ' ' LYS . 3.5 mt -133.24 129.06 37.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.017 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.808 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -99.59 135.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.12 0.486 . . . . 0.0 111.12 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.808 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.08 98.71 4.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.833 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.46 -147.93 13.05 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.029 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.01 -22.91 34.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.486 2.124 . . . . 0.0 112.26 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -101.7 -4.44 26.48 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.96 -138.83 16.47 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.173 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.427 HD13 ' HE2' ' A' ' 165' ' ' LYS . 4.3 mm? -57.77 -37.38 73.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.476 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 81.41 39.2 12.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.793 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.524 ' N ' HD13 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -176.53 -177.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.054 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t -133.24 158.87 41.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.27 162.17 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.62 138.42 52.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.526 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.86 130.35 9.99 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.007 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.37 -27.47 43.67 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.443 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 18.3 t -89.65 119.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.45 -55.83 5.04 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.047 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -112.6 50.42 0.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.529 0.68 . . . . 0.0 109.523 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.43 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.6 tt0 -43.81 115.91 0.89 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 2.9 t-80 -106.8 -25.87 11.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.452 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.433 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -95.74 123.91 54.35 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.394 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.93 80.85 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.058 1.839 . . . . 0.0 112.27 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.71 55.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.26 123.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.749 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 28.37 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.81 -166.24 1.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.9 mm -102.8 134.89 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CG ' HG12 ' A' ' 183' ' ' ILE . 18.1 m-85 -134.45 153.13 52.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.588 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.62 HG11 ' CD1' ' A' ' 194' ' ' ILE . 49.0 t -80.29 142.06 14.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.084 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 208' ' ' ILE . 4.2 t -124.47 -17.79 5.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -159.31 136.27 9.54 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.174 0.512 . . . . 0.0 112.061 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.683 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -120.85 135.12 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.747 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 172' ' ' PHE . 1.7 mp -81.54 117.66 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -36.95 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.005 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.11 23.75 25.76 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.999 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.74 -78.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.229 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -139.11 -57.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.772 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.97 -45.79 76.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.683 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.2 t-160 -59.33 -55.73 31.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.876 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -51.45 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.36 -50.27 22.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.87 -34.8 29.74 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 114.096 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 66.26 34.66 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.153 0.477 . . . . 0.0 110.21 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.627 ' CD2' HG21 ' A' ' 161' ' ' ILE . 2.1 pp -102.5 140.17 37.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.992 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -117.59 169.62 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.902 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.473 HG23 ' HA ' ' A' ' 192' ' ' THR . 34.1 mt -62.97 127.78 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.768 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.91 -21.34 7.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.778 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.85 159.82 29.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 111.242 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.712 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -116.96 129.89 56.34 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.362 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.537 HD13 HG22 ' A' ' 243' ' ' VAL . 32.4 mm -100.29 117.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.562 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.574 HD21 ' HG2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -97.67 -5.74 34.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 175.26 149.66 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.85 0.357 . . . . 0.0 111.297 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.862 HG13 ' HG ' ' A' ' 241' ' ' LEU . 2.1 t -123.87 119.18 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.895 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.434 ' CG ' HG23 ' A' ' 239' ' ' VAL . 1.9 m-20 57.9 -85.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.217 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 59.6 p -139.35 10.99 2.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.26 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 215' ' ' VAL . 11.0 p -109.8 140.74 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.46 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.12 106.08 2.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.223 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.548 HD21 ' CG2' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -99.15 37.54 1.53 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.143 0.497 . . . . 0.0 110.269 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -98.6 166.65 11.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.338 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 46.12 27.98 0.6 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.903 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 227' ' ' ASP . 4.8 p -133.78 164.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.762 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.403 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -70.46 169.26 14.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.733 0.778 . . . . 0.0 112.093 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.877 ' O ' HG23 ' A' ' 229' ' ' VAL . 61.8 t60 -57.27 -36.85 71.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.76 -52.38 51.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.2 OUTLIER -60.33 -35.64 76.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.678 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.024 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.6 t -57.77 -41.72 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.247 0.546 . . . . 0.0 109.855 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.406 ' HA ' ' CG ' ' A' ' 233' ' ' LYS . . . -64.59 -34.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.657 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.536 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -66.54 -50.39 63.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 235' ' ' THR . 3.0 pp -73.27 -40.03 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.441 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -64.42 -36.39 84.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.372 . . . . 0.0 111.825 -178.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -20.53 46.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.661 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . 1.066 HG21 HG21 ' A' ' 239' ' ' VAL . 28.3 p -58.14 -172.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.274 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.11 -149.81 0.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.389 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 165' ' ' LYS . 55.6 m-20 -45.03 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 121.16 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.929 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.066 HG21 HG21 ' A' ' 235' ' ' THR . 12.5 p -120.6 128.01 75.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.116 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.5 OUTLIER -101.62 120.41 40.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.862 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.9 mp -96.73 142.2 29.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' A' ' 213' ' ' LEU . 2.2 ttmt -106.5 121.35 44.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.365 0.602 . . . . 0.0 110.102 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 211' ' ' LYS . 54.0 t -120.28 150.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.474 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.83 126.17 51.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.964 -179.258 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.742 0.306 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 ptp -128.61 140.97 51.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -98.04 138.51 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.636 HG22 HD21 ' A' ' 163' ' ' LEU . 34.7 mm -124.97 119.52 56.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.731 ' C ' HD23 ' A' ' 163' ' ' LEU . 10.1 ttpp -110.23 133.63 53.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.81 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.913 HD12 HD22 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -130.41 129.88 43.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.141 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 238' ' ' VAL . 0.4 OUTLIER -97.41 122.97 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.192 0.52 . . . . 0.0 110.09 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.456 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -57.76 90.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.267 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.59 43.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.97 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.06 -21.33 72.23 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.239 1.959 . . . . 0.0 112.334 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -102.25 -4.28 25.96 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.92 -147.47 18.1 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.913 HD22 HD12 ' A' ' 163' ' ' LEU . 16.0 mt -66.14 -38.06 87.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 111.338 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.6 35.49 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.528 ' HE1' HD13 ' A' ' 170' ' ' LEU . 6.8 p90 -173.43 -170.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 m -133.95 163.47 29.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -127.45 158.15 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.053 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.916 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.4 138.0 51.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.31 133.05 11.02 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.889 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.95 -20.41 55.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.847 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.402 ' HB ' ' N ' ' A' ' 224' ' ' MET . 12.2 t -89.36 117.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.69 4.83 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.919 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.52 54.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.205 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.479 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.0 tt0 -46.45 118.87 2.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.753 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 18.0 t-80 -103.0 -30.47 10.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.999 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 190' ' ' TYR . 10.3 mm -95.96 133.48 25.25 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.76 75.44 4.47 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.045 1.83 . . . . 0.0 112.961 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.19 20.13 3.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.687 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -141.48 126.81 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.383 0.592 . . . . 0.0 111.153 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -101.92 42.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.3 -164.79 1.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.324 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -105.28 133.49 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 110.111 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.566 ' HB2' HD11 ' A' ' 183' ' ' ILE . 20.7 m-85 -134.87 153.68 51.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 194' ' ' ILE . 21.2 t -80.21 141.4 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.335 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 208' ' ' ILE . 1.6 t -122.69 -20.18 6.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.64 ' C ' HD13 ' A' ' 194' ' ' ILE . 12.1 tttp -157.58 136.14 11.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.046 0.451 . . . . 0.0 111.995 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.64 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.2 mm -120.24 135.15 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.8 mm -81.19 117.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -37.4 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.94 24.04 40.76 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.982 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.85 -67.85 1.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.28 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -147.56 -58.27 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.887 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -63.32 -47.08 83.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -59.42 -56.34 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.759 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -51.98 29.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.427 ' OD2' HG22 ' A' ' 164' ' ' ILE . 3.2 m-20 -73.42 -50.65 20.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -83.74 -32.12 25.09 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.461 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.42 45.78 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.357 0.579 . . . . 0.0 110.202 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.578 HD23 HG21 ' A' ' 161' ' ' ILE . 4.2 pp -113.52 140.23 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.089 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.68 164.02 15.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.546 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 192' ' ' THR . 42.1 mt -57.67 139.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.9 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.94 -18.75 28.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.81 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.11 144.23 45.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.756 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.3 ttpm? -104.97 129.46 53.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.285 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.58 HD13 ' CG2' ' A' ' 243' ' ' VAL . 22.1 mm -91.21 116.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 1.7 pp -90.14 -8.43 51.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.55 155.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 0.0 110.523 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.738 HG13 ' HG ' ' A' ' 241' ' ' LEU . 23.3 t -131.13 119.39 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.159 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.72 -85.57 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.9 t -141.56 13.38 2.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.146 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.1 p -109.16 140.23 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -102.28 100.1 1.95 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.218 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.5 OUTLIER -109.21 45.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.503 0.668 . . . . 0.0 109.387 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.84 27.11 5.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.422 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -158.94 29.82 0.21 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.338 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 227' ' ' ASP . 8.8 p -152.43 166.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.046 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.405 ' H ' HG22 ' A' ' 223' ' ' VAL . 17.1 mtt -58.52 168.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.738 0.78 . . . . 0.0 112.793 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.2 t60 -57.4 -35.52 70.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.58 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.38 -51.81 57.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.615 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.448 ' HB2' HG13 ' A' ' 223' ' ' VAL . 1.1 m-20 -59.91 -36.09 76.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.87 92.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.81 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 225' ' ' HIS . 23.7 t -57.52 -41.32 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.55 74.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.53 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.818 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -66.16 -43.0 88.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.563 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.59 HD11 HG21 ' A' ' 174' ' ' ILE . 1.1 mt -73.4 -46.37 49.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.45 -34.16 70.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.176 0.513 . . . . 0.0 111.152 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -60.35 -20.76 60.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.356 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . 1.009 HG21 HG21 ' A' ' 239' ' ' VAL . 17.8 p -69.42 -166.59 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.68 -148.98 0.26 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.504 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.74 -81.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.67 HG21 ' NZ ' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -95.49 118.55 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.015 0.436 . . . . 0.0 110.742 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.009 HG21 HG21 ' A' ' 235' ' ' THR . 12.3 p -120.23 136.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.207 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.2 m-85 -106.74 119.33 39.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.151 0.5 . . . . 0.0 111.736 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.738 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.3 mp -103.06 134.81 45.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.26 133.87 51.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.824 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 211' ' ' LYS . 69.2 t -130.81 148.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.482 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.7 124.47 51.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.78 45.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 0.0 111.419 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.4 131.38 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.716 HG21 ' CD2' ' A' ' 206' ' ' LEU . 30.5 mm -120.67 133.87 65.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.813 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.68 ' C ' HD23 ' A' ' 163' ' ' LEU . 27.2 ttpt -122.01 129.22 52.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.527 0.204 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 200' ' ' ALA . 2.0 mt -127.32 141.17 51.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.563 0.22 . . . . 0.0 110.429 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -106.78 132.55 53.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 110.592 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.626 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -73.39 82.59 1.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.817 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.2 -167.4 38.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.156 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.26 -20.4 66.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.185 1.923 . . . . 0.0 112.407 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -96.77 -2.13 44.91 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.1 -148.95 17.4 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.437 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.02 -37.37 76.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.006 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 100.32 19.29 19.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.212 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.507 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 1.5 p90 -170.6 -170.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.934 0.367 . . . . 0.0 110.803 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.75 161.84 34.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.018 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.802 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.58 159.53 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.53 137.69 50.92 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.02 129.9 9.75 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 120.003 -1.094 . . . . 0.0 114.147 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.55 -22.6 59.9 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.402 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.3 t -89.85 116.51 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.14 -56.0 5.05 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.996 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -110.23 52.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.418 0.628 . . . . 0.0 109.322 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.436 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.7 tt0 -46.35 114.3 0.78 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.678 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 2.2 t-80 -103.13 -25.41 13.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.1 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.446 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -95.34 132.21 28.23 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.204 -179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.26 79.97 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.147 1.898 . . . . 0.0 112.831 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.5 55.17 0.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.965 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -169.21 130.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.648 0.261 . . . . 0.0 110.937 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.12 28.78 6.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.8 t -111.32 -162.89 0.82 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.25 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.9 mm -106.36 133.21 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.283 0.564 . . . . 0.0 110.483 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.446 ' CG ' HG12 ' A' ' 183' ' ' ILE . 22.9 m-85 -135.14 154.59 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.708 HG21 HD13 ' A' ' 206' ' ' LEU . 42.7 t -80.14 141.21 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.656 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.0 t -121.91 -26.12 4.86 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 137.59 22.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.922 0.392 . . . . 0.0 111.641 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.567 ' CD1' HG11 ' A' ' 191' ' ' VAL . 1.2 mm -120.95 135.74 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.543 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.01 114.16 21.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -39.8 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.819 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.54 31.25 57.22 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.059 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.06 -53.94 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -162.8 -57.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.004 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.787 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.45 -45.57 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 194' ' ' ILE . 8.5 t-160 -60.03 -56.58 19.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.664 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -52.1 25.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.67 -50.57 20.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -77.79 -31.61 48.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.897 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 61.71 30.59 18.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.987 0.422 . . . . 0.0 110.354 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.716 ' CD2' HG21 ' A' ' 161' ' ' ILE . 3.3 pp -107.4 140.48 40.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.861 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -125.82 177.32 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.58 114.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 135.33 -17.67 4.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.907 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.67 149.34 32.85 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.901 0.351 . . . . 0.0 111.189 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.73 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.1 ttmt -109.04 129.91 55.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.509 HD13 ' CG2' ' A' ' 243' ' ' VAL . 22.5 mm -94.35 119.09 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.651 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.795 HD21 ' CG ' ' A' ' 242' ' ' LYS . 1.3 pp -94.91 -9.23 34.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 174.15 152.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.906 HG13 ' HG ' ' A' ' 241' ' ' LEU . 4.3 t -122.99 119.34 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.967 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 239' ' ' VAL . 26.6 t-20 57.98 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 94.2 p -140.54 14.02 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.596 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.5 p -109.41 139.73 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.287 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.78 107.11 2.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.971 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.5 OUTLIER -105.63 39.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.195 0.522 . . . . 0.0 110.607 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.26 168.77 10.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.46 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.0 p30 47.13 26.75 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.105 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.413 HG21 ' CB ' ' A' ' 227' ' ' ASP . 5.4 p -135.8 163.4 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.808 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 mtm -67.13 170.25 7.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.739 0.78 . . . . 0.0 111.903 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.829 ' O ' HG23 ' A' ' 229' ' ' VAL . 67.4 t60 -57.42 -36.05 70.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.253 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -62.3 -52.35 64.04 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.413 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.0 OUTLIER -60.49 -36.55 78.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.577 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 174' ' ' ILE . . . -61.53 -38.59 87.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.023 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.3 t -59.32 -41.78 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.619 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.83 76.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.821 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -64.55 -40.8 96.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.607 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.802 HD11 HG21 ' A' ' 174' ' ' ILE . 9.4 mt -73.2 -41.74 63.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -57.42 -41.05 79.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.178 0.513 . . . . 0.0 111.591 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.54 -19.97 42.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.91 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.897 HG21 HG21 ' A' ' 239' ' ' VAL . 18.4 p -67.39 -171.49 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 111.439 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -143.89 -145.47 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.342 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 165' ' ' LYS . 1.9 m-20 -44.47 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 118.004 0.365 . . . . 0.0 111.696 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.55 119.78 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.897 HG21 HG21 ' A' ' 235' ' ' THR . 9.8 p -118.07 131.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.784 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 7.2 m-85 -102.18 118.11 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.265 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.906 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.1 mp -97.37 139.73 32.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.795 ' CG ' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -107.01 130.71 54.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.175 0.512 . . . . 0.0 110.348 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 211' ' ' LYS . 55.9 t -127.89 148.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.0 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.28 131.98 54.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.755 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt . . . . . 0 C--N 1.327 -0.373 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.071 -179.281 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG11 ' HD2' ' A' ' 242' ' ' LYS . 13.2 t . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.131 0.491 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.73 152.7 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.297 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -112.62 120.6 42.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.731 HG22 ' CD2' ' A' ' 163' ' ' LEU . 41.2 mm -100.36 118.54 47.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.375 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.658 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -102.53 132.4 48.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.739 HD21 ' CD1' ' A' ' 241' ' ' LEU . 0.0 OUTLIER -136.14 129.57 31.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.856 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.891 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -97.97 135.16 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 0.0 111.42 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.891 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -66.33 91.37 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.669 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.87 -165.61 32.92 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.368 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -20.54 50.53 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.197 1.931 . . . . 0.0 112.214 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.26 -4.49 31.8 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.42 -135.15 12.88 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.338 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.538 HD12 ' HE1' ' A' ' 172' ' ' PHE . 4.2 mm? -58.74 -37.86 77.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.807 0.337 . . . . 0.0 110.96 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 86.87 27.26 29.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.098 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.538 ' HE1' HD12 ' A' ' 170' ' ' LEU . 2.6 p90 -175.21 -172.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -131.0 160.91 33.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.818 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -124.42 155.55 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.924 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.48 138.0 51.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.67 136.44 13.36 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.0 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -88.17 -21.07 46.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.535 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.12 116.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.43 -57.46 4.44 Favored Glycine 0 C--N 1.329 0.15 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.91 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -104.99 49.46 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.484 0.659 . . . . 0.0 109.323 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.2 tt0 -44.41 112.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.724 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 18.2 t-80 -97.78 -30.94 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.782 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.453 HG13 ' CD1' ' A' ' 190' ' ' TYR . 18.3 mm -96.72 127.9 37.81 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.398 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.68 78.37 2.44 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.005 1.804 . . . . 0.0 112.876 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.26 10.97 3.56 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.049 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.75 136.72 42.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.572 0.686 . . . . 0.0 111.333 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.416 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 68.7 m-20 -108.74 30.68 6.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 190' ' ' TYR . 5.0 t -116.28 -164.25 0.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.1 mm -109.11 131.32 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.082 0.468 . . . . 0.0 110.541 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.453 ' CD1' HG13 ' A' ' 183' ' ' ILE . 3.1 m-85 -135.1 155.58 50.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.11 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.737 HG21 HD13 ' A' ' 206' ' ' LEU . 46.8 t -79.79 140.27 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.494 ' HA ' HG23 ' A' ' 208' ' ' ILE . 4.1 t -124.67 -14.74 6.72 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.49 133.59 12.43 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.062 0.458 . . . . 0.0 111.566 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.713 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.4 OUTLIER -121.09 134.45 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.019 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.0 118.37 29.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.086 0.47 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -41.99 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.485 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.69 28.68 57.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.868 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.09 -80.17 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.34 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -137.99 -62.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.67 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -62.14 -46.38 89.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.21 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.713 ' HB2' HG22 ' A' ' 194' ' ' ILE . 10.2 t-160 -62.25 -55.86 24.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.661 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -69.79 -52.62 23.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -74.47 -50.93 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.47 -29.32 36.65 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.337 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 64.69 32.11 11.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.392 0.596 . . . . 0.0 110.508 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.737 HD13 HG21 ' A' ' 191' ' ' VAL . 3.6 pp -102.88 140.45 37.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.752 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -123.67 175.65 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 111.08 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.7 mt -62.32 115.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 133.16 -17.9 4.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.53 154.78 40.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.034 0.417 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.713 ' O ' HG13 ' A' ' 243' ' ' VAL . 24.3 ttpt -112.6 129.91 56.21 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.42 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 220' ' ' LEU . 14.8 mm -102.03 116.03 44.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.748 HD21 ' HG2' ' A' ' 242' ' ' LYS . 0.5 OUTLIER -94.67 -12.96 26.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -178.94 148.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.872 0.368 . . . . 0.0 111.531 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.723 HG12 ' CG2' ' A' ' 239' ' ' VAL . 0.2 OUTLIER -117.0 119.53 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.025 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.1 t30 56.55 -87.8 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.4 m -135.98 11.0 3.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.657 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.63 140.82 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 122.549 0.339 . . . . 0.0 110.661 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.84 105.44 2.64 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.525 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 HG22 ' A' ' 212' ' ' ILE . 0.4 OUTLIER -98.76 30.11 3.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.113 0.483 . . . . 0.0 110.144 178.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.71 163.93 12.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 23.4 t70 45.04 27.77 0.32 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.653 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 224' ' ' MET . 6.3 p -133.12 165.81 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.438 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.431 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.07 165.39 18.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.607 0.718 . . . . 0.0 111.794 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.0 t60 -57.59 -35.82 70.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.676 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -35.98 76.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.66 91.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.4 t -58.78 -42.18 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.718 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.25 79.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.356 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -63.56 -40.51 97.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.818 HD11 HG21 ' A' ' 174' ' ' ILE . 2.8 mt -74.03 -40.43 62.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.019 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -55.35 -46.31 76.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -60.75 -20.22 60.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.571 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.835 HG21 HG21 ' A' ' 239' ' ' VAL . 43.9 p -54.58 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.73 0.3 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.66 -151.8 0.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 165' ' ' LYS . 18.9 m-20 -45.35 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.861 0.3 . . . . 0.0 111.2 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.401 HG22 ' CG ' ' A' ' 162' ' ' LYS . 2.5 p -93.98 120.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.741 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.835 HG21 HG21 ' A' ' 235' ' ' THR . 9.5 p -115.07 119.32 61.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.085 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.88 119.5 38.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.915 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.739 ' CD1' HD21 ' A' ' 163' ' ' LEU . 1.3 mp -97.66 151.38 20.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.748 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -107.64 117.9 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.822 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 211' ' ' LYS . 58.4 t -120.47 152.23 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.75 120.92 36.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.84 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.004 -179.41 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.794 0.33 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.29 152.1 38.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.01 146.81 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 31.1 mm -123.18 119.14 56.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.716 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.406 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 1.8 ttpt -107.81 119.45 39.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.614 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.814 HD21 HD23 ' A' ' 170' ' ' LEU . 3.7 pp -137.17 138.7 40.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.439 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -96.89 131.57 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 0.0 110.981 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.512 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -51.39 90.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.6 171.98 5.28 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.671 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.06 -31.76 91.18 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.101 1.867 . . . . 0.0 112.399 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.23 15.67 28.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.54 -160.42 13.43 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.42 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -64.06 -27.2 68.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.52 0.2 . . . . 0.0 111.405 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.81 41.84 5.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.656 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -175.61 -173.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.818 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -134.26 156.11 48.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.795 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.94 160.86 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -130.57 139.36 50.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.218 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -110.83 132.27 10.85 Favored Glycine 0 CA--C 1.502 -0.751 0 C-N-CA 120.141 -1.028 . . . . 0.0 114.336 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.24 -24.05 49.24 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 114.927 -0.636 . . . . 0.0 113.227 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.0 117.06 32.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.67 -57.51 4.75 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.884 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.91 45.97 0.94 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.415 0.626 . . . . 0.0 109.46 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.455 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -42.3 112.16 0.31 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 9.6 t-80 -98.73 -30.11 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.616 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.577 HD11 ' CB ' ' A' ' 190' ' ' TYR . 8.9 mm -96.57 124.87 49.22 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.24 77.74 2.39 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.778 1.652 . . . . 0.0 112.469 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.15 14.56 2.69 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.043 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -139.14 131.16 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.621 0.71 . . . . 0.0 111.117 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.77 25.28 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.2 t -110.06 -164.61 0.94 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 175' ' ' ALA . 2.2 mm -101.75 134.3 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.205 0.526 . . . . 0.0 110.095 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.577 ' CB ' HD11 ' A' ' 183' ' ' ILE . 14.1 m-85 -133.37 148.81 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.524 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 206' ' ' LEU . 34.3 t -79.99 141.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.608 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.0 t -121.97 -26.67 4.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.479 ' C ' HD13 ' A' ' 194' ' ' ILE . 11.9 ttpt -147.63 136.57 22.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 111.822 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.754 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.8 OUTLIER -121.52 135.87 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.157 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.0 mm -80.61 114.0 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.75 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.718 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.24 25.23 53.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.881 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.24 -108.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.2 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -106.3 -62.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -66.64 -45.13 80.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.569 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.754 ' HB2' HG22 ' A' ' 194' ' ' ILE . 2.2 t-80 -59.08 -57.41 13.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -53.16 18.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.67 -50.99 15.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.99 53.21 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.813 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 62.15 28.42 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.913 0.357 . . . . 0.0 110.803 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.579 HD22 HD12 ' A' ' 241' ' ' LEU . 2.9 pp -99.41 139.13 35.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.96 177.34 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 40.0 mt -64.43 126.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.732 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.43 -14.9 10.8 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.531 ' OD1' HG11 ' A' ' 243' ' ' VAL . 0.4 OUTLIER -78.93 145.79 33.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.057 0.429 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.732 ' O ' HG13 ' A' ' 243' ' ' VAL . 13.2 ttmt -103.05 128.57 49.86 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.749 HD13 ' CG2' ' A' ' 243' ' ' VAL . 33.9 mm -99.98 120.49 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 112.141 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.511 HD12 ' HG2' ' A' ' 242' ' ' LYS . 1.6 mt -85.46 -60.72 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.239 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -134.39 155.4 50.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.961 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.723 HG13 HD22 ' A' ' 241' ' ' LEU . 11.8 t -125.14 120.41 58.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.911 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 59.99 -85.21 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.4 m -142.86 13.45 1.89 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.829 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.0 p -109.77 140.43 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.021 0.439 . . . . 0.0 111.659 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.96 104.93 2.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.082 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.547 HD22 ' HB1' ' A' ' 228' ' ' ALA . 0.4 OUTLIER -99.16 37.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 110.704 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -91.93 159.29 15.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.845 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 48.39 31.23 2.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.486 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.443 HG21 ' CB ' ' A' ' 227' ' ' ASP . 3.9 p -133.58 161.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.008 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 11.1 mtt -68.32 170.03 9.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.716 0.77 . . . . 0.0 112.117 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.3 t60 -57.33 -36.88 71.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.306 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.65 -51.81 60.61 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.443 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.1 t0 -59.64 -36.43 76.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.547 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.976 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 225' ' ' HIS . 29.1 t -57.16 -41.81 78.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.01 75.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.202 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.657 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -64.82 -40.28 94.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.604 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.795 HD11 HG21 ' A' ' 174' ' ' ILE . 6.0 mt -70.05 -48.74 56.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -58.41 -33.68 69.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.07 0.462 . . . . 0.0 111.404 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -59.33 -21.24 59.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 232' ' ' LEU . 25.2 p -63.51 -166.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.729 0.3 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.85 -148.28 0.25 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 240' ' ' TYR . 0.5 OUTLIER -96.54 123.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.574 ' CG1' HG21 ' A' ' 235' ' ' THR . 16.7 t -111.84 137.11 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.722 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.467 ' CE1' HG13 ' A' ' 238' ' ' VAL . 2.1 m-85 -115.61 118.74 33.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.671 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.723 HD22 HG13 ' A' ' 215' ' ' VAL . 0.4 OUTLIER -97.77 139.35 33.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.511 ' HG2' HD12 ' A' ' 213' ' ' LEU . 3.0 ttmt -106.92 130.04 54.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.749 ' CG2' HD13 ' A' ' 212' ' ' ILE . 60.9 t -136.97 149.6 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.23 121.79 37.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.066 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mttm . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.288 -179.151 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.765 0.317 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.09 147.56 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.592 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -115.55 120.69 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.2 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.987 HG22 HD21 ' A' ' 163' ' ' LEU . 31.9 mm -109.76 118.19 56.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.675 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.703 ' C ' HD23 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -103.91 129.06 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.987 HD21 HG22 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -126.33 132.32 51.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.11 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.06 124.51 49.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 110.353 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 87.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.27 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.07 179.01 53.55 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.125 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.6 -20.37 33.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.187 1.924 . . . . 0.0 112.394 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.91 8.18 41.24 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.97 -150.27 18.22 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.9 mm? -62.35 -37.99 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.73 0.3 . . . . 0.0 111.288 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 100.9 33.39 5.0 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.005 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.2 OUTLIER -173.89 -166.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.093 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -137.4 161.54 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.794 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.33 158.51 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.883 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.13 137.65 53.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.494 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.43 130.14 9.82 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.783 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -83.83 -23.39 52.97 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.63 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.91 116.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.48 -56.27 4.69 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.995 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.79 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.345 0.593 . . . . 0.0 109.434 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 5.3 tt0 -43.61 112.92 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.678 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 2.5 t-80 -104.3 -25.0 13.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.326 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.15 130.32 31.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.332 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.6 76.52 3.21 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.104 1.869 . . . . 0.0 112.779 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.62 48.41 0.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.05 123.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.65 25.33 5.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.295 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -109.61 -168.14 1.29 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.6 mm -99.51 136.88 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.197 0.522 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 20.6 m-85 -135.5 152.29 51.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.669 HG21 HD12 ' A' ' 206' ' ' LEU . 29.7 t -80.18 140.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.494 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.8 t -125.14 -24.02 4.09 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -150.56 136.55 18.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.104 0.478 . . . . 0.0 111.889 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.3 mm -121.12 135.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.182 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.13 113.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -36.48 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.83 40.19 49.01 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.202 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.06 -60.74 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -149.96 -61.96 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.751 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 1.023 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -65.24 -46.59 79.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.297 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.638 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.6 t-160 -61.42 -56.13 23.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.01 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -52.36 25.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -74.31 -50.74 17.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.41 -36.64 26.25 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 121.086 -0.578 . . . . 0.0 114.167 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 39.38 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.05 0.453 . . . . 0.0 110.681 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 1.023 HD21 ' HB1' ' A' ' 200' ' ' ALA . 1.7 pt? -109.61 140.33 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.536 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -121.79 171.71 8.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 0.0 111.159 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 192' ' ' THR . 53.5 mt -62.49 120.63 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.64 -19.55 4.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.9 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.66 152.51 31.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.85 0.325 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.765 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -113.52 129.22 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.387 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.586 ' HA ' HG22 ' A' ' 243' ' ' VAL . 31.8 mm -90.08 119.24 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 111.507 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -89.81 -26.42 20.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -171.89 149.21 2.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.76 HG13 ' HG ' ' A' ' 241' ' ' LEU . 2.5 t -117.42 119.0 60.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.83 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 239' ' ' VAL . 2.2 m-20 56.2 -85.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 215' ' ' VAL . 9.5 m -138.18 12.18 2.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.663 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.3 p -109.63 140.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-O 120.922 0.391 . . . . 0.0 111.056 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.02 89.49 0.71 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.728 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.921 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -71.72 -7.66 49.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.37 178.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.566 ' N ' HD12 ' A' ' 220' ' ' LEU . 3.8 pt-20 -62.29 168.72 3.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.194 0.521 . . . . 0.0 110.831 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 t0 47.52 25.5 0.65 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 220' ' ' LEU . 2.9 p -136.44 164.41 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.807 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.5 168.87 11.94 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.65 0.738 . . . . 0.0 111.576 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.6 t60 -57.96 -37.21 73.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.042 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.94 -52.88 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.512 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -62.04 -34.34 76.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 109.888 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.77 89.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.778 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.0 t -59.41 -41.72 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.767 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.44 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.703 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -66.29 -50.66 62.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.867 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 235' ' ' THR . 2.6 pp -74.57 -39.67 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -59.05 -39.62 82.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.402 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -59.09 -20.34 52.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.741 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 239' ' ' VAL . 34.6 p -57.75 -172.17 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.574 0.226 . . . . 0.0 111.323 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -133.88 -146.9 0.27 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.877 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -81.95 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 122.543 0.337 . . . . 0.0 111.792 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.27 122.34 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.012 HG21 HG21 ' A' ' 235' ' ' THR . 12.9 p -117.53 132.69 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.9 m-85 -105.4 119.45 39.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.922 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.76 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.0 mp -97.71 140.59 31.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.51 117.74 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.213 0.53 . . . . 0.0 110.215 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 211' ' ' LYS . 65.2 t -117.61 147.81 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.069 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.35 121.25 39.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.733 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 243' ' ' VAL . 11.4 p . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.798 0.333 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.0 ptm -124.58 154.4 40.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.313 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.03 130.89 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.398 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.874 HG22 ' CD2' ' A' ' 163' ' ' LEU . 37.9 mm -100.52 117.09 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.458 ' C ' HD23 ' A' ' 163' ' ' LEU . 7.7 ttpt -98.66 125.12 43.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.108 0.48 . . . . 0.0 112.273 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.874 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -136.28 129.51 31.59 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.39 131.08 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.123 0.487 . . . . 0.0 111.292 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 69.31 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.52 -160.22 7.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.27 -20.13 49.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.132 1.888 . . . . 0.0 112.401 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -92.26 -4.63 53.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.36 -149.41 19.45 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.57 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.588 HD12 HD12 ' A' ' 163' ' ' LEU . 4.2 mm? -56.96 -37.87 72.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 110.982 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 200' ' ' ALA . . . 92.2 26.41 18.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.972 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 4.1 p90 -174.97 -168.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 110.943 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 192' ' ' THR . 4.0 m -135.65 163.85 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.585 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.58 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -129.17 161.17 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 111.301 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.905 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.92 137.88 51.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.31 130.34 9.53 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.712 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.86 -18.23 61.83 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.558 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.96 117.76 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.38 -57.87 4.67 Favored Glycine 0 C--N 1.329 0.141 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.055 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -109.78 57.39 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.592 0.71 . . . . 0.0 109.301 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.2 tt0 -48.5 116.26 1.52 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.701 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 4.0 t-80 -101.6 -27.02 13.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.913 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.414 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.24 134.57 23.43 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 79.41 2.59 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.138 1.892 . . . . 0.0 113.101 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.52 50.95 0.73 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.242 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -168.9 131.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.663 0.268 . . . . 0.0 110.884 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.065 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -169.1 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.905 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.5 mm -102.69 134.96 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.253 0.549 . . . . 0.0 110.112 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CG ' HG12 ' A' ' 183' ' ' ILE . 15.3 m-85 -133.84 155.35 50.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.626 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.605 HG11 ' CD1' ' A' ' 194' ' ' ILE . 40.3 t -80.28 141.44 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.329 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.556 ' C ' HD12 ' A' ' 208' ' ' ILE . 7.9 t -125.53 -21.55 4.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -153.42 136.13 15.27 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.683 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.655 HG22 ' HB2' ' A' ' 201' ' ' HIS . 2.5 mm -120.87 135.91 59.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.69 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.5 mm -80.17 116.88 25.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 110.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -37.03 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.023 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.74 27.19 34.9 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.981 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.56 -115.53 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.42 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.412 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -98.58 -57.42 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.934 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -67.31 -47.15 71.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.905 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.655 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.1 t-160 -59.52 -56.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.24 -52.74 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -74.0 -51.36 16.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.0 -38.19 36.19 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.728 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.28 41.21 4.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.292 0.568 . . . . 0.0 110.198 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.934 HD21 ' HB1' ' A' ' 200' ' ' ALA . 0.8 OUTLIER -111.28 140.23 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.999 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -118.77 179.53 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.763 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 192' ' ' THR . 7.4 mm -72.41 113.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.058 0.456 . . . . 0.0 111.556 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.2 -13.57 3.54 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.662 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -78.93 159.3 27.78 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 117.038 0.419 . . . . 0.0 110.982 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.733 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -120.76 130.12 53.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.657 HD13 ' CG2' ' A' ' 243' ' ' VAL . 32.7 mm -93.17 117.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.666 HD21 ' CG ' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -95.33 -4.97 44.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.63 153.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.755 0.312 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 218' ' ' VAL . 42.7 t -132.23 119.63 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.467 ' ND2' HG23 ' A' ' 239' ' ' VAL . 24.3 m-20 59.94 -84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.44 13.02 1.96 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.07 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.9 p -109.31 139.84 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.943 0.401 . . . . 0.0 111.529 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.14 101.9 2.33 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.387 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.98 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -109.17 45.66 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.478 0.656 . . . . 0.0 109.65 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 26.78 4.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.164 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -158.12 32.19 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.952 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 227' ' ' ASP . 7.0 p -153.4 166.1 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.443 ' N ' HG22 ' A' ' 223' ' ' VAL . 3.9 mtm -62.13 168.43 3.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.632 0.729 . . . . 0.0 112.076 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.87 ' O ' HG23 ' A' ' 229' ' ' VAL . 54.5 t60 -56.93 -36.18 69.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.031 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.15 -52.89 52.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.489 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -62.36 -34.98 77.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.166 0.508 . . . . 0.0 109.929 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 231' ' ' ALA . . . -60.67 -38.39 84.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.664 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.2 t -59.52 -41.64 85.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.89 -33.22 72.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.058 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.98 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.3 -41.15 96.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.896 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 229' ' ' VAL . 1.7 mt -73.99 -41.9 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.102 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -61.77 -39.57 92.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.149 0.499 . . . . 0.0 111.237 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -60.67 -19.61 58.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.866 HG21 HG21 ' A' ' 239' ' ' VAL . 30.2 p -57.73 -166.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.761 -0.2 . . . . 0.0 110.928 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -152.93 -160.74 1.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.233 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -28.82 -61.6 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.21 126.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 235' ' ' THR . 4.2 p -120.65 126.11 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 121.32 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.763 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 215' ' ' VAL . 0.3 OUTLIER -97.24 146.57 24.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.067 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.666 ' CG ' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -108.39 118.02 35.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.022 0.439 . . . . 0.0 109.936 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 211' ' ' LYS . 58.4 t -127.56 148.77 32.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.983 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.2 121.46 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.084 0.468 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.461 ' O ' HG12 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -132.12 154.55 49.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.998 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.83 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 0.0 111.794 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.943 HG21 HD23 ' A' ' 206' ' ' LEU . 34.5 mm -113.66 118.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.611 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.761 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -94.54 131.23 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.689 0.281 . . . . 0.0 111.331 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.795 HD11 HD11 ' A' ' 241' ' ' LEU . 11.5 mt -131.71 128.79 39.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.829 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -98.25 128.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.13 0.49 . . . . 0.0 110.145 179.05 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.647 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -63.15 91.94 0.05 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.008 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.14 -171.04 37.37 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.892 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.84 -24.8 74.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.211 1.94 . . . . 0.0 112.535 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -4.18 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.48 -144.27 18.37 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.366 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 18.3 mt -67.14 -37.83 84.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.271 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 97.94 34.26 5.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.622 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 7.3 p90 -175.07 -168.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 111.013 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 192' ' ' THR . 22.7 t -136.33 161.02 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.836 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.52 161.48 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.997 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.884 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -131.1 138.7 49.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.6 130.67 9.67 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.598 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.58 -25.08 54.88 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.637 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.53 120.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.91 5.02 Favored Glycine 0 C--N 1.331 0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 113.004 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -114.93 54.14 0.79 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.443 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -45.54 107.33 0.1 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.314 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.648 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 5.3 t-80 -93.74 -26.78 16.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.011 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.435 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -96.46 121.85 59.0 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.034 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.72 71.01 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.999 1.799 . . . . 0.0 112.532 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 123.66 51.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.712 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.89 129.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.3 30.89 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.4 t -114.52 -165.73 1.04 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.884 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -103.22 135.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.435 ' CG ' HG12 ' A' ' 183' ' ' ILE . 20.6 m-85 -135.87 153.72 51.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.736 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 194' ' ' ILE . 46.5 t -80.76 142.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 173' ' ' SER . 1.9 t -122.7 -20.73 5.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.556 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -158.59 136.95 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.997 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.642 HD12 ' CD1' ' A' ' 206' ' ' LEU . 2.8 mm -120.57 135.65 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.995 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.6 mm -80.45 116.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -37.82 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.9 24.22 41.08 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.216 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.48 -114.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.121 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -109.94 -48.11 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.771 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.13 -47.07 72.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.409 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.0 t-160 -59.55 -56.08 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -69.77 -52.0 29.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.85 -51.15 17.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.62 -34.77 21.52 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.217 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 66.02 26.67 10.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.188 0.494 . . . . 0.0 110.552 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 161' ' ' ILE . 3.9 pp -96.05 140.86 30.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -122.04 170.15 10.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 34.6 mt -58.22 113.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.51 -19.61 3.18 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.723 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.14 129.88 39.03 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.824 0.312 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.885 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.5 OUTLIER -96.48 129.11 43.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.627 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 189' ' ' ILE . 16.2 mm -103.13 137.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.802 0.334 . . . . 0.0 111.667 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.687 HD11 ' HG2' ' A' ' 242' ' ' LYS . 1.4 pp -115.53 -12.59 11.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.034 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -175.9 152.45 1.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 110.657 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.721 ' O ' HG12 ' A' ' 218' ' ' VAL . 38.4 t -130.43 119.09 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 58.43 -85.04 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.99 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 12.95 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.674 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.29 140.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 120.827 0.346 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.58 100.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.049 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.598 HD21 HG21 ' A' ' 215' ' ' VAL . 0.5 OUTLIER -99.25 34.73 2.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.383 0.611 . . . . 0.0 109.864 178.235 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -103.35 163.68 12.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 46.38 26.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.665 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 224' ' ' MET . 5.2 p -134.21 165.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 2.9 mtt -69.51 168.34 14.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.718 0.77 . . . . 0.0 112.026 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.859 ' O ' HG23 ' A' ' 229' ' ' VAL . 64.2 t60 -58.11 -36.31 72.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.017 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.6 -51.72 57.52 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -35.57 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.473 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.14 92.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.403 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.2 t -58.09 -41.83 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.97 74.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.467 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -67.31 -41.4 85.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.234 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 174' ' ' ILE . 4.3 mt -73.44 -45.18 55.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -34.62 71.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.816 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -64.47 -20.35 66.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.63 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.956 HG21 HG21 ' A' ' 239' ' ' VAL . 26.2 p -62.25 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -140.76 -150.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 7.1 m-20 -45.08 -81.18 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.286 0.234 . . . . 0.0 111.609 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.8 118.48 42.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.168 0.509 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.956 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -120.82 127.31 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.199 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.34 123.79 46.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.795 HD11 HD11 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -97.07 149.32 22.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.687 ' HG2' HD11 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -107.64 116.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.2 p -124.06 140.36 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.881 -177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.55 121.73 40.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.167 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.751 0.31 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.84 149.27 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.43 142.85 28.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.306 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.711 HD13 ' HB3' ' A' ' 206' ' ' LEU . 2.7 mt -118.03 119.62 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.783 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.539 ' CG ' HG22 ' A' ' 238' ' ' VAL . 14.9 ttpt -100.84 130.75 46.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.002 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.985 HD11 HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -132.09 132.04 42.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.816 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -97.2 135.09 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.242 0.544 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.784 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -70.11 96.01 1.03 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.085 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.8 -158.25 27.58 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.959 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.86 -20.72 68.76 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.097 1.865 . . . . 0.0 112.422 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.27 -2.49 31.0 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.4 -135.77 14.25 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.126 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 4.4 mm? -58.21 -33.25 69.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 111.046 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.03 32.99 37.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.699 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 11.6 p90 -175.42 -174.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.4 m -129.85 160.29 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 111.545 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.753 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -122.91 157.09 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.9 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.99 137.53 52.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -111.45 130.92 9.99 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.753 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.62 -23.74 57.55 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.587 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.1 t -90.06 117.92 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.96 -56.04 5.03 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.918 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -112.42 53.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.439 0.638 . . . . 0.0 109.414 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.5 tt0 -45.87 113.24 0.58 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.684 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 3.8 t-80 -102.66 -26.04 13.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.277 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.434 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -95.99 132.99 25.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.275 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.88 76.34 4.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 113.007 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.59 47.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.083 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.64 130.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 0.0 110.948 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.4 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 1.3 m120 -102.47 28.13 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.28 -162.46 0.8 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.751 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.9 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -106.38 136.04 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.434 ' CG ' HG12 ' A' ' 183' ' ' ILE . 21.8 m-85 -135.77 150.3 49.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.388 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 194' ' ' ILE . 26.9 t -80.73 138.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.703 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.6 t -123.23 -18.48 6.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -152.16 133.53 14.49 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.782 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.6 mm -120.93 135.6 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.151 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -81.02 113.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 109.866 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -37.19 102.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.28 23.6 13.32 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.262 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.0 -107.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.411 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -104.44 -58.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -67.23 -47.99 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.035 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.8 t-160 -58.46 -56.11 26.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -52.32 27.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.44 -51.38 15.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 163' ' ' LEU . . . -85.52 -35.78 11.45 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.686 -0.768 . . . . 0.0 114.402 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 62.17 0.74 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.401 0.62 . . . . 0.0 110.578 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 200' ' ' ALA . 0.3 OUTLIER -122.5 132.88 54.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.92 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -112.14 165.72 11.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.972 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.703 HG23 ' HA ' ' A' ' 192' ' ' THR . 37.9 mt -64.06 111.54 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.76 -14.07 2.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.204 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.24 153.01 28.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.107 0.453 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.742 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -114.32 129.36 56.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.675 ' HA ' HG22 ' A' ' 243' ' ' VAL . 43.1 mm -90.5 122.93 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.566 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.785 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -90.46 -27.09 19.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.171 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 177.09 150.21 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.738 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.843 HG22 HD23 ' A' ' 241' ' ' LEU . 2.2 t -116.19 118.92 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.017 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 56.42 -86.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.28 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.6 m -136.39 11.06 3.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.072 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 215' ' ' VAL . 8.1 p -109.23 140.39 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -108.64 88.53 0.53 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.056 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.875 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -68.07 -13.81 62.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 178.538 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.638 ' N ' HD12 ' A' ' 220' ' ' LEU . 1.5 pt-20 -63.24 169.59 3.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.19 0.519 . . . . 0.0 110.72 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.39 24.42 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.795 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.875 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.2 p -144.86 156.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.92 167.5 0.79 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.93 0.872 . . . . 0.0 112.592 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.0 t60 -57.66 -35.01 69.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.099 -1.41 . . . . 0.0 110.685 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.3 -52.05 51.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.052 0.454 . . . . 0.0 111.996 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.495 ' HB2' HG22 ' A' ' 223' ' ' VAL . 8.6 m-20 -61.27 -35.42 77.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.49 90.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.775 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.6 t -59.04 -41.3 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.12 75.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.1 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 218' ' ' VAL . . . -63.45 -39.74 95.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.32 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.753 HD11 HG21 ' A' ' 174' ' ' ILE . 9.0 mt -73.16 -44.24 60.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.166 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -37.0 70.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 111.575 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.0 -20.3 65.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.909 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.893 HG21 HG21 ' A' ' 239' ' ' VAL . 22.8 p -65.43 -175.67 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.754 0.312 . . . . 0.0 111.323 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.53 -150.03 0.35 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.227 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 165' ' ' LYS . 2.1 m-20 -44.31 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.712 0.233 . . . . 0.0 111.288 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.539 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.5 OUTLIER -94.11 122.54 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.676 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.893 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -118.83 135.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -102.63 135.33 44.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.985 HD11 HD11 ' A' ' 163' ' ' LEU . 3.6 mt -113.46 135.34 53.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.467 ' HG2' HD23 ' A' ' 213' ' ' LEU . 2.6 ttpp -106.66 117.5 34.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.174 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 211' ' ' LYS . 75.1 t -129.48 148.79 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.95 121.12 35.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.963 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.165 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.568 HG11 ' HE2' ' A' ' 242' ' ' LYS . 16.2 t . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.637 0.256 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -93.39 140.01 30.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.63 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.76 HG21 HD23 ' A' ' 206' ' ' LEU . 48.6 mm -123.9 119.21 56.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.798 ' O ' HD23 ' A' ' 163' ' ' LEU . 19.1 ttpt -105.57 132.31 51.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.373 . . . . 0.0 111.606 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.875 HD22 ' HA ' ' A' ' 200' ' ' ALA . 2.3 mt -131.61 129.77 41.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.062 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.751 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -98.17 134.54 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 110.973 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.751 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -74.79 106.31 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.912 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.14 -147.13 8.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.217 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.38 -23.06 38.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.064 1.842 . . . . 0.0 112.055 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -102.14 -4.73 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.62 -135.32 13.67 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.109 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.587 HD12 HD12 ' A' ' 163' ' ' LEU . 4.5 mm? -58.49 -37.11 74.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.115 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.556 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 83.48 39.35 9.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.651 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.25 -173.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.97 0.414 . . . . 0.0 110.704 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 m -133.13 160.39 37.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -125.84 162.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.825 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.074 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.83 129.38 9.5 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.431 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.67 -20.6 55.88 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.255 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 187' ' ' ASN . 17.6 t -89.83 116.99 32.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.27 -58.5 4.03 Favored Glycine 0 C--N 1.329 0.164 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.944 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -102.97 48.55 0.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.472 0.654 . . . . 0.0 109.429 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.448 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -44.51 113.5 0.55 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 7.4 t-80 -98.44 -31.31 12.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.743 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.439 HG13 ' CG ' ' A' ' 190' ' ' TYR . 9.8 mm -96.4 123.91 52.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.198 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.49 78.67 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.982 1.788 . . . . 0.0 112.566 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 130.88 5.73 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.013 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -132.88 144.85 50.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.669 0.735 . . . . 0.0 111.35 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ASN . . . . . 0.416 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.2 m-80 -104.85 -28.05 11.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -62.98 -163.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.5 mm -101.13 141.35 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.25 0.548 . . . . 0.0 110.819 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CG ' HG13 ' A' ' 183' ' ' ILE . 17.6 m-85 -135.58 155.05 51.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.839 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 194' ' ' ILE . 36.7 t -85.16 142.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.451 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 208' ' ' ILE . 1.4 t -123.74 -24.26 4.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LYS . . . . . 0.617 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -157.15 138.25 13.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.09 0.472 . . . . 0.0 112.01 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.617 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.6 mm -121.35 135.78 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.483 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.556 HD13 ' C ' ' A' ' 171' ' ' GLY . 3.5 mp -80.73 115.6 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -38.26 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.97 29.37 43.04 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.167 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.99 -64.73 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.182 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.21 -57.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.388 . . . . 0.0 110.689 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.875 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.44 -44.55 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.811 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.7 t-80 -59.63 -55.89 28.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.678 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -51.54 30.29 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.84 -49.47 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.64 -35.24 14.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.789 -0.72 . . . . 0.0 114.398 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 51.66 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.375 0.607 . . . . 0.0 109.962 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.76 HD23 HG21 ' A' ' 161' ' ' ILE . 4.1 pp -120.81 140.44 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.224 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.71 174.97 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.019 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 192' ' ' THR . 35.9 mt -67.6 126.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.827 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 127.03 -19.39 6.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.622 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -77.03 149.44 35.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.792 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -110.83 128.21 55.69 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.896 0.379 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.859 HD13 ' CG2' ' A' ' 243' ' ' VAL . 26.8 mm -92.79 124.71 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.884 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.466 HD21 ' HD2' ' A' ' 211' ' ' LYS . 3.3 mt -85.48 -67.26 0.82 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.263 0.554 . . . . 0.0 110.151 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.03 155.11 50.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.703 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.859 HG13 ' HG ' ' A' ' 241' ' ' LEU . 26.0 t -124.3 120.11 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.61 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 t30 59.31 -86.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.9 t -141.26 14.44 2.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.665 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.75 140.64 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.89 97.33 1.42 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.051 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 215' ' ' VAL . 0.4 OUTLIER -101.84 43.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -120.12 30.07 7.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.732 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -168.65 33.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 227' ' ' ASP . 9.6 p -152.41 165.29 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.431 ' N ' HG22 ' A' ' 223' ' ' VAL . 1.1 mpt? -63.51 172.68 1.93 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.727 0.775 . . . . 0.0 112.173 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 229' ' ' VAL . 66.7 t60 -57.44 -37.62 73.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.583 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.54 -53.14 46.36 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASP . . . . . 0.529 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -63.12 -34.21 77.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.78 -38.21 84.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.646 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.8 t -60.08 -41.39 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.142 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.91 -32.81 74.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.875 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -65.33 -42.08 93.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.315 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 229' ' ' VAL . 0.7 OUTLIER -73.69 -48.07 34.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.446 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.48 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 111.979 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.53 -20.7 57.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.715 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . 0.999 HG21 HG21 ' A' ' 239' ' ' VAL . 30.6 p -60.82 -169.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.687 0.279 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.71 -152.01 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -44.34 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.549 0.214 . . . . 0.0 111.439 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.423 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.3 OUTLIER -97.05 121.81 47.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.944 0.402 . . . . 0.0 110.711 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.999 HG21 HG21 ' A' ' 235' ' ' THR . 12.5 p -120.16 132.95 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 2.6 m-85 -105.21 119.58 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.859 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.0 mp -101.55 138.19 38.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.568 ' HE2' HG11 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -107.06 129.22 54.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.986 0.422 . . . . 0.0 110.046 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.859 ' CG2' HD13 ' A' ' 212' ' ' ILE . 53.6 t -130.82 148.32 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.691 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.7 131.09 52.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.768 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.082 -179.665 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.83 0.348 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -100.44 158.98 15.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 144.73 36.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.31 125.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 14.7 ptp -132.03 154.51 49.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.882 0.373 . . . . 0.0 111.25 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.93 145.08 30.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.829 HG21 HD23 ' A' ' 206' ' ' LEU . 41.1 mm -125.44 116.71 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.728 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.8 mtmt -90.7 131.51 36.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.004 0.431 . . . . 0.0 111.108 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.006 HD11 HD11 ' A' ' 241' ' ' LEU . 2.1 mt -121.23 128.39 52.36 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.967 HD12 HG22 ' A' ' 238' ' ' VAL . 13.0 mm -97.25 134.21 36.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 111.375 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.475 ' HE2' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -80.15 56.99 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.043 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.99 -156.0 0.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.51 -22.98 44.05 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.212 1.941 . . . . 0.0 112.434 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -4.49 47.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.1 -130.84 10.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.271 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 163' ' ' LEU . 4.5 mm? -62.37 -36.46 82.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 110.95 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 26.56 23.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.109 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 1.7 p90 -174.57 -168.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 111.202 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -134.7 158.96 42.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.729 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -124.73 160.49 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.918 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -125.05 137.3 54.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.16 129.91 9.61 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.499 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.15 -22.67 54.2 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.76 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 187' ' ' ASN . 19.8 t -89.99 118.64 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.89 -57.12 4.96 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.967 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -110.39 52.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.6 tt0 -44.8 116.21 1.03 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.671 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 8.7 t-80 -103.89 -27.75 12.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.238 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.436 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.41 123.45 54.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.371 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.62 81.47 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.007 1.804 . . . . 0.0 112.648 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.28 55.32 0.68 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.028 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.41 129.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.812 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.54 ' HB3' HG22 ' A' ' 178' ' ' VAL . 7.7 m120 -103.74 29.46 5.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m -111.0 -160.9 0.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.7 mm -110.79 136.65 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.9 m-85 -135.47 154.06 51.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.545 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.504 HG11 ' CD1' ' A' ' 194' ' ' ILE . 40.1 t -80.9 142.22 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.2 t -123.97 -24.09 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.54 ' C ' HD13 ' A' ' 194' ' ' ILE . 9.4 ttpt -155.43 138.52 15.54 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.72 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.724 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -121.27 135.12 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.498 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.86 123.62 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -39.53 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.58 26.11 37.55 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.283 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.27 -69.23 1.4 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.172 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.456 ' HB1' ' H ' ' A' ' 164' ' ' ILE . . . -148.46 -59.31 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.954 0.407 . . . . 0.0 110.388 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.691 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -63.97 -43.81 94.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.724 ' HB2' HG22 ' A' ' 194' ' ' ILE . 7.7 t-160 -66.07 -55.8 14.75 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -69.4 -52.76 23.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 164' ' ' ILE . 2.5 t70 -75.01 -50.56 16.14 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.474 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -77.9 -31.25 49.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.134 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 62.19 32.23 17.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.179 0.49 . . . . 0.0 110.182 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.829 HD23 HG21 ' A' ' 161' ' ' ILE . 3.8 pp -101.3 140.32 35.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.904 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 194' ' ' ILE . 11.3 pt20 -123.01 167.21 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 46.2 mt -58.06 116.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.3 -17.94 3.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.439 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -78.95 149.16 32.39 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 120.743 0.306 . . . . 0.0 111.062 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.771 ' O ' HG13 ' A' ' 243' ' ' VAL . 5.9 ptmt -112.94 128.87 56.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.462 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.725 ' HA ' HG22 ' A' ' 243' ' ' VAL . 26.9 mm -90.1 121.58 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.315 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 0.7 OUTLIER -101.73 2.5 38.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 163.83 155.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.814 HG13 ' CD2' ' A' ' 241' ' ' LEU . 57.5 t -132.14 118.57 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.441 ' HA ' ' CE2' ' A' ' 240' ' ' TYR . 26.9 m-20 58.08 -85.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.5 OUTLIER -141.18 14.32 2.23 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.668 177.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.749 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.2 p -109.17 140.38 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.97 0.414 . . . . 0.0 111.3 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.75 94.61 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.968 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.1 OUTLIER -102.31 44.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.696 0.76 . . . . 0.0 109.026 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 25.58 5.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.601 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.71 33.38 0.4 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.745 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 227' ' ' ASP . 10.1 p -152.76 166.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.039 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.46 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.69 170.52 2.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.725 0.774 . . . . 0.0 112.284 -179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.869 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.2 t60 -57.55 -36.28 71.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.307 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.18 -52.56 54.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.498 ' CB ' HG21 ' A' ' 223' ' ' VAL . 2.4 t0 -62.01 -35.22 77.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.959 0.409 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.15 89.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.872 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 225' ' ' HIS . 18.2 t -59.37 -41.36 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.31 -33.25 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.474 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.968 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.23 -41.48 96.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 174' ' ' ILE . 3.5 mt -73.96 -48.77 28.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.611 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -61.49 -34.54 75.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.957 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -64.39 -20.22 66.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.732 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . 1.141 HG21 HG21 ' A' ' 239' ' ' VAL . 18.3 p -66.01 -162.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.516 0.198 . . . . 0.0 111.443 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 236' ' ' TYR . 1.7 m-85 -131.02 -153.46 0.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.146 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.19 -77.03 0.02 OUTLIER 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.566 0.347 . . . . 0.0 111.787 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.967 HG22 HD12 ' A' ' 164' ' ' ILE . 53.5 t -102.88 121.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.106 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.141 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -118.87 124.07 72.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.588 ' C ' HD23 ' A' ' 241' ' ' LEU . 0.6 OUTLIER -94.76 138.03 33.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.405 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 1.006 HD11 HD11 ' A' ' 163' ' ' LEU . 0.8 OUTLIER -114.77 147.25 40.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.76 119.8 40.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 110.304 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 211' ' ' LYS . 71.8 t -128.75 146.63 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.787 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.98 132.1 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.675 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -94.88 128.64 38.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.911 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.13 111.38 3.06 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.043 1.828 . . . . 0.0 112.459 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 m -96.3 121.57 38.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -82.94 81.19 8.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.956 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.101 179.883 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 61.61 -179.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.661 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -82.74 105.47 13.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 130.95 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.52 ' SD ' HD11 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -132.18 147.5 52.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.117 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.61 144.15 27.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.963 HG21 HD23 ' A' ' 206' ' ' LEU . 43.0 mm -125.45 118.94 53.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.636 ' O ' HD23 ' A' ' 163' ' ' LEU . 8.9 ttmt -97.57 126.31 42.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 241' ' ' LEU . 12.4 mt -127.41 128.92 46.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.326 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.787 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -101.28 133.5 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.053 0.454 . . . . 0.0 110.719 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.787 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -68.9 74.17 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.089 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.74 -161.61 0.4 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.368 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.72 -24.37 25.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.327 2.018 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -101.32 -1.95 32.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.04 -138.02 14.68 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.365 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 24.1 mt -69.6 -33.59 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.844 0.355 . . . . 0.0 111.126 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.29 27.63 11.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.491 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 3.7 p90 -170.58 -169.27 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.0 t -136.92 162.97 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.686 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -123.6 160.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.187 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.906 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.02 138.01 52.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -109.35 130.18 9.85 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.818 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -83.78 -23.2 53.77 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.425 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.403 ' HB ' ' N ' ' A' ' 224' ' ' MET . 10.5 t -89.88 120.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.66 -56.43 5.05 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.075 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.06 57.58 0.79 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.543 0.687 . . . . 0.0 109.391 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.452 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.6 tt0 -47.66 116.95 1.62 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.706 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 2.4 t-80 -102.06 -25.16 13.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.952 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.1 mp -96.48 129.44 33.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.35 78.1 2.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.053 1.835 . . . . 0.0 112.829 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.57 50.96 0.63 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.748 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.13 123.87 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.741 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 28.74 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 -166.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.58 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.906 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -102.98 134.89 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.226 0.536 . . . . 0.0 110.522 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.442 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.3 m-85 -135.33 154.23 51.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.684 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 206' ' ' LEU . 44.6 t -80.7 141.43 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.402 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.8 t -123.07 -26.04 4.43 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.478 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -150.61 137.18 18.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.912 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 191' ' ' VAL . 1.3 mm -121.28 135.25 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.33 118.39 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.52 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.57 23.97 16.05 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.136 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.18 -78.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.431 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -137.56 -58.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.954 0.407 . . . . 0.0 110.879 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.859 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -63.31 -45.92 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -59.13 -55.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.953 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -52.06 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.64 -50.51 20.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -82.4 -32.81 27.18 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.259 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 63.2 31.92 15.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.281 0.541 . . . . 0.0 110.259 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.963 HD23 HG21 ' A' ' 161' ' ' ILE . 4.7 pp -102.68 140.43 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.638 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 176.33 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.283 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 51.1 mt -64.28 112.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.07 -17.0 2.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.865 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.9 147.87 32.94 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.923 0.362 . . . . 0.0 111.028 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.733 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -110.48 129.17 55.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.326 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.72 HD13 ' CG2' ' A' ' 243' ' ' VAL . 43.0 mm -92.17 116.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 0.9 OUTLIER -96.5 -2.27 45.52 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.122 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.47 152.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.731 HG23 HD21 ' A' ' 220' ' ' LEU . 40.8 t -130.55 118.63 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.14 -84.51 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.317 0.386 . . . . 0.0 110.066 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 215' ' ' VAL . 50.4 m -139.94 11.69 2.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.23 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.1 p -109.19 140.71 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.65 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.21 108.72 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.442 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.939 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -119.37 50.6 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.457 0.646 . . . . 0.0 109.492 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 26.05 4.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.532 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -159.9 30.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.322 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 227' ' ' ASP . 9.7 p -148.7 166.44 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.342 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.421 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.38 170.69 2.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.697 0.761 . . . . 0.0 112.256 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.88 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.9 t60 -57.74 -37.42 73.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.086 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.27 -52.53 46.64 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.468 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -62.5 -34.68 77.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.105 0.478 . . . . 0.0 109.886 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.414 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.93 -38.73 86.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.653 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.7 t -59.88 -41.52 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.136 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.45 72.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.411 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.939 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -65.23 -42.61 93.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.281 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.686 HD11 HG21 ' A' ' 174' ' ' ILE . 1.7 mt -73.59 -41.94 62.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.491 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.08 -40.91 86.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.62 -20.41 32.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.786 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . 1.04 HG21 HG21 ' A' ' 239' ' ' VAL . 21.2 p -66.09 -166.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 0.0 111.044 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.45 -150.14 0.33 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.329 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 165' ' ' LYS . 5.5 m-20 -44.4 -80.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.327 0.251 . . . . 0.0 111.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.6 121.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.985 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.04 HG21 HG21 ' A' ' 235' ' ' THR . 9.3 p -120.77 130.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 4.2 m-85 -99.74 120.67 40.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 163' ' ' LEU . 1.3 mt -96.92 137.92 35.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.44 ' HG2' HD21 ' A' ' 213' ' ' LEU . 18.8 ttpt -107.26 120.74 42.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 211' ' ' LYS . 52.8 t -122.58 147.58 26.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.251 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.431 ' HB2' HD22 ' A' ' 213' ' ' LEU . . . -117.26 131.79 56.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.151 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 128.13 44.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.01 50.31 3.07 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.18 1.92 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.99 153.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.74 78.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.058 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -91.22 172.61 8.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.809 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -112.22 118.44 35.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.7 120.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 18.9 ptm -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -95.49 143.81 26.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.549 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.953 HG21 HD23 ' A' ' 206' ' ' LEU . 35.6 mm -125.28 119.13 54.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.78 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.7 ttpt -105.31 129.21 53.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 111.681 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.951 HD21 HG22 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -129.37 129.99 45.46 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.34 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.755 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -97.5 133.42 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.575 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.755 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -72.47 102.04 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.153 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.92 -153.86 20.99 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.936 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.31 -22.46 46.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.105 1.87 . . . . 0.0 112.364 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.73 -4.23 26.81 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.54 -138.94 14.89 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 163' ' ' LEU . 3.9 mm? -57.07 -37.85 72.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.1 37.61 9.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.893 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -174.52 -166.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.398 . . . . 0.0 111.039 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 192' ' ' THR . 9.2 t -138.83 158.34 44.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.863 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.664 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -123.91 161.92 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.922 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.06 137.53 52.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.435 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.91 129.84 9.48 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.807 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.77 -20.71 55.42 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.755 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.408 ' HB ' ' N ' ' A' ' 224' ' ' MET . 9.5 t -90.23 117.94 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.44 -56.55 5.01 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.181 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -112.88 55.23 0.7 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.635 0.731 . . . . 0.0 109.301 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.446 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.35 119.96 2.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.729 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 7.7 t-80 -103.05 -31.0 10.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.931 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.445 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -97.14 125.09 47.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.214 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.69 78.98 0.95 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.15 1.9 . . . . 0.0 112.861 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.75 46.07 0.49 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.199 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.11 128.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -98.66 12.49 35.24 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.476 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -165.99 1.35 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.0 OUTLIER -103.41 139.84 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.124 0.488 . . . . 0.0 110.559 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.445 ' CG ' HG12 ' A' ' 183' ' ' ILE . 29.5 m-85 -136.09 151.55 49.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 194' ' ' ILE . 21.4 t -81.47 140.31 16.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.562 ' HA ' HG23 ' A' ' 208' ' ' ILE . 3.7 t -124.68 -25.45 3.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.555 ' C ' HD13 ' A' ' 194' ' ' ILE . 9.8 tttp -149.27 135.41 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 111.761 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.555 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.0 OUTLIER -121.01 135.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.186 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.22 117.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -36.39 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.49 23.88 29.13 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.076 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.0 -82.27 0.11 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.325 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.44 -57.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.816 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.02 -44.2 85.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.516 ' HB2' HG22 ' A' ' 194' ' ' ILE . 4.2 t-160 -62.52 -55.62 25.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.536 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -69.68 -52.2 27.84 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -74.08 -50.45 19.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.92 -29.98 33.11 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.913 -0.661 . . . . 0.0 114.488 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 61.41 33.56 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.307 0.554 . . . . 0.0 110.47 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.953 HD23 HG21 ' A' ' 161' ' ' ILE . 1.8 pp -101.01 142.13 32.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -121.6 171.99 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 192' ' ' THR . 53.2 mt -63.96 132.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.05 9.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.734 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.66 150.68 39.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.117 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.729 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -112.82 129.15 56.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.554 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.764 HD13 ' CG2' ' A' ' 243' ' ' VAL . 38.9 mm -89.88 117.38 33.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.597 HD21 ' HG2' ' A' ' 242' ' ' LYS . 2.3 pp -97.79 -2.24 41.5 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.31 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.243 -0.286 . . . . 0.0 110.853 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 218' ' ' VAL . 24.5 t -132.3 119.27 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.234 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.47 ' OD1' HG23 ' A' ' 239' ' ' VAL . 2.4 m120 59.29 -85.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 p -141.98 13.49 2.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.893 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.708 HG13 ' CD2' ' A' ' 220' ' ' LEU . 10.8 p -109.39 140.33 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.69 100.57 2.16 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 1.013 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -108.97 48.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.716 0.769 . . . . 0.0 109.061 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.74 27.39 4.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.592 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.28 32.72 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.131 0.491 . . . . 0.0 110.124 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.483 HG21 ' CB ' ' A' ' 227' ' ' ASP . 7.6 p -149.38 166.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.101 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.44 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.74 169.19 3.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.736 0.779 . . . . 0.0 112.009 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.3 t60 -57.52 -36.4 71.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.84 -52.42 50.59 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.9 OUTLIER -61.65 -34.95 76.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.044 0.45 . . . . 0.0 109.985 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.423 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.88 -39.24 88.46 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.622 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.1 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.156 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.61 73.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.213 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 1.013 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.02 -40.87 97.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.086 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 174' ' ' ILE . 6.5 mt -70.6 -40.88 72.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.126 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -37.31 86.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -20.76 43.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.554 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . 1.051 HG21 HG21 ' A' ' 239' ' ' VAL . 17.5 p -70.38 -166.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.637 0.256 . . . . 0.0 111.069 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.94 -150.5 0.33 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.411 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 85.2 m-20 -43.42 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 122.442 0.297 . . . . 0.0 111.515 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.434 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.3 OUTLIER -95.69 120.57 45.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.69 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.051 HG21 HG21 ' A' ' 235' ' ' THR . 9.5 p -120.26 133.43 67.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -105.06 118.9 37.7 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.276 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.7 mp -99.13 139.38 34.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.597 ' HG2' HD21 ' A' ' 213' ' ' LEU . 16.7 ttmt -107.29 130.9 54.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 0.0 110.492 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.764 ' CG2' HD13 ' A' ' 212' ' ' ILE . 56.2 t -132.68 146.06 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.83 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.31 127.9 44.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.38 66.95 6.73 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.435 2.09 . . . . 0.0 112.423 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.02 156.65 41.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 59.8 34.73 21.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.146 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.916 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.0 -176.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -79.66 97.32 6.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.37 124.52 68.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.351 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.9 ptp -129.49 151.68 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -99.41 143.58 29.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 111.544 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.853 HG22 HD21 ' A' ' 163' ' ' LEU . 47.9 mm -118.09 117.93 56.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.498 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.617 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -103.74 129.28 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.853 HD21 HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -132.35 129.78 39.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.066 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.826 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -98.43 133.89 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 110.572 179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.826 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -75.85 137.41 40.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.278 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -155.21 -153.29 6.47 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.379 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.83 -21.67 49.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.273 1.982 . . . . 0.0 112.586 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -97.0 -4.6 39.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.85 -127.73 8.13 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.643 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.68 HD22 ' HE2' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.725 0.298 . . . . 0.0 110.591 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.6 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 93.25 22.91 25.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.572 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.65 -171.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.2 t -133.16 164.36 27.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.699 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -128.49 158.5 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.157 0.503 . . . . 0.0 112.029 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.916 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.24 138.87 51.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.139 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.88 134.18 11.8 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.85 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.22 -24.58 47.31 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.614 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 187' ' ' ASN . 10.4 t -89.98 120.28 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.31 4.97 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.374 -0.441 . . . . 0.0 113.112 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -118.09 56.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.9 tt0 -46.67 118.75 2.14 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.689 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 6.1 t-80 -107.69 -24.22 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.375 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.427 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.77 133.24 24.7 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.86 80.86 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.096 1.864 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.21 55.76 0.76 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.875 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.68 131.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.411 ' HB2' HG22 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -104.42 30.43 5.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.3 t -111.04 -166.94 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.2 mm -106.04 135.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 0.0 110.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 211' ' ' LYS . 17.8 m-85 -133.98 152.83 52.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.734 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.507 HG21 HD13 ' A' ' 206' ' ' LEU . 29.4 t -80.41 140.62 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.502 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.554 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.5 t -123.29 -24.7 4.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.729 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.5 OUTLIER -146.12 134.71 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 111.722 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.729 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.0 OUTLIER -120.81 135.21 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.114 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.3 mm -81.12 116.93 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.28 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.875 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.06 24.21 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.078 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.99 -71.36 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.6 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -140.02 -67.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.715 0.293 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.773 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -60.47 -46.96 88.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.021 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.718 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.8 t-160 -59.54 -55.96 27.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -70.53 -53.09 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.22 -50.21 20.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.1 -30.44 46.63 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.827 -0.701 . . . . 0.0 114.129 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.91 46.97 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.402 0.62 . . . . 0.0 109.98 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.773 HD21 ' HB1' ' A' ' 200' ' ' ALA . 3.4 pp -117.27 139.63 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.082 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.44 169.27 9.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.975 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.7 mt -61.57 119.17 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.577 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.18 -17.65 4.81 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.64 146.94 44.2 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 117.008 0.404 . . . . 0.0 110.696 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.728 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.1 ptpt -106.78 128.59 54.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.56 ' HA ' HG22 ' A' ' 243' ' ' VAL . 29.0 mm -95.39 115.72 35.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.14 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.663 HD21 ' CG ' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -94.52 -9.68 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.971 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 176.21 148.09 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.765 0.316 . . . . 0.0 110.692 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.792 HG13 ' HG ' ' A' ' 241' ' ' LEU . 10.2 t -122.82 118.98 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.448 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 57.58 -85.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.005 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.1 m -139.0 13.09 2.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.618 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.34 141.27 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 122.534 0.334 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -105.55 87.91 0.55 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.213 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.899 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -75.16 -5.7 45.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 111.268 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.532 ' N ' HD12 ' A' ' 220' ' ' LEU . 4.0 pt-20 -67.3 167.81 11.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 t70 46.83 26.27 0.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.962 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.899 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.1 p -136.36 165.24 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.643 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.437 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -67.82 168.25 11.89 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.703 0.763 . . . . 0.0 111.606 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.0 t60 -58.37 -36.89 74.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.998 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -52.76 38.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.446 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.2 OUTLIER -61.13 -34.8 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.0 110.118 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.86 92.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.963 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.8 t -58.27 -42.08 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.16 77.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.222 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -64.6 -39.28 93.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.173 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.77 HD12 ' HA ' ' A' ' 229' ' ' VAL . 2.5 mt -73.5 -42.32 61.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -58.75 -34.06 70.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -62.84 -20.23 64.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.399 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.922 HG21 HG21 ' A' ' 239' ' ' VAL . 26.2 p -64.49 -171.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.767 0.318 . . . . 0.0 111.151 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -143.1 -151.61 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.229 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.9 OUTLIER -43.03 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.538 0.335 . . . . 0.0 111.479 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.449 HG21 ' HD3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER -94.96 120.42 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.689 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.922 HG21 HG21 ' A' ' 235' ' ' THR . 9.2 p -119.79 120.26 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -100.57 120.15 39.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.792 ' HG ' HG13 ' A' ' 215' ' ' VAL . 1.0 OUTLIER -99.79 149.4 23.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.004 0.431 . . . . 0.0 110.522 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.663 ' CG ' HD21 ' A' ' 213' ' ' LEU . 2.7 tpmt? -108.62 118.26 36.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.196 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 211' ' ' LYS . 54.4 t -123.27 149.2 27.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.967 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.14 133.44 28.69 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.023 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.9 115.24 3.01 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.273 1.982 . . . . 0.0 112.624 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.9 m -82.84 176.9 8.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.704 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 60.31 81.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.006 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -119.01 152.89 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.03 131.98 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.688 HG11 ' HD2' ' A' ' 242' ' ' LYS . 24.1 t -108.49 137.27 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -132.26 147.1 52.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -101.66 132.34 47.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.632 HG21 HD23 ' A' ' 206' ' ' LEU . 4.3 mt -125.45 118.47 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.186 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.418 ' HB2' HG12 ' A' ' 238' ' ' VAL . 1.5 pttt -99.08 137.55 37.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.309 0.576 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.728 HD11 ' CD1' ' A' ' 241' ' ' LEU . 5.7 mt -118.7 140.38 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.525 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.84 ' CD1' HG22 ' A' ' 238' ' ' VAL . 19.9 mm -96.46 131.46 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.067 0.461 . . . . 0.0 111.16 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 57.03 2.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.262 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.06 -161.64 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.062 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -20.24 54.06 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.208 1.939 . . . . 0.0 112.689 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -96.68 8.27 44.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.3 -145.14 18.32 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.493 HD12 HD12 ' A' ' 163' ' ' LEU . 4.3 mm? -61.11 -37.27 82.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.761 0.315 . . . . 0.0 111.045 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.76 26.72 8.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.685 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -175.63 -169.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.017 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.6 t -134.84 158.62 43.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.691 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.77 160.21 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.833 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.0 138.15 53.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.17 129.45 9.36 Favored Glycine 0 CA--C 1.5 -0.847 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.964 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -78.1 -28.58 55.97 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.76 122.16 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.11 -55.37 4.96 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.936 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -116.63 49.77 1.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.497 0.665 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.3 tt0 -42.37 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.669 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 5.6 t-80 -83.58 -28.11 28.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.129 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -96.52 129.64 32.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 81.91 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.056 1.837 . . . . 0.0 113.128 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.55 52.86 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.195 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.94 135.2 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.574 0.226 . . . . 0.0 110.74 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.419 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.5 OUTLIER -108.12 24.14 13.44 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.83 -168.13 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.833 HD13 ' O ' ' A' ' 175' ' ' ALA . 2.4 mm -104.58 134.42 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.278 0.561 . . . . 0.0 110.281 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.409 ' CD1' HG12 ' A' ' 183' ' ' ILE . 26.0 m-85 -135.19 151.17 50.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.593 HG21 HD13 ' A' ' 206' ' ' LEU . 39.2 t -80.12 141.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.284 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.439 ' HA ' HG23 ' A' ' 208' ' ' ILE . 2.7 t -122.94 -23.01 5.1 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -150.36 134.19 16.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.75 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 206' ' ' LEU . 1.0 OUTLIER -119.78 135.38 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.18 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.01 118.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.422 . . . . 0.0 109.919 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -37.75 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 50.03 31.69 18.52 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.392 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.68 -75.94 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.363 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -134.86 -60.21 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 0.0 110.731 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.672 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.36 -45.14 77.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.3 t-160 -60.21 -56.13 25.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.528 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -70.53 -53.19 17.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -51.35 15.07 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.568 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -77.14 -31.04 53.99 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.822 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 60.56 30.45 19.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.125 0.462 . . . . 0.0 110.636 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.632 HD23 HG21 ' A' ' 161' ' ' ILE . 4.0 pp -102.31 129.14 48.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.19 173.81 6.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.1 mt -64.44 113.44 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.38 -15.04 3.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.78 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.05 142.21 39.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.935 0.368 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.721 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.8 ttpm? -102.58 128.83 49.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.111 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.75 HD13 ' CG2' ' A' ' 243' ' ' VAL . 30.4 mm -96.71 116.42 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 244' ' ' ALA . 2.5 mt -79.3 -68.01 0.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.48 47.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.945 HG22 HD23 ' A' ' 241' ' ' LEU . 3.1 t -114.82 119.32 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.497 ' ND2' HG23 ' A' ' 239' ' ' VAL . 55.7 m-20 58.45 -84.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -140.32 12.94 2.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.839 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.6 p -109.69 139.87 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.003 0.43 . . . . 0.0 111.039 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.88 111.06 3.04 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.392 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.6 OUTLIER -104.17 40.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 109.932 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -97.23 163.5 12.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.787 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 48.72 27.47 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.519 HG21 ' CB ' ' A' ' 227' ' ' ASP . 6.2 p -131.2 163.73 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.585 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -69.57 169.93 11.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.703 0.763 . . . . 0.0 112.176 -179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.8 t60 -56.93 -36.36 70.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.318 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -52.13 60.94 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.519 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -60.13 -36.25 77.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.22 93.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.3 t -57.88 -41.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.219 0.533 . . . . 0.0 109.595 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.25 -33.39 75.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.714 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -64.76 -43.13 94.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.646 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -74.11 -47.3 37.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.877 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.45 -40.37 78.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.73 -20.34 33.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.899 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . 1.096 HG21 HG21 ' A' ' 239' ' ' VAL . 16.7 p -65.99 -163.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.286 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -139.67 -150.58 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.52 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.872 0.469 . . . . 0.0 112.097 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.84 HG22 ' CD1' ' A' ' 164' ' ' ILE . 23.7 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.361 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.096 HG21 HG21 ' A' ' 235' ' ' THR . 12.9 p -116.56 131.15 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -90.94 141.98 28.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.351 0.595 . . . . 0.0 111.421 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.945 HD23 HG22 ' A' ' 215' ' ' VAL . 6.8 mt -118.89 138.14 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.92 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.688 ' HD2' HG11 ' A' ' 158' ' ' VAL . 3.6 ttpm? -106.61 124.27 49.35 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.75 ' CG2' HD13 ' A' ' 212' ' ' ILE . 53.6 t -131.66 149.67 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 213' ' ' LEU . . . -114.91 121.11 42.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.558 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.97 114.19 62.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.33 112.02 3.43 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.023 1.815 . . . . 0.0 112.431 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 t -143.79 36.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.786 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -88.87 -31.57 18.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.145 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.856 0.36 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.26 155.76 50.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.48 131.63 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.1 t -114.28 127.64 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 15.5 ptm -126.68 146.31 50.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.431 . . . . 0.0 111.351 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.96 140.76 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.06 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.94 HG22 HD21 ' A' ' 163' ' ' LEU . 36.6 mm -120.41 117.34 53.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.782 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.2 ttmt -103.91 127.85 51.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.71 0.29 . . . . 0.0 111.73 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.94 HD21 HG22 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -127.37 129.07 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.309 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -99.02 127.38 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.187 0.518 . . . . 0.0 110.693 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.587 ' HE2' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -66.65 79.47 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.848 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.73 38.64 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.14 -20.92 48.7 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.339 2.026 . . . . 0.0 112.431 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -99.29 -5.06 30.45 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.82 -133.71 12.01 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.078 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.745 HD12 HD12 ' A' ' 163' ' ' LEU . 1.9 mm? -60.76 -36.02 77.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.596 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 80.2 33.29 32.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.045 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.585 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 3.7 p90 -177.09 -173.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 192' ' ' THR . 0.6 OUTLIER -134.69 159.63 40.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.04 161.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.023 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.887 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -131.05 138.1 49.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -114.68 131.21 9.67 Favored Glycine 0 CA--C 1.502 -0.729 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.673 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.79 -22.16 58.41 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.54 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.87 117.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.98 5.02 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.077 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -113.09 55.0 0.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.528 0.68 . . . . 0.0 109.384 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.56 115.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.69 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 14.2 t-80 -100.39 -32.14 10.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.537 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.2 mm -96.7 127.41 39.56 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.146 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.36 78.73 2.26 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.021 1.814 . . . . 0.0 113.079 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.4 10.14 4.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.016 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.01 134.58 44.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.525 0.662 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 10.7 m-80 -106.74 26.27 10.21 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.28 -164.66 0.93 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.64 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.7 mm -105.64 132.46 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.243 0.544 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.422 ' CD1' HG13 ' A' ' 183' ' ' ILE . 9.8 m-85 -135.13 153.99 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.496 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.604 HG21 HD12 ' A' ' 206' ' ' LEU . 33.1 t -79.54 141.34 15.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.268 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 173' ' ' SER . 8.1 t -121.53 -21.55 6.2 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.32 136.79 14.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.964 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.9 mm -121.2 136.23 58.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -79.92 115.31 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.032 0.444 . . . . 0.0 109.809 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -37.76 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.932 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.03 50.8 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.827 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.03 -81.75 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.596 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -129.56 -60.94 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.932 0.396 . . . . 0.0 111.163 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.899 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -66.57 -42.35 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.628 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.3 t-160 -63.75 -55.38 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -51.63 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.5 -49.1 28.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.1 -37.16 11.6 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.885 -0.674 . . . . 0.0 114.363 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.51 51.33 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.453 0.644 . . . . 0.0 109.936 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.899 HD21 ' HB1' ' A' ' 200' ' ' ALA . 1.9 pt? -116.64 139.76 50.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.779 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.5 165.13 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 192' ' ' THR . 37.8 mt -60.8 112.45 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.85 -14.59 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.61 143.23 36.6 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.123 0.462 . . . . 0.0 111.141 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.741 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.1 ttpt -103.95 129.22 51.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.302 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.916 HD13 ' CG2' ' A' ' 243' ' ' VAL . 20.5 mm -90.74 124.8 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 111.693 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.49 HD12 ' HG2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -93.55 -39.11 11.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.581 0.705 . . . . 0.0 110.098 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -166.21 154.67 10.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.918 HG23 HD21 ' A' ' 220' ' ' LEU . 24.2 t -124.47 119.88 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.583 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 61.3 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.4 m -143.26 13.52 1.81 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.8 140.25 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 111.425 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.97 107.48 2.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.038 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.918 HD21 HG23 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -100.39 37.84 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.258 0.552 . . . . 0.0 110.242 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -99.56 162.85 12.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.473 0.654 . . . . 0.0 111.881 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 48.41 27.56 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.645 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.437 HG21 ' CB ' ' A' ' 227' ' ' ASP . 4.9 p -132.67 162.9 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 168.4 9.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.793 0.806 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.835 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.9 t60 -57.51 -36.32 71.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.929 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.17 -51.79 58.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.437 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.1 t70 -59.23 -36.64 75.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.032 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 225' ' ' HIS . 16.6 t -56.38 -41.57 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.647 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.64 74.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.481 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 220' ' ' LEU . . . -65.19 -50.35 66.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.867 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 235' ' ' THR . 3.7 pp -73.6 -40.74 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.475 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.539 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -57.79 -37.95 74.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.476 . . . . 0.0 111.481 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.49 -20.31 59.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.792 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . 1.093 HG21 HG21 ' A' ' 239' ' ' VAL . 25.7 p -61.72 -163.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.403 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -138.35 -151.13 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 1.5 m-20 -44.42 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.342 0.26 0 C-N-CA 122.391 0.277 . . . . 0.0 111.673 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.06 118.76 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.093 HG21 HG21 ' A' ' 235' ' ' THR . 14.2 p -120.51 126.13 74.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.262 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.85 120.22 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.775 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.7 mp -98.13 142.7 29.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.49 ' HG2' HD12 ' A' ' 213' ' ' LEU . 1.9 ttpt -107.12 118.09 35.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.916 ' CG2' HD13 ' A' ' 212' ' ' ILE . 37.7 t -123.5 149.19 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.099 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 213' ' ' LEU . . . -132.86 128.03 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 109.44 42.67 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.43 84.3 1.19 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.14 1.893 . . . . 0.0 111.853 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.4 m -157.19 161.6 39.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -137.25 30.15 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.124 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -135.95 -179.79 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -95.86 138.9 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 120.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.648 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.38 155.18 48.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.397 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -124.08 126.98 47.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.963 0.411 . . . . 0.0 111.203 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.835 HG21 HD23 ' A' ' 206' ' ' LEU . 35.4 mm -99.32 118.92 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.583 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 240' ' ' TYR . 2.7 ttpp -106.36 127.94 53.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.763 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -135.22 152.22 51.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.866 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.568 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -108.99 130.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.568 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -54.65 90.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.127 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.26 170.89 44.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.549 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.3 -20.46 32.21 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.264 1.976 . . . . 0.0 112.645 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -2.0 35.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.08 -150.51 18.71 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.929 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.425 ' CD1' HG11 ' A' ' 239' ' ' VAL . 4.5 mm? -60.49 -37.52 81.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.04 29.29 10.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.701 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.55 179.3 1.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.6 t -124.64 164.0 20.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.774 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -128.0 162.65 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.319 0.581 . . . . 0.0 112.292 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.908 ' HB2' ' CG2' ' A' ' 192' ' ' THR . . . -130.51 139.91 50.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.159 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -117.3 133.74 10.77 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.108 -1.044 . . . . 0.0 113.908 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -88.18 -15.41 60.76 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.716 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 224' ' ' MET . 5.4 t -90.68 115.55 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 117.604 0.702 . . . . 0.0 112.204 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -57.29 4.03 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.223 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.09 54.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.1 mt-30 -45.79 119.69 2.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.629 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 16.9 t-80 -109.43 -28.42 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.72 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.74 121.72 58.85 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.797 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.61 80.76 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.217 1.945 . . . . 0.0 112.486 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.37 54.31 0.7 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.986 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.64 119.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.8 m120 -96.14 38.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 m -119.44 -166.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.009 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.873 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -104.67 135.74 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.128 0.49 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 25.6 m-85 -135.72 150.89 49.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.685 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.489 HG21 HD13 ' A' ' 206' ' ' LEU . 21.5 t -79.95 142.12 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.506 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.908 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 6.7 p -117.1 -39.76 3.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.552 ' C ' HD13 ' A' ' 194' ' ' ILE . 29.9 tttp -137.53 137.99 39.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.899 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.634 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -120.6 134.74 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.66 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.48 113.71 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.382 . . . . 0.0 110.101 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -36.42 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.463 -0.79 . . . . 0.0 113.123 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.55 21.3 27.49 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.247 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.78 -91.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.093 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -61.2 -46.53 90.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.634 ' HB2' HG22 ' A' ' 194' ' ' ILE . 2.8 t-80 -59.23 -57.27 13.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -71.13 -52.8 17.24 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.55 -50.62 20.44 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 161' ' ' ILE . . . -76.11 -33.5 49.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.714 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.5 34.99 17.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.126 0.489 . . . . 0.0 110.003 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.835 HD23 HG21 ' A' ' 161' ' ' ILE . 3.5 pp -108.07 139.94 41.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.222 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -115.99 -179.42 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 191' ' ' VAL . 21.4 mt -69.18 134.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.34 -14.03 30.63 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.244 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.27 134.59 46.92 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.201 0.501 . . . . 0.0 110.936 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.869 ' O ' HG23 ' A' ' 243' ' ' VAL . 18.9 tttt -92.29 129.2 38.3 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 120.896 0.379 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.462 HG21 HD23 ' A' ' 241' ' ' LEU . 18.7 mm -109.78 138.61 36.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.481 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.789 HD21 ' HG2' ' A' ' 242' ' ' LYS . 2.2 pp -118.2 -9.31 10.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -170.59 153.4 4.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.973 0.416 . . . . 0.0 111.675 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.778 HG12 ' CG2' ' A' ' 239' ' ' VAL . 0.3 OUTLIER -125.62 118.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.56 ' HB2' HG23 ' A' ' 239' ' ' VAL . 28.1 t30 56.04 -87.48 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 215' ' ' VAL . 10.4 m -137.25 13.74 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.614 0.245 . . . . 0.0 110.637 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.24 140.57 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -99.6 92.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.597 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.869 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -77.75 -3.92 43.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 178.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.479 ' N ' HD12 ' A' ' 220' ' ' LEU . 3.4 pt-20 -68.26 167.54 14.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 111.229 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.05 25.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.623 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 220' ' ' LEU . 3.1 p -138.01 162.48 31.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.446 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.413 ' HA ' ' HB ' ' A' ' 178' ' ' VAL . 8.4 mtt -67.19 169.25 8.94 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.739 0.78 . . . . 0.0 111.955 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.88 ' O ' HG23 ' A' ' 229' ' ' VAL . 53.5 t60 -58.29 -36.97 74.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.193 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.21 -52.34 42.36 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.1 OUTLIER -62.1 -34.9 77.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 109.884 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.85 88.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.686 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 225' ' ' HIS . 23.3 t -59.1 -41.61 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.258 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.6 74.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.299 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.594 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -69.79 -38.71 76.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.1 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.774 HD11 HG21 ' A' ' 174' ' ' ILE . 1.5 mt -72.97 -39.74 65.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.658 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -33.61 76.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.161 0.505 . . . . 0.0 110.785 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.1 -20.3 65.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.69 HG21 HG21 ' A' ' 239' ' ' VAL . 71.2 p -51.86 176.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.74 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -139.33 -148.94 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -41.61 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.654 0.381 . . . . 0.0 111.785 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.43 124.95 59.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.778 ' CG2' HG12 ' A' ' 215' ' ' VAL . 8.1 p -113.6 120.21 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.416 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -111.93 118.27 35.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 109.65 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.604 ' HG ' HG13 ' A' ' 215' ' ' VAL . 1.6 mp -100.4 153.17 19.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.789 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.3 OUTLIER -106.44 116.32 31.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.1 p -113.24 144.56 20.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.436 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.49 122.74 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.765 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -102.11 133.88 20.39 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 108.3 2.66 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.17 1.914 . . . . 0.0 112.31 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.1 t -63.6 -24.64 67.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.644 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.98 -60.11 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.927 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.162 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.805 0.335 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.65 -179.66 4.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 94.8 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.96 131.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptm -132.15 152.23 51.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -100.53 139.37 36.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 206' ' ' LEU . 10.5 mt -125.53 118.64 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.753 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -99.47 139.42 35.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.293 0.568 . . . . 0.0 112.13 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.987 HD11 HD11 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -129.29 129.55 45.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.026 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.764 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -96.91 134.49 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.764 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -73.29 94.34 2.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.925 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.45 -158.57 24.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.139 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.52 -23.34 75.08 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.234 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -101.86 -4.28 26.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.11 -136.5 13.63 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.444 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.543 HD13 ' HE2' ' A' ' 165' ' ' LYS . 3.9 mm? -59.75 -33.27 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.61 31.7 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.546 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.594 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -175.13 -172.93 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 110.871 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -132.98 160.49 36.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.882 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.632 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -121.95 155.99 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.165 0.507 . . . . 0.0 111.226 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.913 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -126.63 138.32 53.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.235 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.26 129.98 9.19 Favored Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.759 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 187' ' ' ASN . . . -84.83 -16.0 66.5 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.696 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.4 ' HB ' ' N ' ' A' ' 224' ' ' MET . 11.3 t -90.96 115.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.672 0.736 . . . . 0.0 112.012 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.86 -57.74 4.27 Favored Glycine 0 C--N 1.329 0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.083 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -102.72 51.8 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.442 0.639 . . . . 0.0 109.684 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.424 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.2 mt-30 -45.23 117.9 1.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.664 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 8.1 t-80 -105.87 -32.06 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.843 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 190' ' ' TYR . 19.1 mm -95.47 126.05 47.26 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.338 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 77.62 1.19 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.29 1.993 . . . . 0.0 113.24 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.33 10.62 4.51 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.12 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -133.45 131.4 39.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.585 0.693 . . . . 0.0 111.348 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.431 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 9.8 m120 -103.8 29.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.44 -165.01 1.01 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -103.3 129.88 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.195 0.521 . . . . 0.0 110.421 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.452 ' CD1' HG13 ' A' ' 183' ' ' ILE . 4.5 m-85 -134.54 155.06 51.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.981 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.506 HG11 ' CD1' ' A' ' 194' ' ' ILE . 32.1 t -80.33 138.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.619 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.505 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.8 t -121.67 -19.07 6.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 133.17 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 0.0 111.609 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.677 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.3 OUTLIER -120.58 134.03 65.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 mm -82.31 117.65 28.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.401 . . . . 0.0 110.034 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -41.97 101.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.61 24.21 38.83 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.84 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.23 -89.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.329 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -131.44 -56.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.983 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -66.87 -46.3 75.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.677 ' HB2' HG22 ' A' ' 194' ' ' ILE . 9.7 t-160 -59.99 -56.06 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.681 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -52.62 22.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.38 -51.13 15.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.545 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -79.46 -28.57 51.98 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.022 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 63.57 30.87 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.022 0.411 . . . . 0.0 110.522 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 206' ' ' LEU . 2.6 pp -102.91 141.12 36.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.05 167.86 13.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.505 HG23 ' HA ' ' A' ' 192' ' ' THR . 35.1 mt -59.0 106.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 145.48 -16.95 1.85 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.914 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.55 ' OD2' HG11 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -79.4 148.04 32.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.946 0.373 . . . . 0.0 110.894 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.694 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.7 OUTLIER -112.21 130.34 55.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.821 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.621 HG21 HD21 ' A' ' 220' ' ' LEU . 19.6 mm -92.97 116.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.444 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.69 HD21 ' HG3' ' A' ' 242' ' ' LYS . 0.9 OUTLIER -91.84 -10.39 39.95 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 172.12 145.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.499 0.32 . . . . 0.0 110.339 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.935 HG22 HD23 ' A' ' 241' ' ' LEU . 4.9 t -118.85 119.35 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 36.7 t30 56.56 -86.6 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.153 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 5.8 m -137.5 12.61 2.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.655 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.2 p -109.4 140.6 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.694 0.283 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.8 87.46 0.55 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.261 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.885 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -72.12 -9.05 57.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.107 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.563 ' N ' HD12 ' A' ' 220' ' ' LEU . 2.1 pt-20 -67.67 168.22 11.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 t70 49.15 24.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.963 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.885 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.7 p -137.4 163.73 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.651 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.4 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.8 OUTLIER -66.84 167.11 12.03 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.596 0.712 . . . . 0.0 111.447 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.6 t60 -58.01 -36.46 72.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.046 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -52.33 49.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -61.93 -34.74 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.38 87.11 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.565 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 225' ' ' HIS . 37.6 t -59.16 -41.03 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.379 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.09 74.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.51 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -65.97 -45.39 81.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 174' ' ' ILE . 1.1 mt -74.12 -39.77 63.12 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.426 ' HG3' HG12 ' A' ' 229' ' ' VAL . 11.2 mmtt -58.23 -46.52 85.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -57.81 -19.81 31.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.282 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 239' ' ' VAL . 29.9 p -56.4 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.682 0.277 . . . . 0.0 111.372 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -153.07 0.45 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.371 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 165' ' ' LYS . 3.7 m-20 -42.49 -80.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.407 0.283 . . . . 0.0 111.55 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 238' ' ' VAL . 2.6 p -98.15 116.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.052 0.453 . . . . 0.0 110.831 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 235' ' ' THR . 13.5 p -112.91 126.81 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.752 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.57 141.79 28.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.719 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.987 HD11 HD11 ' A' ' 163' ' ' LEU . 6.7 mt -118.16 136.56 53.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.491 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.69 ' HG3' HD21 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -107.41 117.72 34.84 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 211' ' ' LYS . 73.6 t -125.2 151.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.81 125.96 54.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.84 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.89 109.72 41.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.893 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.38 82.92 2.13 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.179 1.92 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.32 138.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -103.7 82.63 2.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.073 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.922 0.392 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.48 -170.94 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.74 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.58 93.66 6.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.525 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.45 120.23 47.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.608 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.421 ' O ' HG12 ' A' ' 243' ' ' VAL . 9.3 ptp -132.73 148.58 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -105.26 140.54 38.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.898 HD13 ' HB3' ' A' ' 206' ' ' LEU . 2.1 mt -104.87 119.24 53.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -99.54 119.92 38.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.412 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 170' ' ' LEU . 3.3 pp -137.25 146.09 44.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.553 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -97.83 135.21 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.279 0.562 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.553 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -49.83 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.395 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.46 156.0 7.51 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.512 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.39 -24.09 41.55 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.995 1.797 . . . . 0.0 112.245 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.22 15.37 29.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.69 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 119.24 -151.05 17.72 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.257 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.44 HD11 HG21 ' A' ' 239' ' ' VAL . 4.6 mm? -73.38 -37.05 66.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.497 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 96.09 34.22 6.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.506 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.545 ' N ' HD13 ' A' ' 195' ' ' ILE . 0.3 OUTLIER -176.49 -172.7 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.3 m -137.69 157.64 46.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 228' ' ' ALA . 1.0 OUTLIER -121.59 162.52 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.276 0.56 . . . . 0.0 111.444 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 182' ' ' HIS . . . -125.43 139.2 53.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.074 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.99 129.44 9.52 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.959 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -79.91 -31.11 40.57 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.559 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.28 123.2 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.12 -56.07 5.06 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.008 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -114.48 48.8 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.554 0.693 . . . . 0.0 109.542 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.0 tt0 -43.19 105.95 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.713 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 15.4 t-80 -90.29 -31.72 16.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.786 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.402 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.6 mm -96.84 121.74 58.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.152 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.45 78.99 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.118 1.878 . . . . 0.0 113.111 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 128.55 6.64 4.59 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.114 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.36 129.43 44.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.6 0.7 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 27.7 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 -162.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.955 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 175' ' ' ALA . 4.8 mm -102.33 137.3 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.482 0.658 . . . . 0.0 110.781 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.402 ' CD1' HG13 ' A' ' 183' ' ' ILE . 14.1 m-85 -135.43 144.62 46.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.961 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 206' ' ' LEU . 47.8 t -80.29 139.03 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.814 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.757 ' HA ' HG23 ' A' ' 208' ' ' ILE . 5.0 t -123.74 -14.66 7.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.638 ' C ' HD13 ' A' ' 194' ' ' ILE . 14.8 ttmt -155.32 133.27 11.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.068 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.646 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -121.36 135.29 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.545 HD13 ' N ' ' A' ' 172' ' ' PHE . 1.8 mp -80.77 118.01 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -38.36 100.72 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.946 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.8 22.97 35.73 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.127 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.73 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.225 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.82 -53.61 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 110.692 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -65.07 -45.53 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.646 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.9 t-160 -59.42 -56.36 23.04 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -52.89 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.76 -50.42 20.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.53 -27.3 59.51 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.883 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 59.86 26.06 15.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.1 0.45 . . . . 0.0 110.797 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.898 ' HB3' HD13 ' A' ' 161' ' ' ILE . 3.7 pp -97.6 139.7 33.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -121.79 170.16 10.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.95 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.757 HG23 ' HA ' ' A' ' 192' ' ' THR . 46.8 mt -60.84 112.66 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.5 3.74 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.255 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.771 ' OD2' HG21 ' A' ' 243' ' ' VAL . 0.8 OUTLIER -77.83 138.3 38.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.126 0.463 . . . . 0.0 111.296 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.877 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -94.39 129.82 40.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.316 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.58 HG21 HD23 ' A' ' 241' ' ' LEU . 22.8 mm -110.8 134.65 52.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.477 . . . . 0.0 111.899 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.438 HD11 ' HG2' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -117.06 -3.12 11.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.694 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -172.97 148.34 1.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.968 0.413 . . . . 0.0 111.523 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.744 HG13 ' HG ' ' A' ' 241' ' ' LEU . 3.3 t -130.06 119.97 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.054 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 61.26 -85.39 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.0 t -144.17 14.79 1.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.951 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.4 p -109.04 140.0 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.96 0.409 . . . . 0.0 111.595 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.65 102.95 2.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.261 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -100.29 38.33 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.531 . . . . 0.0 110.197 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -93.4 164.21 13.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.448 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.6 t0 45.38 29.99 0.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.504 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 224' ' ' MET . 3.5 p -133.67 167.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.48 ' H ' HG22 ' A' ' 223' ' ' VAL . 4.2 mtm -75.41 172.72 12.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.779 0.8 . . . . 0.0 112.654 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 229' ' ' VAL . 17.1 t-80 -57.29 -38.51 74.08 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.362 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.33 -51.79 64.54 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.421 ' CB ' HG21 ' A' ' 223' ' ' VAL . 4.2 t0 -60.0 -36.32 76.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.85 0.357 . . . . 0.0 110.806 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.528 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.55 -38.89 92.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.2 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.5 t -57.7 -43.05 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.166 0.508 . . . . 0.0 109.631 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.97 -32.61 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.21 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.717 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -63.9 -39.32 93.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.542 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 229' ' ' VAL . 2.1 mt -70.38 -42.93 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.61 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.02 -33.55 72.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.94 -25.2 66.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.72 ' HB ' HG22 ' A' ' 239' ' ' VAL . 31.0 p -56.17 -173.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.034 0.445 . . . . 0.0 111.638 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -145.21 -149.85 0.3 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -39.15 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.036 0.534 . . . . 0.0 112.383 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.02 120.93 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.885 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.72 HG22 ' HB ' ' A' ' 235' ' ' THR . 42.9 t -107.03 119.97 57.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.52 118.81 34.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.731 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.744 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.9 mp -98.82 153.11 19.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' A' ' 213' ' ' LEU . 1.7 tppp? -106.4 117.05 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.5 p -124.71 144.22 35.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.511 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.607 ' HB3' ' HD2' ' A' ' 211' ' ' LYS . . . -115.35 127.17 55.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -93.84 109.25 40.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.59 120.54 6.99 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.177 1.918 . . . . 0.0 111.908 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 4.9 p 50.62 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.455 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.26 -76.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.844 0.354 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -109.94 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -96.61 137.27 35.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.005 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.03 120.44 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.115 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.56 153.96 50.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.55 126.33 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.927 HD13 ' HB3' ' A' ' 206' ' ' LEU . 1.8 mt -98.4 118.9 45.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -106.62 121.92 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.646 HD11 ' CD1' ' A' ' 170' ' ' LEU . 3.4 pp -136.46 145.92 45.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.716 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -97.29 134.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.124 0.487 . . . . 0.0 111.473 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -48.67 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.391 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.42 166.89 8.42 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.779 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.38 -27.4 75.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.297 1.998 . . . . 0.0 112.317 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -101.65 15.56 28.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.875 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.52 -152.86 17.53 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.724 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.646 ' CD1' HD11 ' A' ' 163' ' ' LEU . 4.1 mm? -61.78 -34.47 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.726 0.298 . . . . 0.0 111.151 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.03 35.99 6.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.41 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -165.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.745 0.307 . . . . 0.0 110.688 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.9 t -139.52 162.48 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.409 HD12 ' ND1' ' A' ' 225' ' ' HIS . 1.3 pp -129.54 159.86 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.214 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.914 ' HB2' ' CG2' ' A' ' 192' ' ' THR . . . -125.52 137.97 53.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -109.12 130.47 10.03 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.859 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.4 -25.16 52.09 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.416 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 187' ' ' ASN . 18.0 t -89.93 117.3 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -56.05 5.05 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.092 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -109.8 49.22 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.563 0.697 . . . . 0.0 109.31 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.6 tt0 -43.55 115.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.67 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 4.8 t-80 -107.04 -26.32 11.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.497 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 126.74 43.01 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.35 81.24 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.151 1.901 . . . . 0.0 112.909 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.82 56.67 0.84 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.019 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 117.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.685 0.279 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 178' ' ' VAL . 65.7 m-20 -95.11 44.43 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.928 0.394 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.17 -161.13 0.94 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.882 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -111.66 134.44 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 211' ' ' LYS . 21.3 m-85 -135.45 154.28 51.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.633 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG11 HD11 ' A' ' 194' ' ' ILE . 36.2 t -80.22 143.18 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.753 0.311 . . . . 0.0 111.117 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.914 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 18.1 p -117.7 -49.37 2.55 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -136.58 139.38 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 111.95 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 HD12 ' A' ' 206' ' ' LEU . 2.2 mm -118.22 136.36 55.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.753 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.64 113.85 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.444 . . . . 0.0 109.946 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -35.56 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.346 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.93 27.37 44.48 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.239 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -70.82 -70.82 1.12 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.386 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.16 -61.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -60.85 -45.34 94.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.517 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.2 t-160 -59.31 -56.42 22.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.885 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -52.87 18.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.8 -50.87 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.21 -33.89 43.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.838 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 38.35 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.184 0.516 . . . . 0.0 110.399 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.927 ' HB3' HD13 ' A' ' 161' ' ' ILE . 3.7 pp -107.97 140.46 41.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.029 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -124.56 174.43 7.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.648 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 192' ' ' THR . 2.7 mm -64.21 127.74 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 121.59 -16.49 9.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.702 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.36 139.65 37.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.922 0.361 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.726 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.1 ttmt -100.61 128.8 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.249 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.598 ' HA ' HG22 ' A' ' 243' ' ' VAL . 20.8 mm -94.78 119.14 42.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.849 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -95.5 -5.49 42.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 175.3 154.26 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.799 HG13 HD23 ' A' ' 241' ' ' LEU . 2.4 t -126.15 120.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.68 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.2 t30 59.33 -86.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.7 m -141.14 12.98 2.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.913 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 215' ' ' VAL . 8.1 p -109.43 140.59 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.34 104.71 2.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.672 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.43 HD22 ' HB1' ' A' ' 228' ' ' ALA . 0.3 OUTLIER -98.1 33.56 2.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.449 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -93.57 158.87 15.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.405 0.621 . . . . 0.0 112.036 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 49.73 30.44 3.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.329 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 224' ' ' MET . 5.0 p -134.16 164.83 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.19 169.54 10.18 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.745 0.783 . . . . 0.0 112.493 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.879 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.9 t60 -57.89 -36.57 72.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.861 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -51.46 60.44 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.411 ' CB ' HG21 ' A' ' 223' ' ' VAL . 7.8 t70 -59.44 -36.34 75.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.989 0.423 . . . . 0.0 110.918 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.43 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.97 -39.75 93.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.6 t -57.04 -41.47 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.239 0.543 . . . . 0.0 109.553 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.84 74.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.675 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.491 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -63.68 -50.73 68.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.993 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 233' ' ' LYS . 3.8 pp -73.62 -40.73 63.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.769 0.318 . . . . 0.0 111.222 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.606 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.2 OUTLIER -59.38 -33.29 71.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.571 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -21.18 63.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.902 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 232' ' ' LEU . 32.8 p -54.19 -175.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -136.17 -145.78 0.22 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -38.72 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 128.06 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 0.0 111.765 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 170' ' ' LEU . 38.9 t -114.4 119.88 62.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.51 119.95 37.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 215' ' ' VAL . 1.1 mt -96.73 145.77 25.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.937 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -107.86 117.15 33.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 211' ' ' LYS . 75.7 t -127.85 150.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.378 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -123.82 123.51 40.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -93.09 129.73 38.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.39 103.98 1.5 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.17 1.913 . . . . 0.0 112.196 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 p -95.05 146.29 24.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.944 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -80.09 -59.56 2.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.05 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.778 0.323 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -146.89 -176.89 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.9 131.49 36.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 t -108.6 139.72 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.985 0.421 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.12 154.05 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.64 134.7 55.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.783 HG22 HD21 ' A' ' 163' ' ' LEU . 38.3 mm -119.37 118.78 58.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.84 ' O ' HD23 ' A' ' 163' ' ' LEU . 4.9 ttmm -99.71 131.65 45.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.84 HD23 ' O ' ' A' ' 162' ' ' LYS . 3.5 mt -133.24 129.06 37.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.017 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.808 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -99.59 135.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.12 0.486 . . . . 0.0 111.12 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.808 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.08 98.71 4.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.833 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.46 -147.93 13.05 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.029 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.01 -22.91 34.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.486 2.124 . . . . 0.0 112.26 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -101.7 -4.44 26.48 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.96 -138.83 16.47 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.173 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.427 HD13 ' HE2' ' A' ' 165' ' ' LYS . 4.3 mm? -57.77 -37.38 73.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.476 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 81.41 39.2 12.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.793 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.524 ' N ' HD13 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -176.53 -177.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.054 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t -133.24 158.87 41.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.27 162.17 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.62 138.42 52.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.526 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.86 130.35 9.99 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.007 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.37 -27.47 43.67 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.443 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 18.3 t -89.65 119.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.45 -55.83 5.04 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.047 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -112.6 50.42 0.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.529 0.68 . . . . 0.0 109.523 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.43 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.6 tt0 -43.81 115.91 0.89 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 2.9 t-80 -106.8 -25.87 11.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.452 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.433 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -95.74 123.91 54.35 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.394 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.93 80.85 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.058 1.839 . . . . 0.0 112.27 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.71 55.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.26 123.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.749 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 28.37 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.81 -166.24 1.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.9 mm -102.8 134.89 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CG ' HG12 ' A' ' 183' ' ' ILE . 18.1 m-85 -134.45 153.13 52.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.588 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.62 HG11 ' CD1' ' A' ' 194' ' ' ILE . 49.0 t -80.29 142.06 14.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.084 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 208' ' ' ILE . 4.2 t -124.47 -17.79 5.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -159.31 136.27 9.54 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.174 0.512 . . . . 0.0 112.061 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.683 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -120.85 135.12 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.747 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 172' ' ' PHE . 1.7 mp -81.54 117.66 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -36.95 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.005 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.11 23.75 25.76 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.999 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.74 -78.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.229 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -139.11 -57.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.772 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.97 -45.79 76.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.683 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.2 t-160 -59.33 -55.73 31.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.876 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -51.45 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.36 -50.27 22.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.87 -34.8 29.74 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 114.096 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 66.26 34.66 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.153 0.477 . . . . 0.0 110.21 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.627 ' CD2' HG21 ' A' ' 161' ' ' ILE . 2.1 pp -102.5 140.17 37.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.992 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -117.59 169.62 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.902 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.473 HG23 ' HA ' ' A' ' 192' ' ' THR . 34.1 mt -62.97 127.78 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.768 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.91 -21.34 7.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.778 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.85 159.82 29.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 111.242 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.712 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -116.96 129.89 56.34 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.362 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.537 HD13 HG22 ' A' ' 243' ' ' VAL . 32.4 mm -100.29 117.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.562 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.574 HD21 ' HG2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -97.67 -5.74 34.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 175.26 149.66 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.85 0.357 . . . . 0.0 111.297 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.862 HG13 ' HG ' ' A' ' 241' ' ' LEU . 2.1 t -123.87 119.18 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.895 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.434 ' CG ' HG23 ' A' ' 239' ' ' VAL . 1.9 m-20 57.9 -85.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.217 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 59.6 p -139.35 10.99 2.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.26 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 215' ' ' VAL . 11.0 p -109.8 140.74 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.46 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.12 106.08 2.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.223 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.548 HD21 ' CG2' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -99.15 37.54 1.53 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.143 0.497 . . . . 0.0 110.269 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -98.6 166.65 11.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.338 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 46.12 27.98 0.6 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.903 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 227' ' ' ASP . 4.8 p -133.78 164.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.762 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.403 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -70.46 169.26 14.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.733 0.778 . . . . 0.0 112.093 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.877 ' O ' HG23 ' A' ' 229' ' ' VAL . 61.8 t60 -57.27 -36.85 71.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.76 -52.38 51.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.2 OUTLIER -60.33 -35.64 76.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.678 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.024 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.6 t -57.77 -41.72 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.247 0.546 . . . . 0.0 109.855 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.406 ' HA ' ' CG ' ' A' ' 233' ' ' LYS . . . -64.59 -34.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.657 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.536 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -66.54 -50.39 63.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 235' ' ' THR . 3.0 pp -73.27 -40.03 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.441 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -64.42 -36.39 84.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.372 . . . . 0.0 111.825 -178.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -20.53 46.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.661 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . 1.066 HG21 HG21 ' A' ' 239' ' ' VAL . 28.3 p -58.14 -172.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.274 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.11 -149.81 0.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.389 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 165' ' ' LYS . 55.6 m-20 -45.03 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 121.16 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.929 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.066 HG21 HG21 ' A' ' 235' ' ' THR . 12.5 p -120.6 128.01 75.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.116 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.5 OUTLIER -101.62 120.41 40.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.862 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.9 mp -96.73 142.2 29.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' A' ' 213' ' ' LEU . 2.2 ttmt -106.5 121.35 44.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.365 0.602 . . . . 0.0 110.102 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 211' ' ' LYS . 54.0 t -120.28 150.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.474 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.83 126.17 51.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -93.42 117.74 67.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.964 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.66 67.95 8.44 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.179 1.919 . . . . 0.0 112.186 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.7 t 60.77 174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -146.92 -70.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.042 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.293 -0.861 . . . . 0.0 111.031 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.921 0.391 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.24 -177.01 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -108.71 108.6 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.16 129.19 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 ptp -128.61 140.97 51.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -98.04 138.51 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.636 HG22 HD21 ' A' ' 163' ' ' LEU . 34.7 mm -124.97 119.52 56.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.731 ' C ' HD23 ' A' ' 163' ' ' LEU . 10.1 ttpp -110.23 133.63 53.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.81 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.913 HD12 HD22 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -130.41 129.88 43.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.141 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 238' ' ' VAL . 0.4 OUTLIER -97.41 122.97 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.192 0.52 . . . . 0.0 110.09 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.456 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -57.76 90.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.267 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.59 43.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.97 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.06 -21.33 72.23 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.239 1.959 . . . . 0.0 112.334 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -102.25 -4.28 25.96 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.92 -147.47 18.1 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.913 HD22 HD12 ' A' ' 163' ' ' LEU . 16.0 mt -66.14 -38.06 87.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 111.338 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.6 35.49 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.528 ' HE1' HD13 ' A' ' 170' ' ' LEU . 6.8 p90 -173.43 -170.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 m -133.95 163.47 29.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -127.45 158.15 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.053 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.916 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.4 138.0 51.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.31 133.05 11.02 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.889 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.95 -20.41 55.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.847 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.402 ' HB ' ' N ' ' A' ' 224' ' ' MET . 12.2 t -89.36 117.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.69 4.83 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.919 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.52 54.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.205 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.479 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.0 tt0 -46.45 118.87 2.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.753 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 18.0 t-80 -103.0 -30.47 10.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.999 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 190' ' ' TYR . 10.3 mm -95.96 133.48 25.25 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.76 75.44 4.47 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.045 1.83 . . . . 0.0 112.961 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.19 20.13 3.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.687 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -141.48 126.81 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.383 0.592 . . . . 0.0 111.153 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -101.92 42.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.3 -164.79 1.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.324 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -105.28 133.49 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 110.111 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.566 ' HB2' HD11 ' A' ' 183' ' ' ILE . 20.7 m-85 -134.87 153.68 51.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 194' ' ' ILE . 21.2 t -80.21 141.4 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.335 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 208' ' ' ILE . 1.6 t -122.69 -20.18 6.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.64 ' C ' HD13 ' A' ' 194' ' ' ILE . 12.1 tttp -157.58 136.14 11.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.046 0.451 . . . . 0.0 111.995 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.64 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.2 mm -120.24 135.15 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.8 mm -81.19 117.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -37.4 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.94 24.04 40.76 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.982 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.85 -67.85 1.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.28 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -147.56 -58.27 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.887 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -63.32 -47.08 83.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -59.42 -56.34 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.759 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -51.98 29.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.427 ' OD2' HG22 ' A' ' 164' ' ' ILE . 3.2 m-20 -73.42 -50.65 20.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -83.74 -32.12 25.09 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.461 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.42 45.78 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.357 0.579 . . . . 0.0 110.202 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.578 HD23 HG21 ' A' ' 161' ' ' ILE . 4.2 pp -113.52 140.23 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.089 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.68 164.02 15.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.546 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 192' ' ' THR . 42.1 mt -57.67 139.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.9 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.94 -18.75 28.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.81 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.11 144.23 45.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.756 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.3 ttpm? -104.97 129.46 53.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.285 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.58 HD13 ' CG2' ' A' ' 243' ' ' VAL . 22.1 mm -91.21 116.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 1.7 pp -90.14 -8.43 51.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.55 155.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 0.0 110.523 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.738 HG13 ' HG ' ' A' ' 241' ' ' LEU . 23.3 t -131.13 119.39 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.159 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.72 -85.57 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.9 t -141.56 13.38 2.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.146 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.1 p -109.16 140.23 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -102.28 100.1 1.95 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.218 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.5 OUTLIER -109.21 45.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.503 0.668 . . . . 0.0 109.387 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.84 27.11 5.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.422 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -158.94 29.82 0.21 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.338 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 227' ' ' ASP . 8.8 p -152.43 166.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.046 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.405 ' H ' HG22 ' A' ' 223' ' ' VAL . 17.1 mtt -58.52 168.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.738 0.78 . . . . 0.0 112.793 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.2 t60 -57.4 -35.52 70.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.58 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.38 -51.81 57.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.615 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.448 ' HB2' HG13 ' A' ' 223' ' ' VAL . 1.1 m-20 -59.91 -36.09 76.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.87 92.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.81 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 225' ' ' HIS . 23.7 t -57.52 -41.32 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.55 74.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.53 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.818 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -66.16 -43.0 88.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.563 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.59 HD11 HG21 ' A' ' 174' ' ' ILE . 1.1 mt -73.4 -46.37 49.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.45 -34.16 70.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.176 0.513 . . . . 0.0 111.152 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -60.35 -20.76 60.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.356 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . 1.009 HG21 HG21 ' A' ' 239' ' ' VAL . 17.8 p -69.42 -166.59 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.68 -148.98 0.26 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.504 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.74 -81.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.67 HG21 ' NZ ' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -95.49 118.55 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.015 0.436 . . . . 0.0 110.742 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.009 HG21 HG21 ' A' ' 235' ' ' THR . 12.3 p -120.23 136.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.207 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.2 m-85 -106.74 119.33 39.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.151 0.5 . . . . 0.0 111.736 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.738 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.3 mp -103.06 134.81 45.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.26 133.87 51.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.824 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 211' ' ' LYS . 69.2 t -130.81 148.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.482 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.7 124.47 51.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 111.22 51.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.212 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.6 101.52 1.2 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.272 1.982 . . . . 0.0 112.368 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.8 m -157.86 161.41 38.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -84.35 116.81 23.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.995 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.801 0.334 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -95.79 178.55 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -88.15 145.45 25.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.101 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.17 130.02 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.774 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.78 45.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 0.0 111.419 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.4 131.38 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.716 HG21 ' CD2' ' A' ' 206' ' ' LEU . 30.5 mm -120.67 133.87 65.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.813 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.68 ' C ' HD23 ' A' ' 163' ' ' LEU . 27.2 ttpt -122.01 129.22 52.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.527 0.204 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 200' ' ' ALA . 2.0 mt -127.32 141.17 51.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.563 0.22 . . . . 0.0 110.429 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -106.78 132.55 53.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 110.592 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.626 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -73.39 82.59 1.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.817 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.2 -167.4 38.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.156 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.26 -20.4 66.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.185 1.923 . . . . 0.0 112.407 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -96.77 -2.13 44.91 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.1 -148.95 17.4 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.437 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.02 -37.37 76.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.006 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 100.32 19.29 19.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.212 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.507 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 1.5 p90 -170.6 -170.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.934 0.367 . . . . 0.0 110.803 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.75 161.84 34.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.018 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.802 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.58 159.53 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.53 137.69 50.92 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.02 129.9 9.75 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 120.003 -1.094 . . . . 0.0 114.147 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.55 -22.6 59.9 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.402 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.3 t -89.85 116.51 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.14 -56.0 5.05 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.996 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -110.23 52.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.418 0.628 . . . . 0.0 109.322 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.436 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.7 tt0 -46.35 114.3 0.78 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.678 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 2.2 t-80 -103.13 -25.41 13.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.1 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.446 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -95.34 132.21 28.23 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.204 -179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.26 79.97 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.147 1.898 . . . . 0.0 112.831 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.5 55.17 0.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.965 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -169.21 130.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.648 0.261 . . . . 0.0 110.937 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.12 28.78 6.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.8 t -111.32 -162.89 0.82 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.25 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.9 mm -106.36 133.21 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.283 0.564 . . . . 0.0 110.483 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.446 ' CG ' HG12 ' A' ' 183' ' ' ILE . 22.9 m-85 -135.14 154.59 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.708 HG21 HD13 ' A' ' 206' ' ' LEU . 42.7 t -80.14 141.21 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.656 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.0 t -121.91 -26.12 4.86 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 137.59 22.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.922 0.392 . . . . 0.0 111.641 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.567 ' CD1' HG11 ' A' ' 191' ' ' VAL . 1.2 mm -120.95 135.74 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.543 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.01 114.16 21.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -39.8 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.819 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.54 31.25 57.22 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.059 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.06 -53.94 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -162.8 -57.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.004 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.787 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.45 -45.57 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 194' ' ' ILE . 8.5 t-160 -60.03 -56.58 19.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.664 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -52.1 25.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.67 -50.57 20.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -77.79 -31.61 48.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.897 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 61.71 30.59 18.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.987 0.422 . . . . 0.0 110.354 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.716 ' CD2' HG21 ' A' ' 161' ' ' ILE . 3.3 pp -107.4 140.48 40.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.861 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -125.82 177.32 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.58 114.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 135.33 -17.67 4.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.907 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.67 149.34 32.85 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.901 0.351 . . . . 0.0 111.189 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.73 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.1 ttmt -109.04 129.91 55.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.509 HD13 ' CG2' ' A' ' 243' ' ' VAL . 22.5 mm -94.35 119.09 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.651 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.795 HD21 ' CG ' ' A' ' 242' ' ' LYS . 1.3 pp -94.91 -9.23 34.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 174.15 152.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.906 HG13 ' HG ' ' A' ' 241' ' ' LEU . 4.3 t -122.99 119.34 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.967 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 239' ' ' VAL . 26.6 t-20 57.98 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 94.2 p -140.54 14.02 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.596 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.5 p -109.41 139.73 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.287 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.78 107.11 2.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.971 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.5 OUTLIER -105.63 39.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.195 0.522 . . . . 0.0 110.607 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.26 168.77 10.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.46 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.0 p30 47.13 26.75 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.105 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.413 HG21 ' CB ' ' A' ' 227' ' ' ASP . 5.4 p -135.8 163.4 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.808 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 mtm -67.13 170.25 7.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.739 0.78 . . . . 0.0 111.903 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.829 ' O ' HG23 ' A' ' 229' ' ' VAL . 67.4 t60 -57.42 -36.05 70.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.253 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -62.3 -52.35 64.04 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.413 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.0 OUTLIER -60.49 -36.55 78.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.577 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 174' ' ' ILE . . . -61.53 -38.59 87.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.023 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.3 t -59.32 -41.78 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.619 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.83 76.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.821 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -64.55 -40.8 96.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.607 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.802 HD11 HG21 ' A' ' 174' ' ' ILE . 9.4 mt -73.2 -41.74 63.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -57.42 -41.05 79.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.178 0.513 . . . . 0.0 111.591 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.54 -19.97 42.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.91 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.897 HG21 HG21 ' A' ' 239' ' ' VAL . 18.4 p -67.39 -171.49 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 111.439 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -143.89 -145.47 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.342 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 165' ' ' LYS . 1.9 m-20 -44.47 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 118.004 0.365 . . . . 0.0 111.696 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.55 119.78 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.897 HG21 HG21 ' A' ' 235' ' ' THR . 9.8 p -118.07 131.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.784 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 7.2 m-85 -102.18 118.11 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.265 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.906 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.1 mp -97.37 139.73 32.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.795 ' CG ' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -107.01 130.71 54.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.175 0.512 . . . . 0.0 110.348 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 211' ' ' LYS . 55.9 t -127.89 148.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.0 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.28 131.98 54.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.755 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -93.33 116.13 66.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.071 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.06 118.33 4.37 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.138 1.892 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 64.0 m -118.35 147.02 43.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.054 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.2 m120 67.59 -69.48 0.14 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.174 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.0 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -99.7 -165.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 119.78 40.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.797 0.332 . . . . 0.0 111.071 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG11 ' HD2' ' A' ' 242' ' ' LYS . 13.2 t -100.14 139.71 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.175 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.73 152.7 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.297 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -112.62 120.6 42.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.731 HG22 ' CD2' ' A' ' 163' ' ' LEU . 41.2 mm -100.36 118.54 47.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.375 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.658 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -102.53 132.4 48.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.739 HD21 ' CD1' ' A' ' 241' ' ' LEU . 0.0 OUTLIER -136.14 129.57 31.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.856 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.891 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -97.97 135.16 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 0.0 111.42 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.891 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -66.33 91.37 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.669 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.87 -165.61 32.92 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.368 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -20.54 50.53 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.197 1.931 . . . . 0.0 112.214 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.26 -4.49 31.8 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.42 -135.15 12.88 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.338 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.538 HD12 ' HE1' ' A' ' 172' ' ' PHE . 4.2 mm? -58.74 -37.86 77.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.807 0.337 . . . . 0.0 110.96 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 86.87 27.26 29.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.098 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.538 ' HE1' HD12 ' A' ' 170' ' ' LEU . 2.6 p90 -175.21 -172.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -131.0 160.91 33.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.818 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -124.42 155.55 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.924 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.48 138.0 51.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.67 136.44 13.36 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.0 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -88.17 -21.07 46.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.535 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.12 116.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.43 -57.46 4.44 Favored Glycine 0 C--N 1.329 0.15 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.91 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -104.99 49.46 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.484 0.659 . . . . 0.0 109.323 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.2 tt0 -44.41 112.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.724 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 18.2 t-80 -97.78 -30.94 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.782 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.453 HG13 ' CD1' ' A' ' 190' ' ' TYR . 18.3 mm -96.72 127.9 37.81 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.398 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.68 78.37 2.44 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.005 1.804 . . . . 0.0 112.876 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.26 10.97 3.56 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.049 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.75 136.72 42.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.572 0.686 . . . . 0.0 111.333 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.416 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 68.7 m-20 -108.74 30.68 6.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 190' ' ' TYR . 5.0 t -116.28 -164.25 0.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.1 mm -109.11 131.32 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.082 0.468 . . . . 0.0 110.541 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.453 ' CD1' HG13 ' A' ' 183' ' ' ILE . 3.1 m-85 -135.1 155.58 50.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.11 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.737 HG21 HD13 ' A' ' 206' ' ' LEU . 46.8 t -79.79 140.27 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.494 ' HA ' HG23 ' A' ' 208' ' ' ILE . 4.1 t -124.67 -14.74 6.72 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.49 133.59 12.43 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.062 0.458 . . . . 0.0 111.566 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.713 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.4 OUTLIER -121.09 134.45 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.019 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.0 118.37 29.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.086 0.47 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -41.99 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.485 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.69 28.68 57.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.868 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.09 -80.17 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.34 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -137.99 -62.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.67 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -62.14 -46.38 89.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.21 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.713 ' HB2' HG22 ' A' ' 194' ' ' ILE . 10.2 t-160 -62.25 -55.86 24.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.661 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -69.79 -52.62 23.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -74.47 -50.93 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.47 -29.32 36.65 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.337 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 64.69 32.11 11.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.392 0.596 . . . . 0.0 110.508 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.737 HD13 HG21 ' A' ' 191' ' ' VAL . 3.6 pp -102.88 140.45 37.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.752 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -123.67 175.65 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 111.08 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.7 mt -62.32 115.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 133.16 -17.9 4.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.53 154.78 40.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.034 0.417 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.713 ' O ' HG13 ' A' ' 243' ' ' VAL . 24.3 ttpt -112.6 129.91 56.21 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.42 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 220' ' ' LEU . 14.8 mm -102.03 116.03 44.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.748 HD21 ' HG2' ' A' ' 242' ' ' LYS . 0.5 OUTLIER -94.67 -12.96 26.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -178.94 148.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.872 0.368 . . . . 0.0 111.531 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.723 HG12 ' CG2' ' A' ' 239' ' ' VAL . 0.2 OUTLIER -117.0 119.53 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.025 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.1 t30 56.55 -87.8 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.4 m -135.98 11.0 3.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.657 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.63 140.82 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 122.549 0.339 . . . . 0.0 110.661 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.84 105.44 2.64 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.525 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 HG22 ' A' ' 212' ' ' ILE . 0.4 OUTLIER -98.76 30.11 3.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.113 0.483 . . . . 0.0 110.144 178.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.71 163.93 12.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 23.4 t70 45.04 27.77 0.32 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.653 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 224' ' ' MET . 6.3 p -133.12 165.81 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.438 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.431 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.07 165.39 18.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.607 0.718 . . . . 0.0 111.794 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.0 t60 -57.59 -35.82 70.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.676 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -35.98 76.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.66 91.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.4 t -58.78 -42.18 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.718 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.25 79.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.356 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -63.56 -40.51 97.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.818 HD11 HG21 ' A' ' 174' ' ' ILE . 2.8 mt -74.03 -40.43 62.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.019 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -55.35 -46.31 76.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -60.75 -20.22 60.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.571 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.835 HG21 HG21 ' A' ' 239' ' ' VAL . 43.9 p -54.58 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.73 0.3 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.66 -151.8 0.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 165' ' ' LYS . 18.9 m-20 -45.35 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.861 0.3 . . . . 0.0 111.2 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.401 HG22 ' CG ' ' A' ' 162' ' ' LYS . 2.5 p -93.98 120.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.741 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.835 HG21 HG21 ' A' ' 235' ' ' THR . 9.5 p -115.07 119.32 61.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.085 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.88 119.5 38.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.915 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.739 ' CD1' HD21 ' A' ' 163' ' ' LEU . 1.3 mp -97.66 151.38 20.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.748 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -107.64 117.9 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.822 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 211' ' ' LYS . 58.4 t -120.47 152.23 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.75 120.92 36.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.84 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -93.7 122.02 63.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.28 130.46 7.18 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.157 1.904 . . . . 0.0 112.455 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.2 160.24 14.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.76 -74.94 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.866 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.182 179.873 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -71.51 -177.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.702 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.9 111.23 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.857 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.98 125.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.243 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.29 152.1 38.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.01 146.81 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 31.1 mm -123.18 119.14 56.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.716 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.406 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 1.8 ttpt -107.81 119.45 39.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.614 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.814 HD21 HD23 ' A' ' 170' ' ' LEU . 3.7 pp -137.17 138.7 40.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.439 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -96.89 131.57 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 0.0 110.981 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.512 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -51.39 90.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.6 171.98 5.28 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.671 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.06 -31.76 91.18 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.101 1.867 . . . . 0.0 112.399 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.23 15.67 28.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.54 -160.42 13.43 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.42 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -64.06 -27.2 68.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.52 0.2 . . . . 0.0 111.405 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.81 41.84 5.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.656 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -175.61 -173.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.818 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -134.26 156.11 48.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.795 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.94 160.86 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -130.57 139.36 50.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.218 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -110.83 132.27 10.85 Favored Glycine 0 CA--C 1.502 -0.751 0 C-N-CA 120.141 -1.028 . . . . 0.0 114.336 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.24 -24.05 49.24 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 114.927 -0.636 . . . . 0.0 113.227 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.0 117.06 32.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.67 -57.51 4.75 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.884 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.91 45.97 0.94 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.415 0.626 . . . . 0.0 109.46 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.455 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -42.3 112.16 0.31 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 9.6 t-80 -98.73 -30.11 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.616 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.577 HD11 ' CB ' ' A' ' 190' ' ' TYR . 8.9 mm -96.57 124.87 49.22 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.24 77.74 2.39 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.778 1.652 . . . . 0.0 112.469 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.15 14.56 2.69 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.043 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -139.14 131.16 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.621 0.71 . . . . 0.0 111.117 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.77 25.28 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.2 t -110.06 -164.61 0.94 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 175' ' ' ALA . 2.2 mm -101.75 134.3 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.205 0.526 . . . . 0.0 110.095 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.577 ' CB ' HD11 ' A' ' 183' ' ' ILE . 14.1 m-85 -133.37 148.81 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.524 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 206' ' ' LEU . 34.3 t -79.99 141.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.608 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.0 t -121.97 -26.67 4.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.479 ' C ' HD13 ' A' ' 194' ' ' ILE . 11.9 ttpt -147.63 136.57 22.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 111.822 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.754 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.8 OUTLIER -121.52 135.87 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.157 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.0 mm -80.61 114.0 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.75 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.718 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.24 25.23 53.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.881 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.24 -108.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.2 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -106.3 -62.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -66.64 -45.13 80.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.569 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.754 ' HB2' HG22 ' A' ' 194' ' ' ILE . 2.2 t-80 -59.08 -57.41 13.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -53.16 18.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.67 -50.99 15.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.99 53.21 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.813 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 62.15 28.42 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.913 0.357 . . . . 0.0 110.803 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.579 HD22 HD12 ' A' ' 241' ' ' LEU . 2.9 pp -99.41 139.13 35.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.96 177.34 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 40.0 mt -64.43 126.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.732 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.43 -14.9 10.8 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.531 ' OD1' HG11 ' A' ' 243' ' ' VAL . 0.4 OUTLIER -78.93 145.79 33.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.057 0.429 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.732 ' O ' HG13 ' A' ' 243' ' ' VAL . 13.2 ttmt -103.05 128.57 49.86 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.749 HD13 ' CG2' ' A' ' 243' ' ' VAL . 33.9 mm -99.98 120.49 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 112.141 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.511 HD12 ' HG2' ' A' ' 242' ' ' LYS . 1.6 mt -85.46 -60.72 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.239 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -134.39 155.4 50.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.961 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.723 HG13 HD22 ' A' ' 241' ' ' LEU . 11.8 t -125.14 120.41 58.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.911 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 59.99 -85.21 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.4 m -142.86 13.45 1.89 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.829 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.0 p -109.77 140.43 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.021 0.439 . . . . 0.0 111.659 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.96 104.93 2.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.082 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.547 HD22 ' HB1' ' A' ' 228' ' ' ALA . 0.4 OUTLIER -99.16 37.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 110.704 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -91.93 159.29 15.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.845 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 48.39 31.23 2.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.486 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.443 HG21 ' CB ' ' A' ' 227' ' ' ASP . 3.9 p -133.58 161.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.008 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 11.1 mtt -68.32 170.03 9.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.716 0.77 . . . . 0.0 112.117 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.3 t60 -57.33 -36.88 71.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.306 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.65 -51.81 60.61 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.443 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.1 t0 -59.64 -36.43 76.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.547 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.976 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 225' ' ' HIS . 29.1 t -57.16 -41.81 78.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.01 75.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.202 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.657 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -64.82 -40.28 94.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.604 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.795 HD11 HG21 ' A' ' 174' ' ' ILE . 6.0 mt -70.05 -48.74 56.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -58.41 -33.68 69.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.07 0.462 . . . . 0.0 111.404 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -59.33 -21.24 59.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 232' ' ' LEU . 25.2 p -63.51 -166.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.729 0.3 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.85 -148.28 0.25 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 240' ' ' TYR . 0.5 OUTLIER -96.54 123.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.574 ' CG1' HG21 ' A' ' 235' ' ' THR . 16.7 t -111.84 137.11 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.722 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.467 ' CE1' HG13 ' A' ' 238' ' ' VAL . 2.1 m-85 -115.61 118.74 33.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.671 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.723 HD22 HG13 ' A' ' 215' ' ' VAL . 0.4 OUTLIER -97.77 139.35 33.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.511 ' HG2' HD12 ' A' ' 213' ' ' LEU . 3.0 ttmt -106.92 130.04 54.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.749 ' CG2' HD13 ' A' ' 212' ' ' ILE . 60.9 t -136.97 149.6 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.23 121.79 37.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.066 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.76 134.14 26.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.288 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.7 109.59 2.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.226 1.951 . . . . 0.0 112.326 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 m -60.94 150.75 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.988 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -164.86 114.09 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.073 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.814 0.34 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.16 176.65 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -80.25 105.2 11.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.86 137.23 26.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.576 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.09 147.56 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.592 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -115.55 120.69 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.2 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.987 HG22 HD21 ' A' ' 163' ' ' LEU . 31.9 mm -109.76 118.19 56.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.675 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.703 ' C ' HD23 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -103.91 129.06 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.987 HD21 HG22 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -126.33 132.32 51.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.11 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.06 124.51 49.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 110.353 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 87.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.27 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.07 179.01 53.55 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.125 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.6 -20.37 33.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.187 1.924 . . . . 0.0 112.394 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.91 8.18 41.24 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.97 -150.27 18.22 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.9 mm? -62.35 -37.99 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.73 0.3 . . . . 0.0 111.288 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 100.9 33.39 5.0 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.005 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.2 OUTLIER -173.89 -166.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.093 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -137.4 161.54 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.794 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.33 158.51 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.883 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.13 137.65 53.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.494 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.43 130.14 9.82 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.783 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -83.83 -23.39 52.97 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.63 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.91 116.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.48 -56.27 4.69 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.995 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.79 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.345 0.593 . . . . 0.0 109.434 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 5.3 tt0 -43.61 112.92 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.678 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 2.5 t-80 -104.3 -25.0 13.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.326 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.15 130.32 31.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.332 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.6 76.52 3.21 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.104 1.869 . . . . 0.0 112.779 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.62 48.41 0.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.05 123.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.65 25.33 5.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.295 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -109.61 -168.14 1.29 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.6 mm -99.51 136.88 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.197 0.522 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 20.6 m-85 -135.5 152.29 51.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.669 HG21 HD12 ' A' ' 206' ' ' LEU . 29.7 t -80.18 140.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.494 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.8 t -125.14 -24.02 4.09 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -150.56 136.55 18.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.104 0.478 . . . . 0.0 111.889 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.3 mm -121.12 135.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.182 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.13 113.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -36.48 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.83 40.19 49.01 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.202 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.06 -60.74 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -149.96 -61.96 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.751 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 1.023 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -65.24 -46.59 79.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.297 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.638 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.6 t-160 -61.42 -56.13 23.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.01 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -52.36 25.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -74.31 -50.74 17.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.41 -36.64 26.25 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 121.086 -0.578 . . . . 0.0 114.167 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 39.38 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.05 0.453 . . . . 0.0 110.681 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 1.023 HD21 ' HB1' ' A' ' 200' ' ' ALA . 1.7 pt? -109.61 140.33 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.536 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -121.79 171.71 8.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 0.0 111.159 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 192' ' ' THR . 53.5 mt -62.49 120.63 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.64 -19.55 4.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.9 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.66 152.51 31.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.85 0.325 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.765 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -113.52 129.22 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.387 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.586 ' HA ' HG22 ' A' ' 243' ' ' VAL . 31.8 mm -90.08 119.24 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 111.507 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -89.81 -26.42 20.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -171.89 149.21 2.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.76 HG13 ' HG ' ' A' ' 241' ' ' LEU . 2.5 t -117.42 119.0 60.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.83 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 239' ' ' VAL . 2.2 m-20 56.2 -85.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 215' ' ' VAL . 9.5 m -138.18 12.18 2.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.663 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.3 p -109.63 140.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-O 120.922 0.391 . . . . 0.0 111.056 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.02 89.49 0.71 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.728 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.921 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -71.72 -7.66 49.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.37 178.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.566 ' N ' HD12 ' A' ' 220' ' ' LEU . 3.8 pt-20 -62.29 168.72 3.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.194 0.521 . . . . 0.0 110.831 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 t0 47.52 25.5 0.65 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 220' ' ' LEU . 2.9 p -136.44 164.41 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.807 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.5 168.87 11.94 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.65 0.738 . . . . 0.0 111.576 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.6 t60 -57.96 -37.21 73.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.042 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.94 -52.88 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.512 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -62.04 -34.34 76.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 109.888 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.77 89.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.778 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.0 t -59.41 -41.72 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.767 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.44 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.703 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -66.29 -50.66 62.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.867 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 235' ' ' THR . 2.6 pp -74.57 -39.67 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -59.05 -39.62 82.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.402 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -59.09 -20.34 52.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.741 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 239' ' ' VAL . 34.6 p -57.75 -172.17 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.574 0.226 . . . . 0.0 111.323 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -133.88 -146.9 0.27 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.877 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -81.95 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 122.543 0.337 . . . . 0.0 111.792 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.27 122.34 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.012 HG21 HG21 ' A' ' 235' ' ' THR . 12.9 p -117.53 132.69 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.9 m-85 -105.4 119.45 39.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.922 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.76 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.0 mp -97.71 140.59 31.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.51 117.74 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.213 0.53 . . . . 0.0 110.215 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 211' ' ' LYS . 65.2 t -117.61 147.81 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.069 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.35 121.25 39.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.733 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 122.4 61.86 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.73 91.38 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.002 1.802 . . . . 0.0 112.192 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -174.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.158 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -164.51 86.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.135 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -126.67 -170.6 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -116.58 105.02 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 243' ' ' VAL . 11.4 p -101.76 127.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.743 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.0 ptm -124.58 154.4 40.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.313 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.03 130.89 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.398 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.874 HG22 ' CD2' ' A' ' 163' ' ' LEU . 37.9 mm -100.52 117.09 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.458 ' C ' HD23 ' A' ' 163' ' ' LEU . 7.7 ttpt -98.66 125.12 43.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.108 0.48 . . . . 0.0 112.273 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.874 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -136.28 129.51 31.59 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.39 131.08 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.123 0.487 . . . . 0.0 111.292 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 69.31 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.52 -160.22 7.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.27 -20.13 49.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.132 1.888 . . . . 0.0 112.401 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -92.26 -4.63 53.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.36 -149.41 19.45 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.57 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.588 HD12 HD12 ' A' ' 163' ' ' LEU . 4.2 mm? -56.96 -37.87 72.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 110.982 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 200' ' ' ALA . . . 92.2 26.41 18.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.972 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 4.1 p90 -174.97 -168.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 110.943 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 192' ' ' THR . 4.0 m -135.65 163.85 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.585 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.58 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -129.17 161.17 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 111.301 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.905 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.92 137.88 51.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.31 130.34 9.53 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.712 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.86 -18.23 61.83 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.558 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.96 117.76 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.38 -57.87 4.67 Favored Glycine 0 C--N 1.329 0.141 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.055 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -109.78 57.39 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.592 0.71 . . . . 0.0 109.301 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.2 tt0 -48.5 116.26 1.52 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.701 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 4.0 t-80 -101.6 -27.02 13.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.913 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.414 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.24 134.57 23.43 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 79.41 2.59 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.138 1.892 . . . . 0.0 113.101 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.52 50.95 0.73 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.242 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -168.9 131.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.663 0.268 . . . . 0.0 110.884 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.065 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -169.1 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.905 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.5 mm -102.69 134.96 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.253 0.549 . . . . 0.0 110.112 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CG ' HG12 ' A' ' 183' ' ' ILE . 15.3 m-85 -133.84 155.35 50.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.626 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.605 HG11 ' CD1' ' A' ' 194' ' ' ILE . 40.3 t -80.28 141.44 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.329 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.556 ' C ' HD12 ' A' ' 208' ' ' ILE . 7.9 t -125.53 -21.55 4.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -153.42 136.13 15.27 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.683 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.655 HG22 ' HB2' ' A' ' 201' ' ' HIS . 2.5 mm -120.87 135.91 59.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.69 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.5 mm -80.17 116.88 25.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 110.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -37.03 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.023 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.74 27.19 34.9 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.981 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.56 -115.53 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.42 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.412 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -98.58 -57.42 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.934 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -67.31 -47.15 71.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.905 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.655 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.1 t-160 -59.52 -56.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.24 -52.74 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -74.0 -51.36 16.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.0 -38.19 36.19 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.728 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.28 41.21 4.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.292 0.568 . . . . 0.0 110.198 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.934 HD21 ' HB1' ' A' ' 200' ' ' ALA . 0.8 OUTLIER -111.28 140.23 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.999 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -118.77 179.53 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.763 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 192' ' ' THR . 7.4 mm -72.41 113.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.058 0.456 . . . . 0.0 111.556 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.2 -13.57 3.54 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.662 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -78.93 159.3 27.78 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 117.038 0.419 . . . . 0.0 110.982 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.733 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -120.76 130.12 53.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.657 HD13 ' CG2' ' A' ' 243' ' ' VAL . 32.7 mm -93.17 117.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.666 HD21 ' CG ' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -95.33 -4.97 44.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.63 153.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.755 0.312 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 218' ' ' VAL . 42.7 t -132.23 119.63 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.467 ' ND2' HG23 ' A' ' 239' ' ' VAL . 24.3 m-20 59.94 -84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.44 13.02 1.96 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.07 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.9 p -109.31 139.84 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.943 0.401 . . . . 0.0 111.529 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.14 101.9 2.33 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.387 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.98 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -109.17 45.66 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.478 0.656 . . . . 0.0 109.65 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 26.78 4.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.164 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -158.12 32.19 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.952 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 227' ' ' ASP . 7.0 p -153.4 166.1 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.443 ' N ' HG22 ' A' ' 223' ' ' VAL . 3.9 mtm -62.13 168.43 3.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.632 0.729 . . . . 0.0 112.076 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.87 ' O ' HG23 ' A' ' 229' ' ' VAL . 54.5 t60 -56.93 -36.18 69.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.031 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.15 -52.89 52.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.489 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -62.36 -34.98 77.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.166 0.508 . . . . 0.0 109.929 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 231' ' ' ALA . . . -60.67 -38.39 84.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.664 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.2 t -59.52 -41.64 85.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.89 -33.22 72.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.058 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.98 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.3 -41.15 96.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.896 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 229' ' ' VAL . 1.7 mt -73.99 -41.9 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.102 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -61.77 -39.57 92.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.149 0.499 . . . . 0.0 111.237 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -60.67 -19.61 58.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.866 HG21 HG21 ' A' ' 239' ' ' VAL . 30.2 p -57.73 -166.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.761 -0.2 . . . . 0.0 110.928 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -152.93 -160.74 1.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.233 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -28.82 -61.6 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.21 126.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 235' ' ' THR . 4.2 p -120.65 126.11 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 121.32 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.763 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 215' ' ' VAL . 0.3 OUTLIER -97.24 146.57 24.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.067 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.666 ' CG ' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -108.39 118.02 35.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.022 0.439 . . . . 0.0 109.936 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 211' ' ' LYS . 58.4 t -127.56 148.77 32.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.983 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.2 121.46 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 122.32 60.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.031 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.69 93.27 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.131 1.888 . . . . 0.0 112.195 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.79 -169.66 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.8 32.09 20.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.11 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.763 0.316 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -177.44 3.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.986 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.4 96.05 3.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.0 t -101.34 134.62 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.73 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.461 ' O ' HG12 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -132.12 154.55 49.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.998 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.83 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 0.0 111.794 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.943 HG21 HD23 ' A' ' 206' ' ' LEU . 34.5 mm -113.66 118.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.611 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.761 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -94.54 131.23 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.689 0.281 . . . . 0.0 111.331 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.795 HD11 HD11 ' A' ' 241' ' ' LEU . 11.5 mt -131.71 128.79 39.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.829 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -98.25 128.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.13 0.49 . . . . 0.0 110.145 179.05 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.647 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -63.15 91.94 0.05 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.008 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.14 -171.04 37.37 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.892 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.84 -24.8 74.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.211 1.94 . . . . 0.0 112.535 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -4.18 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.48 -144.27 18.37 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.366 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 18.3 mt -67.14 -37.83 84.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.271 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 97.94 34.26 5.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.622 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 7.3 p90 -175.07 -168.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 111.013 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 192' ' ' THR . 22.7 t -136.33 161.02 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.836 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.52 161.48 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.997 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.884 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -131.1 138.7 49.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.6 130.67 9.67 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.598 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.58 -25.08 54.88 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.637 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.53 120.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.91 5.02 Favored Glycine 0 C--N 1.331 0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 113.004 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -114.93 54.14 0.79 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.443 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -45.54 107.33 0.1 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.314 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.648 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 5.3 t-80 -93.74 -26.78 16.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.011 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.435 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -96.46 121.85 59.0 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.034 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.72 71.01 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.999 1.799 . . . . 0.0 112.532 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 123.66 51.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.712 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.89 129.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.3 30.89 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.4 t -114.52 -165.73 1.04 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.884 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -103.22 135.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.435 ' CG ' HG12 ' A' ' 183' ' ' ILE . 20.6 m-85 -135.87 153.72 51.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.736 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 194' ' ' ILE . 46.5 t -80.76 142.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 173' ' ' SER . 1.9 t -122.7 -20.73 5.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.556 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -158.59 136.95 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.997 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.642 HD12 ' CD1' ' A' ' 206' ' ' LEU . 2.8 mm -120.57 135.65 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.995 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.6 mm -80.45 116.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -37.82 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.9 24.22 41.08 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.216 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.48 -114.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.121 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -109.94 -48.11 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.771 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.13 -47.07 72.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.409 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.0 t-160 -59.55 -56.08 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -69.77 -52.0 29.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.85 -51.15 17.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.62 -34.77 21.52 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.217 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 66.02 26.67 10.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.188 0.494 . . . . 0.0 110.552 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 161' ' ' ILE . 3.9 pp -96.05 140.86 30.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -122.04 170.15 10.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 34.6 mt -58.22 113.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.51 -19.61 3.18 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.723 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.14 129.88 39.03 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.824 0.312 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.885 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.5 OUTLIER -96.48 129.11 43.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.627 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 189' ' ' ILE . 16.2 mm -103.13 137.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.802 0.334 . . . . 0.0 111.667 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.687 HD11 ' HG2' ' A' ' 242' ' ' LYS . 1.4 pp -115.53 -12.59 11.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.034 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -175.9 152.45 1.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 110.657 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.721 ' O ' HG12 ' A' ' 218' ' ' VAL . 38.4 t -130.43 119.09 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 58.43 -85.04 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.99 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 12.95 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.674 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.29 140.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 120.827 0.346 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.58 100.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.049 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.598 HD21 HG21 ' A' ' 215' ' ' VAL . 0.5 OUTLIER -99.25 34.73 2.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.383 0.611 . . . . 0.0 109.864 178.235 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -103.35 163.68 12.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 46.38 26.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.665 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 224' ' ' MET . 5.2 p -134.21 165.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 2.9 mtt -69.51 168.34 14.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.718 0.77 . . . . 0.0 112.026 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.859 ' O ' HG23 ' A' ' 229' ' ' VAL . 64.2 t60 -58.11 -36.31 72.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.017 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.6 -51.72 57.52 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -35.57 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.473 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.14 92.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.403 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.2 t -58.09 -41.83 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.97 74.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.467 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -67.31 -41.4 85.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.234 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 174' ' ' ILE . 4.3 mt -73.44 -45.18 55.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -34.62 71.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.816 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -64.47 -20.35 66.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.63 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.956 HG21 HG21 ' A' ' 239' ' ' VAL . 26.2 p -62.25 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -140.76 -150.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 7.1 m-20 -45.08 -81.18 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.286 0.234 . . . . 0.0 111.609 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.8 118.48 42.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.168 0.509 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.956 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -120.82 127.31 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.199 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.34 123.79 46.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.795 HD11 HD11 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -97.07 149.32 22.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.687 ' HG2' HD11 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -107.64 116.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.2 p -124.06 140.36 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.881 -177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.55 121.73 40.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.167 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.32 115.91 65.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.87 66.54 8.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.191 1.927 . . . . 0.0 112.094 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.98 34.18 11.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.3 t30 60.0 85.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.077 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.31 113.58 23.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.8 t -107.88 122.88 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.25 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.84 149.27 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.43 142.85 28.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.306 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.711 HD13 ' HB3' ' A' ' 206' ' ' LEU . 2.7 mt -118.03 119.62 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.783 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.539 ' CG ' HG22 ' A' ' 238' ' ' VAL . 14.9 ttpt -100.84 130.75 46.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.002 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.985 HD11 HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -132.09 132.04 42.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.816 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -97.2 135.09 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.242 0.544 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.784 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -70.11 96.01 1.03 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.085 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.8 -158.25 27.58 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.959 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.86 -20.72 68.76 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.097 1.865 . . . . 0.0 112.422 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.27 -2.49 31.0 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.4 -135.77 14.25 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.126 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 4.4 mm? -58.21 -33.25 69.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 111.046 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.03 32.99 37.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.699 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 11.6 p90 -175.42 -174.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.4 m -129.85 160.29 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 111.545 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.753 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -122.91 157.09 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.9 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.99 137.53 52.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -111.45 130.92 9.99 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.753 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.62 -23.74 57.55 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.587 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.1 t -90.06 117.92 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.96 -56.04 5.03 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.918 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -112.42 53.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.439 0.638 . . . . 0.0 109.414 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.5 tt0 -45.87 113.24 0.58 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.684 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 3.8 t-80 -102.66 -26.04 13.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.277 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.434 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -95.99 132.99 25.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.275 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.88 76.34 4.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 113.007 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.59 47.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.083 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.64 130.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 0.0 110.948 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.4 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 1.3 m120 -102.47 28.13 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.28 -162.46 0.8 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.751 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.9 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -106.38 136.04 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.434 ' CG ' HG12 ' A' ' 183' ' ' ILE . 21.8 m-85 -135.77 150.3 49.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.388 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 194' ' ' ILE . 26.9 t -80.73 138.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.703 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.6 t -123.23 -18.48 6.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -152.16 133.53 14.49 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.782 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.6 mm -120.93 135.6 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.151 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -81.02 113.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 109.866 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -37.19 102.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.28 23.6 13.32 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.262 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.0 -107.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.411 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -104.44 -58.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -67.23 -47.99 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.035 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.8 t-160 -58.46 -56.11 26.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -52.32 27.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.44 -51.38 15.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 163' ' ' LEU . . . -85.52 -35.78 11.45 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.686 -0.768 . . . . 0.0 114.402 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 62.17 0.74 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.401 0.62 . . . . 0.0 110.578 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 200' ' ' ALA . 0.3 OUTLIER -122.5 132.88 54.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.92 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -112.14 165.72 11.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.972 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.703 HG23 ' HA ' ' A' ' 192' ' ' THR . 37.9 mt -64.06 111.54 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.76 -14.07 2.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.204 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.24 153.01 28.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.107 0.453 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.742 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -114.32 129.36 56.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.675 ' HA ' HG22 ' A' ' 243' ' ' VAL . 43.1 mm -90.5 122.93 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.566 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.785 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -90.46 -27.09 19.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.171 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 177.09 150.21 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.738 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.843 HG22 HD23 ' A' ' 241' ' ' LEU . 2.2 t -116.19 118.92 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.017 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 56.42 -86.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.28 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.6 m -136.39 11.06 3.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.072 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 215' ' ' VAL . 8.1 p -109.23 140.39 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -108.64 88.53 0.53 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.056 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.875 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -68.07 -13.81 62.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 178.538 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.638 ' N ' HD12 ' A' ' 220' ' ' LEU . 1.5 pt-20 -63.24 169.59 3.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.19 0.519 . . . . 0.0 110.72 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.39 24.42 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.795 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.875 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.2 p -144.86 156.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.92 167.5 0.79 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.93 0.872 . . . . 0.0 112.592 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.0 t60 -57.66 -35.01 69.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.099 -1.41 . . . . 0.0 110.685 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.3 -52.05 51.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.052 0.454 . . . . 0.0 111.996 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.495 ' HB2' HG22 ' A' ' 223' ' ' VAL . 8.6 m-20 -61.27 -35.42 77.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.49 90.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.775 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.6 t -59.04 -41.3 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.12 75.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.1 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 218' ' ' VAL . . . -63.45 -39.74 95.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.32 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.753 HD11 HG21 ' A' ' 174' ' ' ILE . 9.0 mt -73.16 -44.24 60.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.166 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -37.0 70.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 111.575 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.0 -20.3 65.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.909 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.893 HG21 HG21 ' A' ' 239' ' ' VAL . 22.8 p -65.43 -175.67 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.754 0.312 . . . . 0.0 111.323 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.53 -150.03 0.35 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.227 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 165' ' ' LYS . 2.1 m-20 -44.31 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.712 0.233 . . . . 0.0 111.288 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.539 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.5 OUTLIER -94.11 122.54 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.676 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.893 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -118.83 135.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -102.63 135.33 44.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.985 HD11 HD11 ' A' ' 163' ' ' LEU . 3.6 mt -113.46 135.34 53.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.467 ' HG2' HD23 ' A' ' 213' ' ' LEU . 2.6 ttpp -106.66 117.5 34.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.174 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 211' ' ' LYS . 75.1 t -129.48 148.79 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.95 121.12 35.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.963 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 133.37 27.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.165 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.08 113.92 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.967 1.778 . . . . 0.0 111.917 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.43 155.11 36.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.243 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -157.92 -59.96 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.807 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.062 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -143.66 151.92 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -95.44 121.86 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.568 HG11 ' HE2' ' A' ' 242' ' ' LYS . 16.2 t -115.56 135.1 56.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -93.39 140.01 30.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.63 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.76 HG21 HD23 ' A' ' 206' ' ' LEU . 48.6 mm -123.9 119.21 56.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.798 ' O ' HD23 ' A' ' 163' ' ' LEU . 19.1 ttpt -105.57 132.31 51.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.373 . . . . 0.0 111.606 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.875 HD22 ' HA ' ' A' ' 200' ' ' ALA . 2.3 mt -131.61 129.77 41.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.062 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.751 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -98.17 134.54 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 110.973 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.751 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -74.79 106.31 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.912 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.14 -147.13 8.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.217 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.38 -23.06 38.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.064 1.842 . . . . 0.0 112.055 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -102.14 -4.73 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.62 -135.32 13.67 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.109 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.587 HD12 HD12 ' A' ' 163' ' ' LEU . 4.5 mm? -58.49 -37.11 74.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.115 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.556 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 83.48 39.35 9.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.651 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.25 -173.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.97 0.414 . . . . 0.0 110.704 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 m -133.13 160.39 37.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -125.84 162.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.825 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.074 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.83 129.38 9.5 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.431 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.67 -20.6 55.88 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.255 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 187' ' ' ASN . 17.6 t -89.83 116.99 32.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.27 -58.5 4.03 Favored Glycine 0 C--N 1.329 0.164 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.944 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -102.97 48.55 0.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.472 0.654 . . . . 0.0 109.429 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.448 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -44.51 113.5 0.55 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 7.4 t-80 -98.44 -31.31 12.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.743 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.439 HG13 ' CG ' ' A' ' 190' ' ' TYR . 9.8 mm -96.4 123.91 52.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.198 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.49 78.67 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.982 1.788 . . . . 0.0 112.566 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 130.88 5.73 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.013 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -132.88 144.85 50.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.669 0.735 . . . . 0.0 111.35 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASN . . . . . 0.416 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.2 m-80 -104.85 -28.05 11.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -62.98 -163.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.5 mm -101.13 141.35 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.25 0.548 . . . . 0.0 110.819 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CG ' HG13 ' A' ' 183' ' ' ILE . 17.6 m-85 -135.58 155.05 51.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.839 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 194' ' ' ILE . 36.7 t -85.16 142.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.451 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 208' ' ' ILE . 1.4 t -123.74 -24.26 4.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.617 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -157.15 138.25 13.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.09 0.472 . . . . 0.0 112.01 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.617 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.6 mm -121.35 135.78 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.483 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.556 HD13 ' C ' ' A' ' 171' ' ' GLY . 3.5 mp -80.73 115.6 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -38.26 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.97 29.37 43.04 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.167 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.99 -64.73 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.182 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.21 -57.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.388 . . . . 0.0 110.689 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.875 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.44 -44.55 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.811 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.7 t-80 -59.63 -55.89 28.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.678 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -51.54 30.29 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.84 -49.47 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.64 -35.24 14.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.789 -0.72 . . . . 0.0 114.398 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 51.66 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.375 0.607 . . . . 0.0 109.962 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.76 HD23 HG21 ' A' ' 161' ' ' ILE . 4.1 pp -120.81 140.44 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.224 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.71 174.97 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.019 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 192' ' ' THR . 35.9 mt -67.6 126.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.827 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 127.03 -19.39 6.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.622 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -77.03 149.44 35.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.792 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -110.83 128.21 55.69 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.896 0.379 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.859 HD13 ' CG2' ' A' ' 243' ' ' VAL . 26.8 mm -92.79 124.71 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.884 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.466 HD21 ' HD2' ' A' ' 211' ' ' LYS . 3.3 mt -85.48 -67.26 0.82 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.263 0.554 . . . . 0.0 110.151 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.03 155.11 50.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.703 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.859 HG13 ' HG ' ' A' ' 241' ' ' LEU . 26.0 t -124.3 120.11 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.61 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 t30 59.31 -86.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.9 t -141.26 14.44 2.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.665 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.75 140.64 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.89 97.33 1.42 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.051 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 215' ' ' VAL . 0.4 OUTLIER -101.84 43.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -120.12 30.07 7.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.732 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -168.65 33.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 227' ' ' ASP . 9.6 p -152.41 165.29 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.431 ' N ' HG22 ' A' ' 223' ' ' VAL . 1.1 mpt? -63.51 172.68 1.93 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.727 0.775 . . . . 0.0 112.173 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 229' ' ' VAL . 66.7 t60 -57.44 -37.62 73.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.583 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.54 -53.14 46.36 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASP . . . . . 0.529 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -63.12 -34.21 77.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.78 -38.21 84.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.646 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.8 t -60.08 -41.39 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.142 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.91 -32.81 74.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.875 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -65.33 -42.08 93.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.315 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 229' ' ' VAL . 0.7 OUTLIER -73.69 -48.07 34.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.446 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.48 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 111.979 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.53 -20.7 57.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.715 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . 0.999 HG21 HG21 ' A' ' 239' ' ' VAL . 30.6 p -60.82 -169.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.687 0.279 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.71 -152.01 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -44.34 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.549 0.214 . . . . 0.0 111.439 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.423 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.3 OUTLIER -97.05 121.81 47.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.944 0.402 . . . . 0.0 110.711 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.999 HG21 HG21 ' A' ' 235' ' ' THR . 12.5 p -120.16 132.95 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 2.6 m-85 -105.21 119.58 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.859 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.0 mp -101.55 138.19 38.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.568 ' HE2' HG11 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -107.06 129.22 54.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.986 0.422 . . . . 0.0 110.046 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.859 ' CG2' HD13 ' A' ' 212' ' ' ILE . 53.6 t -130.82 148.32 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.691 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.7 131.09 52.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.768 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -93.61 109.86 43.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.082 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.39 111.09 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.049 1.833 . . . . 0.0 112.249 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 73.2 m -92.14 66.09 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.46 35.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.016 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.693 0.282 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 14.7 ptp -132.03 154.51 49.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.882 0.373 . . . . 0.0 111.25 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.93 145.08 30.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.829 HG21 HD23 ' A' ' 206' ' ' LEU . 41.1 mm -125.44 116.71 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.728 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.8 mtmt -90.7 131.51 36.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.004 0.431 . . . . 0.0 111.108 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.006 HD11 HD11 ' A' ' 241' ' ' LEU . 2.1 mt -121.23 128.39 52.36 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.967 HD12 HG22 ' A' ' 238' ' ' VAL . 13.0 mm -97.25 134.21 36.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 111.375 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.475 ' HE2' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -80.15 56.99 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.043 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.99 -156.0 0.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.51 -22.98 44.05 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.212 1.941 . . . . 0.0 112.434 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -4.49 47.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.1 -130.84 10.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.271 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 163' ' ' LEU . 4.5 mm? -62.37 -36.46 82.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 110.95 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 26.56 23.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.109 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 1.7 p90 -174.57 -168.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 111.202 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -134.7 158.96 42.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.729 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -124.73 160.49 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.918 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -125.05 137.3 54.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.16 129.91 9.61 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.499 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.15 -22.67 54.2 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.76 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 187' ' ' ASN . 19.8 t -89.99 118.64 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.89 -57.12 4.96 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.967 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -110.39 52.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.6 tt0 -44.8 116.21 1.03 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.671 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 16.6 t60 -103.89 -27.75 12.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.238 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.436 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.41 123.45 54.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.371 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.62 81.47 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.007 1.804 . . . . 0.0 112.648 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.28 55.32 0.68 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.028 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.41 129.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.812 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.54 ' HB3' HG22 ' A' ' 178' ' ' VAL . 7.7 m120 -103.74 29.46 5.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m -111.0 -160.9 0.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.7 mm -110.79 136.65 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.9 m-85 -135.47 154.06 51.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.545 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.504 HG11 ' CD1' ' A' ' 194' ' ' ILE . 40.1 t -80.9 142.22 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.2 t -123.97 -24.09 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.54 ' C ' HD13 ' A' ' 194' ' ' ILE . 9.4 ttpt -155.43 138.52 15.54 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.72 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.724 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -121.27 135.12 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.498 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.86 123.62 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -39.53 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.58 26.11 37.55 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.283 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.27 -69.23 1.4 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.172 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.456 ' HB1' ' H ' ' A' ' 164' ' ' ILE . . . -148.46 -59.31 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.954 0.407 . . . . 0.0 110.388 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.691 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -63.97 -43.81 94.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.724 ' HB2' HG22 ' A' ' 194' ' ' ILE . 7.7 t-160 -66.07 -55.8 14.75 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -69.4 -52.76 23.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 164' ' ' ILE . 2.5 t70 -75.01 -50.56 16.14 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.474 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -77.9 -31.25 49.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.134 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 62.19 32.23 17.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.179 0.49 . . . . 0.0 110.182 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.829 HD23 HG21 ' A' ' 161' ' ' ILE . 3.8 pp -101.3 140.32 35.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.904 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 194' ' ' ILE . 11.3 pt20 -123.01 167.21 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 46.2 mt -58.06 116.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.3 -17.94 3.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.439 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -78.95 149.16 32.39 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 120.743 0.306 . . . . 0.0 111.062 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.771 ' O ' HG13 ' A' ' 243' ' ' VAL . 5.9 ptmt -112.94 128.87 56.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.462 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.725 ' HA ' HG22 ' A' ' 243' ' ' VAL . 26.9 mm -90.1 121.58 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.315 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 0.7 OUTLIER -101.73 2.5 38.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 163.83 155.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.814 HG13 ' CD2' ' A' ' 241' ' ' LEU . 57.5 t -132.14 118.57 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.441 ' HA ' ' CE2' ' A' ' 240' ' ' TYR . 26.9 m-20 58.08 -85.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.5 OUTLIER -141.18 14.32 2.23 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.668 177.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.749 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.2 p -109.17 140.38 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.97 0.414 . . . . 0.0 111.3 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.75 94.61 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.968 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.1 OUTLIER -102.31 44.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.696 0.76 . . . . 0.0 109.026 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 25.58 5.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.601 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.71 33.38 0.4 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.745 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 227' ' ' ASP . 10.1 p -152.76 166.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.039 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.46 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.69 170.52 2.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.725 0.774 . . . . 0.0 112.284 -179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.869 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.2 t60 -57.55 -36.28 71.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.307 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.18 -52.56 54.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.498 ' CB ' HG21 ' A' ' 223' ' ' VAL . 2.4 t0 -62.01 -35.22 77.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.959 0.409 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.15 89.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.872 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 225' ' ' HIS . 18.2 t -59.37 -41.36 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.31 -33.25 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.474 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.968 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.23 -41.48 96.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 174' ' ' ILE . 3.5 mt -73.96 -48.77 28.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.611 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -61.49 -34.54 75.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.957 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -64.39 -20.22 66.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.732 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 1.141 HG21 HG21 ' A' ' 239' ' ' VAL . 18.3 p -66.01 -162.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.516 0.198 . . . . 0.0 111.443 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 236' ' ' TYR . 1.7 m-85 -131.02 -153.46 0.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.146 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.19 -77.03 0.02 OUTLIER 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.566 0.347 . . . . 0.0 111.787 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.967 HG22 HD12 ' A' ' 164' ' ' ILE . 53.5 t -102.88 121.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.106 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.141 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -118.87 124.07 72.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.588 ' C ' HD23 ' A' ' 241' ' ' LEU . 0.6 OUTLIER -94.76 138.03 33.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.405 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 1.006 HD11 HD11 ' A' ' 163' ' ' LEU . 0.8 OUTLIER -114.77 147.25 40.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.76 119.8 40.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 110.304 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 211' ' ' LYS . 71.8 t -128.75 146.63 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.787 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.98 132.1 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.675 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.911 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.3 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.737 0.303 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.52 ' SD ' HD11 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -132.18 147.5 52.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.117 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.61 144.15 27.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.963 HG21 HD23 ' A' ' 206' ' ' LEU . 43.0 mm -125.45 118.94 53.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.636 ' O ' HD23 ' A' ' 163' ' ' LEU . 8.9 ttmt -97.57 126.31 42.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 241' ' ' LEU . 12.4 mt -127.41 128.92 46.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.326 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.787 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -101.28 133.5 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.053 0.454 . . . . 0.0 110.719 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.787 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -68.9 74.17 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.089 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.74 -161.61 0.4 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.368 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.72 -24.37 25.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.327 2.018 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -101.32 -1.95 32.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.04 -138.02 14.68 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.365 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 24.1 mt -69.6 -33.59 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.844 0.355 . . . . 0.0 111.126 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.29 27.63 11.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.491 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 3.7 p90 -170.58 -169.27 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.0 t -136.92 162.97 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.686 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -123.6 160.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.187 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.906 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.02 138.01 52.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -109.35 130.18 9.85 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.818 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -83.78 -23.2 53.77 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.425 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.403 ' HB ' ' N ' ' A' ' 224' ' ' MET . 10.5 t -89.88 120.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.66 -56.43 5.05 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.075 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.06 57.58 0.79 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.543 0.687 . . . . 0.0 109.391 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.452 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.6 tt0 -47.66 116.95 1.62 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.706 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 6.0 t60 -102.06 -25.16 13.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.952 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.1 mp -96.48 129.44 33.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.35 78.1 2.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.053 1.835 . . . . 0.0 112.829 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.57 50.96 0.63 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.748 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.13 123.87 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.741 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 28.74 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 -166.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.58 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.906 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -102.98 134.89 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.226 0.536 . . . . 0.0 110.522 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.442 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.3 m-85 -135.33 154.23 51.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.684 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 206' ' ' LEU . 44.6 t -80.7 141.43 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.402 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.8 t -123.07 -26.04 4.43 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.478 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -150.61 137.18 18.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.912 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 191' ' ' VAL . 1.3 mm -121.28 135.25 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.33 118.39 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.52 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.57 23.97 16.05 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.136 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.18 -78.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.431 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -137.56 -58.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.954 0.407 . . . . 0.0 110.879 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.859 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -63.31 -45.92 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -59.13 -55.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.953 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -52.06 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.64 -50.51 20.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -82.4 -32.81 27.18 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.259 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 63.2 31.92 15.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.281 0.541 . . . . 0.0 110.259 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.963 HD23 HG21 ' A' ' 161' ' ' ILE . 4.7 pp -102.68 140.43 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.638 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 176.33 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.283 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 51.1 mt -64.28 112.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.07 -17.0 2.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.865 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.9 147.87 32.94 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.923 0.362 . . . . 0.0 111.028 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.733 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -110.48 129.17 55.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.326 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.72 HD13 ' CG2' ' A' ' 243' ' ' VAL . 43.0 mm -92.17 116.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 0.9 OUTLIER -96.5 -2.27 45.52 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.122 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.47 152.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.731 HG23 HD21 ' A' ' 220' ' ' LEU . 40.8 t -130.55 118.63 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.14 -84.51 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.317 0.386 . . . . 0.0 110.066 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 215' ' ' VAL . 50.4 m -139.94 11.69 2.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.23 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.1 p -109.19 140.71 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.65 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.21 108.72 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.442 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.939 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -119.37 50.6 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.457 0.646 . . . . 0.0 109.492 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 26.05 4.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.532 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -159.9 30.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.322 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 227' ' ' ASP . 9.7 p -148.7 166.44 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.342 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.421 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.38 170.69 2.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.697 0.761 . . . . 0.0 112.256 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.88 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.9 t60 -57.74 -37.42 73.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.086 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.27 -52.53 46.64 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.468 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -62.5 -34.68 77.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.105 0.478 . . . . 0.0 109.886 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.414 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.93 -38.73 86.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.653 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.7 t -59.88 -41.52 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.136 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.45 72.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.411 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.939 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -65.23 -42.61 93.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.281 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.686 HD11 HG21 ' A' ' 174' ' ' ILE . 1.7 mt -73.59 -41.94 62.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.491 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.08 -40.91 86.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.62 -20.41 32.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.786 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 1.04 HG21 HG21 ' A' ' 239' ' ' VAL . 21.2 p -66.09 -166.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 0.0 111.044 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.45 -150.14 0.33 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.329 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 165' ' ' LYS . 5.5 m-20 -44.4 -80.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.327 0.251 . . . . 0.0 111.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.6 121.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.985 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.04 HG21 HG21 ' A' ' 235' ' ' THR . 9.3 p -120.77 130.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 4.2 m-85 -99.74 120.67 40.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 163' ' ' LEU . 1.3 mt -96.92 137.92 35.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.44 ' HG2' HD21 ' A' ' 213' ' ' LEU . 18.8 ttpt -107.26 120.74 42.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 211' ' ' LYS . 52.8 t -122.58 147.58 26.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.251 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.431 ' HB2' HD22 ' A' ' 213' ' ' LEU . . . -117.26 131.79 56.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.151 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.796 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.849 0.356 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 18.9 ptm -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -95.49 143.81 26.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.549 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.953 HG21 HD23 ' A' ' 206' ' ' LEU . 35.6 mm -125.28 119.13 54.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.78 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.7 ttpt -105.31 129.21 53.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 111.681 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.951 HD21 HG22 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -129.37 129.99 45.46 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.34 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.755 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -97.5 133.42 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.575 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.755 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -72.47 102.04 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.153 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.92 -153.86 20.99 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.936 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.31 -22.46 46.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.105 1.87 . . . . 0.0 112.364 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.73 -4.23 26.81 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.54 -138.94 14.89 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 163' ' ' LEU . 3.9 mm? -57.07 -37.85 72.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.1 37.61 9.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.893 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -174.52 -166.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.398 . . . . 0.0 111.039 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 192' ' ' THR . 9.2 t -138.83 158.34 44.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.863 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.664 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -123.91 161.92 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.922 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.06 137.53 52.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.435 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.91 129.84 9.48 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.807 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.77 -20.71 55.42 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.755 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.408 ' HB ' ' N ' ' A' ' 224' ' ' MET . 9.5 t -90.23 117.94 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.44 -56.55 5.01 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.181 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -112.88 55.23 0.7 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.635 0.731 . . . . 0.0 109.301 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.446 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.35 119.96 2.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.729 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 14.7 t60 -103.05 -31.0 10.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.931 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.445 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -97.14 125.09 47.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.214 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.69 78.98 0.95 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.15 1.9 . . . . 0.0 112.861 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.75 46.07 0.49 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.199 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.11 128.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -98.66 12.49 35.24 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.476 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -165.99 1.35 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.0 OUTLIER -103.41 139.84 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.124 0.488 . . . . 0.0 110.559 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.445 ' CG ' HG12 ' A' ' 183' ' ' ILE . 29.5 m-85 -136.09 151.55 49.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 194' ' ' ILE . 21.4 t -81.47 140.31 16.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.562 ' HA ' HG23 ' A' ' 208' ' ' ILE . 3.7 t -124.68 -25.45 3.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.555 ' C ' HD13 ' A' ' 194' ' ' ILE . 9.8 tttp -149.27 135.41 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 111.761 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.555 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.0 OUTLIER -121.01 135.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.186 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.22 117.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -36.39 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.49 23.88 29.13 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.076 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.0 -82.27 0.11 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.325 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.44 -57.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.816 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.02 -44.2 85.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.516 ' HB2' HG22 ' A' ' 194' ' ' ILE . 4.2 t-160 -62.52 -55.62 25.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.536 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -69.68 -52.2 27.84 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -74.08 -50.45 19.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.92 -29.98 33.11 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.913 -0.661 . . . . 0.0 114.488 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 61.41 33.56 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.307 0.554 . . . . 0.0 110.47 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.953 HD23 HG21 ' A' ' 161' ' ' ILE . 1.8 pp -101.01 142.13 32.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -121.6 171.99 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 192' ' ' THR . 53.2 mt -63.96 132.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.05 9.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.734 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.66 150.68 39.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.117 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.729 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -112.82 129.15 56.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.554 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.764 HD13 ' CG2' ' A' ' 243' ' ' VAL . 38.9 mm -89.88 117.38 33.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.597 HD21 ' HG2' ' A' ' 242' ' ' LYS . 2.3 pp -97.79 -2.24 41.5 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.31 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.243 -0.286 . . . . 0.0 110.853 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 218' ' ' VAL . 24.5 t -132.3 119.27 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.234 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.47 ' OD1' HG23 ' A' ' 239' ' ' VAL . 2.4 m120 59.29 -85.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 p -141.98 13.49 2.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.893 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.708 HG13 ' CD2' ' A' ' 220' ' ' LEU . 10.8 p -109.39 140.33 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.69 100.57 2.16 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 1.013 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -108.97 48.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.716 0.769 . . . . 0.0 109.061 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.74 27.39 4.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.592 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.28 32.72 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.131 0.491 . . . . 0.0 110.124 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.483 HG21 ' CB ' ' A' ' 227' ' ' ASP . 7.6 p -149.38 166.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.101 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.44 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.74 169.19 3.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.736 0.779 . . . . 0.0 112.009 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.3 t60 -57.52 -36.4 71.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.84 -52.42 50.59 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.9 OUTLIER -61.65 -34.95 76.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.044 0.45 . . . . 0.0 109.985 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.423 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.88 -39.24 88.46 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.622 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.1 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.156 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.61 73.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.213 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 1.013 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.02 -40.87 97.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.086 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 174' ' ' ILE . 6.5 mt -70.6 -40.88 72.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.126 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -37.31 86.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -20.76 43.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.554 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 1.051 HG21 HG21 ' A' ' 239' ' ' VAL . 17.5 p -70.38 -166.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.637 0.256 . . . . 0.0 111.069 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.94 -150.5 0.33 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.411 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 85.2 m-20 -43.42 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 122.442 0.297 . . . . 0.0 111.515 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.434 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.3 OUTLIER -95.69 120.57 45.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.69 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.051 HG21 HG21 ' A' ' 235' ' ' THR . 9.5 p -120.26 133.43 67.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -105.06 118.9 37.7 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.276 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.7 mp -99.13 139.38 34.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.597 ' HG2' HD21 ' A' ' 213' ' ' LEU . 16.7 ttmt -107.29 130.9 54.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 0.0 110.492 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.764 ' CG2' HD13 ' A' ' 212' ' ' ILE . 56.2 t -132.68 146.06 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.83 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.868 0.366 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.9 ptp -129.49 151.68 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -99.41 143.58 29.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 111.544 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.853 HG22 HD21 ' A' ' 163' ' ' LEU . 47.9 mm -118.09 117.93 56.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.498 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.617 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -103.74 129.28 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.853 HD21 HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -132.35 129.78 39.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.066 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.826 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -98.43 133.89 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 110.572 179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.826 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -75.85 137.41 40.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.278 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -155.21 -153.29 6.47 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.379 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.83 -21.67 49.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.273 1.982 . . . . 0.0 112.586 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -97.0 -4.6 39.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.85 -127.73 8.13 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.643 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.68 HD22 ' HE2' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.725 0.298 . . . . 0.0 110.591 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.6 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 93.25 22.91 25.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.572 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.65 -171.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.2 t -133.16 164.36 27.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.699 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -128.49 158.5 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.157 0.503 . . . . 0.0 112.029 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.916 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.24 138.87 51.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.139 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.88 134.18 11.8 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.85 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.22 -24.58 47.31 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.614 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 187' ' ' ASN . 10.4 t -89.98 120.28 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.31 4.97 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.374 -0.441 . . . . 0.0 113.112 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -118.09 56.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.9 tt0 -46.67 118.75 2.14 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.689 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 13.4 t60 -107.69 -24.22 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.375 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.427 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.77 133.24 24.7 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.86 80.86 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.096 1.864 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.21 55.76 0.76 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.875 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.68 131.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.411 ' HB2' HG22 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -104.42 30.43 5.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.3 t -111.04 -166.94 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.2 mm -106.04 135.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 0.0 110.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 211' ' ' LYS . 17.8 m-85 -133.98 152.83 52.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.734 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.507 HG21 HD13 ' A' ' 206' ' ' LEU . 29.4 t -80.41 140.62 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.502 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.554 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.5 t -123.29 -24.7 4.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.729 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.5 OUTLIER -146.12 134.71 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 111.722 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.729 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.0 OUTLIER -120.81 135.21 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.114 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.3 mm -81.12 116.93 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.28 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.875 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.06 24.21 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.078 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.99 -71.36 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.6 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -140.02 -67.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.715 0.293 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.773 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -60.47 -46.96 88.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.021 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.718 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.8 t-160 -59.54 -55.96 27.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -70.53 -53.09 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.22 -50.21 20.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.1 -30.44 46.63 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.827 -0.701 . . . . 0.0 114.129 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.91 46.97 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.402 0.62 . . . . 0.0 109.98 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.773 HD21 ' HB1' ' A' ' 200' ' ' ALA . 3.4 pp -117.27 139.63 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.082 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.44 169.27 9.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.975 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.7 mt -61.57 119.17 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.577 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.18 -17.65 4.81 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.64 146.94 44.2 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 117.008 0.404 . . . . 0.0 110.696 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.728 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.1 ptpt -106.78 128.59 54.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.56 ' HA ' HG22 ' A' ' 243' ' ' VAL . 29.0 mm -95.39 115.72 35.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.14 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.663 HD21 ' CG ' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -94.52 -9.68 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.971 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 176.21 148.09 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.765 0.316 . . . . 0.0 110.692 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.792 HG13 ' HG ' ' A' ' 241' ' ' LEU . 10.2 t -122.82 118.98 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.448 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 57.58 -85.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.005 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.1 m -139.0 13.09 2.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.618 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.34 141.27 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 122.534 0.334 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -105.55 87.91 0.55 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.213 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.899 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -75.16 -5.7 45.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 111.268 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.532 ' N ' HD12 ' A' ' 220' ' ' LEU . 4.0 pt-20 -67.3 167.81 11.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 t70 46.83 26.27 0.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.962 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.899 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.1 p -136.36 165.24 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.643 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.437 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -67.82 168.25 11.89 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.703 0.763 . . . . 0.0 111.606 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.0 t60 -58.37 -36.89 74.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.998 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -52.76 38.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.446 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.2 OUTLIER -61.13 -34.8 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.0 110.118 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.86 92.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.963 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.8 t -58.27 -42.08 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.16 77.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.222 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -64.6 -39.28 93.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.173 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.77 HD12 ' HA ' ' A' ' 229' ' ' VAL . 2.5 mt -73.5 -42.32 61.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -58.75 -34.06 70.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -62.84 -20.23 64.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.399 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.922 HG21 HG21 ' A' ' 239' ' ' VAL . 26.2 p -64.49 -171.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.767 0.318 . . . . 0.0 111.151 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -143.1 -151.61 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.229 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.9 OUTLIER -43.03 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.538 0.335 . . . . 0.0 111.479 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.449 HG21 ' HD3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER -94.96 120.42 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.689 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.922 HG21 HG21 ' A' ' 235' ' ' THR . 9.2 p -119.79 120.26 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -100.57 120.15 39.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.792 ' HG ' HG13 ' A' ' 215' ' ' VAL . 1.0 OUTLIER -99.79 149.4 23.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.004 0.431 . . . . 0.0 110.522 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.663 ' CG ' HD21 ' A' ' 213' ' ' LEU . 2.7 tpmt? -108.62 118.26 36.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.196 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 211' ' ' LYS . 54.4 t -123.27 149.2 27.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.967 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.023 -179.347 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.688 HG11 ' HD2' ' A' ' 242' ' ' LYS . 24.1 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.81 0.338 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -132.26 147.1 52.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -101.66 132.34 47.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.632 HG21 HD23 ' A' ' 206' ' ' LEU . 4.3 mt -125.45 118.47 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.186 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.418 ' HB2' HG12 ' A' ' 238' ' ' VAL . 1.5 pttt -99.08 137.55 37.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.309 0.576 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.728 HD11 ' CD1' ' A' ' 241' ' ' LEU . 5.7 mt -118.7 140.38 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.525 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.84 ' CD1' HG22 ' A' ' 238' ' ' VAL . 19.9 mm -96.46 131.46 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.067 0.461 . . . . 0.0 111.16 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 57.03 2.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.262 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.06 -161.64 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.062 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -20.24 54.06 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.208 1.939 . . . . 0.0 112.689 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -96.68 8.27 44.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.3 -145.14 18.32 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.493 HD12 HD12 ' A' ' 163' ' ' LEU . 4.3 mm? -61.11 -37.27 82.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.761 0.315 . . . . 0.0 111.045 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.76 26.72 8.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.685 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -175.63 -169.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.017 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.6 t -134.84 158.62 43.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.691 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.77 160.21 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.833 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.0 138.15 53.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.17 129.45 9.36 Favored Glycine 0 CA--C 1.5 -0.847 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.964 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -78.1 -28.58 55.97 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.76 122.16 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.11 -55.37 4.96 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.936 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -116.63 49.77 1.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.497 0.665 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.3 tt0 -42.37 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.669 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 16.7 t60 -83.58 -28.11 28.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.129 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -96.52 129.64 32.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 81.91 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.056 1.837 . . . . 0.0 113.128 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.55 52.86 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.195 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.94 135.2 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.574 0.226 . . . . 0.0 110.74 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.419 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.5 OUTLIER -108.12 24.14 13.44 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.83 -168.13 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.833 HD13 ' O ' ' A' ' 175' ' ' ALA . 2.4 mm -104.58 134.42 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.278 0.561 . . . . 0.0 110.281 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.409 ' CD1' HG12 ' A' ' 183' ' ' ILE . 26.0 m-85 -135.19 151.17 50.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.593 HG21 HD13 ' A' ' 206' ' ' LEU . 39.2 t -80.12 141.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.284 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.439 ' HA ' HG23 ' A' ' 208' ' ' ILE . 2.7 t -122.94 -23.01 5.1 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -150.36 134.19 16.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.75 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 206' ' ' LEU . 1.0 OUTLIER -119.78 135.38 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.18 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.01 118.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.422 . . . . 0.0 109.919 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -37.75 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 50.03 31.69 18.52 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.392 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.68 -75.94 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.363 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -134.86 -60.21 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 0.0 110.731 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.672 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.36 -45.14 77.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.3 t-160 -60.21 -56.13 25.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.528 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -70.53 -53.19 17.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -51.35 15.07 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.568 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -77.14 -31.04 53.99 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.822 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 60.56 30.45 19.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.125 0.462 . . . . 0.0 110.636 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.632 HD23 HG21 ' A' ' 161' ' ' ILE . 4.0 pp -102.31 129.14 48.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.19 173.81 6.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.1 mt -64.44 113.44 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.38 -15.04 3.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.78 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.05 142.21 39.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.935 0.368 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.721 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.8 ttpm? -102.58 128.83 49.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.111 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.75 HD13 ' CG2' ' A' ' 243' ' ' VAL . 30.4 mm -96.71 116.42 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 244' ' ' ALA . 2.5 mt -79.3 -68.01 0.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.48 47.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.945 HG22 HD23 ' A' ' 241' ' ' LEU . 3.1 t -114.82 119.32 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.497 ' ND2' HG23 ' A' ' 239' ' ' VAL . 55.7 m-20 58.45 -84.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -140.32 12.94 2.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.839 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.6 p -109.69 139.87 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.003 0.43 . . . . 0.0 111.039 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.88 111.06 3.04 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.392 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.6 OUTLIER -104.17 40.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 109.932 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -97.23 163.5 12.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.787 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 48.72 27.47 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.519 HG21 ' CB ' ' A' ' 227' ' ' ASP . 6.2 p -131.2 163.73 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.585 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -69.57 169.93 11.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.703 0.763 . . . . 0.0 112.176 -179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.8 t60 -56.93 -36.36 70.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.318 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -52.13 60.94 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.519 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -60.13 -36.25 77.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.22 93.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.3 t -57.88 -41.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.219 0.533 . . . . 0.0 109.595 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.25 -33.39 75.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.714 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -64.76 -43.13 94.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.646 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -74.11 -47.3 37.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.877 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.45 -40.37 78.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.73 -20.34 33.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.899 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 1.096 HG21 HG21 ' A' ' 239' ' ' VAL . 16.7 p -65.99 -163.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.286 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -139.67 -150.58 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.52 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.872 0.469 . . . . 0.0 112.097 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.84 HG22 ' CD1' ' A' ' 164' ' ' ILE . 23.7 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.361 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.096 HG21 HG21 ' A' ' 235' ' ' THR . 12.9 p -116.56 131.15 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -90.94 141.98 28.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.351 0.595 . . . . 0.0 111.421 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.945 HD23 HG22 ' A' ' 215' ' ' VAL . 6.8 mt -118.89 138.14 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.92 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.688 ' HD2' HG11 ' A' ' 158' ' ' VAL . 3.6 ttpm? -106.61 124.27 49.35 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.75 ' CG2' HD13 ' A' ' 212' ' ' ILE . 53.6 t -131.66 149.67 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 213' ' ' LEU . . . -114.91 121.11 42.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.558 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.726 0.298 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 15.5 ptm -126.68 146.31 50.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.431 . . . . 0.0 111.351 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.96 140.76 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.06 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.94 HG22 HD21 ' A' ' 163' ' ' LEU . 36.6 mm -120.41 117.34 53.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.782 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.2 ttmt -103.91 127.85 51.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.71 0.29 . . . . 0.0 111.73 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.94 HD21 HG22 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -127.37 129.07 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.309 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -99.02 127.38 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.187 0.518 . . . . 0.0 110.693 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.587 ' HE2' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -66.65 79.47 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.848 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.73 38.64 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.14 -20.92 48.7 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.339 2.026 . . . . 0.0 112.431 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -99.29 -5.06 30.45 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.82 -133.71 12.01 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.078 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.745 HD12 HD12 ' A' ' 163' ' ' LEU . 1.9 mm? -60.76 -36.02 77.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.596 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 80.2 33.29 32.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.045 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.585 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 3.7 p90 -177.09 -173.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 192' ' ' THR . 0.6 OUTLIER -134.69 159.63 40.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.04 161.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.023 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.887 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -131.05 138.1 49.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -114.68 131.21 9.67 Favored Glycine 0 CA--C 1.502 -0.729 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.673 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.79 -22.16 58.41 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.54 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.87 117.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.98 5.02 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.077 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -113.09 55.0 0.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.528 0.68 . . . . 0.0 109.384 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.56 115.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.69 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 38.3 t60 -100.39 -32.14 10.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.537 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.2 mm -96.7 127.41 39.56 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.146 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.36 78.73 2.26 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.021 1.814 . . . . 0.0 113.079 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.4 10.14 4.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.016 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.01 134.58 44.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.525 0.662 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 7.8 m120 -106.74 26.27 10.21 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.28 -164.66 0.93 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.64 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.7 mm -105.64 132.46 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.243 0.544 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.422 ' CD1' HG13 ' A' ' 183' ' ' ILE . 9.8 m-85 -135.13 153.99 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.496 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.604 HG21 HD12 ' A' ' 206' ' ' LEU . 33.1 t -79.54 141.34 15.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.268 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 173' ' ' SER . 8.1 t -121.53 -21.55 6.2 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.32 136.79 14.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.964 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.9 mm -121.2 136.23 58.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -79.92 115.31 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.032 0.444 . . . . 0.0 109.809 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -37.76 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.932 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.03 50.8 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.827 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.03 -81.75 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.596 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -129.56 -60.94 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.932 0.396 . . . . 0.0 111.163 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.899 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -66.57 -42.35 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.628 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.3 t-160 -63.75 -55.38 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -51.63 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.5 -49.1 28.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.1 -37.16 11.6 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.885 -0.674 . . . . 0.0 114.363 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.51 51.33 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.453 0.644 . . . . 0.0 109.936 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.899 HD21 ' HB1' ' A' ' 200' ' ' ALA . 1.9 pt? -116.64 139.76 50.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.779 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.5 165.13 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 192' ' ' THR . 37.8 mt -60.8 112.45 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.85 -14.59 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.61 143.23 36.6 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.123 0.462 . . . . 0.0 111.141 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.741 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.1 ttpt -103.95 129.22 51.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.302 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.916 HD13 ' CG2' ' A' ' 243' ' ' VAL . 20.5 mm -90.74 124.8 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 111.693 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.49 HD12 ' HG2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -93.55 -39.11 11.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.581 0.705 . . . . 0.0 110.098 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -166.21 154.67 10.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.918 HG23 HD21 ' A' ' 220' ' ' LEU . 24.2 t -124.47 119.88 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.583 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 61.3 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.4 m -143.26 13.52 1.81 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.8 140.25 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 111.425 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.97 107.48 2.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.038 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.918 HD21 HG23 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -100.39 37.84 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.258 0.552 . . . . 0.0 110.242 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -99.56 162.85 12.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.473 0.654 . . . . 0.0 111.881 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 48.41 27.56 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.645 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.437 HG21 ' CB ' ' A' ' 227' ' ' ASP . 4.9 p -132.67 162.9 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 168.4 9.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.793 0.806 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.835 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.9 t60 -57.51 -36.32 71.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.929 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.17 -51.79 58.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.437 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.1 t70 -59.23 -36.64 75.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.032 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 225' ' ' HIS . 16.6 t -56.38 -41.57 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.647 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.64 74.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.481 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 220' ' ' LEU . . . -65.19 -50.35 66.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.867 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 235' ' ' THR . 3.7 pp -73.6 -40.74 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.475 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.539 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -57.79 -37.95 74.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.476 . . . . 0.0 111.481 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.49 -20.31 59.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.792 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 1.093 HG21 HG21 ' A' ' 239' ' ' VAL . 25.7 p -61.72 -163.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.403 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -138.35 -151.13 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 1.5 m-20 -44.42 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.342 0.26 0 C-N-CA 122.391 0.277 . . . . 0.0 111.673 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.06 118.76 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.093 HG21 HG21 ' A' ' 235' ' ' THR . 14.2 p -120.51 126.13 74.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.262 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.85 120.22 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.775 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.7 mp -98.13 142.7 29.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.49 ' HG2' HD12 ' A' ' 213' ' ' LEU . 1.9 ttpt -107.12 118.09 35.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.916 ' CG2' HD13 ' A' ' 212' ' ' ILE . 37.7 t -123.5 149.19 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.099 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 213' ' ' LEU . . . -132.86 128.03 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.206 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.05 0.452 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.38 155.18 48.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.397 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -124.08 126.98 47.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.963 0.411 . . . . 0.0 111.203 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.835 HG21 HD23 ' A' ' 206' ' ' LEU . 35.4 mm -99.32 118.92 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.583 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 240' ' ' TYR . 2.7 ttpp -106.36 127.94 53.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.763 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -135.22 152.22 51.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.866 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.568 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -108.99 130.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.568 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -54.65 90.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.127 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.26 170.89 44.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.549 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.3 -20.46 32.21 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.264 1.976 . . . . 0.0 112.645 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -2.0 35.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.08 -150.51 18.71 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.929 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.425 ' CD1' HG11 ' A' ' 239' ' ' VAL . 4.5 mm? -60.49 -37.52 81.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.04 29.29 10.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.701 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.55 179.3 1.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.6 t -124.64 164.0 20.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.774 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -128.0 162.65 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.319 0.581 . . . . 0.0 112.292 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.908 ' HB2' ' CG2' ' A' ' 192' ' ' THR . . . -130.51 139.91 50.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.159 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -117.3 133.74 10.77 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.108 -1.044 . . . . 0.0 113.908 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -88.18 -15.41 60.76 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.716 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 224' ' ' MET . 5.4 t -90.68 115.55 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 117.604 0.702 . . . . 0.0 112.204 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -57.29 4.03 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.223 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.09 54.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.1 mt-30 -45.79 119.69 2.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.629 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 28.4 t60 -109.43 -28.42 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.72 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.74 121.72 58.85 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.797 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.61 80.76 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.217 1.945 . . . . 0.0 112.486 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.37 54.31 0.7 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.986 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.64 119.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.8 m120 -96.14 38.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 m -119.44 -166.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.009 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.873 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -104.67 135.74 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.128 0.49 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 25.6 m-85 -135.72 150.89 49.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.685 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.489 HG21 HD13 ' A' ' 206' ' ' LEU . 21.5 t -79.95 142.12 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.506 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.908 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 6.7 p -117.1 -39.76 3.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.552 ' C ' HD13 ' A' ' 194' ' ' ILE . 29.9 tttp -137.53 137.99 39.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.899 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.634 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -120.6 134.74 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.66 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.48 113.71 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.382 . . . . 0.0 110.101 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -36.42 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.463 -0.79 . . . . 0.0 113.123 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.55 21.3 27.49 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.247 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.78 -91.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.093 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -61.2 -46.53 90.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.634 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.4 t-160 -59.23 -57.27 13.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -71.13 -52.8 17.24 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.55 -50.62 20.44 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 161' ' ' ILE . . . -76.11 -33.5 49.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.714 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.5 34.99 17.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.126 0.489 . . . . 0.0 110.003 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.835 HD23 HG21 ' A' ' 161' ' ' ILE . 3.5 pp -108.07 139.94 41.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.222 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -115.99 -179.42 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 191' ' ' VAL . 21.4 mt -69.18 134.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.34 -14.03 30.63 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.244 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.27 134.59 46.92 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.201 0.501 . . . . 0.0 110.936 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.869 ' O ' HG23 ' A' ' 243' ' ' VAL . 18.9 tttt -92.29 129.2 38.3 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 120.896 0.379 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.462 HG21 HD23 ' A' ' 241' ' ' LEU . 18.7 mm -109.78 138.61 36.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.481 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.789 HD21 ' HG2' ' A' ' 242' ' ' LYS . 2.2 pp -118.2 -9.31 10.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -170.59 153.4 4.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.973 0.416 . . . . 0.0 111.675 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.778 HG12 ' CG2' ' A' ' 239' ' ' VAL . 0.3 OUTLIER -125.62 118.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.56 ' HB2' HG23 ' A' ' 239' ' ' VAL . 28.1 t30 56.04 -87.48 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 215' ' ' VAL . 10.4 m -137.25 13.74 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.614 0.245 . . . . 0.0 110.637 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.24 140.57 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -99.6 92.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.597 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.869 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -77.75 -3.92 43.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 178.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.479 ' N ' HD12 ' A' ' 220' ' ' LEU . 3.4 pt-20 -68.26 167.54 14.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 111.229 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.05 25.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.623 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 220' ' ' LEU . 3.1 p -138.01 162.48 31.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.446 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.413 ' HA ' ' HB ' ' A' ' 178' ' ' VAL . 8.4 mtt -67.19 169.25 8.94 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.739 0.78 . . . . 0.0 111.955 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.88 ' O ' HG23 ' A' ' 229' ' ' VAL . 53.5 t60 -58.29 -36.97 74.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.193 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.21 -52.34 42.36 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.1 OUTLIER -62.1 -34.9 77.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 109.884 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.85 88.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.686 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 225' ' ' HIS . 23.3 t -59.1 -41.61 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.258 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.6 74.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.299 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.594 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -69.79 -38.71 76.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.1 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.774 HD11 HG21 ' A' ' 174' ' ' ILE . 1.5 mt -72.97 -39.74 65.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.658 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -33.61 76.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.161 0.505 . . . . 0.0 110.785 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.1 -20.3 65.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.69 HG21 HG21 ' A' ' 239' ' ' VAL . 71.2 p -51.86 176.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.74 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -139.33 -148.94 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -41.61 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.654 0.381 . . . . 0.0 111.785 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.43 124.95 59.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.778 ' CG2' HG12 ' A' ' 215' ' ' VAL . 8.1 p -113.6 120.21 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.416 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -111.93 118.27 35.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 109.65 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.604 ' HG ' HG13 ' A' ' 215' ' ' VAL . 1.6 mp -100.4 153.17 19.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.789 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.3 OUTLIER -106.44 116.32 31.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.1 p -113.24 144.56 20.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.436 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.49 122.74 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.765 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.2 mttm . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 -179.656 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.818 0.342 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptm -132.15 152.23 51.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -100.53 139.37 36.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 206' ' ' LEU . 10.5 mt -125.53 118.64 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.753 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -99.47 139.42 35.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.293 0.568 . . . . 0.0 112.13 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.987 HD11 HD11 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -129.29 129.55 45.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.026 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.764 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -96.91 134.49 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.764 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -73.29 94.34 2.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.925 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.45 -158.57 24.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.139 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.52 -23.34 75.08 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.234 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -101.86 -4.28 26.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.11 -136.5 13.63 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.444 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.543 HD13 ' HE2' ' A' ' 165' ' ' LYS . 3.9 mm? -59.75 -33.27 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.61 31.7 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.546 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.594 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -175.13 -172.93 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 110.871 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -132.98 160.49 36.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.882 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.632 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -121.95 155.99 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.165 0.507 . . . . 0.0 111.226 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.913 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -126.63 138.32 53.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.235 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.26 129.98 9.19 Favored Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.759 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 187' ' ' ASN . . . -84.83 -16.0 66.5 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.696 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.4 ' HB ' ' N ' ' A' ' 224' ' ' MET . 11.3 t -90.96 115.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.672 0.736 . . . . 0.0 112.012 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.86 -57.74 4.27 Favored Glycine 0 C--N 1.329 0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.083 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -102.72 51.8 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.442 0.639 . . . . 0.0 109.684 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.424 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.2 mt-30 -45.23 117.9 1.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.664 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 24.1 t60 -105.87 -32.06 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.843 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 190' ' ' TYR . 19.1 mm -95.47 126.05 47.26 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.338 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 77.62 1.19 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.29 1.993 . . . . 0.0 113.24 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.33 10.62 4.51 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.12 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -133.45 131.4 39.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.585 0.693 . . . . 0.0 111.348 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.431 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 9.8 m120 -103.8 29.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.44 -165.01 1.01 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -103.3 129.88 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.195 0.521 . . . . 0.0 110.421 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.452 ' CD1' HG13 ' A' ' 183' ' ' ILE . 4.5 m-85 -134.54 155.06 51.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.981 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.506 HG11 ' CD1' ' A' ' 194' ' ' ILE . 32.1 t -80.33 138.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.619 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.505 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.8 t -121.67 -19.07 6.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 133.17 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 0.0 111.609 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.677 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.3 OUTLIER -120.58 134.03 65.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 mm -82.31 117.65 28.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.401 . . . . 0.0 110.034 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -41.97 101.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.61 24.21 38.83 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.84 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.23 -89.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.329 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -131.44 -56.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.983 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -66.87 -46.3 75.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.677 ' HB2' HG22 ' A' ' 194' ' ' ILE . 9.7 t-160 -59.99 -56.06 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.681 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -52.62 22.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.38 -51.13 15.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.545 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -79.46 -28.57 51.98 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.022 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 63.57 30.87 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.022 0.411 . . . . 0.0 110.522 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 206' ' ' LEU . 2.6 pp -102.91 141.12 36.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.05 167.86 13.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.505 HG23 ' HA ' ' A' ' 192' ' ' THR . 35.1 mt -59.0 106.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 145.48 -16.95 1.85 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.914 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.55 ' OD2' HG11 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -79.4 148.04 32.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.946 0.373 . . . . 0.0 110.894 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.694 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.7 OUTLIER -112.21 130.34 55.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.821 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.621 HG21 HD21 ' A' ' 220' ' ' LEU . 19.6 mm -92.97 116.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.444 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.69 HD21 ' HG3' ' A' ' 242' ' ' LYS . 0.9 OUTLIER -91.84 -10.39 39.95 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 172.12 145.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.499 0.32 . . . . 0.0 110.339 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.935 HG22 HD23 ' A' ' 241' ' ' LEU . 4.9 t -118.85 119.35 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 36.7 t30 56.56 -86.6 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.153 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 5.8 m -137.5 12.61 2.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.655 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.2 p -109.4 140.6 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.694 0.283 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.8 87.46 0.55 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.261 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.885 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -72.12 -9.05 57.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.107 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.563 ' N ' HD12 ' A' ' 220' ' ' LEU . 2.1 pt-20 -67.67 168.22 11.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 t70 49.15 24.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.963 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.885 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.7 p -137.4 163.73 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.651 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.4 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.8 OUTLIER -66.84 167.11 12.03 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.596 0.712 . . . . 0.0 111.447 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.6 t60 -58.01 -36.46 72.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.046 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -52.33 49.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -61.93 -34.74 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.38 87.11 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.565 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 225' ' ' HIS . 37.6 t -59.16 -41.03 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.379 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.09 74.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.51 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -65.97 -45.39 81.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 174' ' ' ILE . 1.1 mt -74.12 -39.77 63.12 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.426 ' HG3' HG12 ' A' ' 229' ' ' VAL . 11.2 mmtt -58.23 -46.52 85.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -57.81 -19.81 31.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.282 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 239' ' ' VAL . 29.9 p -56.4 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.682 0.277 . . . . 0.0 111.372 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -153.07 0.45 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.371 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 165' ' ' LYS . 3.7 m-20 -42.49 -80.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.407 0.283 . . . . 0.0 111.55 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 238' ' ' VAL . 2.6 p -98.15 116.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.052 0.453 . . . . 0.0 110.831 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 235' ' ' THR . 13.5 p -112.91 126.81 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.752 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.57 141.79 28.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.719 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.987 HD11 HD11 ' A' ' 163' ' ' LEU . 6.7 mt -118.16 136.56 53.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.491 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.69 ' HG3' HD21 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -107.41 117.72 34.84 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 211' ' ' LYS . 73.6 t -125.2 151.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.81 125.96 54.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.84 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.893 -179.22 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.968 0.413 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.421 ' O ' HG12 ' A' ' 243' ' ' VAL . 9.3 ptp -132.73 148.58 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -105.26 140.54 38.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.898 HD13 ' HB3' ' A' ' 206' ' ' LEU . 2.1 mt -104.87 119.24 53.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -99.54 119.92 38.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.412 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 170' ' ' LEU . 3.3 pp -137.25 146.09 44.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.553 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -97.83 135.21 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.279 0.562 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.553 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -49.83 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.395 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.46 156.0 7.51 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.512 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.39 -24.09 41.55 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.995 1.797 . . . . 0.0 112.245 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.22 15.37 29.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.69 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 119.24 -151.05 17.72 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.257 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.44 HD11 HG21 ' A' ' 239' ' ' VAL . 4.6 mm? -73.38 -37.05 66.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.497 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 96.09 34.22 6.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.506 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.545 ' N ' HD13 ' A' ' 195' ' ' ILE . 0.3 OUTLIER -176.49 -172.7 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.3 m -137.69 157.64 46.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 228' ' ' ALA . 1.0 OUTLIER -121.59 162.52 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.276 0.56 . . . . 0.0 111.444 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 182' ' ' HIS . . . -125.43 139.2 53.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.074 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.99 129.44 9.52 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.959 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -79.91 -31.11 40.57 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.559 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.28 123.2 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.12 -56.07 5.06 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.008 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -114.48 48.8 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.554 0.693 . . . . 0.0 109.542 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.0 tt0 -43.19 105.95 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.713 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 34.4 t60 -90.29 -31.72 16.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.786 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.402 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.6 mm -96.84 121.74 58.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.152 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.45 78.99 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.118 1.878 . . . . 0.0 113.111 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 128.55 6.64 4.59 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.114 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.36 129.43 44.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.6 0.7 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 27.7 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 -162.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.955 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 175' ' ' ALA . 4.8 mm -102.33 137.3 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.482 0.658 . . . . 0.0 110.781 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.402 ' CD1' HG13 ' A' ' 183' ' ' ILE . 14.1 m-85 -135.43 144.62 46.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.961 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 206' ' ' LEU . 47.8 t -80.29 139.03 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.814 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.757 ' HA ' HG23 ' A' ' 208' ' ' ILE . 5.0 t -123.74 -14.66 7.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.638 ' C ' HD13 ' A' ' 194' ' ' ILE . 14.8 ttmt -155.32 133.27 11.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.068 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.646 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -121.36 135.29 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.545 HD13 ' N ' ' A' ' 172' ' ' PHE . 1.8 mp -80.77 118.01 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -38.36 100.72 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.946 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.8 22.97 35.73 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.127 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.73 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.225 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.82 -53.61 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 110.692 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -65.07 -45.53 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.646 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.9 t-160 -59.42 -56.36 23.04 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -52.89 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.76 -50.42 20.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.53 -27.3 59.51 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.883 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 59.86 26.06 15.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.1 0.45 . . . . 0.0 110.797 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.898 ' HB3' HD13 ' A' ' 161' ' ' ILE . 3.7 pp -97.6 139.7 33.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -121.79 170.16 10.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.95 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.757 HG23 ' HA ' ' A' ' 192' ' ' THR . 46.8 mt -60.84 112.66 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.5 3.74 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.255 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.771 ' OD2' HG21 ' A' ' 243' ' ' VAL . 0.8 OUTLIER -77.83 138.3 38.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.126 0.463 . . . . 0.0 111.296 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.877 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -94.39 129.82 40.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.316 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.58 HG21 HD23 ' A' ' 241' ' ' LEU . 22.8 mm -110.8 134.65 52.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.477 . . . . 0.0 111.899 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.438 HD11 ' HG2' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -117.06 -3.12 11.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.694 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -172.97 148.34 1.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.968 0.413 . . . . 0.0 111.523 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.744 HG13 ' HG ' ' A' ' 241' ' ' LEU . 3.3 t -130.06 119.97 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.054 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 61.26 -85.39 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.0 t -144.17 14.79 1.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.951 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.4 p -109.04 140.0 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.96 0.409 . . . . 0.0 111.595 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.65 102.95 2.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.261 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -100.29 38.33 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.531 . . . . 0.0 110.197 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -93.4 164.21 13.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.448 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.6 t0 45.38 29.99 0.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.504 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 224' ' ' MET . 3.5 p -133.67 167.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.48 ' H ' HG22 ' A' ' 223' ' ' VAL . 4.2 mtm -75.41 172.72 12.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.779 0.8 . . . . 0.0 112.654 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.5 t60 -57.29 -38.51 74.08 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.362 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.33 -51.79 64.54 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.421 ' CB ' HG21 ' A' ' 223' ' ' VAL . 4.2 t0 -60.0 -36.32 76.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.85 0.357 . . . . 0.0 110.806 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.528 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.55 -38.89 92.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.2 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.5 t -57.7 -43.05 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.166 0.508 . . . . 0.0 109.631 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.97 -32.61 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.21 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.717 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -63.9 -39.32 93.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.542 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 229' ' ' VAL . 2.1 mt -70.38 -42.93 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.61 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.02 -33.55 72.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.94 -25.2 66.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.72 ' HB ' HG22 ' A' ' 239' ' ' VAL . 31.0 p -56.17 -173.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.034 0.445 . . . . 0.0 111.638 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -145.21 -149.85 0.3 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -39.15 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.036 0.534 . . . . 0.0 112.383 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.02 120.93 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.885 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.72 HG22 ' HB ' ' A' ' 235' ' ' THR . 42.9 t -107.03 119.97 57.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.52 118.81 34.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.731 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.744 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.9 mp -98.82 153.11 19.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' A' ' 213' ' ' LEU . 1.7 tppp? -106.4 117.05 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.5 p -124.71 144.22 35.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.511 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.607 ' HB3' ' HD2' ' A' ' 211' ' ' LYS . . . -115.35 127.17 55.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.143 -179.565 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.56 153.96 50.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.55 126.33 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.927 HD13 ' HB3' ' A' ' 206' ' ' LEU . 1.8 mt -98.4 118.9 45.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -106.62 121.92 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.646 HD11 ' CD1' ' A' ' 170' ' ' LEU . 3.4 pp -136.46 145.92 45.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.716 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -97.29 134.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.124 0.487 . . . . 0.0 111.473 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -48.67 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.391 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.42 166.89 8.42 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.779 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.38 -27.4 75.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.297 1.998 . . . . 0.0 112.317 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -101.65 15.56 28.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.875 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.52 -152.86 17.53 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.724 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.646 ' CD1' HD11 ' A' ' 163' ' ' LEU . 4.1 mm? -61.78 -34.47 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.726 0.298 . . . . 0.0 111.151 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.03 35.99 6.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.41 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -165.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.745 0.307 . . . . 0.0 110.688 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.9 t -139.52 162.48 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.409 HD12 ' ND1' ' A' ' 225' ' ' HIS . 1.3 pp -129.54 159.86 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.214 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.914 ' HB2' ' CG2' ' A' ' 192' ' ' THR . . . -125.52 137.97 53.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -109.12 130.47 10.03 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.859 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.4 -25.16 52.09 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.416 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 187' ' ' ASN . 18.0 t -89.93 117.3 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -56.05 5.05 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.092 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -109.8 49.22 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.563 0.697 . . . . 0.0 109.31 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.2 tt0 -43.55 115.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.67 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 11.2 t60 -107.04 -26.32 11.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.497 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 126.74 43.01 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.35 81.24 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.151 1.901 . . . . 0.0 112.909 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.82 56.67 0.84 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.019 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 117.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.685 0.279 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 178' ' ' VAL . 65.7 m-20 -95.11 44.43 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.928 0.394 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.17 -161.13 0.94 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.882 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -111.66 134.44 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 211' ' ' LYS . 21.3 m-85 -135.45 154.28 51.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.633 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.583 HG11 HD11 ' A' ' 194' ' ' ILE . 36.2 t -80.22 143.18 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.753 0.311 . . . . 0.0 111.117 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.914 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 18.1 p -117.7 -49.37 2.55 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -136.58 139.38 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 111.95 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 HD12 ' A' ' 206' ' ' LEU . 2.2 mm -118.22 136.36 55.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.753 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.64 113.85 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.444 . . . . 0.0 109.946 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -35.56 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.346 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.93 27.37 44.48 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.239 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -70.82 -70.82 1.12 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.386 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.16 -61.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -60.85 -45.34 94.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.517 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.2 t-160 -59.31 -56.42 22.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.885 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -52.87 18.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.8 -50.87 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.21 -33.89 43.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.838 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 38.35 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.184 0.516 . . . . 0.0 110.399 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.927 ' HB3' HD13 ' A' ' 161' ' ' ILE . 3.7 pp -107.97 140.46 41.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.029 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -124.56 174.43 7.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.648 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 192' ' ' THR . 2.7 mm -64.21 127.74 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 121.59 -16.49 9.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.702 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.36 139.65 37.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.922 0.361 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.726 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.1 ttmt -100.61 128.8 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.249 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.598 ' HA ' HG22 ' A' ' 243' ' ' VAL . 20.8 mm -94.78 119.14 42.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.849 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -95.5 -5.49 42.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 175.3 154.26 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.799 HG13 HD23 ' A' ' 241' ' ' LEU . 2.4 t -126.15 120.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.68 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.2 t30 59.33 -86.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.7 m -141.14 12.98 2.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.913 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 215' ' ' VAL . 8.1 p -109.43 140.59 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.34 104.71 2.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.672 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.43 HD22 ' HB1' ' A' ' 228' ' ' ALA . 0.3 OUTLIER -98.1 33.56 2.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.449 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -93.57 158.87 15.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.405 0.621 . . . . 0.0 112.036 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 49.73 30.44 3.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.329 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 224' ' ' MET . 5.0 p -134.16 164.83 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.19 169.54 10.18 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.745 0.783 . . . . 0.0 112.493 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.879 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.9 t60 -57.89 -36.57 72.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.861 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -51.46 60.44 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.411 ' CB ' HG21 ' A' ' 223' ' ' VAL . 7.8 t70 -59.44 -36.34 75.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.989 0.423 . . . . 0.0 110.918 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.43 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.97 -39.75 93.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.6 t -57.04 -41.47 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.239 0.543 . . . . 0.0 109.553 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.84 74.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.675 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.491 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -63.68 -50.73 68.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.993 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 233' ' ' LYS . 3.8 pp -73.62 -40.73 63.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.769 0.318 . . . . 0.0 111.222 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.606 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.2 OUTLIER -59.38 -33.29 71.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.571 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -21.18 63.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.902 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 232' ' ' LEU . 32.8 p -54.19 -175.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -136.17 -145.78 0.22 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -38.72 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 128.06 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 0.0 111.765 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 170' ' ' LEU . 38.9 t -114.4 119.88 62.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.51 119.95 37.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 215' ' ' VAL . 1.1 mt -96.73 145.77 25.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.937 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -107.86 117.15 33.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 211' ' ' LYS . 75.7 t -127.85 150.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.378 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -123.82 123.51 40.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 mttp . . . . . 0 CA--C 1.533 0.321 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.062 -179.36 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.985 0.421 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.12 154.05 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.64 134.7 55.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.783 HG22 HD21 ' A' ' 163' ' ' LEU . 38.3 mm -119.37 118.78 58.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.84 ' O ' HD23 ' A' ' 163' ' ' LEU . 4.9 ttmm -99.71 131.65 45.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.84 HD23 ' O ' ' A' ' 162' ' ' LYS . 3.5 mt -133.24 129.06 37.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.017 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.808 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -99.59 135.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.12 0.486 . . . . 0.0 111.12 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.808 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.08 98.71 4.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.833 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.46 -147.93 13.05 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.029 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.01 -22.91 34.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.486 2.124 . . . . 0.0 112.26 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -101.7 -4.44 26.48 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.96 -138.83 16.47 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.173 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.427 HD13 ' HE2' ' A' ' 165' ' ' LYS . 4.3 mm? -57.77 -37.38 73.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.476 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 81.41 39.2 12.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.793 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.524 ' N ' HD13 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -176.53 -177.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.054 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t -133.24 158.87 41.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.27 162.17 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.62 138.42 52.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.526 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.86 130.35 9.99 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.007 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.37 -27.47 43.67 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.443 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 18.3 t -89.65 119.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.45 -55.83 5.04 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.047 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -112.6 50.42 0.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.529 0.68 . . . . 0.0 109.523 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.43 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.6 tt0 -43.81 115.91 0.89 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 7.3 t60 -106.8 -25.87 11.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.452 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.433 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -95.74 123.91 54.35 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.394 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.93 80.85 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.058 1.839 . . . . 0.0 112.27 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.71 55.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.26 123.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.749 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 28.37 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.81 -166.24 1.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.9 mm -102.8 134.89 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CG ' HG12 ' A' ' 183' ' ' ILE . 18.1 m-85 -134.45 153.13 52.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.588 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.62 HG11 ' CD1' ' A' ' 194' ' ' ILE . 49.0 t -80.29 142.06 14.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.084 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 208' ' ' ILE . 4.2 t -124.47 -17.79 5.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -159.31 136.27 9.54 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.174 0.512 . . . . 0.0 112.061 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.683 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -120.85 135.12 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.747 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 172' ' ' PHE . 1.7 mp -81.54 117.66 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -36.95 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.005 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.11 23.75 25.76 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.999 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.74 -78.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.229 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -139.11 -57.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.772 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.97 -45.79 76.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.683 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.2 t-160 -59.33 -55.73 31.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.876 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -51.45 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.36 -50.27 22.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.87 -34.8 29.74 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 114.096 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 66.26 34.66 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.153 0.477 . . . . 0.0 110.21 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.627 ' CD2' HG21 ' A' ' 161' ' ' ILE . 2.1 pp -102.5 140.17 37.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.992 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -117.59 169.62 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.902 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.473 HG23 ' HA ' ' A' ' 192' ' ' THR . 34.1 mt -62.97 127.78 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.768 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.91 -21.34 7.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.778 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.85 159.82 29.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 111.242 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.712 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -116.96 129.89 56.34 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.362 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.537 HD13 HG22 ' A' ' 243' ' ' VAL . 32.4 mm -100.29 117.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.562 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.574 HD21 ' HG2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -97.67 -5.74 34.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 175.26 149.66 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.85 0.357 . . . . 0.0 111.297 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.862 HG13 ' HG ' ' A' ' 241' ' ' LEU . 2.1 t -123.87 119.18 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.895 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.434 ' CG ' HG23 ' A' ' 239' ' ' VAL . 1.9 m-20 57.9 -85.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.217 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 59.6 p -139.35 10.99 2.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.26 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 215' ' ' VAL . 11.0 p -109.8 140.74 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.46 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.12 106.08 2.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.223 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.548 HD21 ' CG2' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -99.15 37.54 1.53 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.143 0.497 . . . . 0.0 110.269 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -98.6 166.65 11.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.338 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 46.12 27.98 0.6 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.903 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 227' ' ' ASP . 4.8 p -133.78 164.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.762 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.403 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -70.46 169.26 14.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.733 0.778 . . . . 0.0 112.093 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.877 ' O ' HG23 ' A' ' 229' ' ' VAL . 61.8 t60 -57.27 -36.85 71.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.76 -52.38 51.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.2 OUTLIER -60.33 -35.64 76.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.678 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.024 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.6 t -57.77 -41.72 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.247 0.546 . . . . 0.0 109.855 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.406 ' HA ' ' CG ' ' A' ' 233' ' ' LYS . . . -64.59 -34.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.657 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.536 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -66.54 -50.39 63.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 235' ' ' THR . 3.0 pp -73.27 -40.03 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.441 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -64.42 -36.39 84.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.372 . . . . 0.0 111.825 -178.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -20.53 46.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.661 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 1.066 HG21 HG21 ' A' ' 239' ' ' VAL . 28.3 p -58.14 -172.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.274 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.11 -149.81 0.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.389 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 165' ' ' LYS . 55.6 m-20 -45.03 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 121.16 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.929 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.066 HG21 HG21 ' A' ' 235' ' ' THR . 12.5 p -120.6 128.01 75.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.116 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.5 OUTLIER -101.62 120.41 40.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.862 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.9 mp -96.73 142.2 29.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' A' ' 213' ' ' LEU . 2.2 ttmt -106.5 121.35 44.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.365 0.602 . . . . 0.0 110.102 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 211' ' ' LYS . 54.0 t -120.28 150.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.474 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.83 126.17 51.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.964 -179.258 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.742 0.306 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 ptp -128.61 140.97 51.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -98.04 138.51 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.636 HG22 HD21 ' A' ' 163' ' ' LEU . 34.7 mm -124.97 119.52 56.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.731 ' C ' HD23 ' A' ' 163' ' ' LEU . 10.1 ttpp -110.23 133.63 53.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.81 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.913 HD12 HD22 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -130.41 129.88 43.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.141 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 238' ' ' VAL . 0.4 OUTLIER -97.41 122.97 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.192 0.52 . . . . 0.0 110.09 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.456 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -57.76 90.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.267 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.59 43.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.97 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.06 -21.33 72.23 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.239 1.959 . . . . 0.0 112.334 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -102.25 -4.28 25.96 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.92 -147.47 18.1 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.913 HD22 HD12 ' A' ' 163' ' ' LEU . 16.0 mt -66.14 -38.06 87.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 111.338 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.6 35.49 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.528 ' HE1' HD13 ' A' ' 170' ' ' LEU . 6.8 p90 -173.43 -170.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 m -133.95 163.47 29.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -127.45 158.15 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.053 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.916 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.4 138.0 51.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.31 133.05 11.02 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.889 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.95 -20.41 55.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.847 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.402 ' HB ' ' N ' ' A' ' 224' ' ' MET . 12.2 t -89.36 117.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.69 4.83 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.919 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.52 54.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.205 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.479 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.0 tt0 -46.45 118.87 2.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.753 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 35.2 t60 -103.0 -30.47 10.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.999 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 190' ' ' TYR . 10.3 mm -95.96 133.48 25.25 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.76 75.44 4.47 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.045 1.83 . . . . 0.0 112.961 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.19 20.13 3.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.687 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -141.48 126.81 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.383 0.592 . . . . 0.0 111.153 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -101.92 42.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.3 -164.79 1.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.324 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -105.28 133.49 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 110.111 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.566 ' HB2' HD11 ' A' ' 183' ' ' ILE . 20.7 m-85 -134.87 153.68 51.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 194' ' ' ILE . 21.2 t -80.21 141.4 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.335 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 208' ' ' ILE . 1.6 t -122.69 -20.18 6.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.64 ' C ' HD13 ' A' ' 194' ' ' ILE . 12.1 tttp -157.58 136.14 11.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.046 0.451 . . . . 0.0 111.995 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.64 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.2 mm -120.24 135.15 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.8 mm -81.19 117.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -37.4 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.94 24.04 40.76 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.982 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.85 -67.85 1.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.28 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -147.56 -58.27 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.887 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -63.32 -47.08 83.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -59.42 -56.34 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.759 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -51.98 29.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.427 ' OD2' HG22 ' A' ' 164' ' ' ILE . 3.2 m-20 -73.42 -50.65 20.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -83.74 -32.12 25.09 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.461 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.42 45.78 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.357 0.579 . . . . 0.0 110.202 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.578 HD23 HG21 ' A' ' 161' ' ' ILE . 4.2 pp -113.52 140.23 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.089 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.68 164.02 15.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.546 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 192' ' ' THR . 42.1 mt -57.67 139.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.9 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.94 -18.75 28.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.81 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.11 144.23 45.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.756 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.3 ttpm? -104.97 129.46 53.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.285 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.58 HD13 ' CG2' ' A' ' 243' ' ' VAL . 22.1 mm -91.21 116.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 1.7 pp -90.14 -8.43 51.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.55 155.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 0.0 110.523 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.738 HG13 ' HG ' ' A' ' 241' ' ' LEU . 23.3 t -131.13 119.39 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.159 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.72 -85.57 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.9 t -141.56 13.38 2.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.146 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.1 p -109.16 140.23 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -102.28 100.1 1.95 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.218 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.5 OUTLIER -109.21 45.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.503 0.668 . . . . 0.0 109.387 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.84 27.11 5.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.422 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -158.94 29.82 0.21 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.338 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 227' ' ' ASP . 8.8 p -152.43 166.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.046 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.405 ' H ' HG22 ' A' ' 223' ' ' VAL . 17.1 mtt -58.52 168.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.738 0.78 . . . . 0.0 112.793 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.2 t60 -57.4 -35.52 70.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.58 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.38 -51.81 57.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.615 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.448 ' HB2' HG13 ' A' ' 223' ' ' VAL . 1.1 m-20 -59.91 -36.09 76.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.87 92.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.81 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 225' ' ' HIS . 23.7 t -57.52 -41.32 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.55 74.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.53 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.818 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -66.16 -43.0 88.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.563 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.59 HD11 HG21 ' A' ' 174' ' ' ILE . 1.1 mt -73.4 -46.37 49.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.45 -34.16 70.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.176 0.513 . . . . 0.0 111.152 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -60.35 -20.76 60.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.356 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 1.009 HG21 HG21 ' A' ' 239' ' ' VAL . 17.8 p -69.42 -166.59 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.68 -148.98 0.26 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.504 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.74 -81.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.67 HG21 ' NZ ' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -95.49 118.55 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.015 0.436 . . . . 0.0 110.742 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.009 HG21 HG21 ' A' ' 235' ' ' THR . 12.3 p -120.23 136.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.207 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.2 m-85 -106.74 119.33 39.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.151 0.5 . . . . 0.0 111.736 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.738 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.3 mp -103.06 134.81 45.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.26 133.87 51.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.824 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 211' ' ' LYS . 69.2 t -130.81 148.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.482 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.7 124.47 51.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.212 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.78 45.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 0.0 111.419 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.4 131.38 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.716 HG21 ' CD2' ' A' ' 206' ' ' LEU . 30.5 mm -120.67 133.87 65.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.813 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.68 ' C ' HD23 ' A' ' 163' ' ' LEU . 27.2 ttpt -122.01 129.22 52.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.527 0.204 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 200' ' ' ALA . 2.0 mt -127.32 141.17 51.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.563 0.22 . . . . 0.0 110.429 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -106.78 132.55 53.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 110.592 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.626 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -73.39 82.59 1.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.817 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.2 -167.4 38.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.156 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.26 -20.4 66.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.185 1.923 . . . . 0.0 112.407 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -96.77 -2.13 44.91 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.1 -148.95 17.4 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.437 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.02 -37.37 76.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.006 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 100.32 19.29 19.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.212 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.507 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 1.5 p90 -170.6 -170.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.934 0.367 . . . . 0.0 110.803 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.75 161.84 34.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.018 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.802 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.58 159.53 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.53 137.69 50.92 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.02 129.9 9.75 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 120.003 -1.094 . . . . 0.0 114.147 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.55 -22.6 59.9 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.402 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.3 t -89.85 116.51 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.14 -56.0 5.05 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.996 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -110.23 52.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.418 0.628 . . . . 0.0 109.322 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.436 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.7 tt0 -46.35 114.3 0.78 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.678 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 6.4 t60 -103.13 -25.41 13.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.1 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.446 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -95.34 132.21 28.23 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.204 -179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.26 79.97 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.147 1.898 . . . . 0.0 112.831 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.5 55.17 0.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.965 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -169.21 130.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.648 0.261 . . . . 0.0 110.937 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.12 28.78 6.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.8 t -111.32 -162.89 0.82 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.25 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.9 mm -106.36 133.21 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.283 0.564 . . . . 0.0 110.483 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.446 ' CG ' HG12 ' A' ' 183' ' ' ILE . 22.9 m-85 -135.14 154.59 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.708 HG21 HD13 ' A' ' 206' ' ' LEU . 42.7 t -80.14 141.21 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.656 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.0 t -121.91 -26.12 4.86 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 137.59 22.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.922 0.392 . . . . 0.0 111.641 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.567 ' CD1' HG11 ' A' ' 191' ' ' VAL . 1.2 mm -120.95 135.74 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.543 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.01 114.16 21.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -39.8 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.819 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.54 31.25 57.22 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.059 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.06 -53.94 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -162.8 -57.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.004 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.787 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.45 -45.57 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 194' ' ' ILE . 8.5 t-160 -60.03 -56.58 19.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.664 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -52.1 25.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.67 -50.57 20.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -77.79 -31.61 48.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.897 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 61.71 30.59 18.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.987 0.422 . . . . 0.0 110.354 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.716 ' CD2' HG21 ' A' ' 161' ' ' ILE . 3.3 pp -107.4 140.48 40.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.861 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -125.82 177.32 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.58 114.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 135.33 -17.67 4.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.907 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.67 149.34 32.85 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.901 0.351 . . . . 0.0 111.189 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.73 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.1 ttmt -109.04 129.91 55.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.509 HD13 ' CG2' ' A' ' 243' ' ' VAL . 22.5 mm -94.35 119.09 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.651 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.795 HD21 ' CG ' ' A' ' 242' ' ' LYS . 1.3 pp -94.91 -9.23 34.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 174.15 152.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.906 HG13 ' HG ' ' A' ' 241' ' ' LEU . 4.3 t -122.99 119.34 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.967 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 239' ' ' VAL . 26.6 t-20 57.98 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 94.2 p -140.54 14.02 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.596 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.5 p -109.41 139.73 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.287 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.78 107.11 2.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.971 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.5 OUTLIER -105.63 39.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.195 0.522 . . . . 0.0 110.607 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.26 168.77 10.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.46 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.0 p30 47.13 26.75 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.105 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.413 HG21 ' CB ' ' A' ' 227' ' ' ASP . 5.4 p -135.8 163.4 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.808 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 mtm -67.13 170.25 7.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.739 0.78 . . . . 0.0 111.903 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.829 ' O ' HG23 ' A' ' 229' ' ' VAL . 67.4 t60 -57.42 -36.05 70.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.253 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -62.3 -52.35 64.04 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.413 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.0 OUTLIER -60.49 -36.55 78.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.577 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 174' ' ' ILE . . . -61.53 -38.59 87.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.023 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.3 t -59.32 -41.78 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.619 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.83 76.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.821 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -64.55 -40.8 96.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.607 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.802 HD11 HG21 ' A' ' 174' ' ' ILE . 9.4 mt -73.2 -41.74 63.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -57.42 -41.05 79.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.178 0.513 . . . . 0.0 111.591 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.54 -19.97 42.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.91 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.897 HG21 HG21 ' A' ' 239' ' ' VAL . 18.4 p -67.39 -171.49 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 111.439 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -143.89 -145.47 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.342 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 165' ' ' LYS . 1.9 m-20 -44.47 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 118.004 0.365 . . . . 0.0 111.696 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.55 119.78 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.897 HG21 HG21 ' A' ' 235' ' ' THR . 9.8 p -118.07 131.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.784 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 7.2 m-85 -102.18 118.11 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.265 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.906 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.1 mp -97.37 139.73 32.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.795 ' CG ' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -107.01 130.71 54.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.175 0.512 . . . . 0.0 110.348 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 211' ' ' LYS . 55.9 t -127.89 148.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.0 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.28 131.98 54.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.755 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt . . . . . 0 C--N 1.327 -0.373 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.071 -179.281 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.415 HG11 ' HD2' ' A' ' 242' ' ' LYS . 13.2 t . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 121.131 0.491 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.73 152.7 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.297 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -112.62 120.6 42.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.731 HG22 ' CD2' ' A' ' 163' ' ' LEU . 41.2 mm -100.36 118.54 47.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.375 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.658 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -102.53 132.4 48.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.739 HD21 ' CD1' ' A' ' 241' ' ' LEU . 0.0 OUTLIER -136.14 129.57 31.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.856 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.891 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -97.97 135.16 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 0.0 111.42 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.891 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -66.33 91.37 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.669 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.87 -165.61 32.92 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.368 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -20.54 50.53 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.197 1.931 . . . . 0.0 112.214 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.26 -4.49 31.8 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.42 -135.15 12.88 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.338 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.538 HD12 ' HE1' ' A' ' 172' ' ' PHE . 4.2 mm? -58.74 -37.86 77.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.807 0.337 . . . . 0.0 110.96 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 86.87 27.26 29.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.098 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.538 ' HE1' HD12 ' A' ' 170' ' ' LEU . 2.6 p90 -175.21 -172.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -131.0 160.91 33.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.818 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -124.42 155.55 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.924 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.48 138.0 51.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.67 136.44 13.36 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.0 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -88.17 -21.07 46.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.535 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.12 116.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.43 -57.46 4.44 Favored Glycine 0 C--N 1.329 0.15 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.91 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -104.99 49.46 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.484 0.659 . . . . 0.0 109.323 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.9 tt0 -44.41 112.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.724 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 45.4 t60 -97.78 -30.94 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.782 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.453 HG13 ' CD1' ' A' ' 190' ' ' TYR . 18.3 mm -96.72 127.9 37.81 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.398 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.68 78.37 2.44 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.005 1.804 . . . . 0.0 112.876 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.26 10.97 3.56 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.049 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.75 136.72 42.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.572 0.686 . . . . 0.0 111.333 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.416 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 68.7 m-20 -108.74 30.68 6.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 190' ' ' TYR . 5.0 t -116.28 -164.25 0.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.1 mm -109.11 131.32 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.082 0.468 . . . . 0.0 110.541 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.453 ' CD1' HG13 ' A' ' 183' ' ' ILE . 3.1 m-85 -135.1 155.58 50.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.11 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.737 HG21 HD13 ' A' ' 206' ' ' LEU . 46.8 t -79.79 140.27 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.494 ' HA ' HG23 ' A' ' 208' ' ' ILE . 4.1 t -124.67 -14.74 6.72 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.49 133.59 12.43 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.062 0.458 . . . . 0.0 111.566 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.713 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.4 OUTLIER -121.09 134.45 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.019 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.0 118.37 29.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.086 0.47 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -41.99 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.485 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.69 28.68 57.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.868 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.09 -80.17 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.34 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -137.99 -62.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.67 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -62.14 -46.38 89.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.21 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.713 ' HB2' HG22 ' A' ' 194' ' ' ILE . 10.2 t-160 -62.25 -55.86 24.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.661 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -69.79 -52.62 23.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -74.47 -50.93 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.47 -29.32 36.65 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.337 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 64.69 32.11 11.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.392 0.596 . . . . 0.0 110.508 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.737 HD13 HG21 ' A' ' 191' ' ' VAL . 3.6 pp -102.88 140.45 37.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.752 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -123.67 175.65 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 111.08 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.7 mt -62.32 115.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 133.16 -17.9 4.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.53 154.78 40.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.034 0.417 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.713 ' O ' HG13 ' A' ' 243' ' ' VAL . 24.3 ttpt -112.6 129.91 56.21 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.42 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 220' ' ' LEU . 14.8 mm -102.03 116.03 44.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.748 HD21 ' HG2' ' A' ' 242' ' ' LYS . 0.5 OUTLIER -94.67 -12.96 26.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -178.94 148.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.872 0.368 . . . . 0.0 111.531 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.723 HG12 ' CG2' ' A' ' 239' ' ' VAL . 0.2 OUTLIER -117.0 119.53 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.1 t30 56.55 -87.8 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.4 m -135.98 11.0 3.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.657 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.63 140.82 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 122.549 0.339 . . . . 0.0 110.661 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.84 105.44 2.64 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.525 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 HG22 ' A' ' 212' ' ' ILE . 0.4 OUTLIER -98.76 30.11 3.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.113 0.483 . . . . 0.0 110.144 178.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.71 163.93 12.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 23.4 t70 45.04 27.77 0.32 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.653 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 224' ' ' MET . 6.3 p -133.12 165.81 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.438 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.431 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.07 165.39 18.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.607 0.718 . . . . 0.0 111.794 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.0 t60 -57.59 -35.82 70.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.676 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -35.98 76.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.66 91.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.4 t -58.78 -42.18 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.718 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.25 79.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.356 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -63.56 -40.51 97.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.818 HD11 HG21 ' A' ' 174' ' ' ILE . 2.8 mt -74.03 -40.43 62.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.019 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -55.35 -46.31 76.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -60.75 -20.22 60.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.571 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.835 HG21 HG21 ' A' ' 239' ' ' VAL . 43.9 p -54.58 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.73 0.3 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.66 -151.8 0.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 165' ' ' LYS . 18.9 m-20 -45.35 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.861 0.3 . . . . 0.0 111.2 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.401 HG22 ' CG ' ' A' ' 162' ' ' LYS . 2.5 p -93.98 120.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.741 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.835 HG21 HG21 ' A' ' 235' ' ' THR . 9.5 p -115.07 119.32 61.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.085 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.88 119.5 38.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.915 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.739 ' CD1' HD21 ' A' ' 163' ' ' LEU . 1.3 mp -97.66 151.38 20.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.748 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -107.64 117.9 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.822 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 211' ' ' LYS . 58.4 t -120.47 152.23 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.75 120.92 36.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.84 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.004 -179.41 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.794 0.33 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.29 152.1 38.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.01 146.81 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 31.1 mm -123.18 119.14 56.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.716 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.406 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 1.8 ttpt -107.81 119.45 39.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.614 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.814 HD21 HD23 ' A' ' 170' ' ' LEU . 3.7 pp -137.17 138.7 40.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.439 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -96.89 131.57 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 0.0 110.981 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.512 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -51.39 90.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.6 171.98 5.28 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.671 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.06 -31.76 91.18 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.101 1.867 . . . . 0.0 112.399 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.23 15.67 28.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.54 -160.42 13.43 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.42 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -64.06 -27.2 68.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.52 0.2 . . . . 0.0 111.405 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.81 41.84 5.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.656 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -175.61 -173.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.818 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -134.26 156.11 48.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.795 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.94 160.86 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -130.57 139.36 50.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.218 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -110.83 132.27 10.85 Favored Glycine 0 CA--C 1.502 -0.751 0 C-N-CA 120.141 -1.028 . . . . 0.0 114.336 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.24 -24.05 49.24 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 114.927 -0.636 . . . . 0.0 113.227 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.0 117.06 32.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.67 -57.51 4.75 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.884 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.91 45.97 0.94 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.415 0.626 . . . . 0.0 109.46 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.455 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -42.3 112.16 0.31 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 21.9 t60 -98.73 -30.11 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.616 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.577 HD11 ' CB ' ' A' ' 190' ' ' TYR . 8.9 mm -96.57 124.87 49.22 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.24 77.74 2.39 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.778 1.652 . . . . 0.0 112.469 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.15 14.56 2.69 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.043 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -139.14 131.16 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.621 0.71 . . . . 0.0 111.117 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.77 25.28 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.2 t -110.06 -164.61 0.94 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 175' ' ' ALA . 2.2 mm -101.75 134.3 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.205 0.526 . . . . 0.0 110.095 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.577 ' CB ' HD11 ' A' ' 183' ' ' ILE . 14.1 m-85 -133.37 148.81 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.524 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 206' ' ' LEU . 34.3 t -79.99 141.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.608 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.0 t -121.97 -26.67 4.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.479 ' C ' HD13 ' A' ' 194' ' ' ILE . 11.9 ttpt -147.63 136.57 22.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 111.822 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.754 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.8 OUTLIER -121.52 135.87 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.157 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.0 mm -80.61 114.0 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.75 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.718 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.24 25.23 53.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.881 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.24 -108.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.2 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -106.3 -62.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -66.64 -45.13 80.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.569 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.754 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.6 t-160 -59.08 -57.41 13.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -53.16 18.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.67 -50.99 15.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.99 53.21 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.813 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 62.15 28.42 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.913 0.357 . . . . 0.0 110.803 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.579 HD22 HD12 ' A' ' 241' ' ' LEU . 2.9 pp -99.41 139.13 35.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.96 177.34 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 40.0 mt -64.43 126.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.732 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.43 -14.9 10.8 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.531 ' OD1' HG11 ' A' ' 243' ' ' VAL . 0.4 OUTLIER -78.93 145.79 33.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.057 0.429 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.732 ' O ' HG13 ' A' ' 243' ' ' VAL . 13.2 ttmt -103.05 128.57 49.86 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.749 HD13 ' CG2' ' A' ' 243' ' ' VAL . 33.9 mm -99.98 120.49 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 112.141 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.511 HD12 ' HG2' ' A' ' 242' ' ' LYS . 1.6 mt -85.46 -60.72 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.239 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -134.39 155.4 50.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.961 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.723 HG13 HD22 ' A' ' 241' ' ' LEU . 11.8 t -125.14 120.41 58.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.911 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 59.99 -85.21 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.4 m -142.86 13.45 1.89 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.829 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.0 p -109.77 140.43 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.021 0.439 . . . . 0.0 111.659 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.96 104.93 2.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.082 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.547 HD22 ' HB1' ' A' ' 228' ' ' ALA . 0.4 OUTLIER -99.16 37.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 110.704 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -91.93 159.29 15.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.845 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 48.39 31.23 2.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.486 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.443 HG21 ' CB ' ' A' ' 227' ' ' ASP . 3.9 p -133.58 161.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.008 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 11.1 mtt -68.32 170.03 9.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.716 0.77 . . . . 0.0 112.117 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.3 t60 -57.33 -36.88 71.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.306 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.65 -51.81 60.61 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.443 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.1 t0 -59.64 -36.43 76.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.547 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.976 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 225' ' ' HIS . 29.1 t -57.16 -41.81 78.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.01 75.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.202 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.657 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -64.82 -40.28 94.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.604 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.795 HD11 HG21 ' A' ' 174' ' ' ILE . 6.0 mt -70.05 -48.74 56.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -58.41 -33.68 69.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.07 0.462 . . . . 0.0 111.404 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -59.33 -21.24 59.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 232' ' ' LEU . 25.2 p -63.51 -166.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.729 0.3 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.85 -148.28 0.25 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 240' ' ' TYR . 0.5 OUTLIER -96.54 123.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.574 ' CG1' HG21 ' A' ' 235' ' ' THR . 16.7 t -111.84 137.11 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.722 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.467 ' CE1' HG13 ' A' ' 238' ' ' VAL . 2.1 m-85 -115.61 118.74 33.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.671 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.723 HD22 HG13 ' A' ' 215' ' ' VAL . 0.4 OUTLIER -97.77 139.35 33.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.511 ' HG2' HD12 ' A' ' 213' ' ' LEU . 3.0 ttmt -106.92 130.04 54.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.749 ' CG2' HD13 ' A' ' 212' ' ' ILE . 60.9 t -136.97 149.6 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.23 121.79 37.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.066 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mttm . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.288 -179.151 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.765 0.317 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.09 147.56 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.592 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -115.55 120.69 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.2 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.987 HG22 HD21 ' A' ' 163' ' ' LEU . 31.9 mm -109.76 118.19 56.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.675 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.703 ' C ' HD23 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -103.91 129.06 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.987 HD21 HG22 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -126.33 132.32 51.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.11 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.06 124.51 49.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 110.353 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 87.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.27 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.07 179.01 53.55 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.125 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.6 -20.37 33.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.187 1.924 . . . . 0.0 112.394 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.91 8.18 41.24 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.97 -150.27 18.22 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.9 mm? -62.35 -37.99 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.73 0.3 . . . . 0.0 111.288 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 100.9 33.39 5.0 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.005 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.2 OUTLIER -173.89 -166.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.093 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -137.4 161.54 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.794 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.33 158.51 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.883 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.13 137.65 53.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.494 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.43 130.14 9.82 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.783 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -83.83 -23.39 52.97 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.63 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.91 116.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.48 -56.27 4.69 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.995 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.79 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.345 0.593 . . . . 0.0 109.434 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 5.3 tt0 -43.61 112.92 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.678 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 5.8 t60 -104.3 -25.0 13.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.326 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.15 130.32 31.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.332 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.6 76.52 3.21 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.104 1.869 . . . . 0.0 112.779 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.62 48.41 0.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.05 123.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.65 25.33 5.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.295 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -109.61 -168.14 1.29 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.6 mm -99.51 136.88 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.197 0.522 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 20.6 m-85 -135.5 152.29 51.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.669 HG21 HD12 ' A' ' 206' ' ' LEU . 29.7 t -80.18 140.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.494 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.8 t -125.14 -24.02 4.09 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -150.56 136.55 18.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.104 0.478 . . . . 0.0 111.889 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.3 mm -121.12 135.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.182 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.13 113.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -36.48 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.83 40.19 49.01 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.202 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.06 -60.74 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -149.96 -61.96 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.751 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 1.023 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -65.24 -46.59 79.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.297 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.638 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.6 t-160 -61.42 -56.13 23.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.01 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -52.36 25.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -74.31 -50.74 17.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.41 -36.64 26.25 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 121.086 -0.578 . . . . 0.0 114.167 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 39.38 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.05 0.453 . . . . 0.0 110.681 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 1.023 HD21 ' HB1' ' A' ' 200' ' ' ALA . 1.7 pt? -109.61 140.33 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.536 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -121.79 171.71 8.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 0.0 111.159 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 192' ' ' THR . 53.5 mt -62.49 120.63 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.64 -19.55 4.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.9 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.66 152.51 31.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.85 0.325 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.765 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -113.52 129.22 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.387 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.586 ' HA ' HG22 ' A' ' 243' ' ' VAL . 31.8 mm -90.08 119.24 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 111.507 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -89.81 -26.42 20.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -171.89 149.21 2.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.76 HG13 ' HG ' ' A' ' 241' ' ' LEU . 2.5 t -117.42 119.0 60.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.83 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 239' ' ' VAL . 2.2 m-20 56.2 -85.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 215' ' ' VAL . 9.5 m -138.18 12.18 2.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.663 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.3 p -109.63 140.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-O 120.922 0.391 . . . . 0.0 111.056 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.02 89.49 0.71 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.728 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.921 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -71.72 -7.66 49.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.37 178.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.566 ' N ' HD12 ' A' ' 220' ' ' LEU . 3.8 pt-20 -62.29 168.72 3.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.194 0.521 . . . . 0.0 110.831 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 t0 47.52 25.5 0.65 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 220' ' ' LEU . 2.9 p -136.44 164.41 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.807 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.5 168.87 11.94 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.65 0.738 . . . . 0.0 111.576 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.6 t60 -57.96 -37.21 73.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.042 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.94 -52.88 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.512 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -62.04 -34.34 76.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 109.888 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.77 89.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.778 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.0 t -59.41 -41.72 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.767 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.44 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.703 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -66.29 -50.66 62.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.867 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 235' ' ' THR . 2.6 pp -74.57 -39.67 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -59.05 -39.62 82.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.402 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -59.09 -20.34 52.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.741 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 239' ' ' VAL . 34.6 p -57.75 -172.17 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.574 0.226 . . . . 0.0 111.323 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -133.88 -146.9 0.27 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.877 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -81.95 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 122.543 0.337 . . . . 0.0 111.792 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.27 122.34 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.012 HG21 HG21 ' A' ' 235' ' ' THR . 12.9 p -117.53 132.69 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.9 m-85 -105.4 119.45 39.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.922 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.76 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.0 mp -97.71 140.59 31.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.51 117.74 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.213 0.53 . . . . 0.0 110.215 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 211' ' ' LYS . 65.2 t -117.61 147.81 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.069 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.35 121.25 39.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.733 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 243' ' ' VAL . 11.4 p . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.798 0.333 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.0 ptm -124.58 154.4 40.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.313 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.03 130.89 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.398 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.874 HG22 ' CD2' ' A' ' 163' ' ' LEU . 37.9 mm -100.52 117.09 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.458 ' C ' HD23 ' A' ' 163' ' ' LEU . 7.7 ttpt -98.66 125.12 43.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.108 0.48 . . . . 0.0 112.273 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.874 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -136.28 129.51 31.59 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.39 131.08 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.123 0.487 . . . . 0.0 111.292 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 69.31 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.52 -160.22 7.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.27 -20.13 49.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.132 1.888 . . . . 0.0 112.401 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -92.26 -4.63 53.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.36 -149.41 19.45 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.57 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.588 HD12 HD12 ' A' ' 163' ' ' LEU . 4.2 mm? -56.96 -37.87 72.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 110.982 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 200' ' ' ALA . . . 92.2 26.41 18.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.972 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 4.1 p90 -174.97 -168.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 110.943 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 192' ' ' THR . 4.0 m -135.65 163.85 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.585 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.58 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -129.17 161.17 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 111.301 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.905 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.92 137.88 51.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.31 130.34 9.53 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.712 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.86 -18.23 61.83 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.558 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.96 117.76 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.38 -57.87 4.67 Favored Glycine 0 C--N 1.329 0.141 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.055 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -109.78 57.39 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.592 0.71 . . . . 0.0 109.301 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.2 tt0 -48.5 116.26 1.52 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.701 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 10.0 t60 -101.6 -27.02 13.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.913 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.414 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.24 134.57 23.43 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 79.41 2.59 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.138 1.892 . . . . 0.0 113.101 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.52 50.95 0.73 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.242 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -168.9 131.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.663 0.268 . . . . 0.0 110.884 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.065 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -169.1 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.905 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.5 mm -102.69 134.96 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.253 0.549 . . . . 0.0 110.112 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CG ' HG12 ' A' ' 183' ' ' ILE . 15.3 m-85 -133.84 155.35 50.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.626 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.605 HG11 ' CD1' ' A' ' 194' ' ' ILE . 40.3 t -80.28 141.44 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.329 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.556 ' C ' HD12 ' A' ' 208' ' ' ILE . 7.9 t -125.53 -21.55 4.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -153.42 136.13 15.27 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.683 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.655 HG22 ' HB2' ' A' ' 201' ' ' HIS . 2.5 mm -120.87 135.91 59.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.69 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.5 mm -80.17 116.88 25.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 110.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -37.03 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.023 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.74 27.19 34.9 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.981 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.56 -115.53 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.42 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.412 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -98.58 -57.42 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.934 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -67.31 -47.15 71.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.905 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.655 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.1 t-160 -59.52 -56.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.24 -52.74 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -74.0 -51.36 16.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.0 -38.19 36.19 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.728 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.28 41.21 4.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.292 0.568 . . . . 0.0 110.198 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.934 HD21 ' HB1' ' A' ' 200' ' ' ALA . 0.8 OUTLIER -111.28 140.23 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.999 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -118.77 179.53 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.763 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 192' ' ' THR . 7.4 mm -72.41 113.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.058 0.456 . . . . 0.0 111.556 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.2 -13.57 3.54 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.662 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -78.93 159.3 27.78 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 117.038 0.419 . . . . 0.0 110.982 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.733 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -120.76 130.12 53.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.657 HD13 ' CG2' ' A' ' 243' ' ' VAL . 32.7 mm -93.17 117.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.666 HD21 ' CG ' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -95.33 -4.97 44.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.63 153.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.755 0.312 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 218' ' ' VAL . 42.7 t -132.23 119.63 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.467 ' ND2' HG23 ' A' ' 239' ' ' VAL . 24.3 m-20 59.94 -84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.44 13.02 1.96 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.07 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.9 p -109.31 139.84 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.943 0.401 . . . . 0.0 111.529 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.14 101.9 2.33 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.387 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.98 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -109.17 45.66 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.478 0.656 . . . . 0.0 109.65 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 26.78 4.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.164 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -158.12 32.19 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.952 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 227' ' ' ASP . 7.0 p -153.4 166.1 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.443 ' N ' HG22 ' A' ' 223' ' ' VAL . 3.9 mtm -62.13 168.43 3.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.632 0.729 . . . . 0.0 112.076 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.87 ' O ' HG23 ' A' ' 229' ' ' VAL . 54.5 t60 -56.93 -36.18 69.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.031 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.15 -52.89 52.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.489 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -62.36 -34.98 77.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.166 0.508 . . . . 0.0 109.929 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 231' ' ' ALA . . . -60.67 -38.39 84.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.664 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.2 t -59.52 -41.64 85.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.89 -33.22 72.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.058 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.98 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.3 -41.15 96.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.896 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 229' ' ' VAL . 1.7 mt -73.99 -41.9 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.102 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -61.77 -39.57 92.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.149 0.499 . . . . 0.0 111.237 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -60.67 -19.61 58.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.866 HG21 HG21 ' A' ' 239' ' ' VAL . 30.2 p -57.73 -166.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.761 -0.2 . . . . 0.0 110.928 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -152.93 -160.74 1.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.233 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -28.82 -61.6 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.21 126.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 235' ' ' THR . 4.2 p -120.65 126.11 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 121.32 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.763 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 215' ' ' VAL . 0.3 OUTLIER -97.24 146.57 24.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.067 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.666 ' CG ' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -108.39 118.02 35.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.022 0.439 . . . . 0.0 109.936 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 211' ' ' LYS . 58.4 t -127.56 148.77 32.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.983 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.2 121.46 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.084 0.468 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.461 ' O ' HG12 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -132.12 154.55 49.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.998 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.83 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 0.0 111.794 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.943 HG21 HD23 ' A' ' 206' ' ' LEU . 34.5 mm -113.66 118.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.611 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.761 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -94.54 131.23 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.689 0.281 . . . . 0.0 111.331 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.795 HD11 HD11 ' A' ' 241' ' ' LEU . 11.5 mt -131.71 128.79 39.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.829 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -98.25 128.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.13 0.49 . . . . 0.0 110.145 179.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.647 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -63.15 91.94 0.05 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.008 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.14 -171.04 37.37 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.892 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.84 -24.8 74.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.211 1.94 . . . . 0.0 112.535 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -4.18 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.48 -144.27 18.37 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.366 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 18.3 mt -67.14 -37.83 84.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.271 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 97.94 34.26 5.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.622 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 7.3 p90 -175.07 -168.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 111.013 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 192' ' ' THR . 22.7 t -136.33 161.02 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.836 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.52 161.48 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.997 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.884 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -131.1 138.7 49.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.6 130.67 9.67 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.598 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.58 -25.08 54.88 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.637 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.53 120.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.91 5.02 Favored Glycine 0 C--N 1.331 0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 113.004 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -114.93 54.14 0.79 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.443 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -45.54 107.33 0.1 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.648 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 15.0 t60 -93.74 -26.78 16.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.011 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.435 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -96.46 121.85 59.0 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.034 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.72 71.01 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.999 1.799 . . . . 0.0 112.532 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 123.66 51.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.712 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.89 129.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.3 30.89 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.4 t -114.52 -165.73 1.04 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.884 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -103.22 135.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.435 ' CG ' HG12 ' A' ' 183' ' ' ILE . 20.6 m-85 -135.87 153.72 51.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.736 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 194' ' ' ILE . 46.5 t -80.76 142.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 173' ' ' SER . 1.9 t -122.7 -20.73 5.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.556 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -158.59 136.95 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.997 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.642 HD12 ' CD1' ' A' ' 206' ' ' LEU . 2.8 mm -120.57 135.65 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.995 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.6 mm -80.45 116.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -37.82 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.9 24.22 41.08 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.216 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.48 -114.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.121 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -109.94 -48.11 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.771 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.13 -47.07 72.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.409 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.0 t-160 -59.55 -56.08 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -69.77 -52.0 29.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.85 -51.15 17.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.62 -34.77 21.52 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.217 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 66.02 26.67 10.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.188 0.494 . . . . 0.0 110.552 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 161' ' ' ILE . 3.9 pp -96.05 140.86 30.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -122.04 170.15 10.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 34.6 mt -58.22 113.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.51 -19.61 3.18 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.723 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.14 129.88 39.03 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.824 0.312 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.885 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.5 OUTLIER -96.48 129.11 43.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.627 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 189' ' ' ILE . 16.2 mm -103.13 137.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.802 0.334 . . . . 0.0 111.667 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.687 HD11 ' HG2' ' A' ' 242' ' ' LYS . 1.4 pp -115.53 -12.59 11.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.034 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -175.9 152.45 1.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 110.657 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.721 ' O ' HG12 ' A' ' 218' ' ' VAL . 38.4 t -130.43 119.09 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 58.43 -85.04 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.99 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 12.95 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.674 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.29 140.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 120.827 0.346 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.58 100.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.049 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.598 HD21 HG21 ' A' ' 215' ' ' VAL . 0.5 OUTLIER -99.25 34.73 2.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.383 0.611 . . . . 0.0 109.864 178.235 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -103.35 163.68 12.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 46.38 26.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.665 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 224' ' ' MET . 5.2 p -134.21 165.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 2.9 mtt -69.51 168.34 14.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.718 0.77 . . . . 0.0 112.026 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.859 ' O ' HG23 ' A' ' 229' ' ' VAL . 64.2 t60 -58.11 -36.31 72.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.017 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.6 -51.72 57.52 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -35.57 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.473 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.14 92.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.403 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.2 t -58.09 -41.83 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.97 74.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.467 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -67.31 -41.4 85.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.234 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 174' ' ' ILE . 4.3 mt -73.44 -45.18 55.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -34.62 71.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.816 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -64.47 -20.35 66.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.63 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.956 HG21 HG21 ' A' ' 239' ' ' VAL . 26.2 p -62.25 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -140.76 -150.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 7.1 m-20 -45.08 -81.18 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.286 0.234 . . . . 0.0 111.609 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.8 118.48 42.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.168 0.509 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.956 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -120.82 127.31 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.199 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.34 123.79 46.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.795 HD11 HD11 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -97.07 149.32 22.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.687 ' HG2' HD11 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -107.64 116.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.2 p -124.06 140.36 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.881 -177.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.55 121.73 40.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.167 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.293 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.751 0.31 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.84 149.27 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.43 142.85 28.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.306 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.711 HD13 ' HB3' ' A' ' 206' ' ' LEU . 2.7 mt -118.03 119.62 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.783 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.539 ' CG ' HG22 ' A' ' 238' ' ' VAL . 14.9 ttpt -100.84 130.75 46.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.002 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.985 HD11 HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -132.09 132.04 42.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.816 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -97.2 135.09 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.242 0.544 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.784 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -70.11 96.01 1.03 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.085 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.8 -158.25 27.58 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.959 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.86 -20.72 68.76 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.097 1.865 . . . . 0.0 112.422 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.27 -2.49 31.0 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.4 -135.77 14.25 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.126 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 4.4 mm? -58.21 -33.25 69.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 111.046 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.03 32.99 37.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.699 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 11.6 p90 -175.42 -174.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.4 m -129.85 160.29 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 111.545 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.753 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -122.91 157.09 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.9 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.99 137.53 52.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -111.45 130.92 9.99 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.753 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.62 -23.74 57.55 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.587 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.1 t -90.06 117.92 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.96 -56.04 5.03 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.918 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -112.42 53.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.439 0.638 . . . . 0.0 109.414 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.5 tt0 -45.87 113.24 0.58 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.684 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 9.4 t60 -102.66 -26.04 13.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.277 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.434 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -95.99 132.99 25.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.275 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.88 76.34 4.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 113.007 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.59 47.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.083 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.64 130.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 0.0 110.948 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.4 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 1.3 m120 -102.47 28.13 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.28 -162.46 0.8 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.751 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.9 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -106.38 136.04 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.434 ' CG ' HG12 ' A' ' 183' ' ' ILE . 21.8 m-85 -135.77 150.3 49.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.388 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 194' ' ' ILE . 26.9 t -80.73 138.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.703 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.6 t -123.23 -18.48 6.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -152.16 133.53 14.49 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.782 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.6 mm -120.93 135.6 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.151 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -81.02 113.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 109.866 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -37.19 102.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.28 23.6 13.32 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.262 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.0 -107.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.411 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -104.44 -58.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -67.23 -47.99 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.035 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.8 t-160 -58.46 -56.11 26.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -52.32 27.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.44 -51.38 15.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 163' ' ' LEU . . . -85.52 -35.78 11.45 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.686 -0.768 . . . . 0.0 114.402 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 62.17 0.74 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.401 0.62 . . . . 0.0 110.578 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 200' ' ' ALA . 0.3 OUTLIER -122.5 132.88 54.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.92 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -112.14 165.72 11.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.972 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.703 HG23 ' HA ' ' A' ' 192' ' ' THR . 37.9 mt -64.06 111.54 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.76 -14.07 2.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.204 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.24 153.01 28.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.107 0.453 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.742 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -114.32 129.36 56.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.675 ' HA ' HG22 ' A' ' 243' ' ' VAL . 43.1 mm -90.5 122.93 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.566 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.785 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -90.46 -27.09 19.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.171 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 177.09 150.21 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.738 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.843 HG22 HD23 ' A' ' 241' ' ' LEU . 2.2 t -116.19 118.92 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.017 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 56.42 -86.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.28 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.6 m -136.39 11.06 3.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.072 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 215' ' ' VAL . 8.1 p -109.23 140.39 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -108.64 88.53 0.53 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.056 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.875 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -68.07 -13.81 62.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 178.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.638 ' N ' HD12 ' A' ' 220' ' ' LEU . 1.5 pt-20 -63.24 169.59 3.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.19 0.519 . . . . 0.0 110.72 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.39 24.42 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.795 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.875 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.2 p -144.86 156.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.92 167.5 0.79 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.93 0.872 . . . . 0.0 112.592 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.0 t60 -57.66 -35.01 69.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.099 -1.41 . . . . 0.0 110.685 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.3 -52.05 51.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.052 0.454 . . . . 0.0 111.996 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.495 ' HB2' HG22 ' A' ' 223' ' ' VAL . 8.6 m-20 -61.27 -35.42 77.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.49 90.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.775 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.6 t -59.04 -41.3 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.12 75.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.1 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 218' ' ' VAL . . . -63.45 -39.74 95.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.32 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.753 HD11 HG21 ' A' ' 174' ' ' ILE . 9.0 mt -73.16 -44.24 60.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.166 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -37.0 70.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 111.575 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.0 -20.3 65.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.909 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.893 HG21 HG21 ' A' ' 239' ' ' VAL . 22.8 p -65.43 -175.67 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.754 0.312 . . . . 0.0 111.323 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.53 -150.03 0.35 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.227 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 165' ' ' LYS . 2.1 m-20 -44.31 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.712 0.233 . . . . 0.0 111.288 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.539 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.5 OUTLIER -94.11 122.54 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.676 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.893 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -118.83 135.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -102.63 135.33 44.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.985 HD11 HD11 ' A' ' 163' ' ' LEU . 3.6 mt -113.46 135.34 53.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.467 ' HG2' HD23 ' A' ' 213' ' ' LEU . 2.6 ttpp -106.66 117.5 34.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.174 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 211' ' ' LYS . 75.1 t -129.48 148.79 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.95 121.12 35.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.963 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.165 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.568 HG11 ' HE2' ' A' ' 242' ' ' LYS . 16.2 t . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.637 0.256 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -93.39 140.01 30.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.63 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.76 HG21 HD23 ' A' ' 206' ' ' LEU . 48.6 mm -123.9 119.21 56.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.798 ' O ' HD23 ' A' ' 163' ' ' LEU . 19.1 ttpt -105.57 132.31 51.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.373 . . . . 0.0 111.606 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.875 HD22 ' HA ' ' A' ' 200' ' ' ALA . 2.3 mt -131.61 129.77 41.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.062 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.751 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -98.17 134.54 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 110.973 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.751 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -74.79 106.31 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.912 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.14 -147.13 8.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.217 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.38 -23.06 38.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.064 1.842 . . . . 0.0 112.055 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -102.14 -4.73 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.62 -135.32 13.67 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.109 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.587 HD12 HD12 ' A' ' 163' ' ' LEU . 4.5 mm? -58.49 -37.11 74.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.115 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.556 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 83.48 39.35 9.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.651 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.25 -173.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.97 0.414 . . . . 0.0 110.704 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 m -133.13 160.39 37.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -125.84 162.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.825 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.074 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.83 129.38 9.5 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.431 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.67 -20.6 55.88 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.255 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 187' ' ' ASN . 17.6 t -89.83 116.99 32.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.27 -58.5 4.03 Favored Glycine 0 C--N 1.329 0.164 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.944 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -102.97 48.55 0.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.472 0.654 . . . . 0.0 109.429 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.448 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -44.51 113.5 0.55 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 18.9 t60 -98.44 -31.31 12.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.743 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.439 HG13 ' CG ' ' A' ' 190' ' ' TYR . 9.8 mm -96.4 123.91 52.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.198 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.49 78.67 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.982 1.788 . . . . 0.0 112.566 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 130.88 5.73 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.013 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -132.88 144.85 50.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.669 0.735 . . . . 0.0 111.35 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . 0.416 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.1 m120 -104.85 -28.05 11.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -62.98 -163.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.5 mm -101.13 141.35 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.25 0.548 . . . . 0.0 110.819 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CG ' HG13 ' A' ' 183' ' ' ILE . 17.6 m-85 -135.58 155.05 51.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.839 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 194' ' ' ILE . 36.7 t -85.16 142.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.451 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 208' ' ' ILE . 1.4 t -123.74 -24.26 4.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . 0.617 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -157.15 138.25 13.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.09 0.472 . . . . 0.0 112.01 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.617 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.6 mm -121.35 135.78 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.483 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.556 HD13 ' C ' ' A' ' 171' ' ' GLY . 3.5 mp -80.73 115.6 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -38.26 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.97 29.37 43.04 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.167 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.99 -64.73 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.182 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.21 -57.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.388 . . . . 0.0 110.689 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.875 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.44 -44.55 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.811 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.5 t-160 -59.63 -55.89 28.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.678 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -51.54 30.29 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.84 -49.47 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.64 -35.24 14.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.789 -0.72 . . . . 0.0 114.398 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 51.66 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.375 0.607 . . . . 0.0 109.962 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.76 HD23 HG21 ' A' ' 161' ' ' ILE . 4.1 pp -120.81 140.44 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.224 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.71 174.97 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.019 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 192' ' ' THR . 35.9 mt -67.6 126.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.827 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 127.03 -19.39 6.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.622 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -77.03 149.44 35.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.792 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -110.83 128.21 55.69 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.896 0.379 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.859 HD13 ' CG2' ' A' ' 243' ' ' VAL . 26.8 mm -92.79 124.71 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.884 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.466 HD21 ' HD2' ' A' ' 211' ' ' LYS . 3.3 mt -85.48 -67.26 0.82 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.263 0.554 . . . . 0.0 110.151 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.03 155.11 50.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.703 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.859 HG13 ' HG ' ' A' ' 241' ' ' LEU . 26.0 t -124.3 120.11 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.61 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 t30 59.31 -86.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.9 t -141.26 14.44 2.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.665 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.75 140.64 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.89 97.33 1.42 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.051 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 215' ' ' VAL . 0.4 OUTLIER -101.84 43.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -120.12 30.07 7.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.732 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -168.65 33.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 227' ' ' ASP . 9.6 p -152.41 165.29 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.431 ' N ' HG22 ' A' ' 223' ' ' VAL . 1.1 mpt? -63.51 172.68 1.93 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.727 0.775 . . . . 0.0 112.173 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 229' ' ' VAL . 66.7 t60 -57.44 -37.62 73.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.583 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.54 -53.14 46.36 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . 0.529 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -63.12 -34.21 77.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.78 -38.21 84.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.646 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.8 t -60.08 -41.39 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.142 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.91 -32.81 74.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.875 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -65.33 -42.08 93.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.315 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 229' ' ' VAL . 0.7 OUTLIER -73.69 -48.07 34.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.446 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.48 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 111.979 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.53 -20.7 57.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.715 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . 0.999 HG21 HG21 ' A' ' 239' ' ' VAL . 30.6 p -60.82 -169.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.687 0.279 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.71 -152.01 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -44.34 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.549 0.214 . . . . 0.0 111.439 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.423 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.3 OUTLIER -97.05 121.81 47.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.944 0.402 . . . . 0.0 110.711 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.999 HG21 HG21 ' A' ' 235' ' ' THR . 12.5 p -120.16 132.95 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 2.6 m-85 -105.21 119.58 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.859 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.0 mp -101.55 138.19 38.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.568 ' HE2' HG11 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -107.06 129.22 54.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.986 0.422 . . . . 0.0 110.046 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.859 ' CG2' HD13 ' A' ' 212' ' ' ILE . 53.6 t -130.82 148.32 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.691 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.7 131.09 52.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.768 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp . . . . . 0 CA--C 1.533 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.082 -179.665 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.83 0.348 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -100.44 158.98 15.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 144.73 36.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.31 125.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 14.7 ptp -132.03 154.51 49.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.882 0.373 . . . . 0.0 111.25 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -104.93 145.08 30.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.975 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.829 HG21 HD23 ' A' ' 206' ' ' LEU . 41.1 mm -125.44 116.71 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.456 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.728 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.8 mtmt -90.7 131.51 36.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.004 0.431 . . . . 0.0 111.108 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.006 HD11 HD11 ' A' ' 241' ' ' LEU . 2.1 mt -121.23 128.39 52.36 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.967 HD12 HG22 ' A' ' 238' ' ' VAL . 13.0 mm -97.25 134.21 36.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.163 0.506 . . . . 0.0 111.375 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.475 ' HE2' HD13 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -80.15 56.99 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.043 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.99 -156.0 0.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.51 -22.98 44.05 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.212 1.941 . . . . 0.0 112.434 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.76 -4.49 47.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.1 -130.84 10.49 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.271 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.529 HD12 HD12 ' A' ' 163' ' ' LEU . 4.5 mm? -62.37 -36.46 82.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.726 0.298 . . . . 0.0 110.95 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 90.33 26.56 23.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.109 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 1.7 p90 -174.57 -168.2 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.978 0.418 . . . . 0.0 111.202 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 4.2 m -134.7 158.96 42.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.679 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.729 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -124.73 160.49 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.017 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.918 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -125.05 137.3 54.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.16 129.91 9.61 Favored Glycine 0 CA--C 1.503 -0.667 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.499 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.15 -22.67 54.2 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.76 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.54 HG22 ' HB3' ' A' ' 187' ' ' ASN . 19.8 t -89.99 118.64 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.89 -57.12 4.96 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.967 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -110.39 52.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.518 0.675 . . . . 0.0 109.407 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.6 tt0 -44.8 116.21 1.03 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.671 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 16.6 t60 -103.89 -27.75 12.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.238 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.436 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.41 123.45 54.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.371 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.62 81.47 0.17 Allowed 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.007 1.804 . . . . 0.0 112.648 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.28 55.32 0.68 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.028 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.41 129.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 110.812 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.54 ' HB3' HG22 ' A' ' 178' ' ' VAL . 7.7 m120 -103.74 29.46 5.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.724 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 m -111.0 -160.9 0.73 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.521 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.7 mm -110.79 136.65 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 121.305 0.574 . . . . 0.0 110.642 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.436 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.9 m-85 -135.47 154.06 51.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.545 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.504 HG11 ' CD1' ' A' ' 194' ' ' ILE . 40.1 t -80.9 142.22 14.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.2 t -123.97 -24.09 4.48 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.54 ' C ' HD13 ' A' ' 194' ' ' ILE . 9.4 ttpt -155.43 138.52 15.54 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.72 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.724 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.7 OUTLIER -121.27 135.12 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.498 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.1 mm -81.86 123.62 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -39.53 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.58 26.11 37.55 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.283 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.27 -69.23 1.4 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.172 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.456 ' HB1' ' H ' ' A' ' 164' ' ' ILE . . . -148.46 -59.31 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.954 0.407 . . . . 0.0 110.388 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.691 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -63.97 -43.81 94.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.43 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.724 ' HB2' HG22 ' A' ' 194' ' ' ILE . 7.7 t-160 -66.07 -55.8 14.75 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -69.4 -52.76 23.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 164' ' ' ILE . 2.5 t70 -75.01 -50.56 16.14 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.474 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -77.9 -31.25 49.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.874 -0.679 . . . . 0.0 114.134 -178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 62.19 32.23 17.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.179 0.49 . . . . 0.0 110.182 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.829 HD23 HG21 ' A' ' 161' ' ' ILE . 3.8 pp -101.3 140.32 35.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.904 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 194' ' ' ILE . 11.3 pt20 -123.01 167.21 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 46.2 mt -58.06 116.13 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.836 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.3 -17.94 3.75 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.439 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -78.95 149.16 32.39 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 120.743 0.306 . . . . 0.0 111.062 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.771 ' O ' HG13 ' A' ' 243' ' ' VAL . 5.9 ptmt -112.94 128.87 56.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.462 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.725 ' HA ' HG22 ' A' ' 243' ' ' VAL . 26.9 mm -90.1 121.58 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.315 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 0.7 OUTLIER -101.73 2.5 38.62 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 163.83 155.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.814 HG13 ' CD2' ' A' ' 241' ' ' LEU . 57.5 t -132.14 118.57 37.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.441 ' HA ' ' CE2' ' A' ' 240' ' ' TYR . 26.9 m-20 58.08 -85.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.5 OUTLIER -141.18 14.32 2.23 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.668 177.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.749 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.2 p -109.17 140.38 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.97 0.414 . . . . 0.0 111.3 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.75 94.61 1.31 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.477 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.968 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.1 OUTLIER -102.31 44.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.696 0.76 . . . . 0.0 109.026 178.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 25.58 5.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.601 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -154.71 33.38 0.4 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.745 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.498 HG21 ' CB ' ' A' ' 227' ' ' ASP . 10.1 p -152.76 166.88 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.039 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.46 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.69 170.52 2.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.725 0.774 . . . . 0.0 112.284 -179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.869 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.2 t60 -57.55 -36.28 71.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.307 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.18 -52.56 54.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.498 ' CB ' HG21 ' A' ' 223' ' ' VAL . 2.4 t0 -62.01 -35.22 77.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.959 0.409 . . . . 0.0 110.122 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.15 89.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.872 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 225' ' ' HIS . 18.2 t -59.37 -41.36 84.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.31 -33.25 74.31 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.474 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.968 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.23 -41.48 96.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.079 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.729 HD11 HG21 ' A' ' 174' ' ' ILE . 3.5 mt -73.96 -48.77 28.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.611 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -61.49 -34.54 75.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.026 0.441 . . . . 0.0 111.957 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -64.39 -20.22 66.0 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.732 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 1.141 HG21 HG21 ' A' ' 239' ' ' VAL . 18.3 p -66.01 -162.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.516 0.198 . . . . 0.0 111.443 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 236' ' ' TYR . 1.7 m-85 -131.02 -153.46 0.56 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.146 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -43.19 -77.03 0.02 OUTLIER 'General case' 0 C--N 1.346 0.454 0 C-N-CA 122.566 0.347 . . . . 0.0 111.787 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.967 HG22 HD12 ' A' ' 164' ' ' ILE . 53.5 t -102.88 121.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.106 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.141 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -118.87 124.07 72.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.588 ' C ' HD23 ' A' ' 241' ' ' LEU . 0.6 OUTLIER -94.76 138.03 33.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.405 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 1.006 HD11 HD11 ' A' ' 163' ' ' LEU . 0.8 OUTLIER -114.77 147.25 40.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.858 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.76 119.8 40.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.121 0.486 . . . . 0.0 110.304 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 211' ' ' LYS . 71.8 t -128.75 146.63 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.787 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.98 132.1 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.675 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -94.88 128.64 38.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.911 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.13 111.38 3.06 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.043 1.828 . . . . 0.0 112.459 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 m -96.3 121.57 38.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -82.94 81.19 8.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.956 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.101 179.883 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 61.61 -179.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.661 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -82.74 105.47 13.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.75 130.95 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.969 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.52 ' SD ' HD11 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -132.18 147.5 52.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.117 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -97.61 144.15 27.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.963 HG21 HD23 ' A' ' 206' ' ' LEU . 43.0 mm -125.45 118.94 53.94 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.636 ' O ' HD23 ' A' ' 163' ' ' LEU . 8.9 ttmt -97.57 126.31 42.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 241' ' ' LEU . 12.4 mt -127.41 128.92 46.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.326 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.787 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -101.28 133.5 44.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.053 0.454 . . . . 0.0 110.719 179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.787 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -68.9 74.17 0.28 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.089 -179.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.74 -161.61 0.4 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.368 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.72 -24.37 25.35 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.327 2.018 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 16.0 mmtp -101.32 -1.95 32.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.04 -138.02 14.68 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.365 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 24.1 mt -69.6 -33.59 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.844 0.355 . . . . 0.0 111.126 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 94.29 27.63 11.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.491 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 3.7 p90 -170.58 -169.27 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.0 t -136.92 162.97 31.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 111.246 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.686 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -123.6 160.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.187 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.906 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.02 138.01 52.42 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -109.35 130.18 9.85 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.818 -178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -83.78 -23.2 53.77 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.425 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.403 ' HB ' ' N ' ' A' ' 224' ' ' MET . 10.5 t -89.88 120.77 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.66 -56.43 5.05 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.96 -0.564 . . . . 0.0 113.075 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -117.06 57.58 0.79 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.543 0.687 . . . . 0.0 109.391 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.452 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.6 tt0 -47.66 116.95 1.62 Allowed 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.706 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 6.0 t60 -102.06 -25.16 13.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.952 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.1 mp -96.48 129.44 33.24 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.3 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.35 78.1 2.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.053 1.835 . . . . 0.0 112.829 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 110.57 50.96 0.63 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.748 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.13 123.87 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.741 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -97.97 28.74 3.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.928 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.07 -166.56 1.09 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.58 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.906 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -102.98 134.89 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.226 0.536 . . . . 0.0 110.522 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.442 ' CG ' HG12 ' A' ' 183' ' ' ILE . 19.3 m-85 -135.33 154.23 51.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.684 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.519 HG21 HD13 ' A' ' 206' ' ' LEU . 44.6 t -80.7 141.43 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.402 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 2.8 t -123.07 -26.04 4.43 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.478 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -150.61 137.18 18.86 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.912 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.509 ' CD1' HG11 ' A' ' 191' ' ' VAL . 1.3 mm -121.28 135.25 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.526 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.33 118.39 29.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -38.52 98.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.57 23.97 16.05 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.136 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.18 -78.94 0.24 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.431 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -137.56 -58.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.954 0.407 . . . . 0.0 110.879 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.859 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -63.31 -45.92 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.293 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -59.13 -55.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.953 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -52.06 29.99 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.64 -50.51 20.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -82.4 -32.81 27.18 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.259 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 63.2 31.92 15.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.281 0.541 . . . . 0.0 110.259 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.963 HD23 HG21 ' A' ' 161' ' ' ILE . 4.7 pp -102.68 140.43 36.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.638 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 176.33 6.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.283 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 51.1 mt -64.28 112.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.07 -17.0 2.98 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.865 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.9 147.87 32.94 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.923 0.362 . . . . 0.0 111.028 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.733 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -110.48 129.17 55.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.326 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.72 HD13 ' CG2' ' A' ' 243' ' ' VAL . 43.0 mm -92.17 116.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 111.629 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 0.9 OUTLIER -96.5 -2.27 45.52 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.122 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.47 152.06 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.731 HG23 HD21 ' A' ' 220' ' ' LEU . 40.8 t -130.55 118.63 43.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.969 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 57.14 -84.51 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.317 0.386 . . . . 0.0 110.066 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 215' ' ' VAL . 50.4 m -139.94 11.69 2.43 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.23 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.1 p -109.19 140.71 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 120.957 0.408 . . . . 0.0 111.65 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.21 108.72 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.442 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.939 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -119.37 50.6 1.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.457 0.646 . . . . 0.0 109.492 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.19 26.05 4.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.532 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -159.9 30.68 0.18 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.322 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 227' ' ' ASP . 9.7 p -148.7 166.44 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.342 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.421 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.38 170.69 2.24 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.697 0.761 . . . . 0.0 112.256 -178.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.88 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.9 t60 -57.74 -37.42 73.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.086 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -66.27 -52.53 46.64 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.468 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -62.5 -34.68 77.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.105 0.478 . . . . 0.0 109.886 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.414 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.93 -38.73 86.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.653 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.7 t -59.88 -41.52 86.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.136 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.45 72.45 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.411 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.939 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -65.23 -42.61 93.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.281 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.686 HD11 HG21 ' A' ' 174' ' ' ILE . 1.7 mt -73.59 -41.94 62.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.491 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -59.08 -40.91 86.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.114 0.483 . . . . 0.0 111.97 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.62 -20.41 32.79 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.786 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 1.04 HG21 HG21 ' A' ' 239' ' ' VAL . 21.2 p -66.09 -166.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.68 0.276 . . . . 0.0 111.044 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.45 -150.14 0.33 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.329 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 165' ' ' LYS . 5.5 m-20 -44.4 -80.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.327 0.251 . . . . 0.0 111.595 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.6 121.32 47.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.985 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.04 HG21 HG21 ' A' ' 235' ' ' THR . 9.3 p -120.77 130.97 74.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 4.2 m-85 -99.74 120.67 40.09 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.237 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.942 HD11 HD11 ' A' ' 163' ' ' LEU . 1.3 mt -96.92 137.92 35.27 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.44 ' HG2' HD21 ' A' ' 213' ' ' LEU . 18.8 ttpt -107.26 120.74 42.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.182 0.515 . . . . 0.0 110.014 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 211' ' ' LYS . 52.8 t -122.58 147.58 26.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.251 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.431 ' HB2' HD22 ' A' ' 213' ' ' LEU . . . -117.26 131.79 56.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.151 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.19 128.13 44.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.796 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -84.01 50.31 3.07 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.18 1.92 . . . . 0.0 112.693 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.99 153.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.103 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -114.74 78.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.058 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -91.22 172.61 8.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.809 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -112.22 118.44 35.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.191 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.7 120.53 64.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 18.9 ptm -114.69 140.96 48.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -95.49 143.81 26.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.549 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.953 HG21 HD23 ' A' ' 206' ' ' LEU . 35.6 mm -125.28 119.13 54.66 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.734 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.78 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.7 ttpt -105.31 129.21 53.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 0.0 111.681 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.951 HD21 HG22 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -129.37 129.99 45.46 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.34 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.755 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -97.5 133.42 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.094 0.473 . . . . 0.0 110.575 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.755 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -72.47 102.04 3.11 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.153 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -105.92 -153.86 20.99 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.936 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.31 -22.46 46.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.105 1.87 . . . . 0.0 112.364 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.73 -4.23 26.81 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.54 -138.94 14.89 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.443 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 163' ' ' LEU . 3.9 mm? -57.07 -37.85 72.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 111.229 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.1 37.61 9.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.893 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 170' ' ' LEU . 0.1 OUTLIER -174.52 -166.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.935 0.398 . . . . 0.0 111.039 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 192' ' ' THR . 9.2 t -138.83 158.34 44.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.863 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.664 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -123.91 161.92 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.922 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.06 137.53 52.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.435 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.91 129.84 9.48 Favored Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 119.956 -1.116 . . . . 0.0 113.807 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.77 -20.71 55.42 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.755 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.408 ' HB ' ' N ' ' A' ' 224' ' ' MET . 9.5 t -90.23 117.94 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.44 -56.55 5.01 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.181 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -112.88 55.23 0.7 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.635 0.731 . . . . 0.0 109.301 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.446 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.35 119.96 2.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.729 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 14.7 t60 -103.05 -31.0 10.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.931 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.445 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.5 OUTLIER -97.14 125.09 47.12 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.214 179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.69 78.98 0.95 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.15 1.9 . . . . 0.0 112.861 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 117.75 46.07 0.49 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.199 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.11 128.34 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -98.66 12.49 35.24 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.476 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.44 -165.99 1.35 Allowed 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.585 0.231 . . . . 0.0 110.65 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.0 OUTLIER -103.41 139.84 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.124 0.488 . . . . 0.0 110.559 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.445 ' CG ' HG12 ' A' ' 183' ' ' ILE . 29.5 m-85 -136.09 151.55 49.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.283 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 194' ' ' ILE . 21.4 t -81.47 140.31 16.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.562 ' HA ' HG23 ' A' ' 208' ' ' ILE . 3.7 t -124.68 -25.45 3.98 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.555 ' C ' HD13 ' A' ' 194' ' ' ILE . 9.8 tttp -149.27 135.41 19.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 111.761 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.555 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.0 OUTLIER -121.01 135.1 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.186 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.5 mm -81.22 117.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -36.39 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.49 23.88 29.13 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.076 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.0 -82.27 0.11 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.325 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.44 -57.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.92 0.39 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.816 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.02 -44.2 85.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.77 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.516 ' HB2' HG22 ' A' ' 194' ' ' ILE . 4.2 t-160 -62.52 -55.62 25.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.536 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -69.68 -52.2 27.84 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -74.08 -50.45 19.53 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.92 -29.98 33.11 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.913 -0.661 . . . . 0.0 114.488 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 61.41 33.56 18.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.307 0.554 . . . . 0.0 110.47 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.953 HD23 HG21 ' A' ' 161' ' ' ILE . 1.8 pp -101.01 142.13 32.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -121.6 171.99 8.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.094 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.562 HG23 ' HA ' ' A' ' 192' ' ' THR . 53.2 mt -63.96 132.18 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.05 9.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.734 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -74.66 150.68 39.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.117 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.729 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -112.82 129.15 56.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.554 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.764 HD13 ' CG2' ' A' ' 243' ' ' VAL . 38.9 mm -89.88 117.38 33.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.265 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.597 HD21 ' HG2' ' A' ' 242' ' ' LYS . 2.3 pp -97.79 -2.24 41.5 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.31 151.49 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.243 -0.286 . . . . 0.0 110.853 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 218' ' ' VAL . 24.5 t -132.3 119.27 39.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.234 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.47 ' OD1' HG23 ' A' ' 239' ' ' VAL . 2.4 m120 59.29 -85.5 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.4 p -141.98 13.49 2.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.893 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.708 HG13 ' CD2' ' A' ' 220' ' ' LEU . 10.8 p -109.39 140.33 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.906 0.384 . . . . 0.0 111.382 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -100.69 100.57 2.16 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 1.013 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -108.97 48.01 0.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.716 0.769 . . . . 0.0 109.061 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.74 27.39 4.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.592 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.28 32.72 0.11 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.131 0.491 . . . . 0.0 110.124 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.483 HG21 ' CB ' ' A' ' 227' ' ' ASP . 7.6 p -149.38 166.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.101 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.44 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -62.74 169.19 3.28 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.736 0.779 . . . . 0.0 112.009 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.3 t60 -57.52 -36.4 71.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.407 -1.269 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.84 -52.42 50.59 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.9 OUTLIER -61.65 -34.95 76.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.044 0.45 . . . . 0.0 109.985 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.423 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.88 -39.24 88.46 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.622 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.1 t -59.37 -41.04 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.156 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.61 73.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.213 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 1.013 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.02 -40.87 97.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.086 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 174' ' ' ILE . 6.5 mt -70.6 -40.88 72.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.126 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -37.31 86.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.388 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -20.76 43.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.554 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 1.051 HG21 HG21 ' A' ' 239' ' ' VAL . 17.5 p -70.38 -166.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.637 0.256 . . . . 0.0 111.069 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.94 -150.5 0.33 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.411 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 85.2 m-20 -43.42 -81.36 0.01 OUTLIER 'General case' 0 C--N 1.343 0.304 0 C-N-CA 122.442 0.297 . . . . 0.0 111.515 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.434 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.3 OUTLIER -95.69 120.57 45.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.69 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.051 HG21 HG21 ' A' ' 235' ' ' THR . 9.5 p -120.26 133.43 67.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.869 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -105.06 118.9 37.7 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.276 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.668 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.7 mp -99.13 139.38 34.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.597 ' HG2' HD21 ' A' ' 213' ' ' LEU . 16.7 ttmt -107.29 130.9 54.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 0.0 110.492 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.764 ' CG2' HD13 ' A' ' 212' ' ' ILE . 56.2 t -132.68 146.06 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 -178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.76 124.83 49.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.593 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.31 127.9 44.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.38 66.95 6.73 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.435 2.09 . . . . 0.0 112.423 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.02 156.65 41.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 59.8 34.73 21.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.146 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.916 0.389 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.0 -176.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -79.66 97.32 6.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.37 124.52 68.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.351 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.9 ptp -129.49 151.68 49.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.75 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -99.41 143.58 29.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 111.544 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.853 HG22 HD21 ' A' ' 163' ' ' LEU . 47.9 mm -118.09 117.93 56.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.498 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.617 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -103.74 129.28 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.853 HD21 HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -132.35 129.78 39.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.066 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.826 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -98.43 133.89 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 110.572 179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.826 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -75.85 137.41 40.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.278 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -155.21 -153.29 6.47 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.379 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -57.83 -21.67 49.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.273 1.982 . . . . 0.0 112.586 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -97.0 -4.6 39.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.85 -127.73 8.13 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.643 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.68 HD22 ' HE2' ' A' ' 165' ' ' LYS . 0.6 OUTLIER -68.11 -37.87 81.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.725 0.298 . . . . 0.0 110.591 -179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.6 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 93.25 22.91 25.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.572 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.65 -171.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.2 t -133.16 164.36 27.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.699 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -128.49 158.5 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.157 0.503 . . . . 0.0 112.029 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.916 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.24 138.87 51.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.139 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.412 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.88 134.18 11.8 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.85 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.22 -24.58 47.31 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.614 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 187' ' ' ASN . 10.4 t -89.98 120.28 38.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.31 4.97 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.374 -0.441 . . . . 0.0 113.112 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -118.09 56.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.478 0.656 . . . . 0.0 109.25 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.9 tt0 -46.67 118.75 2.14 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.689 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 13.4 t60 -107.69 -24.22 11.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.375 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.427 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -96.77 133.24 24.7 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -72.86 80.86 1.72 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.096 1.864 . . . . 0.0 112.604 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.21 55.76 0.76 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.875 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.68 131.22 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.411 ' HB2' HG22 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -104.42 30.43 5.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.727 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.3 t -111.04 -166.94 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.361 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.2 mm -106.04 135.49 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.195 0.521 . . . . 0.0 110.171 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 211' ' ' LYS . 17.8 m-85 -133.98 152.83 52.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.734 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.507 HG21 HD13 ' A' ' 206' ' ' LEU . 29.4 t -80.41 140.62 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.502 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.554 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.5 t -123.29 -24.7 4.59 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.729 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.5 OUTLIER -146.12 134.71 22.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 111.722 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.729 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.0 OUTLIER -120.81 135.21 61.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.114 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 32.3 mm -81.12 116.93 26.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -38.28 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.875 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.06 24.21 27.16 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.078 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.99 -71.36 1.01 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.474 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.6 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -140.02 -67.23 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.715 0.293 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.773 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -60.47 -46.96 88.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.021 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.718 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.8 t-160 -59.54 -55.96 27.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -70.53 -53.09 17.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.22 -50.21 20.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.1 -30.44 46.63 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.827 -0.701 . . . . 0.0 114.129 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.91 46.97 6.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.402 0.62 . . . . 0.0 109.98 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.773 HD21 ' HB1' ' A' ' 200' ' ' ALA . 3.4 pp -117.27 139.63 50.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.082 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.44 169.27 9.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.975 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.7 mt -61.57 119.17 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.577 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.18 -17.65 4.81 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.95 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.64 146.94 44.2 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 117.008 0.404 . . . . 0.0 110.696 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.728 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.1 ptpt -106.78 128.59 54.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.604 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.56 ' HA ' HG22 ' A' ' 243' ' ' VAL . 29.0 mm -95.39 115.72 35.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.14 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.663 HD21 ' CG ' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -94.52 -9.68 34.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.971 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 176.21 148.09 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.765 0.316 . . . . 0.0 110.692 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.792 HG13 ' HG ' ' A' ' 241' ' ' LEU . 10.2 t -122.82 118.98 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.448 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 57.58 -85.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.005 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.1 m -139.0 13.09 2.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.618 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.34 141.27 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 122.534 0.334 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -105.55 87.91 0.55 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.213 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.899 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -75.16 -5.7 45.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.723 0.297 . . . . 0.0 111.268 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.532 ' N ' HD12 ' A' ' 220' ' ' LEU . 4.0 pt-20 -67.3 167.81 11.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.2 t70 46.83 26.27 0.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.962 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.899 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.1 p -136.36 165.24 29.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.643 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.437 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -67.82 168.25 11.89 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.703 0.763 . . . . 0.0 111.606 -179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.862 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.0 t60 -58.37 -36.89 74.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.998 178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 -52.76 38.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.446 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.2 OUTLIER -61.13 -34.8 75.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.001 0.429 . . . . 0.0 110.118 179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.86 92.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.963 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.8 t -58.27 -42.08 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.16 77.1 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.222 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -64.6 -39.28 93.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.173 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.77 HD12 ' HA ' ' A' ' 229' ' ' VAL . 2.5 mt -73.5 -42.32 61.97 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -58.75 -34.06 70.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.111 0.481 . . . . 0.0 111.177 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -62.84 -20.23 64.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.399 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.922 HG21 HG21 ' A' ' 239' ' ' VAL . 26.2 p -64.49 -171.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.767 0.318 . . . . 0.0 111.151 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -143.1 -151.61 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.229 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.9 OUTLIER -43.03 -79.98 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.538 0.335 . . . . 0.0 111.479 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.449 HG21 ' HD3' ' A' ' 162' ' ' LYS . 0.5 OUTLIER -94.96 120.42 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.689 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.922 HG21 HG21 ' A' ' 235' ' ' THR . 9.2 p -119.79 120.26 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -100.57 120.15 39.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.792 ' HG ' HG13 ' A' ' 215' ' ' VAL . 1.0 OUTLIER -99.79 149.4 23.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.004 0.431 . . . . 0.0 110.522 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.663 ' CG ' HD21 ' A' ' 213' ' ' LEU . 2.7 tpmt? -108.62 118.26 36.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.196 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 211' ' ' LYS . 54.4 t -123.27 149.2 27.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.82 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.967 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -93.14 133.44 28.69 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.023 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.9 115.24 3.01 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.273 1.982 . . . . 0.0 112.624 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.9 m -82.84 176.9 8.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.704 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 60.31 81.44 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.006 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -119.01 152.89 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.03 131.98 36.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.893 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.688 HG11 ' HD2' ' A' ' 242' ' ' LYS . 24.1 t -108.49 137.27 41.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.149 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -132.26 147.1 52.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.026 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -101.66 132.34 47.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.632 HG21 HD23 ' A' ' 206' ' ' LEU . 4.3 mt -125.45 118.47 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.186 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.418 ' HB2' HG12 ' A' ' 238' ' ' VAL . 1.5 pttt -99.08 137.55 37.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.309 0.576 . . . . 0.0 112.295 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.728 HD11 ' CD1' ' A' ' 241' ' ' LEU . 5.7 mt -118.7 140.38 50.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.525 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.84 ' CD1' HG22 ' A' ' 238' ' ' VAL . 19.9 mm -96.46 131.46 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.067 0.461 . . . . 0.0 111.16 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 57.03 2.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.262 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.06 -161.64 0.2 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.062 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.53 -20.24 54.06 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.208 1.939 . . . . 0.0 112.689 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -96.68 8.27 44.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.3 -145.14 18.32 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.484 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.493 HD12 HD12 ' A' ' 163' ' ' LEU . 4.3 mm? -61.11 -37.27 82.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.761 0.315 . . . . 0.0 111.045 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.76 26.72 8.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.685 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.44 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -175.63 -169.97 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 111.017 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.6 t -134.84 158.62 43.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.553 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.691 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.77 160.21 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.833 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.0 138.15 53.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -110.17 129.45 9.36 Favored Glycine 0 CA--C 1.5 -0.847 0 C-N-CA 119.913 -1.137 . . . . 0.0 113.964 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -78.1 -28.58 55.97 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.552 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.76 122.16 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.11 -55.37 4.96 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.936 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -116.63 49.77 1.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.497 0.665 . . . . 0.0 109.412 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.3 tt0 -42.37 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.669 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 16.7 t60 -83.58 -28.11 28.78 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.129 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 190' ' ' TYR . 0.4 OUTLIER -96.52 129.64 32.66 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.84 81.91 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.056 1.837 . . . . 0.0 113.128 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.55 52.86 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.195 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -167.94 135.2 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.574 0.226 . . . . 0.0 110.74 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.419 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 0.5 OUTLIER -108.12 24.14 13.44 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.83 -168.13 1.41 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.833 HD13 ' O ' ' A' ' 175' ' ' ALA . 2.4 mm -104.58 134.42 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-O 121.278 0.561 . . . . 0.0 110.281 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.409 ' CD1' HG12 ' A' ' 183' ' ' ILE . 26.0 m-85 -135.19 151.17 50.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.252 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.593 HG21 HD13 ' A' ' 206' ' ' LEU . 39.2 t -80.12 141.73 14.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.284 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.439 ' HA ' HG23 ' A' ' 208' ' ' ILE . 2.7 t -122.94 -23.01 5.1 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -150.36 134.19 16.77 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.75 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 206' ' ' LEU . 1.0 OUTLIER -119.78 135.38 60.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.18 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.01 118.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.985 0.422 . . . . 0.0 109.919 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -37.75 94.26 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 50.03 31.69 18.52 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.392 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.68 -75.94 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.363 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -134.86 -60.21 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 0.0 110.731 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.672 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.36 -45.14 77.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.61 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.3 t-160 -60.21 -56.13 25.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.528 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? -70.53 -53.19 17.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -51.35 15.07 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.568 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -77.14 -31.04 53.99 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.822 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 60.56 30.45 19.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.125 0.462 . . . . 0.0 110.636 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.632 HD23 HG21 ' A' ' 161' ' ' ILE . 4.0 pp -102.31 129.14 48.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.924 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -109.19 173.81 6.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.018 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.1 mt -64.44 113.44 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.38 -15.04 3.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.78 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.05 142.21 39.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.935 0.368 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.721 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.8 ttpm? -102.58 128.83 49.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.111 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.75 HD13 ' CG2' ' A' ' 243' ' ' VAL . 30.4 mm -96.71 116.42 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.444 HD11 ' HB2' ' A' ' 244' ' ' ALA . 2.5 mt -79.3 -68.01 0.7 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.48 154.48 47.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.945 HG22 HD23 ' A' ' 241' ' ' LEU . 3.1 t -114.82 119.32 61.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.497 ' ND2' HG23 ' A' ' 239' ' ' VAL . 55.7 m-20 58.45 -84.79 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -140.32 12.94 2.38 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.839 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.6 p -109.69 139.87 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.003 0.43 . . . . 0.0 111.039 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.88 111.06 3.04 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.392 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.6 OUTLIER -104.17 40.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.293 0.568 . . . . 0.0 109.932 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -97.23 163.5 12.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.787 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 48.72 27.47 1.54 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.528 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.519 HG21 ' CB ' ' A' ' 227' ' ' ASP . 6.2 p -131.2 163.73 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.585 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -69.57 169.93 11.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.703 0.763 . . . . 0.0 112.176 -179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.8 t60 -56.93 -36.36 70.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.318 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -52.13 60.94 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.519 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -60.13 -36.25 77.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.926 0.393 . . . . 0.0 110.814 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.22 93.81 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.3 t -57.88 -41.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.219 0.533 . . . . 0.0 109.595 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.25 -33.39 75.4 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.366 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.714 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -64.76 -43.13 94.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.646 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.691 HD11 HG21 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -74.11 -47.3 37.15 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.877 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.45 -40.37 78.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -57.73 -20.34 33.96 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.899 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 1.096 HG21 HG21 ' A' ' 239' ' ' VAL . 16.7 p -65.99 -163.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.286 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -139.67 -150.58 0.33 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.52 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.872 0.469 . . . . 0.0 112.097 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.84 HG22 ' CD1' ' A' ' 164' ' ' ILE . 23.7 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.361 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.096 HG21 HG21 ' A' ' 235' ' ' THR . 12.9 p -116.56 131.15 70.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -90.94 141.98 28.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.351 0.595 . . . . 0.0 111.421 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.945 HD23 HG22 ' A' ' 215' ' ' VAL . 6.8 mt -118.89 138.14 52.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.92 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.688 ' HD2' HG11 ' A' ' 158' ' ' VAL . 3.6 ttpm? -106.61 124.27 49.35 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.75 ' CG2' HD13 ' A' ' 212' ' ' ILE . 53.6 t -131.66 149.67 33.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.783 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 213' ' ' LEU . . . -114.91 121.11 42.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.558 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.97 114.19 62.52 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.708 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.33 112.02 3.43 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.023 1.815 . . . . 0.0 112.431 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.9 t -143.79 36.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.786 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -88.87 -31.57 18.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.145 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.856 0.36 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -135.26 155.76 50.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.48 131.63 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 24.1 t -114.28 127.64 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 15.5 ptm -126.68 146.31 50.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.006 0.431 . . . . 0.0 111.351 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.96 140.76 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.06 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.94 HG22 HD21 ' A' ' 163' ' ' LEU . 36.6 mm -120.41 117.34 53.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.897 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.782 ' C ' HD23 ' A' ' 163' ' ' LEU . 12.2 ttmt -103.91 127.85 51.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.71 0.29 . . . . 0.0 111.73 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.94 HD21 HG22 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -127.37 129.07 46.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.309 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -99.02 127.38 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.187 0.518 . . . . 0.0 110.693 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.587 ' HE2' HD22 ' A' ' 170' ' ' LEU . 0.0 OUTLIER -66.65 79.47 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.848 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.77 -162.73 38.64 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.453 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.14 -20.92 48.7 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.339 2.026 . . . . 0.0 112.431 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -99.29 -5.06 30.45 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.82 -133.71 12.01 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.078 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.745 HD12 HD12 ' A' ' 163' ' ' LEU . 1.9 mm? -60.76 -36.02 77.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.596 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 80.2 33.29 32.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.045 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.585 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 3.7 p90 -177.09 -173.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.875 0.369 . . . . 0.0 110.679 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 192' ' ' THR . 0.6 OUTLIER -134.69 159.63 40.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.002 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.1 pp -122.04 161.57 22.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.023 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.887 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -131.05 138.1 49.45 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.425 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -114.68 131.21 9.67 Favored Glycine 0 CA--C 1.502 -0.729 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.673 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.79 -22.16 58.41 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.54 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.3 t -89.87 117.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.98 5.02 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.077 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -113.09 55.0 0.71 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.528 0.68 . . . . 0.0 109.384 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 1.8 tt0 -45.56 115.88 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.69 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 38.3 t60 -100.39 -32.14 10.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.537 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.422 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.2 mm -96.7 127.41 39.56 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.146 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.36 78.73 2.26 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.021 1.814 . . . . 0.0 113.079 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 126.4 10.14 4.24 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.016 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -133.01 134.58 44.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.525 0.662 . . . . 0.0 111.084 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 7.8 m120 -106.74 26.27 10.21 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.28 -164.66 0.93 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.64 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.887 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.7 mm -105.64 132.46 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.243 0.544 . . . . 0.0 110.448 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.422 ' CD1' HG13 ' A' ' 183' ' ' ILE . 9.8 m-85 -135.13 153.99 51.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.496 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.604 HG21 HD12 ' A' ' 206' ' ' LEU . 33.1 t -79.54 141.34 15.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.268 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.505 HG23 ' HB3' ' A' ' 173' ' ' SER . 8.1 t -121.53 -21.55 6.2 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.32 136.79 14.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.163 0.506 . . . . 0.0 111.964 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.9 mm -121.2 136.23 58.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.826 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -79.92 115.31 22.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.032 0.444 . . . . 0.0 109.809 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -37.76 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.932 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.03 50.8 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.827 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.03 -81.75 0.42 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.586 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.596 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -129.56 -60.94 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.932 0.396 . . . . 0.0 111.163 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.899 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -66.57 -42.35 87.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.608 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.628 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.3 t-160 -63.75 -55.38 23.66 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -51.63 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.5 -49.1 28.39 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.1 -37.16 11.6 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.885 -0.674 . . . . 0.0 114.363 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.51 51.33 2.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.453 0.644 . . . . 0.0 109.936 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.899 HD21 ' HB1' ' A' ' 200' ' ' ALA . 1.9 pt? -116.64 139.76 50.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.779 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.5 165.13 13.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 192' ' ' THR . 37.8 mt -60.8 112.45 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.789 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.85 -14.59 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.075 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.61 143.23 36.6 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.123 0.462 . . . . 0.0 111.141 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.741 ' O ' HG13 ' A' ' 243' ' ' VAL . 9.1 ttpt -103.95 129.22 51.48 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.302 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.916 HD13 ' CG2' ' A' ' 243' ' ' VAL . 20.5 mm -90.74 124.8 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 111.693 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.49 HD12 ' HG2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -93.55 -39.11 11.03 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.581 0.705 . . . . 0.0 110.098 179.324 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -166.21 154.67 10.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.918 HG23 HD21 ' A' ' 220' ' ' LEU . 24.2 t -124.47 119.88 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.583 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 61.3 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.4 m -143.26 13.52 1.81 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.907 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.8 140.25 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 120.932 0.396 . . . . 0.0 111.425 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.97 107.48 2.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.038 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.918 HD21 HG23 ' A' ' 215' ' ' VAL . 0.1 OUTLIER -100.39 37.84 1.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.258 0.552 . . . . 0.0 110.242 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -99.56 162.85 12.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.473 0.654 . . . . 0.0 111.881 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 48.41 27.56 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.645 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.437 HG21 ' CB ' ' A' ' 227' ' ' ASP . 4.9 p -132.67 162.9 39.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.773 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.75 168.4 9.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.793 0.806 . . . . 0.0 112.224 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.835 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.9 t60 -57.51 -36.32 71.39 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.929 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -65.17 -51.79 58.96 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.437 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.1 t70 -59.23 -36.64 75.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.836 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.78 98.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.032 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 225' ' ' HIS . 16.6 t -56.38 -41.57 72.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.647 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.69 -32.64 74.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.481 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.678 ' CB ' HD22 ' A' ' 220' ' ' LEU . . . -65.19 -50.35 66.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.867 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 235' ' ' THR . 3.7 pp -73.6 -40.74 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.475 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.539 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -57.79 -37.95 74.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.101 0.476 . . . . 0.0 111.481 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -60.49 -20.31 59.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.792 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 1.093 HG21 HG21 ' A' ' 239' ' ' VAL . 25.7 p -61.72 -163.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.818 -0.174 . . . . 0.0 111.403 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -138.35 -151.13 0.37 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 165' ' ' LYS . 1.5 m-20 -44.42 -81.16 0.01 OUTLIER 'General case' 0 C--N 1.342 0.26 0 C-N-CA 122.391 0.277 . . . . 0.0 111.673 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.06 118.76 43.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.982 0.42 . . . . 0.0 110.461 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.093 HG21 HG21 ' A' ' 235' ' ' THR . 14.2 p -120.51 126.13 74.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.262 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.85 120.22 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.775 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.7 mp -98.13 142.7 29.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.49 ' HG2' HD12 ' A' ' 213' ' ' LEU . 1.9 ttpt -107.12 118.09 35.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.916 ' CG2' HD13 ' A' ' 212' ' ' ILE . 37.7 t -123.5 149.19 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.099 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 213' ' ' LEU . . . -132.86 128.03 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.579 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.32 109.44 42.67 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.43 84.3 1.19 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.14 1.893 . . . . 0.0 111.853 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 13.4 m -157.19 161.6 39.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -137.25 30.15 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.35 -0.833 . . . . 0.0 111.124 179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.799 0.333 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -135.95 -179.79 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -95.86 138.9 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.84 120.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 111.648 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.38 155.18 48.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.397 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -124.08 126.98 47.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.963 0.411 . . . . 0.0 111.203 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.835 HG21 HD23 ' A' ' 206' ' ' LEU . 35.4 mm -99.32 118.92 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.583 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 240' ' ' TYR . 2.7 ttpp -106.36 127.94 53.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 111.565 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.763 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -135.22 152.22 51.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.866 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.568 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -108.99 130.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.865 0.364 . . . . 0.0 110.285 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.568 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -54.65 90.3 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.127 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -70.26 170.89 44.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.549 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.3 -20.46 32.21 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.264 1.976 . . . . 0.0 112.645 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -2.0 35.84 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.08 -150.51 18.71 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.929 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.425 ' CD1' HG11 ' A' ' 239' ' ' VAL . 4.5 mm? -60.49 -37.52 81.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 93.04 29.29 10.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.701 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.55 179.3 1.17 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.954 0.407 . . . . 0.0 111.097 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.6 t -124.64 164.0 20.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.774 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -128.0 162.65 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.319 0.581 . . . . 0.0 112.292 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.908 ' HB2' ' CG2' ' A' ' 192' ' ' THR . . . -130.51 139.91 50.5 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.159 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -117.3 133.74 10.77 Favored Glycine 0 CA--C 1.507 -0.459 0 C-N-CA 120.108 -1.044 . . . . 0.0 113.908 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -88.18 -15.41 60.76 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.716 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 224' ' ' MET . 5.4 t -90.68 115.55 30.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 117.604 0.702 . . . . 0.0 112.204 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -57.29 4.03 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.223 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.09 54.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.1 mt-30 -45.79 119.69 2.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.006 -0.997 . . . . 0.0 113.629 -178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 28.4 t60 -109.43 -28.42 8.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.72 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.74 121.72 58.85 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.797 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.61 80.76 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.217 1.945 . . . . 0.0 112.486 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 106.37 54.31 0.7 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.986 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.64 119.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.75 0.31 . . . . 0.0 110.676 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.408 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 2.8 m120 -96.14 38.74 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.171 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.1 m -119.44 -166.25 1.25 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.009 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.873 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -104.67 135.74 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 121.128 0.49 . . . . 0.0 110.207 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 25.6 m-85 -135.72 150.89 49.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.685 178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.489 HG21 HD13 ' A' ' 206' ' ' LEU . 21.5 t -79.95 142.12 14.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.506 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.908 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 6.7 p -117.1 -39.76 3.19 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.552 ' C ' HD13 ' A' ' 194' ' ' ILE . 29.9 tttp -137.53 137.99 39.18 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.899 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.634 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -120.6 134.74 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.66 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.4 mm -81.48 113.71 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.903 0.382 . . . . 0.0 110.101 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -36.42 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.463 -0.79 . . . . 0.0 113.123 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.55 21.3 27.49 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.247 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.78 -91.41 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.093 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -122.49 -63.08 1.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.027 0.441 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -61.2 -46.53 90.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.288 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.634 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.4 t-160 -59.23 -57.27 13.78 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -71.13 -52.8 17.24 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.55 -50.62 20.44 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 161' ' ' ILE . . . -76.11 -33.5 49.58 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.959 -0.638 . . . . 0.0 113.714 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.5 34.99 17.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.126 0.489 . . . . 0.0 110.003 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.835 HD23 HG21 ' A' ' 161' ' ' ILE . 3.5 pp -108.07 139.94 41.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.222 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -115.99 -179.42 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 191' ' ' VAL . 21.4 mt -69.18 134.97 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.848 0.356 . . . . 0.0 111.112 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.34 -14.03 30.63 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.244 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -71.27 134.59 46.92 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 117.201 0.501 . . . . 0.0 110.936 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.869 ' O ' HG23 ' A' ' 243' ' ' VAL . 18.9 tttt -92.29 129.2 38.3 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 120.896 0.379 . . . . 0.0 110.589 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.462 HG21 HD23 ' A' ' 241' ' ' LEU . 18.7 mm -109.78 138.61 36.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.481 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.789 HD21 ' HG2' ' A' ' 242' ' ' LYS . 2.2 pp -118.2 -9.31 10.49 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -170.59 153.4 4.16 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.973 0.416 . . . . 0.0 111.675 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.778 HG12 ' CG2' ' A' ' 239' ' ' VAL . 0.3 OUTLIER -125.62 118.86 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.149 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.56 ' HB2' HG23 ' A' ' 239' ' ' VAL . 28.1 t30 56.04 -87.48 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 215' ' ' VAL . 10.4 m -137.25 13.74 3.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.614 0.245 . . . . 0.0 110.637 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.24 140.57 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.771 0.319 . . . . 0.0 110.786 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -99.6 92.43 1.15 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.597 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.869 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -77.75 -3.92 43.71 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 178.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.479 ' N ' HD12 ' A' ' 220' ' ' LEU . 3.4 pt-20 -68.26 167.54 14.16 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 111.229 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 49.05 25.93 1.25 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.623 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.869 HG12 ' O ' ' A' ' 220' ' ' LEU . 3.1 p -138.01 162.48 31.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.446 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.413 ' HA ' ' HB ' ' A' ' 178' ' ' VAL . 8.4 mtt -67.19 169.25 8.94 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.739 0.78 . . . . 0.0 111.955 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.88 ' O ' HG23 ' A' ' 229' ' ' VAL . 53.5 t60 -58.29 -36.97 74.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.193 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.21 -52.34 42.36 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.1 OUTLIER -62.1 -34.9 77.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.061 0.458 . . . . 0.0 109.884 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.52 -38.85 88.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.686 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 225' ' ' HIS . 23.3 t -59.1 -41.61 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.258 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.6 74.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.299 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.594 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -69.79 -38.71 76.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.1 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.774 HD11 HG21 ' A' ' 174' ' ' ILE . 1.5 mt -72.97 -39.74 65.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.658 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -33.61 76.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.161 0.505 . . . . 0.0 110.785 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.1 -20.3 65.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.571 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.69 HG21 HG21 ' A' ' 239' ' ' VAL . 71.2 p -51.86 176.83 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.994 0.426 . . . . 0.0 111.74 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -139.33 -148.94 0.27 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -41.61 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 122.654 0.381 . . . . 0.0 111.785 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.43 124.95 59.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.778 ' CG2' HG12 ' A' ' 215' ' ' VAL . 8.1 p -113.6 120.21 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.416 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 0.1 OUTLIER -111.93 118.27 35.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 109.65 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.604 ' HG ' HG13 ' A' ' 215' ' ' VAL . 1.6 mp -100.4 153.17 19.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.31 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.789 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.3 OUTLIER -106.44 116.32 31.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.1 p -113.24 144.56 20.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.436 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.49 122.74 43.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.765 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -102.11 133.88 20.39 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.249 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 108.3 2.66 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.17 1.914 . . . . 0.0 112.31 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.1 t -63.6 -24.64 67.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.644 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.98 -60.11 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.927 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.162 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.805 0.335 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.65 -179.66 4.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.965 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 94.8 9.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 t -101.96 131.55 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.3 ptm -132.15 152.23 51.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.172 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -100.53 139.37 36.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.943 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 206' ' ' LEU . 10.5 mt -125.53 118.64 52.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.256 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.753 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.7 OUTLIER -99.47 139.42 35.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.293 0.568 . . . . 0.0 112.13 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.987 HD11 HD11 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -129.29 129.55 45.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.026 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.764 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -96.91 134.49 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.282 0.563 . . . . 0.0 111.64 -179.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.764 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -73.29 94.34 2.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.925 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -103.45 -158.57 24.9 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.139 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.52 -23.34 75.08 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.188 1.925 . . . . 0.0 112.234 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -101.86 -4.28 26.53 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 89.11 -136.5 13.63 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.444 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.543 HD13 ' HE2' ' A' ' 165' ' ' LYS . 3.9 mm? -59.75 -33.27 71.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.866 0.365 . . . . 0.0 110.942 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 83.61 31.7 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.546 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.594 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -175.13 -172.93 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 110.871 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.0 t -132.98 160.49 36.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.882 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.632 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -121.95 155.99 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.165 0.507 . . . . 0.0 111.226 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.913 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -126.63 138.32 53.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.235 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.26 129.98 9.19 Favored Glycine 0 CA--C 1.504 -0.653 0 C-N-CA 119.938 -1.125 . . . . 0.0 113.759 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 187' ' ' ASN . . . -84.83 -16.0 66.5 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.696 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.4 ' HB ' ' N ' ' A' ' 224' ' ' MET . 11.3 t -90.96 115.54 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 117.672 0.736 . . . . 0.0 112.012 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.86 -57.74 4.27 Favored Glycine 0 C--N 1.329 0.188 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.083 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -102.72 51.8 0.8 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.442 0.639 . . . . 0.0 109.684 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.424 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.2 mt-30 -45.23 117.9 1.53 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.664 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 24.1 t60 -105.87 -32.06 8.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.843 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 190' ' ' TYR . 19.1 mm -95.47 126.05 47.26 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.338 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 77.62 1.19 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.29 1.993 . . . . 0.0 113.24 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 125.33 10.62 4.51 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.517 -0.849 . . . . 0.0 114.12 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -133.45 131.4 39.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 117.585 0.693 . . . . 0.0 111.348 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.431 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 9.8 m120 -103.8 29.1 6.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.44 -165.01 1.01 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -103.3 129.88 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 121.195 0.521 . . . . 0.0 110.421 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.452 ' CD1' HG13 ' A' ' 183' ' ' ILE . 4.5 m-85 -134.54 155.06 51.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.981 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.506 HG11 ' CD1' ' A' ' 194' ' ' ILE . 32.1 t -80.33 138.56 19.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.619 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.505 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.8 t -121.67 -19.07 6.95 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.5 133.17 14.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.921 0.391 . . . . 0.0 111.609 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.677 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.3 OUTLIER -120.58 134.03 65.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 46.1 mm -82.31 117.65 28.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.941 0.401 . . . . 0.0 110.034 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -41.97 101.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.588 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.61 24.21 38.83 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.84 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.23 -89.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.329 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -131.44 -56.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.948 0.404 . . . . 0.0 110.983 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -66.87 -46.3 75.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.17 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.677 ' HB2' HG22 ' A' ' 194' ' ' ILE . 9.7 t-160 -59.99 -56.06 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.681 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -52.62 22.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.38 -51.13 15.95 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.545 ' CA ' HG23 ' A' ' 161' ' ' ILE . . . -79.46 -28.57 51.98 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.022 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 63.57 30.87 14.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.022 0.411 . . . . 0.0 110.522 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 206' ' ' LEU . 2.6 pp -102.91 141.12 36.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.843 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -123.05 167.86 13.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.764 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.505 HG23 ' HA ' ' A' ' 192' ' ' THR . 35.1 mt -59.0 106.26 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 145.48 -16.95 1.85 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.914 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.55 ' OD2' HG11 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -79.4 148.04 32.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.946 0.373 . . . . 0.0 110.894 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.694 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.7 OUTLIER -112.21 130.34 55.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.821 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.621 HG21 HD21 ' A' ' 220' ' ' LEU . 19.6 mm -92.97 116.1 33.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.444 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.69 HD21 ' HG3' ' A' ' 242' ' ' LYS . 0.9 OUTLIER -91.84 -10.39 39.95 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 172.12 145.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 122.499 0.32 . . . . 0.0 110.339 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.935 HG22 HD23 ' A' ' 241' ' ' LEU . 4.9 t -118.85 119.35 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.402 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 36.7 t30 56.56 -86.6 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.153 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 5.8 m -137.5 12.61 2.98 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.655 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.2 p -109.4 140.6 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.694 0.283 . . . . 0.0 110.721 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.8 87.46 0.55 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.492 -0.861 . . . . 0.0 113.261 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.885 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -72.12 -9.05 57.89 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.107 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.563 ' N ' HD12 ' A' ' 220' ' ' LEU . 2.1 pt-20 -67.67 168.22 11.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.27 0.557 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 t70 49.15 24.46 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.963 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.885 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.7 p -137.4 163.73 30.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.651 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.4 ' N ' ' HB ' ' A' ' 178' ' ' VAL . 0.8 OUTLIER -66.84 167.11 12.03 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.596 0.712 . . . . 0.0 111.447 -179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.6 t60 -58.01 -36.46 72.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.046 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.18 -52.33 49.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -61.93 -34.74 76.63 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.38 87.11 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.565 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 225' ' ' HIS . 37.6 t -59.16 -41.03 82.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.379 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.09 74.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.51 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -65.97 -45.39 81.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.632 HD11 HG21 ' A' ' 174' ' ' ILE . 1.1 mt -74.12 -39.77 63.12 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.582 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.426 ' HG3' HG12 ' A' ' 229' ' ' VAL . 11.2 mmtt -58.23 -46.52 85.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -57.81 -19.81 31.25 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.282 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 239' ' ' VAL . 29.9 p -56.4 -169.27 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.682 0.277 . . . . 0.0 111.372 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.84 -153.07 0.45 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.371 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 165' ' ' LYS . 3.7 m-20 -42.49 -80.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.407 0.283 . . . . 0.0 111.55 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 238' ' ' VAL . 2.6 p -98.15 116.92 42.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.052 0.453 . . . . 0.0 110.831 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 235' ' ' THR . 13.5 p -112.91 126.81 70.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.752 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -91.57 141.79 28.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.719 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.987 HD11 HD11 ' A' ' 163' ' ' LEU . 6.7 mt -118.16 136.56 53.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.491 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.69 ' HG3' HD21 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -107.41 117.72 34.84 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 211' ' ' LYS . 73.6 t -125.2 151.08 30.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.257 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.81 125.96 54.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.84 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -92.89 109.72 41.04 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.893 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.38 82.92 2.13 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.179 1.92 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.32 138.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -103.7 82.63 2.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.073 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.922 0.392 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.48 -170.94 0.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.74 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.58 93.66 6.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.525 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.3 t -98.45 120.23 47.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.608 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.421 ' O ' HG12 ' A' ' 243' ' ' VAL . 9.3 ptp -132.73 148.58 52.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -105.26 140.54 38.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 111.314 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.898 HD13 ' HB3' ' A' ' 206' ' ' LEU . 2.1 mt -104.87 119.24 53.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.143 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -99.54 119.92 38.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.412 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 170' ' ' LEU . 3.3 pp -137.25 146.09 44.35 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.553 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -97.83 135.21 33.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.279 0.562 . . . . 0.0 111.783 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.553 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -49.83 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.395 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.46 156.0 7.51 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.512 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.39 -24.09 41.55 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.995 1.797 . . . . 0.0 112.245 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -102.22 15.37 29.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.69 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 119.24 -151.05 17.72 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.257 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.44 HD11 HG21 ' A' ' 239' ' ' VAL . 4.6 mm? -73.38 -37.05 66.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.757 0.313 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.497 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 96.09 34.22 6.0 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.506 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.545 ' N ' HD13 ' A' ' 195' ' ' ILE . 0.3 OUTLIER -176.49 -172.7 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.3 m -137.69 157.64 46.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.652 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 228' ' ' ALA . 1.0 OUTLIER -121.59 162.52 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.276 0.56 . . . . 0.0 111.444 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 182' ' ' HIS . . . -125.43 139.2 53.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.074 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.99 129.44 9.52 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.959 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -79.91 -31.11 40.57 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.559 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.28 123.2 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.12 -56.07 5.06 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.008 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -114.48 48.8 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.554 0.693 . . . . 0.0 109.542 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 4.0 tt0 -43.19 105.95 0.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.713 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 34.4 t60 -90.29 -31.72 16.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.786 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.402 HG13 ' CD1' ' A' ' 190' ' ' TYR . 10.6 mm -96.84 121.74 58.64 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.152 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.45 78.99 0.87 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.118 1.878 . . . . 0.0 113.111 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 128.55 6.64 4.59 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.114 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.36 129.43 44.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 117.6 0.7 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 27.7 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 -162.41 0.84 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.955 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 175' ' ' ALA . 4.8 mm -102.33 137.3 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.482 0.658 . . . . 0.0 110.781 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.402 ' CD1' HG13 ' A' ' 183' ' ' ILE . 14.1 m-85 -135.43 144.62 46.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.961 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 206' ' ' LEU . 47.8 t -80.29 139.03 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.814 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.757 ' HA ' HG23 ' A' ' 208' ' ' ILE . 5.0 t -123.74 -14.66 7.19 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.638 ' C ' HD13 ' A' ' 194' ' ' ILE . 14.8 ttmt -155.32 133.27 11.44 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.068 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.646 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -121.36 135.29 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.02 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.545 HD13 ' N ' ' A' ' 172' ' ' PHE . 1.8 mp -80.77 118.01 27.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -38.36 100.72 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.946 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.8 22.97 35.73 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.127 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.73 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.225 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -133.82 -53.61 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 110.692 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -65.07 -45.53 84.89 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.071 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.646 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.9 t-160 -59.42 -56.36 23.04 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -52.89 20.65 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.76 -50.42 20.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.53 -27.3 59.51 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.883 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 59.86 26.06 15.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.1 0.45 . . . . 0.0 110.797 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.898 ' HB3' HD13 ' A' ' 161' ' ' ILE . 3.7 pp -97.6 139.7 33.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -121.79 170.16 10.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.95 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.757 HG23 ' HA ' ' A' ' 192' ' ' THR . 46.8 mt -60.84 112.66 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.964 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.5 3.74 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.255 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.771 ' OD2' HG21 ' A' ' 243' ' ' VAL . 0.8 OUTLIER -77.83 138.3 38.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.126 0.463 . . . . 0.0 111.296 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.877 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.2 OUTLIER -94.39 129.82 40.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.316 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.58 HG21 HD23 ' A' ' 241' ' ' LEU . 22.8 mm -110.8 134.65 52.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.477 . . . . 0.0 111.899 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.438 HD11 ' HG2' ' A' ' 242' ' ' LYS . 0.2 OUTLIER -117.06 -3.12 11.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.694 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -172.97 148.34 1.75 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.968 0.413 . . . . 0.0 111.523 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.744 HG13 ' HG ' ' A' ' 241' ' ' LEU . 3.3 t -130.06 119.97 48.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.054 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 61.26 -85.39 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 30.0 t -144.17 14.79 1.67 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.951 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.4 p -109.04 140.0 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 120.96 0.409 . . . . 0.0 111.595 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.65 102.95 2.44 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.261 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.717 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.4 OUTLIER -100.29 38.33 1.51 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.531 . . . . 0.0 110.197 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -93.4 164.21 13.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.448 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.6 t0 45.38 29.99 0.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.504 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 224' ' ' MET . 3.5 p -133.67 167.61 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.48 ' H ' HG22 ' A' ' 223' ' ' VAL . 4.2 mtm -75.41 172.72 12.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.779 0.8 . . . . 0.0 112.654 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.872 ' O ' HG23 ' A' ' 229' ' ' VAL . 58.5 t60 -57.29 -38.51 74.08 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.362 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -63.33 -51.79 64.54 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.421 ' CB ' HG21 ' A' ' 223' ' ' VAL . 4.2 t0 -60.0 -36.32 76.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.85 0.357 . . . . 0.0 110.806 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.528 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.55 -38.89 92.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.2 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.5 t -57.7 -43.05 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.166 0.508 . . . . 0.0 109.631 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.97 -32.61 74.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.21 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.717 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -63.9 -39.32 93.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.542 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 229' ' ' VAL . 2.1 mt -70.38 -42.93 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.61 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -60.02 -33.55 72.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -60.94 -25.2 66.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.72 ' HB ' HG22 ' A' ' 239' ' ' VAL . 31.0 p -56.17 -173.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.034 0.445 . . . . 0.0 111.638 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -145.21 -149.85 0.3 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.537 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -39.15 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.036 0.534 . . . . 0.0 112.383 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 p -97.02 120.93 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.885 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.72 HG22 ' HB ' ' A' ' 235' ' ' THR . 42.9 t -107.03 119.97 57.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.782 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.52 118.81 34.18 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.731 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.744 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.9 mp -98.82 153.11 19.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' A' ' 213' ' ' LEU . 1.7 tppp? -106.4 117.05 33.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.5 p -124.71 144.22 35.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.511 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.607 ' HB3' ' HD2' ' A' ' 211' ' ' LYS . . . -115.35 127.17 55.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.463 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.4 mmmm -93.84 109.25 40.38 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.59 120.54 6.99 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.177 1.918 . . . . 0.0 111.908 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 4.9 p 50.62 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.455 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.26 -76.32 0.52 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.77 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.261 179.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.844 0.354 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -109.94 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -96.61 137.27 35.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.005 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.03 120.44 53.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.115 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.8 ptm -132.56 153.96 50.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.55 126.33 54.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.205 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.927 HD13 ' HB3' ' A' ' 206' ' ' LEU . 1.8 mt -98.4 118.9 45.67 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.127 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -106.62 121.92 45.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.0 112.045 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.646 HD11 ' CD1' ' A' ' 170' ' ' LEU . 3.4 pp -136.46 145.92 45.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.716 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.1 OUTLIER -97.29 134.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.124 0.487 . . . . 0.0 111.473 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -48.67 93.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.391 179.466 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.42 166.89 8.42 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.779 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.38 -27.4 75.57 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.297 1.998 . . . . 0.0 112.317 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -101.65 15.56 28.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.875 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.52 -152.86 17.53 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.724 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.646 ' CD1' HD11 ' A' ' 163' ' ' LEU . 4.1 mm? -61.78 -34.47 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.726 0.298 . . . . 0.0 111.151 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 91.03 35.99 6.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.41 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -165.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.745 0.307 . . . . 0.0 110.688 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.9 t -139.52 162.48 34.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.689 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.409 HD12 ' ND1' ' A' ' 225' ' ' HIS . 1.3 pp -129.54 159.86 41.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.214 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.914 ' HB2' ' CG2' ' A' ' 192' ' ' THR . . . -125.52 137.97 53.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.747 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -109.12 130.47 10.03 Favored Glycine 0 CA--C 1.503 -0.718 0 C-N-CA 120.187 -1.006 . . . . 0.0 113.859 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.4 -25.16 52.09 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.416 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.577 HG22 ' HB3' ' A' ' 187' ' ' ASN . 18.0 t -89.93 117.3 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -56.05 5.05 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.092 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -109.8 49.22 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.563 0.697 . . . . 0.0 109.31 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.2 tt0 -43.55 115.93 0.87 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.67 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 11.2 t60 -107.04 -26.32 11.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.497 177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 126.74 43.01 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.35 81.24 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.151 1.901 . . . . 0.0 112.909 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 101.82 56.67 0.84 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.019 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.57 117.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.685 0.279 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 178' ' ' VAL . 65.7 m-20 -95.11 44.43 1.09 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.928 0.394 . . . . 0.0 111.066 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.17 -161.13 0.94 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.244 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.882 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -111.66 134.44 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 211' ' ' LYS . 21.3 m-85 -135.45 154.28 51.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.633 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.583 HG11 HD11 ' A' ' 194' ' ' ILE . 36.2 t -80.22 143.18 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.753 0.311 . . . . 0.0 111.117 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.914 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 18.1 p -117.7 -49.37 2.55 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -136.58 139.38 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.033 0.444 . . . . 0.0 111.95 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 HD12 ' A' ' 206' ' ' LEU . 2.2 mm -118.22 136.36 55.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.753 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.64 113.85 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.031 0.444 . . . . 0.0 109.946 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -35.56 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.346 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.93 27.37 44.48 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.47 -0.786 . . . . 0.0 113.239 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -70.82 -70.82 1.12 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.386 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.16 -61.19 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.843 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -60.85 -45.34 94.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.107 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.517 ' HB2' HG22 ' A' ' 194' ' ' ILE . 5.2 t-160 -59.31 -56.42 22.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.885 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.52 -52.87 18.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.8 -50.87 18.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.21 -33.89 43.11 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.838 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.25 38.35 10.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.184 0.516 . . . . 0.0 110.399 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.927 ' HB3' HD13 ' A' ' 161' ' ' ILE . 3.7 pp -107.97 140.46 41.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.029 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -124.56 174.43 7.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.648 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.61 HD12 ' C ' ' A' ' 192' ' ' THR . 2.7 mm -64.21 127.74 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.001 0.429 . . . . 0.0 111.321 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 121.59 -16.49 9.01 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.702 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.36 139.65 37.7 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.922 0.361 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.726 ' O ' HG13 ' A' ' 243' ' ' VAL . 2.1 ttmt -100.61 128.8 46.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.249 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.598 ' HA ' HG22 ' A' ' 243' ' ' VAL . 20.8 mm -94.78 119.14 42.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.849 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -95.5 -5.49 42.74 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.885 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 175.3 154.26 0.15 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.76 0.314 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.799 HG13 HD23 ' A' ' 241' ' ' LEU . 2.4 t -126.15 120.15 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.68 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 35.2 t30 59.33 -86.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.7 m -141.14 12.98 2.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.913 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 215' ' ' VAL . 8.1 p -109.43 140.59 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.34 104.71 2.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.672 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.43 HD22 ' HB1' ' A' ' 228' ' ' ALA . 0.3 OUTLIER -98.1 33.56 2.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.449 179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -93.57 158.87 15.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.405 0.621 . . . . 0.0 112.036 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 49.73 30.44 3.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.329 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 224' ' ' MET . 5.0 p -134.16 164.83 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.19 169.54 10.18 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.745 0.783 . . . . 0.0 112.493 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.879 ' O ' HG23 ' A' ' 229' ' ' VAL . 60.9 t60 -57.89 -36.57 72.6 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.861 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -51.46 60.44 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.411 ' CB ' HG21 ' A' ' 223' ' ' VAL . 7.8 t70 -59.44 -36.34 75.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.989 0.423 . . . . 0.0 110.918 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.43 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.97 -39.75 93.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.98 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.6 t -57.04 -41.47 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.239 0.543 . . . . 0.0 109.553 178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.84 74.66 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.675 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.491 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -63.68 -50.73 68.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.993 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.606 HD12 ' N ' ' A' ' 233' ' ' LYS . 3.8 pp -73.62 -40.73 63.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.769 0.318 . . . . 0.0 111.222 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.606 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.2 OUTLIER -59.38 -33.29 71.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.571 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.62 -21.18 63.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.902 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 232' ' ' LEU . 32.8 p -54.19 -175.06 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -136.17 -145.78 0.22 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -38.72 -74.64 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 p -99.22 128.06 51.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.145 0.497 . . . . 0.0 111.765 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 170' ' ' LEU . 38.9 t -114.4 119.88 62.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.51 119.95 37.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.31 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 215' ' ' VAL . 1.1 mt -96.73 145.77 25.49 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.937 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -107.86 117.15 33.36 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 211' ' ' LYS . 75.7 t -127.85 150.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.378 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -123.82 123.51 40.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.117 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -93.09 129.73 38.48 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.062 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.39 103.98 1.5 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.17 1.913 . . . . 0.0 112.196 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 p -95.05 146.29 24.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.944 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -80.09 -59.56 2.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.05 -179.829 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.778 0.323 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -146.89 -176.89 5.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.9 131.49 36.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.9 t -108.6 139.72 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.985 0.421 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.12 154.05 49.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -119.64 134.7 55.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.603 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.783 HG22 HD21 ' A' ' 163' ' ' LEU . 38.3 mm -119.37 118.78 58.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.84 ' O ' HD23 ' A' ' 163' ' ' LEU . 4.9 ttmm -99.71 131.65 45.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.84 HD23 ' O ' ' A' ' 162' ' ' LYS . 3.5 mt -133.24 129.06 37.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.017 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.808 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -99.59 135.32 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.12 0.486 . . . . 0.0 111.12 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.808 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -76.08 98.71 4.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.833 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.46 -147.93 13.05 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.029 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.01 -22.91 34.85 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.486 2.124 . . . . 0.0 112.26 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -101.7 -4.44 26.48 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 85.96 -138.83 16.47 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.173 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.427 HD13 ' HE2' ' A' ' 165' ' ' LYS . 4.3 mm? -57.77 -37.38 73.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.838 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.476 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 81.41 39.2 12.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.793 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.524 ' N ' HD13 ' A' ' 195' ' ' ILE . 0.1 OUTLIER -176.53 -177.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 0.0 111.054 179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 7.7 t -133.24 158.87 41.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.619 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.27 162.17 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.159 0.504 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.62 138.42 52.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.526 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.86 130.35 9.99 Favored Glycine 0 CA--C 1.504 -0.6 0 C-N-CA 120.13 -1.033 . . . . 0.0 114.007 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -82.37 -27.47 43.67 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.443 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 18.3 t -89.65 119.54 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.45 -55.83 5.04 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.047 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -112.6 50.42 0.87 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.529 0.68 . . . . 0.0 109.523 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.43 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.6 tt0 -43.81 115.91 0.89 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 7.3 t60 -106.8 -25.87 11.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.452 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.433 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.6 OUTLIER -95.74 123.91 54.35 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.394 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.93 80.85 0.27 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.058 1.839 . . . . 0.0 112.27 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 104.71 55.96 0.73 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -172.26 123.84 0.49 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.739 0.304 . . . . 0.0 110.749 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.2 28.37 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.831 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.81 -166.24 1.06 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.9 mm -102.8 134.89 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.433 ' CG ' HG12 ' A' ' 183' ' ' ILE . 18.1 m-85 -134.45 153.13 52.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.588 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.62 HG11 ' CD1' ' A' ' 194' ' ' ILE . 49.0 t -80.29 142.06 14.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.084 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.473 ' HA ' HG23 ' A' ' 208' ' ' ILE . 4.2 t -124.47 -17.79 5.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -159.31 136.27 9.54 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.174 0.512 . . . . 0.0 112.061 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.683 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.2 mm -120.85 135.12 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.747 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 172' ' ' PHE . 1.7 mp -81.54 117.66 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -36.95 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.005 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 54.11 23.75 25.76 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.999 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.74 -78.26 0.21 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.229 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -139.11 -57.18 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.929 0.395 . . . . 0.0 110.772 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.97 -45.79 76.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.054 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.683 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.2 t-160 -59.33 -55.73 31.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.876 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -51.45 37.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.36 -50.27 22.87 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.87 -34.8 29.74 Favored Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 114.096 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 66.26 34.66 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.153 0.477 . . . . 0.0 110.21 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.627 ' CD2' HG21 ' A' ' 161' ' ' ILE . 2.1 pp -102.5 140.17 37.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.992 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -117.59 169.62 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.902 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.473 HG23 ' HA ' ' A' ' 192' ' ' THR . 34.1 mt -62.97 127.78 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.768 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.91 -21.34 7.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.778 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.85 159.82 29.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.854 0.359 . . . . 0.0 111.242 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.712 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -116.96 129.89 56.34 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.362 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.537 HD13 HG22 ' A' ' 243' ' ' VAL . 32.4 mm -100.29 117.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.562 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.574 HD21 ' HG2' ' A' ' 242' ' ' LYS . 0.6 OUTLIER -97.67 -5.74 34.65 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 175.26 149.66 0.1 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.85 0.357 . . . . 0.0 111.297 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.862 HG13 ' HG ' ' A' ' 241' ' ' LEU . 2.1 t -123.87 119.18 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.895 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.434 ' CG ' HG23 ' A' ' 239' ' ' VAL . 1.9 m-20 57.9 -85.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.217 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 59.6 p -139.35 10.99 2.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.26 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.624 HG12 ' O ' ' A' ' 215' ' ' VAL . 11.0 p -109.8 140.74 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 120.932 0.396 . . . . 0.0 111.46 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.12 106.08 2.82 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.223 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.548 HD21 ' CG2' ' A' ' 215' ' ' VAL . 0.4 OUTLIER -99.15 37.54 1.53 Allowed 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.143 0.497 . . . . 0.0 110.269 179.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -98.6 166.65 11.24 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.338 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 46.12 27.98 0.6 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.903 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 227' ' ' ASP . 4.8 p -133.78 164.47 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.762 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.403 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -70.46 169.26 14.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.733 0.778 . . . . 0.0 112.093 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.877 ' O ' HG23 ' A' ' 229' ' ' VAL . 61.8 t60 -57.27 -36.85 71.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.273 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.76 -52.38 51.48 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.2 OUTLIER -60.33 -35.64 76.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.678 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.024 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.877 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.6 t -57.77 -41.72 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.247 0.546 . . . . 0.0 109.855 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.406 ' HA ' ' CG ' ' A' ' 233' ' ' LYS . . . -64.59 -34.16 77.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.657 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.536 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -66.54 -50.39 63.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 235' ' ' THR . 3.0 pp -73.27 -40.03 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.441 ' N ' HD12 ' A' ' 232' ' ' LEU . 0.0 OUTLIER -64.42 -36.39 84.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.88 0.372 . . . . 0.0 111.825 -178.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -20.53 46.18 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.661 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 1.066 HG21 HG21 ' A' ' 239' ' ' VAL . 28.3 p -58.14 -172.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.638 0.256 . . . . 0.0 111.274 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -128.11 -149.81 0.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.389 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 165' ' ' LYS . 55.6 m-20 -45.03 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.26 121.16 45.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.929 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.066 HG21 HG21 ' A' ' 235' ' ' THR . 12.5 p -120.6 128.01 75.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.116 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 0.5 OUTLIER -101.62 120.41 40.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.363 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.862 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.9 mp -96.73 142.2 29.05 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' A' ' 213' ' ' LEU . 2.2 ttmt -106.5 121.35 44.11 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.365 0.602 . . . . 0.0 110.102 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 211' ' ' LYS . 54.0 t -120.28 150.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.474 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.83 126.17 51.21 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.824 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -93.42 117.74 67.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.964 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.66 67.95 8.44 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.179 1.919 . . . . 0.0 112.186 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.7 t 60.77 174.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -146.92 -70.84 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.042 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.293 -0.861 . . . . 0.0 111.031 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.921 0.391 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -132.24 -177.01 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -108.71 108.6 19.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.5 t -106.16 129.19 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 2.2 ptp -128.61 140.97 51.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -98.04 138.51 35.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.636 HG22 HD21 ' A' ' 163' ' ' LEU . 34.7 mm -124.97 119.52 56.11 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.114 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.731 ' C ' HD23 ' A' ' 163' ' ' LEU . 10.1 ttpp -110.23 133.63 53.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.81 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.913 HD12 HD22 ' A' ' 170' ' ' LEU . 0.8 OUTLIER -130.41 129.88 43.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.141 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.52 HG12 HG23 ' A' ' 238' ' ' VAL . 0.4 OUTLIER -97.41 122.97 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.192 0.52 . . . . 0.0 110.09 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.456 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -57.76 90.16 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.267 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.5 -172.59 43.44 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.97 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.06 -21.33 72.23 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.239 1.959 . . . . 0.0 112.334 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -102.25 -4.28 25.96 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.92 -147.47 18.1 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.458 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.913 HD22 HD12 ' A' ' 163' ' ' LEU . 16.0 mt -66.14 -38.06 87.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 111.338 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.6 35.49 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.528 ' HE1' HD13 ' A' ' 170' ' ' LEU . 6.8 p90 -173.43 -170.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.8 m -133.95 163.47 29.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.994 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.59 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -127.45 158.15 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.053 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.916 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.4 138.0 51.24 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.31 133.05 11.02 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.889 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.95 -20.41 55.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.847 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.402 ' HB ' ' N ' ' A' ' 224' ' ' MET . 12.2 t -89.36 117.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.69 4.83 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.919 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -108.52 54.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.509 0.671 . . . . 0.0 109.205 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.479 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.0 tt0 -46.45 118.87 2.13 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.753 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 35.2 t60 -103.0 -30.47 10.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.999 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 190' ' ' TYR . 10.3 mm -95.96 133.48 25.25 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -76.76 75.44 4.47 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.045 1.83 . . . . 0.0 112.961 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.19 20.13 3.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.687 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -141.48 126.81 18.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.383 0.592 . . . . 0.0 111.153 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -101.92 42.25 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.924 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.3 -164.79 1.33 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.324 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.916 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -105.28 133.49 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.558 . . . . 0.0 110.111 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.566 ' HB2' HD11 ' A' ' 183' ' ' ILE . 20.7 m-85 -134.87 153.68 51.95 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.999 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 194' ' ' ILE . 21.2 t -80.21 141.4 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.335 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 208' ' ' ILE . 1.6 t -122.69 -20.18 6.03 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.64 ' C ' HD13 ' A' ' 194' ' ' ILE . 12.1 tttp -157.58 136.14 11.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.046 0.451 . . . . 0.0 111.995 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.64 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.2 mm -120.24 135.15 61.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.149 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 25.8 mm -81.19 117.07 26.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -37.4 92.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.94 24.04 40.76 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.982 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.85 -67.85 1.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.28 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -147.56 -58.27 0.26 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.887 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -63.32 -47.08 83.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -59.42 -56.34 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.759 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -51.98 29.02 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.427 ' OD2' HG22 ' A' ' 164' ' ' ILE . 3.2 m-20 -73.42 -50.65 20.65 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -83.74 -32.12 25.09 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.461 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? 64.42 45.78 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.357 0.579 . . . . 0.0 110.202 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.578 HD23 HG21 ' A' ' 161' ' ' ILE . 4.2 pp -113.52 140.23 48.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.089 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.68 164.02 15.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.546 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 192' ' ' THR . 42.1 mt -57.67 139.9 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.9 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.94 -18.75 28.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.81 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.11 144.23 45.03 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.821 0.343 . . . . 0.0 111.035 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.756 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.3 ttpm? -104.97 129.46 53.39 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.285 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.58 HD13 ' CG2' ' A' ' 243' ' ' VAL . 22.1 mm -91.21 116.71 32.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 214' ' ' ALA . 1.7 pp -90.14 -8.43 51.3 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.55 155.18 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 0.0 110.523 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.738 HG13 ' HG ' ' A' ' 241' ' ' LEU . 23.3 t -131.13 119.39 44.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.159 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 59.72 -85.57 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 39.9 t -141.56 13.38 2.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.146 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.1 p -109.16 140.23 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -102.28 100.1 1.95 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.218 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.5 OUTLIER -109.21 45.75 1.03 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.503 0.668 . . . . 0.0 109.387 179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.84 27.11 5.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.422 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.5 p30 -158.94 29.82 0.21 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.338 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 227' ' ' ASP . 8.8 p -152.43 166.22 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.046 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.405 ' H ' HG22 ' A' ' 223' ' ' VAL . 17.1 mtt -58.52 168.09 1.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.738 0.78 . . . . 0.0 112.793 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.2 t60 -57.4 -35.52 70.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.2 -1.363 . . . . 0.0 110.58 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.38 -51.81 57.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.615 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.448 ' HB2' HG13 ' A' ' 223' ' ' VAL . 1.1 m-20 -59.91 -36.09 76.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.385 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.91 -38.87 92.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.81 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 225' ' ' HIS . 23.7 t -57.52 -41.32 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.55 74.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.53 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.818 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -66.16 -43.0 88.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.563 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.59 HD11 HG21 ' A' ' 174' ' ' ILE . 1.1 mt -73.4 -46.37 49.18 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.45 -34.16 70.53 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.176 0.513 . . . . 0.0 111.152 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -60.35 -20.76 60.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.356 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 1.009 HG21 HG21 ' A' ' 239' ' ' VAL . 17.8 p -69.42 -166.59 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -140.68 -148.98 0.26 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.779 -0.192 . . . . 0.0 110.504 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -43.74 -81.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.67 HG21 ' NZ ' ' A' ' 162' ' ' LYS . 0.4 OUTLIER -95.49 118.55 41.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.015 0.436 . . . . 0.0 110.742 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.009 HG21 HG21 ' A' ' 235' ' ' THR . 12.3 p -120.23 136.38 57.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.207 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.2 m-85 -106.74 119.33 39.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.151 0.5 . . . . 0.0 111.736 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.738 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.3 mp -103.06 134.81 45.88 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.26 133.87 51.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.027 0.441 . . . . 0.0 110.824 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 211' ' ' LYS . 69.2 t -130.81 148.5 33.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.482 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -114.7 124.47 51.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.326 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 111.22 51.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.212 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.6 101.52 1.2 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.272 1.982 . . . . 0.0 112.368 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.8 m -157.86 161.41 38.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -84.35 116.81 23.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.995 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.801 0.334 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -95.79 178.55 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -88.15 145.45 25.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.101 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.17 130.02 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.774 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -127.23 153.78 45.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.939 0.4 . . . . 0.0 111.419 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.4 131.38 54.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.716 HG21 ' CD2' ' A' ' 206' ' ' LEU . 30.5 mm -120.67 133.87 65.95 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.813 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.68 ' C ' HD23 ' A' ' 163' ' ' LEU . 27.2 ttpt -122.01 129.22 52.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.527 0.204 . . . . 0.0 111.331 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 200' ' ' ALA . 2.0 mt -127.32 141.17 51.77 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.563 0.22 . . . . 0.0 110.429 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.626 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -106.78 132.55 53.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.101 0.477 . . . . 0.0 110.592 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.626 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -73.39 82.59 1.42 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.817 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.2 -167.4 38.06 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.156 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.26 -20.4 66.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.185 1.923 . . . . 0.0 112.407 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -96.77 -2.13 44.91 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.1 -148.95 17.4 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.437 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.02 -37.37 76.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 111.006 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 100.32 19.29 19.05 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.212 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.507 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 1.5 p90 -170.6 -170.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.934 0.367 . . . . 0.0 110.803 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.75 161.84 34.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.018 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.802 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.58 159.53 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.864 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.53 137.69 50.92 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.431 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.02 129.9 9.75 Favored Glycine 0 CA--C 1.501 -0.783 0 C-N-CA 120.003 -1.094 . . . . 0.0 114.147 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.55 -22.6 59.9 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.402 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.3 t -89.85 116.51 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.14 -56.0 5.05 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.996 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -110.23 52.11 0.74 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.418 0.628 . . . . 0.0 109.322 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.436 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 6.7 tt0 -46.35 114.3 0.78 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.678 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 6.4 t60 -103.13 -25.41 13.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.1 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.446 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -95.34 132.21 28.23 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.204 -179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.26 79.97 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.147 1.898 . . . . 0.0 112.831 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 103.5 55.17 0.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.965 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -169.21 130.42 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.648 0.261 . . . . 0.0 110.937 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -105.12 28.78 6.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 2.8 t -111.32 -162.89 0.82 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.25 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.864 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.9 mm -106.36 133.21 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 121.283 0.564 . . . . 0.0 110.483 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.446 ' CG ' HG12 ' A' ' 183' ' ' ILE . 22.9 m-85 -135.14 154.59 51.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.708 HG21 HD13 ' A' ' 206' ' ' LEU . 42.7 t -80.14 141.21 15.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 121.043 -0.263 . . . . 0.0 110.656 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 3.0 t -121.91 -26.12 4.86 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 137.59 22.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.922 0.392 . . . . 0.0 111.641 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.567 ' CD1' HG11 ' A' ' 191' ' ' VAL . 1.2 mm -120.95 135.74 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.543 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.7 mm -81.01 114.16 21.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -39.8 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.819 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.54 31.25 57.22 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.059 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -79.06 -53.94 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -162.8 -57.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.9 0.381 . . . . 0.0 111.004 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.787 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -66.45 -45.57 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 194' ' ' ILE . 8.5 t-160 -60.03 -56.58 19.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.664 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.31 -52.1 25.27 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -73.67 -50.57 20.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 163' ' ' LEU . . . -77.79 -31.61 48.63 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.897 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 61.71 30.59 18.51 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.987 0.422 . . . . 0.0 110.354 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.716 ' CD2' HG21 ' A' ' 161' ' ' ILE . 3.3 pp -107.4 140.48 40.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.861 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -125.82 177.32 6.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.203 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.58 114.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 135.33 -17.67 4.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.907 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.67 149.34 32.85 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.901 0.351 . . . . 0.0 111.189 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.73 ' O ' HG13 ' A' ' 243' ' ' VAL . 3.1 ttmt -109.04 129.91 55.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.678 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.509 HD13 ' CG2' ' A' ' 243' ' ' VAL . 22.5 mm -94.35 119.09 41.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.651 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.795 HD21 ' CG ' ' A' ' 242' ' ' LYS . 1.3 pp -94.91 -9.23 34.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 174.15 152.2 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.906 HG13 ' HG ' ' A' ' 241' ' ' LEU . 4.3 t -122.99 119.34 57.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.967 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.641 ' HB2' HG23 ' A' ' 239' ' ' VAL . 26.6 t-20 57.98 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 94.2 p -140.54 14.02 2.35 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.596 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.5 p -109.41 139.73 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 120.949 0.404 . . . . 0.0 111.287 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -104.78 107.11 2.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.064 -0.589 . . . . 0.0 111.971 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 231' ' ' ALA . 0.5 OUTLIER -105.63 39.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.195 0.522 . . . . 0.0 110.607 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.26 168.77 10.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.46 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.0 p30 47.13 26.75 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.105 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.413 HG21 ' CB ' ' A' ' 227' ' ' ASP . 5.4 p -135.8 163.4 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.808 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 mtm -67.13 170.25 7.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.739 0.78 . . . . 0.0 111.903 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.829 ' O ' HG23 ' A' ' 229' ' ' VAL . 67.4 t60 -57.42 -36.05 70.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.253 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -62.3 -52.35 64.04 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.413 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.0 OUTLIER -60.49 -36.55 78.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.577 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 174' ' ' ILE . . . -61.53 -38.59 87.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.023 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.829 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.3 t -59.32 -41.78 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.619 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -61.58 -34.83 76.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.311 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.821 ' HB3' HD23 ' A' ' 220' ' ' LEU . . . -64.55 -40.8 96.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.607 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.802 HD11 HG21 ' A' ' 174' ' ' ILE . 9.4 mt -73.2 -41.74 63.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.277 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp -57.42 -41.05 79.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.178 0.513 . . . . 0.0 111.591 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -58.54 -19.97 42.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.91 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.897 HG21 HG21 ' A' ' 239' ' ' VAL . 18.4 p -67.39 -171.49 0.18 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.748 0.309 . . . . 0.0 111.439 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -143.89 -145.47 0.17 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.342 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 165' ' ' LYS . 1.9 m-20 -44.47 -83.42 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 118.004 0.365 . . . . 0.0 111.696 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.55 119.78 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.175 0.512 . . . . 0.0 111.057 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.897 HG21 HG21 ' A' ' 235' ' ' THR . 9.8 p -118.07 131.55 70.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.784 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 7.2 m-85 -102.18 118.11 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.265 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.906 ' HG ' HG13 ' A' ' 215' ' ' VAL . 4.1 mp -97.37 139.73 32.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.795 ' CG ' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -107.01 130.71 54.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.175 0.512 . . . . 0.0 110.348 -179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 211' ' ' LYS . 55.9 t -127.89 148.57 32.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.0 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.28 131.98 54.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.755 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -93.33 116.13 66.04 Favored Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 121.122 -0.231 . . . . 0.0 111.071 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.06 118.33 4.37 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.138 1.892 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 64.0 m -118.35 147.02 43.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.054 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.2 m120 67.59 -69.48 0.14 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.174 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.0 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.9 0.381 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -99.7 -165.37 1.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.45 119.78 40.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.797 0.332 . . . . 0.0 111.071 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.415 HG11 ' HD2' ' A' ' 242' ' ' LYS . 13.2 t -100.14 139.71 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.131 0.491 . . . . 0.0 111.175 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 1.6 ttt -125.73 152.7 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.297 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -112.62 120.6 42.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.854 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.731 HG22 ' CD2' ' A' ' 163' ' ' LEU . 41.2 mm -100.36 118.54 47.19 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.375 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.658 ' C ' HD23 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -102.53 132.4 48.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.739 HD21 ' CD1' ' A' ' 241' ' ' LEU . 0.0 OUTLIER -136.14 129.57 31.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.856 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.891 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -97.97 135.16 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 0.0 111.42 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.891 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -66.33 91.37 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.669 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.87 -165.61 32.92 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.368 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -20.54 50.53 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.197 1.931 . . . . 0.0 112.214 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -99.26 -4.49 31.8 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 88.42 -135.15 12.88 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.338 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.538 HD12 ' HE1' ' A' ' 172' ' ' PHE . 4.2 mm? -58.74 -37.86 77.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.807 0.337 . . . . 0.0 110.96 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 86.87 27.26 29.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.098 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.538 ' HE1' HD12 ' A' ' 170' ' ' LEU . 2.6 p90 -175.21 -172.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.03 0.443 . . . . 0.0 111.36 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.4 t -131.0 160.91 33.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.643 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.818 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -124.42 155.55 32.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.924 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -129.48 138.0 51.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -113.67 136.44 13.36 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.116 -1.04 . . . . 0.0 114.0 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -88.17 -21.07 46.96 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.886 -0.674 . . . . 0.0 113.535 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.1 t -90.12 116.83 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.43 -57.46 4.44 Favored Glycine 0 C--N 1.329 0.15 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.91 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -104.99 49.46 0.81 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.484 0.659 . . . . 0.0 109.323 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.458 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.9 tt0 -44.41 112.41 0.41 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.724 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 45.4 t60 -97.78 -30.94 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.782 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.453 HG13 ' CD1' ' A' ' 190' ' ' TYR . 18.3 mm -96.72 127.9 37.81 Favored Pre-proline 0 N--CA 1.455 -0.202 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.398 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.68 78.37 2.44 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.005 1.804 . . . . 0.0 112.876 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.26 10.97 3.56 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.484 -0.865 . . . . 0.0 114.049 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -134.75 136.72 42.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 117.572 0.686 . . . . 0.0 111.333 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.416 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 68.7 m-20 -108.74 30.68 6.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.296 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 190' ' ' TYR . 5.0 t -116.28 -164.25 0.96 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.577 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.1 mm -109.11 131.32 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 121.082 0.468 . . . . 0.0 110.541 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.453 ' CD1' HG13 ' A' ' 183' ' ' ILE . 3.1 m-85 -135.1 155.58 50.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.11 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.737 HG21 HD13 ' A' ' 206' ' ' LEU . 46.8 t -79.79 140.27 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.494 ' HA ' HG23 ' A' ' 208' ' ' ILE . 4.1 t -124.67 -14.74 6.72 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.49 133.59 12.43 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.062 0.458 . . . . 0.0 111.566 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.713 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.4 OUTLIER -121.09 134.45 64.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.019 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.0 118.37 29.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.086 0.47 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -41.99 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.485 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 56.69 28.68 57.09 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.868 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.09 -80.17 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.34 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -137.99 -62.1 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.905 0.383 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.67 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -62.14 -46.38 89.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.21 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.713 ' HB2' HG22 ' A' ' 194' ' ' ILE . 10.2 t-160 -62.25 -55.86 24.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.661 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -69.79 -52.62 23.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -74.47 -50.93 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.47 -29.32 36.65 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.719 -0.753 . . . . 0.0 114.337 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 64.69 32.11 11.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.392 0.596 . . . . 0.0 110.508 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.737 HD13 HG21 ' A' ' 191' ' ' VAL . 3.6 pp -102.88 140.45 37.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.752 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -123.67 175.65 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 111.08 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 192' ' ' THR . 39.7 mt -62.32 115.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.78 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 133.16 -17.9 4.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.97 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.53 154.78 40.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.034 0.417 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.713 ' O ' HG13 ' A' ' 243' ' ' VAL . 24.3 ttpt -112.6 129.91 56.21 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.42 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 220' ' ' LEU . 14.8 mm -102.03 116.03 44.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.748 HD21 ' HG2' ' A' ' 242' ' ' LYS . 0.5 OUTLIER -94.67 -12.96 26.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -178.94 148.03 0.38 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.872 0.368 . . . . 0.0 111.531 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.723 HG12 ' CG2' ' A' ' 239' ' ' VAL . 0.2 OUTLIER -117.0 119.53 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 33.1 t30 56.55 -87.8 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.4 m -135.98 11.0 3.35 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.657 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.63 140.82 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 122.549 0.339 . . . . 0.0 110.661 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.84 105.44 2.64 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.525 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 HG22 ' A' ' 212' ' ' ILE . 0.4 OUTLIER -98.76 30.11 3.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.113 0.483 . . . . 0.0 110.144 178.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -97.71 163.93 12.61 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.02 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 23.4 t70 45.04 27.77 0.32 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.653 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 224' ' ' MET . 6.3 p -133.12 165.81 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.438 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.431 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.07 165.39 18.15 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.607 0.718 . . . . 0.0 111.794 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.0 t60 -57.59 -35.82 70.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.676 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -65.37 -52.05 56.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -35.98 76.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 110.379 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.66 91.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.008 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.4 t -58.78 -42.18 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.718 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.25 79.33 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.356 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -63.56 -40.51 97.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.107 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.818 HD11 HG21 ' A' ' 174' ' ' ILE . 2.8 mt -74.03 -40.43 62.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.019 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -55.35 -46.31 76.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -60.75 -20.22 60.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.571 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.835 HG21 HG21 ' A' ' 239' ' ' VAL . 43.9 p -54.58 -173.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.73 0.3 . . . . 0.0 111.562 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.66 -151.8 0.4 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 165' ' ' LYS . 18.9 m-20 -45.35 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 117.861 0.3 . . . . 0.0 111.2 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.401 HG22 ' CG ' ' A' ' 162' ' ' LYS . 2.5 p -93.98 120.19 43.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.741 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.835 HG21 HG21 ' A' ' 235' ' ' THR . 9.5 p -115.07 119.32 61.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.085 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.88 119.5 38.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.915 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.739 ' CD1' HD21 ' A' ' 163' ' ' LEU . 1.3 mp -97.66 151.38 20.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.359 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.748 ' HG2' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -107.64 117.9 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.822 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 211' ' ' LYS . 58.4 t -120.47 152.23 23.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.75 120.92 36.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.84 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -93.7 122.02 63.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.004 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.28 130.46 7.18 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.157 1.904 . . . . 0.0 112.455 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.2 160.24 14.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.153 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.76 -74.94 0.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.866 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.182 179.873 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.983 0.421 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -71.51 -177.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.702 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.9 111.23 23.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.857 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 22.0 t -97.98 125.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.243 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 27.1 ptm -120.29 152.1 38.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.01 146.81 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.289 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 240' ' ' TYR . 31.1 mm -123.18 119.14 56.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.716 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.406 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 1.8 ttpt -107.81 119.45 39.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.228 0.537 . . . . 0.0 111.614 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.814 HD21 HD23 ' A' ' 170' ' ' LEU . 3.7 pp -137.17 138.7 40.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.439 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.512 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.2 OUTLIER -96.89 131.57 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.412 . . . . 0.0 110.981 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.512 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -51.39 90.79 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.159 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.6 171.98 5.28 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.671 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.06 -31.76 91.18 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.101 1.867 . . . . 0.0 112.399 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -102.23 15.67 28.45 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.54 -160.42 13.43 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.42 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -64.06 -27.2 68.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.52 0.2 . . . . 0.0 111.405 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 89.81 41.84 5.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.656 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -175.61 -173.88 0.65 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.978 0.418 . . . . 0.0 110.818 179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -134.26 156.11 48.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.258 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.795 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.94 160.86 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -130.57 139.36 50.44 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.218 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -110.83 132.27 10.85 Favored Glycine 0 CA--C 1.502 -0.751 0 C-N-CA 120.141 -1.028 . . . . 0.0 114.336 -178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.24 -24.05 49.24 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 114.927 -0.636 . . . . 0.0 113.227 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.0 117.06 32.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.67 -57.51 4.75 Favored Glycine 0 N--CA 1.454 -0.109 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.884 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.91 45.97 0.94 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.415 0.626 . . . . 0.0 109.46 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.455 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.4 OUTLIER -42.3 112.16 0.31 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -178.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 21.9 t60 -98.73 -30.11 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.616 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.577 HD11 ' CB ' ' A' ' 190' ' ' TYR . 8.9 mm -96.57 124.87 49.22 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.24 77.74 2.39 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.778 1.652 . . . . 0.0 112.469 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 127.15 14.56 2.69 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.526 -0.845 . . . . 0.0 114.043 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -139.14 131.16 27.9 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.621 0.71 . . . . 0.0 111.117 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -103.77 25.28 10.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.2 t -110.06 -164.61 0.94 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 175' ' ' ALA . 2.2 mm -101.75 134.3 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-O 121.205 0.526 . . . . 0.0 110.095 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.577 ' CB ' HD11 ' A' ' 183' ' ' ILE . 14.1 m-85 -133.37 148.81 51.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.524 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 206' ' ' LEU . 34.3 t -79.99 141.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.608 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 5.0 t -121.97 -26.67 4.74 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.479 ' C ' HD13 ' A' ' 194' ' ' ILE . 11.9 ttpt -147.63 136.57 22.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 111.822 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.754 HG22 ' HB2' ' A' ' 201' ' ' HIS . 0.8 OUTLIER -121.52 135.87 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.157 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.0 mm -80.61 114.0 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -39.75 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.718 -178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 57.24 25.23 53.95 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.881 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.24 -108.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.2 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -106.3 -62.37 1.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.824 0.345 . . . . 0.0 110.961 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 172' ' ' PHE . . . -66.64 -45.13 80.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.569 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.754 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.6 t-160 -59.08 -57.41 13.2 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.25 -53.16 18.13 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.67 -50.99 15.59 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.29 -31.99 53.21 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.813 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 62.15 28.42 17.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.913 0.357 . . . . 0.0 110.803 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.579 HD22 HD12 ' A' ' 241' ' ' LEU . 2.9 pp -99.41 139.13 35.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.279 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.96 177.34 5.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.202 0.525 . . . . 0.0 111.604 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 40.0 mt -64.43 126.82 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.732 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 119.43 -14.9 10.8 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.531 ' OD1' HG11 ' A' ' 243' ' ' VAL . 0.4 OUTLIER -78.93 145.79 33.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 117.057 0.429 . . . . 0.0 110.858 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.732 ' O ' HG13 ' A' ' 243' ' ' VAL . 13.2 ttmt -103.05 128.57 49.86 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.749 HD13 ' CG2' ' A' ' 243' ' ' VAL . 33.9 mm -99.98 120.49 49.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.011 0.434 . . . . 0.0 112.141 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.511 HD12 ' HG2' ' A' ' 242' ' ' LYS . 1.6 mt -85.46 -60.72 1.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.239 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -134.39 155.4 50.36 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.961 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.723 HG13 HD22 ' A' ' 241' ' ' LEU . 11.8 t -125.14 120.41 58.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.911 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 59.99 -85.21 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 68.4 m -142.86 13.45 1.89 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.829 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.0 p -109.77 140.43 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.021 0.439 . . . . 0.0 111.659 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.96 104.93 2.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.082 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.547 HD22 ' HB1' ' A' ' 228' ' ' ALA . 0.4 OUTLIER -99.16 37.18 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.146 0.498 . . . . 0.0 110.704 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -91.93 159.29 15.83 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.845 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 48.39 31.23 2.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.486 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.443 HG21 ' CB ' ' A' ' 227' ' ' ASP . 3.9 p -133.58 161.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.008 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 11.1 mtt -68.32 170.03 9.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.716 0.77 . . . . 0.0 112.117 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 229' ' ' VAL . 57.3 t60 -57.33 -36.88 71.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.31 -1.314 . . . . 0.0 111.306 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -64.65 -51.81 60.61 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.443 ' CB ' HG21 ' A' ' 223' ' ' VAL . 1.1 t0 -59.64 -36.43 76.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.893 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.547 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.976 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 225' ' ' HIS . 29.1 t -57.16 -41.81 78.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.0 -33.01 75.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.202 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.657 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -64.82 -40.28 94.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.604 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.795 HD11 HG21 ' A' ' 174' ' ' ILE . 6.0 mt -70.05 -48.74 56.65 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -58.41 -33.68 69.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.07 0.462 . . . . 0.0 111.404 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -59.33 -21.24 59.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.461 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 232' ' ' LEU . 25.2 p -63.51 -166.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.729 0.3 . . . . 0.0 111.088 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -146.85 -148.28 0.25 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -77.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 240' ' ' TYR . 0.5 OUTLIER -96.54 123.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 120.976 0.417 . . . . 0.0 110.46 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.574 ' CG1' HG21 ' A' ' 235' ' ' THR . 16.7 t -111.84 137.11 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.722 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.467 ' CE1' HG13 ' A' ' 238' ' ' VAL . 2.1 m-85 -115.61 118.74 33.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.671 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.723 HD22 HG13 ' A' ' 215' ' ' VAL . 0.4 OUTLIER -97.77 139.35 33.76 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.511 ' HG2' HD12 ' A' ' 213' ' ' LEU . 3.0 ttmt -106.92 130.04 54.65 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.749 ' CG2' HD13 ' A' ' 212' ' ' ILE . 60.9 t -136.97 149.6 26.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.043 0.449 . . . . 0.0 111.595 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.23 121.79 37.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.066 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -93.76 134.14 26.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.288 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.7 109.59 2.46 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.226 1.951 . . . . 0.0 112.326 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 45.1 m -60.94 150.75 32.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.988 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -164.86 114.09 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.073 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.814 0.34 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -126.16 176.65 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.027 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -80.25 105.2 11.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.86 137.23 26.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.576 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.09 147.56 52.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 111.592 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -115.55 120.69 40.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.2 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.987 HG22 HD21 ' A' ' 163' ' ' LEU . 31.9 mm -109.76 118.19 56.3 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.675 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.703 ' C ' HD23 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -103.91 129.06 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.987 HD21 HG22 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -126.33 132.32 51.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.11 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.06 124.51 49.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 110.353 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 87.77 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.27 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.07 179.01 53.55 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.125 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -56.6 -20.37 33.88 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.187 1.924 . . . . 0.0 112.394 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.91 8.18 41.24 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 101.97 -150.27 18.22 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.698 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.9 mm? -62.35 -37.99 87.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.73 0.3 . . . . 0.0 111.288 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 199' ' ' ALA . . . 100.9 33.39 5.0 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.005 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.2 OUTLIER -173.89 -166.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 111.093 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.0 t -137.4 161.54 36.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.794 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.33 158.51 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.434 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.883 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.13 137.65 53.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.494 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -109.43 130.14 9.82 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.113 -1.042 . . . . 0.0 113.783 -178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -83.83 -23.39 52.97 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.63 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 t -89.91 116.64 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.48 -56.27 4.69 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.995 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -105.79 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.345 0.593 . . . . 0.0 109.434 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.439 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 5.3 tt0 -43.61 112.92 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.678 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 5.8 t60 -104.3 -25.0 13.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.326 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.15 130.32 31.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.332 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.6 76.52 3.21 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.104 1.869 . . . . 0.0 112.779 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 114.62 48.41 0.55 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.05 123.95 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.946 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.65 25.33 5.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.295 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.3 t -109.61 -168.14 1.29 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.6 mm -99.51 136.88 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 121.197 0.522 . . . . 0.0 110.446 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 183' ' ' ILE . 20.6 m-85 -135.5 152.29 51.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.931 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.669 HG21 HD12 ' A' ' 206' ' ' LEU . 29.7 t -80.18 140.75 16.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.494 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.8 t -125.14 -24.02 4.09 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -150.56 136.55 18.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.104 0.478 . . . . 0.0 111.889 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.3 mm -121.12 135.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.182 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 29.0 mm -81.13 113.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -36.48 94.46 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 51.83 40.19 49.01 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.202 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.06 -60.74 1.55 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.365 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -149.96 -61.96 0.21 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.073 0.463 . . . . 0.0 110.751 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 1.023 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -65.24 -46.59 79.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.297 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.638 ' HB2' HG22 ' A' ' 194' ' ' ILE . 6.6 t-160 -61.42 -56.13 23.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.01 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -52.36 25.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -74.31 -50.74 17.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -79.41 -36.64 26.25 Favored Glycine 0 N--CA 1.454 -0.137 0 C-N-CA 121.086 -0.578 . . . . 0.0 114.167 -178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.2 39.38 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.05 0.453 . . . . 0.0 110.681 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 1.023 HD21 ' HB1' ' A' ' 200' ' ' ALA . 1.7 pt? -109.61 140.33 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.536 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -121.79 171.71 8.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 0.0 111.159 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 192' ' ' THR . 53.5 mt -62.49 120.63 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.782 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 132.64 -19.55 4.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.9 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.66 152.51 31.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.85 0.325 . . . . 0.0 110.826 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.765 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.3 OUTLIER -113.52 129.22 56.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.387 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.586 ' HA ' HG22 ' A' ' 243' ' ' VAL . 31.8 mm -90.08 119.24 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.842 0.353 . . . . 0.0 111.507 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -89.81 -26.42 20.57 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -171.89 149.21 2.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.271 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.76 HG13 ' HG ' ' A' ' 241' ' ' LEU . 2.5 t -117.42 119.0 60.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.83 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 239' ' ' VAL . 2.2 m-20 56.2 -85.82 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 215' ' ' VAL . 9.5 m -138.18 12.18 2.82 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.663 177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.3 p -109.63 140.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-O 120.922 0.391 . . . . 0.0 111.056 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.02 89.49 0.71 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.728 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.921 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -71.72 -7.66 49.41 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.817 0.341 . . . . 0.0 111.37 178.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.566 ' N ' HD12 ' A' ' 220' ' ' LEU . 3.8 pt-20 -62.29 168.72 3.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.194 0.521 . . . . 0.0 110.831 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 t0 47.52 25.5 0.65 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.921 HG12 ' O ' ' A' ' 220' ' ' LEU . 2.9 p -136.44 164.41 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.807 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -68.5 168.87 11.94 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.65 0.738 . . . . 0.0 111.576 -179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.6 t60 -57.96 -37.21 73.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.042 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -66.94 -52.88 37.54 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.512 ' HB3' HG21 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -62.04 -34.34 76.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.968 0.413 . . . . 0.0 109.888 179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.95 -38.77 89.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.778 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.0 t -59.41 -41.72 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.767 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.44 74.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.703 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 220' ' ' LEU . . . -66.29 -50.66 62.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.867 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 235' ' ' THR . 2.6 pp -74.57 -39.67 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.492 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -59.05 -39.62 82.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.113 0.482 . . . . 0.0 111.402 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -59.09 -20.34 52.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.741 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 1.012 HG21 HG21 ' A' ' 239' ' ' VAL . 34.6 p -57.75 -172.17 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.574 0.226 . . . . 0.0 111.323 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -133.88 -146.9 0.27 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.877 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -81.95 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 122.543 0.337 . . . . 0.0 111.792 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.27 122.34 55.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.012 HG21 HG21 ' A' ' 235' ' ' THR . 12.9 p -117.53 132.69 66.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.945 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 1.9 m-85 -105.4 119.45 39.13 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.922 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.76 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.0 mp -97.71 140.59 31.87 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.51 117.74 34.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.213 0.53 . . . . 0.0 110.215 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 211' ' ' LYS . 65.2 t -117.61 147.81 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.069 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.35 121.25 39.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.733 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 122.4 61.86 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.73 91.38 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.002 1.802 . . . . 0.0 112.192 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -174.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.158 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -164.51 86.19 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.675 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.135 -179.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.788 0.328 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -126.67 -170.6 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -116.58 105.02 11.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.997 0.427 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 243' ' ' VAL . 11.4 p -101.76 127.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.743 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.0 ptm -124.58 154.4 40.7 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.313 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -97.03 130.89 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.398 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.874 HG22 ' CD2' ' A' ' 163' ' ' LEU . 37.9 mm -100.52 117.09 45.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.696 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.458 ' C ' HD23 ' A' ' 163' ' ' LEU . 7.7 ttpt -98.66 125.12 43.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.108 0.48 . . . . 0.0 112.273 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.874 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -136.28 129.51 31.59 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.39 131.08 45.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.123 0.487 . . . . 0.0 111.292 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 69.31 0.17 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.945 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -74.52 -160.22 7.27 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.27 -20.13 49.44 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.132 1.888 . . . . 0.0 112.401 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -92.26 -4.63 53.77 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.36 -149.41 19.45 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.57 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.588 HD12 HD12 ' A' ' 163' ' ' LEU . 4.2 mm? -56.96 -37.87 72.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.907 0.384 . . . . 0.0 110.982 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 200' ' ' ALA . . . 92.2 26.41 18.73 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.972 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 4.1 p90 -174.97 -168.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 110.943 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 192' ' ' THR . 4.0 m -135.65 163.85 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.585 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.58 HG21 HD11 ' A' ' 232' ' ' LEU . 1.2 pp -129.17 161.17 39.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.16 0.505 . . . . 0.0 111.301 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.905 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -128.92 137.88 51.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.31 130.34 9.53 Favored Glycine 0 CA--C 1.503 -0.712 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.712 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -84.86 -18.23 61.83 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.558 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.96 117.76 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.38 -57.87 4.67 Favored Glycine 0 C--N 1.329 0.141 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.055 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -109.78 57.39 0.61 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.592 0.71 . . . . 0.0 109.301 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 3.2 tt0 -48.5 116.26 1.52 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.701 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 10.0 t60 -101.6 -27.02 13.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.913 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.414 HG12 ' CG ' ' A' ' 190' ' ' TYR . 1.0 OUTLIER -96.24 134.57 23.43 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.75 79.41 2.59 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.138 1.892 . . . . 0.0 113.101 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 108.52 50.95 0.73 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.732 -0.747 . . . . 0.0 113.242 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -168.9 131.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.663 0.268 . . . . 0.0 110.884 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.065 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.37 -169.1 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.373 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.905 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.5 mm -102.69 134.96 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 121.253 0.549 . . . . 0.0 110.112 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CG ' HG12 ' A' ' 183' ' ' ILE . 15.3 m-85 -133.84 155.35 50.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.626 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.605 HG11 ' CD1' ' A' ' 194' ' ' ILE . 40.3 t -80.28 141.44 15.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.329 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.556 ' C ' HD12 ' A' ' 208' ' ' ILE . 7.9 t -125.53 -21.55 4.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -153.42 136.13 15.27 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.059 0.457 . . . . 0.0 111.683 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.655 HG22 ' HB2' ' A' ' 201' ' ' HIS . 2.5 mm -120.87 135.91 59.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.69 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 31.5 mm -80.17 116.88 25.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 110.022 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -37.03 99.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.023 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.74 27.19 34.9 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.981 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.56 -115.53 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.42 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.412 ' HB3' ' HA3' ' A' ' 171' ' ' GLY . . . -98.58 -57.42 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.834 0.349 . . . . 0.0 111.075 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.934 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -67.31 -47.15 71.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.905 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.655 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.1 t-160 -59.52 -56.86 16.68 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.24 -52.74 20.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -74.0 -51.36 16.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.0 -38.19 36.19 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.728 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.28 41.21 4.49 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.292 0.568 . . . . 0.0 110.198 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.934 HD21 ' HB1' ' A' ' 200' ' ' ALA . 0.8 OUTLIER -111.28 140.23 46.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.999 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -118.77 179.53 4.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.763 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 192' ' ' THR . 7.4 mm -72.41 113.89 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.058 0.456 . . . . 0.0 111.556 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.2 -13.57 3.54 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.662 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -78.93 159.3 27.78 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 117.038 0.419 . . . . 0.0 110.982 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.733 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -120.76 130.12 53.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.688 179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.657 HD13 ' CG2' ' A' ' 243' ' ' VAL . 32.7 mm -93.17 117.6 36.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.666 HD21 ' CG ' ' A' ' 242' ' ' LYS . 0.7 OUTLIER -95.33 -4.97 44.5 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 213' ' ' LEU . . . 166.63 153.27 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.755 0.312 . . . . 0.0 110.347 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 218' ' ' VAL . 42.7 t -132.23 119.63 40.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.263 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.467 ' ND2' HG23 ' A' ' 239' ' ' VAL . 24.3 m-20 59.94 -84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.44 13.02 1.96 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.07 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 215' ' ' VAL . 7.9 p -109.31 139.84 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 120.943 0.401 . . . . 0.0 111.529 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -101.14 101.9 2.33 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.387 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.98 HD22 ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -109.17 45.66 1.04 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.478 0.656 . . . . 0.0 109.65 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 26.78 4.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.164 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -158.12 32.19 0.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.952 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 227' ' ' ASP . 7.0 p -153.4 166.1 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.093 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.443 ' N ' HG22 ' A' ' 223' ' ' VAL . 3.9 mtm -62.13 168.43 3.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.632 0.729 . . . . 0.0 112.076 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.87 ' O ' HG23 ' A' ' 229' ' ' VAL . 54.5 t60 -56.93 -36.18 69.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.031 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -65.15 -52.89 52.38 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.489 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -62.36 -34.98 77.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.166 0.508 . . . . 0.0 109.929 179.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 231' ' ' ALA . . . -60.67 -38.39 84.76 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.664 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.2 t -59.52 -41.64 85.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.89 -33.22 72.78 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.058 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.98 ' HB1' HD22 ' A' ' 220' ' ' LEU . . . -64.3 -41.15 96.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.896 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 229' ' ' VAL . 1.7 mt -73.99 -41.9 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.102 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -61.77 -39.57 92.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.149 0.499 . . . . 0.0 111.237 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -60.67 -19.61 58.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.866 HG21 HG21 ' A' ' 239' ' ' VAL . 30.2 p -57.73 -166.05 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.761 -0.2 . . . . 0.0 110.928 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -152.93 -160.74 1.17 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.233 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -28.82 -61.6 0.12 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.21 126.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 235' ' ' THR . 4.2 p -120.65 126.11 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 121.32 44.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.763 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 215' ' ' VAL . 0.3 OUTLIER -97.24 146.57 24.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.067 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.666 ' CG ' HD21 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -108.39 118.02 35.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.022 0.439 . . . . 0.0 109.936 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 211' ' ' LYS . 58.4 t -127.56 148.77 32.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.983 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -121.2 121.46 37.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.86 122.32 60.68 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.031 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.69 93.27 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.131 1.888 . . . . 0.0 112.195 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.79 -169.66 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 60.8 32.09 20.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.11 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.763 0.316 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -177.44 3.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.986 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.4 96.05 3.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.0 t -101.34 134.62 41.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.73 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.461 ' O ' HG12 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -132.12 154.55 49.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.998 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.83 149.5 25.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 0.0 111.794 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.943 HG21 HD23 ' A' ' 206' ' ' LEU . 34.5 mm -113.66 118.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.611 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.761 ' O ' HD23 ' A' ' 163' ' ' LEU . 0.1 OUTLIER -94.54 131.23 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.689 0.281 . . . . 0.0 111.331 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.795 HD11 HD11 ' A' ' 241' ' ' LEU . 11.5 mt -131.71 128.79 39.68 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.829 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -98.25 128.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.13 0.49 . . . . 0.0 110.145 179.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.647 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -63.15 91.94 0.05 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.008 -179.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.14 -171.04 37.37 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.892 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.84 -24.8 74.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.211 1.94 . . . . 0.0 112.535 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -4.18 26.1 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.48 -144.27 18.37 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.292 -0.956 . . . . 0.0 112.366 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.729 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 18.3 mt -67.14 -37.83 84.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.271 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 97.94 34.26 5.49 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.622 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 7.3 p90 -175.07 -168.74 0.35 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 111.013 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.407 ' HB3' HG23 ' A' ' 192' ' ' THR . 22.7 t -136.33 161.02 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.836 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -121.52 161.48 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.997 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.884 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -131.1 138.7 49.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 225' ' ' HIS . . . -112.6 130.67 9.67 Favored Glycine 0 CA--C 1.504 -0.627 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.598 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.58 -25.08 54.88 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.637 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.53 120.31 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.14 -55.91 5.02 Favored Glycine 0 C--N 1.331 0.27 0 CA-C-N 116.231 -0.441 . . . . 0.0 113.004 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -114.93 54.14 0.79 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.497 0.665 . . . . 0.0 109.397 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.443 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -45.54 107.33 0.1 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.648 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 15.0 t60 -93.74 -26.78 16.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.011 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.435 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.7 OUTLIER -96.46 121.85 59.0 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.034 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -68.72 71.01 1.07 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.999 1.799 . . . . 0.0 112.532 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 123.66 51.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.712 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -173.89 129.89 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.798 0.332 . . . . 0.0 111.038 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.3 30.89 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.4 t -114.52 -165.73 1.04 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.406 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.884 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.8 mm -103.22 135.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.281 0.562 . . . . 0.0 110.614 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.435 ' CG ' HG12 ' A' ' 183' ' ' ILE . 20.6 m-85 -135.87 153.72 51.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.736 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.627 HG11 HD11 ' A' ' 194' ' ' ILE . 46.5 t -80.76 142.11 14.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 173' ' ' SER . 1.9 t -122.7 -20.73 5.84 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.556 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -158.59 136.95 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.997 -179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.642 HD12 ' CD1' ' A' ' 206' ' ' LEU . 2.8 mm -120.57 135.65 60.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.995 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 33.6 mm -80.45 116.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -37.82 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 55.9 24.22 41.08 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.216 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -69.48 -114.96 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.121 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 170' ' ' LEU . . . -109.94 -48.11 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.721 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.771 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.13 -47.07 72.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.409 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.0 t-160 -59.55 -56.08 26.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.752 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -69.77 -52.0 29.13 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.85 -51.15 17.19 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -82.62 -34.77 21.52 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 120.733 -0.746 . . . . 0.0 114.217 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 66.02 26.67 10.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.188 0.494 . . . . 0.0 110.552 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 161' ' ' ILE . 3.9 pp -96.05 140.86 30.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.866 0.365 . . . . 0.0 110.866 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -122.04 170.15 10.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.599 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 34.6 mt -58.22 113.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.51 -19.61 3.18 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.723 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.14 129.88 39.03 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.824 0.312 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.885 ' O ' HG23 ' A' ' 243' ' ' VAL . 0.5 OUTLIER -96.48 129.11 43.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.627 179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 189' ' ' ILE . 16.2 mm -103.13 137.23 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.802 0.334 . . . . 0.0 111.667 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.687 HD11 ' HG2' ' A' ' 242' ' ' LYS . 1.4 pp -115.53 -12.59 11.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.034 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -175.9 152.45 1.23 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 110.657 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.721 ' O ' HG12 ' A' ' 218' ' ' VAL . 38.4 t -130.43 119.09 45.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.548 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 58.43 -85.04 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.99 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 12.95 2.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.674 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 215' ' ' VAL . 10.4 p -109.29 140.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 120.827 0.346 . . . . 0.0 110.669 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.58 100.55 1.9 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.049 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.598 HD21 HG21 ' A' ' 215' ' ' VAL . 0.5 OUTLIER -99.25 34.73 2.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.383 0.611 . . . . 0.0 109.864 178.235 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -103.35 163.68 12.12 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 46.38 26.7 0.51 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.665 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 224' ' ' MET . 5.2 p -134.21 165.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.425 ' H ' HG22 ' A' ' 223' ' ' VAL . 2.9 mtt -69.51 168.34 14.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.718 0.77 . . . . 0.0 112.026 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.859 ' O ' HG23 ' A' ' 229' ' ' VAL . 64.2 t60 -58.11 -36.31 72.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.017 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.6 -51.72 57.52 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -35.57 74.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.473 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.23 -39.14 92.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.403 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.2 t -58.09 -41.83 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.97 74.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.222 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.467 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -67.31 -41.4 85.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.234 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 174' ' ' ILE . 4.3 mt -73.44 -45.18 55.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -34.62 71.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.816 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -64.47 -20.35 66.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.63 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.956 HG21 HG21 ' A' ' 239' ' ' VAL . 26.2 p -62.25 -165.2 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -140.76 -150.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 165' ' ' LYS . 7.1 m-20 -45.08 -81.18 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.286 0.234 . . . . 0.0 111.609 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.8 118.48 42.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.168 0.509 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.956 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -120.82 127.31 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.199 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.34 123.79 46.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.991 0.424 . . . . 0.0 110.777 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.795 HD11 HD11 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -97.07 149.32 22.08 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.687 ' HG2' HD11 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -107.64 116.23 31.58 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 211' ' ' LYS . 7.2 p -124.06 140.36 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.881 -177.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -119.55 121.73 40.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.167 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.32 115.91 65.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.293 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.87 66.54 8.79 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.191 1.927 . . . . 0.0 112.094 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.98 34.18 11.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.985 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.3 t30 60.0 85.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.077 -179.936 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.875 0.369 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -148.52 156.29 42.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.31 113.58 23.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.811 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 15.8 t -107.88 122.88 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.25 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.84 149.27 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.43 142.85 28.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.306 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.711 HD13 ' HB3' ' A' ' 206' ' ' LEU . 2.7 mt -118.03 119.62 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.783 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.539 ' CG ' HG22 ' A' ' 238' ' ' VAL . 14.9 ttpt -100.84 130.75 46.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.002 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.985 HD11 HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -132.09 132.04 42.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.816 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.784 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -97.2 135.09 32.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.242 0.544 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.784 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -70.11 96.01 1.03 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.085 -179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.8 -158.25 27.58 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.959 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.86 -20.72 68.76 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.097 1.865 . . . . 0.0 112.422 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -101.27 -2.49 31.0 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.4 -135.77 14.25 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.126 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 4.4 mm? -58.21 -33.25 69.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 111.046 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 79.03 32.99 37.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.699 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 11.6 p90 -175.42 -174.77 0.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.778 0.323 . . . . 0.0 110.756 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.4 m -129.85 160.29 33.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.018 0.437 . . . . 0.0 111.545 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.753 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -122.91 157.09 28.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.9 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -127.99 137.53 52.26 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -111.45 130.92 9.99 Favored Glycine 0 CA--C 1.503 -0.657 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.753 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -81.62 -23.74 57.55 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.587 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 15.1 t -90.06 117.92 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.96 -56.04 5.03 Favored Glycine 0 C--N 1.329 0.18 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.918 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -112.42 53.29 0.74 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.439 0.638 . . . . 0.0 109.414 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 2.5 tt0 -45.87 113.24 0.58 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.682 0.994 . . . . 0.0 113.682 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.684 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 9.4 t60 -102.66 -26.04 13.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.277 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.434 HG12 ' CG ' ' A' ' 190' ' ' TYR . 0.9 OUTLIER -95.99 132.99 25.9 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.275 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.88 76.34 4.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.103 1.869 . . . . 0.0 113.007 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 115.59 47.2 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.083 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -169.64 130.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 0.0 110.948 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.4 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 1.3 m120 -102.47 28.13 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.28 -162.46 0.8 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.751 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.9 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.4 mm -106.38 136.04 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 121.197 0.522 . . . . 0.0 110.55 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.434 ' CG ' HG12 ' A' ' 183' ' ' ILE . 21.8 m-85 -135.77 150.3 49.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.388 179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 194' ' ' ILE . 26.9 t -80.73 138.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.703 ' HA ' HG23 ' A' ' 208' ' ' ILE . 1.6 t -123.23 -18.48 6.28 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -152.16 133.53 14.49 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.782 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 201' ' ' HIS . 1.6 mm -120.93 135.6 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.151 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 30.6 mm -81.02 113.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 109.866 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -37.19 102.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 52.28 23.6 13.32 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.57 -0.741 . . . . 0.0 113.262 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -73.0 -107.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.411 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -104.44 -58.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 111.123 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 206' ' ' LEU . . . -67.23 -47.99 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.035 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.8 t-160 -58.46 -56.11 26.3 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -52.32 27.69 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -74.44 -51.38 15.05 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 163' ' ' LEU . . . -85.52 -35.78 11.45 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.686 -0.768 . . . . 0.0 114.402 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.97 62.17 0.74 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.401 0.62 . . . . 0.0 110.578 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 200' ' ' ALA . 0.3 OUTLIER -122.5 132.88 54.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.92 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -112.14 165.72 11.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.972 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.703 HG23 ' HA ' ' A' ' 192' ' ' THR . 37.9 mt -64.06 111.54 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.888 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 140.76 -14.07 2.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.204 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.24 153.01 28.79 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.107 0.453 . . . . 0.0 110.853 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.742 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -114.32 129.36 56.64 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.675 ' HA ' HG22 ' A' ' 243' ' ' VAL . 43.1 mm -90.5 122.93 42.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.566 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.785 ' O ' HD12 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -90.46 -27.09 19.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.171 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . 177.09 150.21 0.16 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.738 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.843 HG22 HD23 ' A' ' 241' ' ' LEU . 2.2 t -116.19 118.92 60.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.017 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 56.42 -86.17 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.28 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.6 m -136.39 11.06 3.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.072 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.689 HG12 ' O ' ' A' ' 215' ' ' VAL . 8.1 p -109.23 140.39 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 120.814 0.34 . . . . 0.0 110.755 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -108.64 88.53 0.53 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.056 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.875 ' O ' HG12 ' A' ' 223' ' ' VAL . 0.3 OUTLIER -68.07 -13.81 62.49 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.85 0.357 . . . . 0.0 110.893 178.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.638 ' N ' HD12 ' A' ' 220' ' ' LEU . 1.5 pt-20 -63.24 169.59 3.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.19 0.519 . . . . 0.0 110.72 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.39 24.42 1.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.795 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.875 HG12 ' O ' ' A' ' 220' ' ' LEU . 4.2 p -144.86 156.09 14.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.736 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.92 167.5 0.79 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.93 0.872 . . . . 0.0 112.592 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 229' ' ' VAL . 62.0 t60 -57.66 -35.01 69.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.099 -1.41 . . . . 0.0 110.685 178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.3 -52.05 51.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.052 0.454 . . . . 0.0 111.996 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.495 ' HB2' HG22 ' A' ' 223' ' ' VAL . 8.6 m-20 -61.27 -35.42 77.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.177 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.49 90.5 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.775 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 225' ' ' HIS . 21.6 t -59.04 -41.3 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.12 75.72 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.1 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 218' ' ' VAL . . . -63.45 -39.74 95.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.32 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.753 HD11 HG21 ' A' ' 174' ' ' ILE . 9.0 mt -73.16 -44.24 60.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.166 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -37.0 70.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 111.575 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -63.0 -20.3 65.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.909 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.893 HG21 HG21 ' A' ' 239' ' ' VAL . 22.8 p -65.43 -175.67 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.754 0.312 . . . . 0.0 111.323 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.53 -150.03 0.35 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.227 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 165' ' ' LYS . 2.1 m-20 -44.31 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.712 0.233 . . . . 0.0 111.288 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.539 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.5 OUTLIER -94.11 122.54 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.676 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.893 HG21 HG21 ' A' ' 235' ' ' THR . 10.6 p -118.83 135.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.242 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -102.63 135.33 44.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.985 HD11 HD11 ' A' ' 163' ' ' LEU . 3.6 mt -113.46 135.34 53.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.467 ' HG2' HD23 ' A' ' 213' ' ' LEU . 2.6 ttpp -106.66 117.5 34.21 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.174 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 211' ' ' LYS . 75.1 t -129.48 148.79 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.146 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -122.95 121.12 35.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.963 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.98 133.37 27.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.165 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.08 113.92 1.63 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.967 1.778 . . . . 0.0 111.917 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.43 155.11 36.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.243 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -157.92 -59.96 0.08 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.807 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.062 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -143.66 151.92 40.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.85 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -95.44 121.86 37.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.027 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.568 HG11 ' HE2' ' A' ' 242' ' ' LYS . 16.2 t -115.56 135.1 56.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.27 142.46 49.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 111.459 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -93.39 140.01 30.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.63 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.76 HG21 HD23 ' A' ' 206' ' ' LEU . 48.6 mm -123.9 119.21 56.32 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.83 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.798 ' O ' HD23 ' A' ' 163' ' ' LEU . 19.1 ttpt -105.57 132.31 51.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.373 . . . . 0.0 111.606 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.875 HD22 ' HA ' ' A' ' 200' ' ' ALA . 2.3 mt -131.61 129.77 41.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.062 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.751 HD13 ' N ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -98.17 134.54 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.161 0.505 . . . . 0.0 110.973 -179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.751 ' N ' HD13 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -74.79 106.31 6.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.912 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -118.14 -147.13 8.28 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.217 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.38 -23.06 38.5 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.064 1.842 . . . . 0.0 112.055 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -102.14 -4.73 25.39 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.62 -135.32 13.67 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.109 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.587 HD12 HD12 ' A' ' 163' ' ' LEU . 4.5 mm? -58.49 -37.11 74.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.772 0.32 . . . . 0.0 111.115 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.556 ' C ' HD13 ' A' ' 195' ' ' ILE . . . 83.48 39.35 9.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.651 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 200' ' ' ALA . 0.1 OUTLIER -176.25 -173.16 0.53 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.97 0.414 . . . . 0.0 110.704 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.1 m -133.13 160.39 37.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.313 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 232' ' ' LEU . 1.1 pp -125.84 162.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.196 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.825 ' O ' HD13 ' A' ' 189' ' ' ILE . . . -130.93 138.48 49.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.074 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 225' ' ' HIS . . . -108.83 129.38 9.5 Favored Glycine 0 CA--C 1.504 -0.623 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.431 -178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 181' ' ' GLN . . . -85.67 -20.6 55.88 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.255 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 187' ' ' ASN . 17.6 t -89.83 116.99 32.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.27 -58.5 4.03 Favored Glycine 0 C--N 1.329 0.164 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.944 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -102.97 48.55 0.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.472 0.654 . . . . 0.0 109.429 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.448 ' HA ' ' HA2' ' A' ' 177' ' ' GLY . 0.9 OUTLIER -44.51 113.5 0.55 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -178.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CG ' ' HB1' ' A' ' 175' ' ' ALA . 18.9 t60 -98.44 -31.31 12.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.743 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.439 HG13 ' CG ' ' A' ' 190' ' ' TYR . 9.8 mm -96.4 123.91 52.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.198 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.49 78.67 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.982 1.788 . . . . 0.0 112.566 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 130.88 5.73 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.013 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -132.88 144.85 50.46 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.669 0.735 . . . . 0.0 111.35 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . 0.416 ' HA ' ' HA3' ' A' ' 177' ' ' GLY . 4.1 m120 -104.85 -28.05 11.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.766 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.5 t -62.98 -163.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.222 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 175' ' ' ALA . 1.5 mm -101.13 141.35 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 121.25 0.548 . . . . 0.0 110.819 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.439 ' CG ' HG13 ' A' ' 183' ' ' ILE . 17.6 m-85 -135.58 155.05 51.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.839 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 194' ' ' ILE . 36.7 t -85.16 142.41 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 121.091 -0.243 . . . . 0.0 110.451 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 208' ' ' ILE . 1.4 t -123.74 -24.26 4.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.617 ' C ' HD13 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -157.15 138.25 13.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.09 0.472 . . . . 0.0 112.01 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.617 HD13 ' C ' ' A' ' 193' ' ' LYS . 1.6 mm -121.35 135.78 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.483 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.556 HD13 ' C ' ' A' ' 171' ' ' GLY . 3.5 mp -80.73 115.6 23.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -38.26 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 53.97 29.37 43.04 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.167 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -72.99 -64.73 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.182 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -149.21 -57.74 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.388 . . . . 0.0 110.689 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.875 ' HA ' HD22 ' A' ' 163' ' ' LEU . . . -67.44 -44.55 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.811 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 194' ' ' ILE . 3.5 t-160 -59.63 -55.89 28.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.678 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -51.54 30.29 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.84 -49.47 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -84.64 -35.24 14.0 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.789 -0.72 . . . . 0.0 114.398 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.71 51.66 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.375 0.607 . . . . 0.0 109.962 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.76 HD23 HG21 ' A' ' 161' ' ' ILE . 4.1 pp -120.81 140.44 51.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.224 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -117.71 174.97 5.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.019 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.461 HD13 ' O ' ' A' ' 192' ' ' THR . 35.9 mt -67.6 126.81 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.827 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 127.03 -19.39 6.09 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.622 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -77.03 149.44 35.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.792 ' O ' HG13 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -110.83 128.21 55.69 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.896 0.379 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.859 HD13 ' CG2' ' A' ' 243' ' ' VAL . 26.8 mm -92.79 124.71 45.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.884 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.466 HD21 ' HD2' ' A' ' 211' ' ' LYS . 3.3 mt -85.48 -67.26 0.82 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.263 0.554 . . . . 0.0 110.151 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.03 155.11 50.72 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.703 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.859 HG13 ' HG ' ' A' ' 241' ' ' LEU . 26.0 t -124.3 120.11 58.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.61 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 29.7 t30 59.31 -86.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.9 t -141.26 14.44 2.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.665 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 215' ' ' VAL . 9.1 p -109.75 140.64 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.882 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -103.89 97.33 1.42 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.051 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.644 HD21 HG21 ' A' ' 215' ' ' VAL . 0.4 OUTLIER -101.84 43.79 1.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -120.12 30.07 7.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.732 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -168.65 33.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 227' ' ' ASP . 9.6 p -152.41 165.29 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.431 ' N ' HG22 ' A' ' 223' ' ' VAL . 1.1 mpt? -63.51 172.68 1.93 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.727 0.775 . . . . 0.0 112.173 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 229' ' ' VAL . 66.7 t60 -57.44 -37.62 73.12 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.583 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.54 -53.14 46.36 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . 0.529 ' CB ' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -63.12 -34.21 77.13 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.54 ' CB ' HD11 ' A' ' 189' ' ' ILE . . . -60.78 -38.21 84.51 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.646 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 225' ' ' HIS . 22.8 t -60.08 -41.39 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.142 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -62.91 -32.81 74.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.875 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 218' ' ' VAL . . . -65.33 -42.08 93.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.315 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 229' ' ' VAL . 0.7 OUTLIER -73.69 -48.07 34.85 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.446 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -38.48 69.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.027 0.442 . . . . 0.0 111.979 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.53 -20.7 57.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.715 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . 0.999 HG21 HG21 ' A' ' 239' ' ' VAL . 30.6 p -60.82 -169.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.687 0.279 . . . . 0.0 111.269 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -134.71 -152.01 0.45 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.426 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 165' ' ' LYS . 0.4 OUTLIER -44.34 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.549 0.214 . . . . 0.0 111.439 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.423 HG22 ' CG ' ' A' ' 162' ' ' LYS . 0.3 OUTLIER -97.05 121.81 47.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.944 0.402 . . . . 0.0 110.711 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.999 HG21 HG21 ' A' ' 235' ' ' THR . 12.5 p -120.16 132.95 68.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.055 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 161' ' ' ILE . 2.6 m-85 -105.21 119.58 39.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.329 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.859 ' HG ' HG13 ' A' ' 215' ' ' VAL . 3.0 mp -101.55 138.19 38.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.568 ' HE2' HG11 ' A' ' 158' ' ' VAL . 0.0 OUTLIER -107.06 129.22 54.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.986 0.422 . . . . 0.0 110.046 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.859 ' CG2' HD13 ' A' ' 212' ' ' ILE . 53.6 t -130.82 148.32 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.691 -178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -125.7 131.09 52.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.768 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -93.61 109.86 43.56 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.082 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.39 111.09 0.58 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.049 1.833 . . . . 0.0 112.249 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 73.2 m -92.14 66.09 4.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.065 0.46 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.46 35.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.016 -179.996 . . . . . . . . 0 0 . 1 stop_ save_